Motif 722 (n=262)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A6NMY6 | ANXA2P2 | Y109 | ochoa | Putative annexin A2-like protein (Annexin A2 pseudogene 2) (Lipocortin II pseudogene) | Calcium-regulated membrane-binding protein whose affinity for calcium is greatly enhanced by anionic phospholipids. It binds two calcium ions with high affinity. May be involved in heat-stress response. {ECO:0000250}. |
O00159 | MYO1C | S736 | ochoa | Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb) | Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails are presumed to bind to membranous compartments, which would be moved relative to actin filaments. Involved in glucose transporter recycling in response to insulin by regulating movement of intracellular GLUT4-containing vesicles to the plasma membrane. Component of the hair cell's (the sensory cells of the inner ear) adaptation-motor complex. Acts as a mediator of adaptation of mechanoelectrical transduction in stereocilia of vestibular hair cells. Binds phosphoinositides and links the actin cytoskeleton to cellular membranes. {ECO:0000269|PubMed:24636949}.; FUNCTION: [Isoform 3]: Involved in regulation of transcription. Associated with transcriptional active ribosomal genes. Appears to cooperate with the WICH chromatin-remodeling complex to facilitate transcription. Necessary for the formation of the first phosphodiester bond during transcription initiation. {ECO:0000250|UniProtKB:Q9WTI7}. |
O00429 | DNM1L | S607 | ochoa | Dynamin-1-like protein (EC 3.6.5.5) (Dnm1p/Vps1p-like protein) (DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less) (Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV) (HdynIV) (Dynamin-related protein 1) | Functions in mitochondrial and peroxisomal division (PubMed:11514614, PubMed:12499366, PubMed:17301055, PubMed:17460227, PubMed:17553808, PubMed:18695047, PubMed:18838687, PubMed:19342591, PubMed:19411255, PubMed:19638400, PubMed:23283981, PubMed:23530241, PubMed:23921378, PubMed:26992161, PubMed:27145208, PubMed:27145933, PubMed:27301544, PubMed:27328748, PubMed:29478834, PubMed:32439975, PubMed:32484300, PubMed:9570752, PubMed:9786947). Mediates membrane fission through oligomerization into membrane-associated tubular structures that wrap around the scission site to constrict and sever the mitochondrial membrane through a GTP hydrolysis-dependent mechanism (PubMed:23530241, PubMed:23584531, PubMed:33850055). The specific recruitment at scission sites is mediated by membrane receptors like MFF, MIEF1 and MIEF2 for mitochondrial membranes (PubMed:23283981, PubMed:23921378, PubMed:29899447). While the recruitment by the membrane receptors is GTP-dependent, the following hydrolysis of GTP induces the dissociation from the receptors and allows DNM1L filaments to curl into closed rings that are probably sufficient to sever a double membrane (PubMed:29899447). Acts downstream of PINK1 to promote mitochondrial fission in a PRKN-dependent manner (PubMed:32484300). Plays an important role in mitochondrial fission during mitosis (PubMed:19411255, PubMed:26992161, PubMed:27301544, PubMed:27328748). Through its function in mitochondrial division, ensures the survival of at least some types of postmitotic neurons, including Purkinje cells, by suppressing oxidative damage (By similarity). Required for normal brain development, including that of cerebellum (PubMed:17460227, PubMed:26992161, PubMed:27145208, PubMed:27301544, PubMed:27328748). Facilitates developmentally regulated apoptosis during neural tube formation (By similarity). Required for a normal rate of cytochrome c release and caspase activation during apoptosis; this requirement may depend upon the cell type and the physiological apoptotic cues (By similarity). Required for formation of endocytic vesicles (PubMed:20688057, PubMed:23792689, PubMed:9570752). Proposed to regulate synaptic vesicle membrane dynamics through association with BCL2L1 isoform Bcl-X(L) which stimulates its GTPase activity in synaptic vesicles; the function may require its recruitment by MFF to clathrin-containing vesicles (PubMed:17015472, PubMed:23792689). Required for programmed necrosis execution (PubMed:22265414). Rhythmic control of its activity following phosphorylation at Ser-637 is essential for the circadian control of mitochondrial ATP production (PubMed:29478834). {ECO:0000250|UniProtKB:Q8K1M6, ECO:0000269|PubMed:11514614, ECO:0000269|PubMed:12499366, ECO:0000269|PubMed:17015472, ECO:0000269|PubMed:17301055, ECO:0000269|PubMed:17460227, ECO:0000269|PubMed:17553808, ECO:0000269|PubMed:18695047, ECO:0000269|PubMed:18838687, ECO:0000269|PubMed:19342591, ECO:0000269|PubMed:19411255, ECO:0000269|PubMed:19638400, ECO:0000269|PubMed:20688057, ECO:0000269|PubMed:22265414, ECO:0000269|PubMed:23283981, ECO:0000269|PubMed:23530241, ECO:0000269|PubMed:23584531, ECO:0000269|PubMed:23792689, ECO:0000269|PubMed:23921378, ECO:0000269|PubMed:26992161, ECO:0000269|PubMed:27145208, ECO:0000269|PubMed:27145933, ECO:0000269|PubMed:27301544, ECO:0000269|PubMed:27328748, ECO:0000269|PubMed:29478834, ECO:0000269|PubMed:29899447, ECO:0000269|PubMed:32439975, ECO:0000269|PubMed:32484300, ECO:0000269|PubMed:33850055, ECO:0000269|PubMed:9570752, ECO:0000269|PubMed:9786947}.; FUNCTION: [Isoform 1]: Inhibits peroxisomal division when overexpressed. {ECO:0000269|PubMed:12618434}.; FUNCTION: [Isoform 4]: Inhibits peroxisomal division when overexpressed. {ECO:0000269|PubMed:12618434}. |
O00488 | ZNF593 | S98 | ochoa | Zinc finger protein 593 (Zinc finger protein T86) | Involved in pre-60S ribosomal particles maturation by promoting the nuclear export of the 60S ribosome (PubMed:32669547). Negatively modulates the DNA binding activity of Oct-2 and therefore its transcriptional regulatory activity (PubMed:9115366). {ECO:0000269|PubMed:9115366, ECO:0000305|PubMed:32669547}. |
O15155 | BET1 | S69 | ochoa | BET1 homolog (hBET1) (Golgi vesicular membrane-trafficking protein p18) | Required for vesicular transport from the ER to the Golgi complex (PubMed:34779586). Functions as a SNARE involved in the docking process of ER-derived vesicles with the cis-Golgi membrane (By similarity). {ECO:0000250|UniProtKB:Q62896, ECO:0000269|PubMed:34779586}. |
O15400 | STX7 | S173 | ochoa | Syntaxin-7 | May be involved in protein trafficking from the plasma membrane to the early endosome (EE) as well as in homotypic fusion of endocytic organelles. Mediates the endocytic trafficking from early endosomes to late endosomes and lysosomes. |
O43149 | ZZEF1 | S1971 | ochoa | Zinc finger ZZ-type and EF-hand domain-containing protein 1 | Histone H3 reader which may act as a transcriptional coactivator for KLF6 and KLF9 transcription factors. {ECO:0000269|PubMed:33227311}. |
O43157 | PLXNB1 | S1535 | ochoa | Plexin-B1 (Semaphorin receptor SEP) | Receptor for SEMA4D (PubMed:19843518, PubMed:20877282, PubMed:21912513). Plays a role in GABAergic synapse development (By similarity). Mediates SEMA4A- and SEMA4D-dependent inhibitory synapse development (By similarity). Plays a role in RHOA activation and subsequent changes of the actin cytoskeleton (PubMed:12196628, PubMed:15210733). Plays a role in axon guidance, invasive growth and cell migration (PubMed:12198496). {ECO:0000250|UniProtKB:Q8CJH3, ECO:0000269|PubMed:12196628, ECO:0000269|PubMed:12198496, ECO:0000269|PubMed:15210733, ECO:0000269|PubMed:19843518, ECO:0000269|PubMed:20877282, ECO:0000269|PubMed:21912513}. |
O43166 | SIPA1L1 | S1632 | ochoa|psp | Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1) | Stimulates the GTPase activity of RAP2A. Promotes reorganization of the actin cytoskeleton and recruits DLG4 to F-actin. Contributes to the regulation of dendritic spine morphogenesis (By similarity). {ECO:0000250}. |
O43502 | RAD51C | S20 | ochoa | DNA repair protein RAD51 homolog 3 (R51H3) (RAD51 homolog C) (RAD51-like protein 2) | Essential for the homologous recombination (HR) pathway of DNA repair. Involved in the homologous recombination repair (HRR) pathway of double-stranded DNA breaks arising during DNA replication or induced by DNA-damaging agents. Part of the RAD51 paralog protein complexes BCDX2 and CX3 which act at different stages of the BRCA1-BRCA2-dependent HR pathway. Upon DNA damage, BCDX2 seems to act downstream of BRCA2 recruitment and upstream of RAD51 recruitment; CX3 seems to act downstream of RAD51 recruitment; both complexes bind predominantly to the intersection of the four duplex arms of the Holliday junction (HJ) and to junction of replication forks. The BCDX2 complex was originally reported to bind single-stranded DNA, single-stranded gaps in duplex DNA and specifically to nicks in duplex DNA. The BCDX2 subcomplex RAD51B:RAD51C exhibits single-stranded DNA-dependent ATPase activity suggesting an involvement in early stages of the HR pathway. Involved in RAD51 foci formation in response to DNA damage suggesting an involvement in early stages of HR probably in the invasion step. Has an early function in DNA repair in facilitating phosphorylation of the checkpoint kinase CHEK2 and thereby transduction of the damage signal, leading to cell cycle arrest and HR activation. Participates in branch migration and HJ resolution and thus is important for processing HR intermediates late in the DNA repair process; the function may be linked to the CX3 complex. Part of a PALB2-scaffolded HR complex containing BRCA2 and which is thought to play a role in DNA repair by HR. Protects RAD51 from ubiquitin-mediated degradation that is enhanced following DNA damage. Plays a role in regulating mitochondrial DNA copy number under conditions of oxidative stress in the presence of RAD51 and XRCC3. Contributes to DNA cross-link resistance, sister chromatid cohesion and genomic stability. Involved in maintaining centrosome number in mitosis. {ECO:0000269|PubMed:14716019, ECO:0000269|PubMed:16215984, ECO:0000269|PubMed:16395335, ECO:0000269|PubMed:19451272, ECO:0000269|PubMed:19783859, ECO:0000269|PubMed:20413593, ECO:0000269|PubMed:23108668, ECO:0000269|PubMed:23149936}. |
O43524 | FOXO3 | S626 | psp | Forkhead box protein O3 (AF6q21 protein) (Forkhead in rhabdomyosarcoma-like 1) | Transcriptional activator that recognizes and binds to the DNA sequence 5'-[AG]TAAA[TC]A-3' and regulates different processes, such as apoptosis and autophagy (PubMed:10102273, PubMed:16751106, PubMed:21329882, PubMed:30513302). Acts as a positive regulator of autophagy in skeletal muscle: in starved cells, enters the nucleus following dephosphorylation and binds the promoters of autophagy genes, such as GABARAP1L, MAP1LC3B and ATG12, thereby activating their expression, resulting in proteolysis of skeletal muscle proteins (By similarity). Triggers apoptosis in the absence of survival factors, including neuronal cell death upon oxidative stress (PubMed:10102273, PubMed:16751106). Participates in post-transcriptional regulation of MYC: following phosphorylation by MAPKAPK5, promotes induction of miR-34b and miR-34c expression, 2 post-transcriptional regulators of MYC that bind to the 3'UTR of MYC transcript and prevent its translation (PubMed:21329882). In response to metabolic stress, translocates into the mitochondria where it promotes mtDNA transcription (PubMed:23283301). In response to metabolic stress, translocates into the mitochondria where it promotes mtDNA transcription. Also acts as a key regulator of chondrogenic commitment of skeletal progenitor cells in response to lipid availability: when lipids levels are low, translocates to the nucleus and promotes expression of SOX9, which induces chondrogenic commitment and suppresses fatty acid oxidation (By similarity). Also acts as a key regulator of regulatory T-cells (Treg) differentiation by activating expression of FOXP3 (PubMed:30513302). {ECO:0000250|UniProtKB:Q9WVH4, ECO:0000269|PubMed:10102273, ECO:0000269|PubMed:16751106, ECO:0000269|PubMed:21329882, ECO:0000269|PubMed:23283301, ECO:0000269|PubMed:30513302}. |
O43683 | BUB1 | S752 | psp | Mitotic checkpoint serine/threonine-protein kinase BUB1 (hBUB1) (EC 2.7.11.1) (BUB1A) | Serine/threonine-protein kinase that performs 2 crucial functions during mitosis: it is essential for spindle-assembly checkpoint signaling and for correct chromosome alignment. Has a key role in the assembly of checkpoint proteins at the kinetochore, being required for the subsequent localization of CENPF, BUB1B, CENPE and MAD2L1. Required for the kinetochore localization of PLK1. Required for centromeric enrichment of AUKRB in prometaphase. Plays an important role in defining SGO1 localization and thereby affects sister chromatid cohesion. Promotes the centromeric localization of TOP2A (PubMed:35044816). Acts as a substrate for anaphase-promoting complex or cyclosome (APC/C) in complex with its activator CDH1 (APC/C-Cdh1). Necessary for ensuring proper chromosome segregation and binding to BUB3 is essential for this function. Can regulate chromosome segregation in a kinetochore-independent manner. Can phosphorylate BUB3. The BUB1-BUB3 complex plays a role in the inhibition of APC/C when spindle-assembly checkpoint is activated and inhibits the ubiquitin ligase activity of APC/C by phosphorylating its activator CDC20. This complex can also phosphorylate MAD1L1. Kinase activity is essential for inhibition of APC/CCDC20 and for chromosome alignment but does not play a major role in the spindle-assembly checkpoint activity. Mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis. {ECO:0000269|PubMed:10198256, ECO:0000269|PubMed:15020684, ECO:0000269|PubMed:15525512, ECO:0000269|PubMed:15723797, ECO:0000269|PubMed:16760428, ECO:0000269|PubMed:17158872, ECO:0000269|PubMed:19487456, ECO:0000269|PubMed:20739936, ECO:0000269|PubMed:35044816}. |
O43896 | KIF1C | S676 | ochoa | Kinesin-like protein KIF1C | Motor required for the retrograde transport of Golgi vesicles to the endoplasmic reticulum. Has a microtubule plus end-directed motility. {ECO:0000269|PubMed:9685376}. |
O60256 | PRPSAP2 | S227 | ochoa | Phosphoribosyl pyrophosphate synthase-associated protein 2 (PRPP synthase-associated protein 2) (41 kDa phosphoribosypyrophosphate synthetase-associated protein) (PAP41) | Seems to play a negative regulatory role in 5-phosphoribose 1-diphosphate synthesis. |
O60271 | SPAG9 | S185 | ochoa | C-Jun-amino-terminal kinase-interacting protein 4 (JIP-4) (JNK-interacting protein 4) (Cancer/testis antigen 89) (CT89) (Human lung cancer oncogene 6 protein) (HLC-6) (JNK-associated leucine-zipper protein) (JLP) (Mitogen-activated protein kinase 8-interacting protein 4) (Proliferation-inducing protein 6) (Protein highly expressed in testis) (PHET) (Sperm surface protein) (Sperm-associated antigen 9) (Sperm-specific protein) (Sunday driver 1) | The JNK-interacting protein (JIP) group of scaffold proteins selectively mediates JNK signaling by aggregating specific components of the MAPK cascade to form a functional JNK signaling module (PubMed:14743216). Regulates lysosomal positioning by acting as an adapter protein which links PIP4P1-positive lysosomes to the dynein-dynactin complex (PubMed:29146937). Assists PIKFYVE selective functionality in microtubule-based endosome-to-TGN trafficking (By similarity). {ECO:0000250|UniProtKB:Q58A65, ECO:0000269|PubMed:14743216, ECO:0000269|PubMed:29146937}. |
O60271 | SPAG9 | S363 | ochoa | C-Jun-amino-terminal kinase-interacting protein 4 (JIP-4) (JNK-interacting protein 4) (Cancer/testis antigen 89) (CT89) (Human lung cancer oncogene 6 protein) (HLC-6) (JNK-associated leucine-zipper protein) (JLP) (Mitogen-activated protein kinase 8-interacting protein 4) (Proliferation-inducing protein 6) (Protein highly expressed in testis) (PHET) (Sperm surface protein) (Sperm-associated antigen 9) (Sperm-specific protein) (Sunday driver 1) | The JNK-interacting protein (JIP) group of scaffold proteins selectively mediates JNK signaling by aggregating specific components of the MAPK cascade to form a functional JNK signaling module (PubMed:14743216). Regulates lysosomal positioning by acting as an adapter protein which links PIP4P1-positive lysosomes to the dynein-dynactin complex (PubMed:29146937). Assists PIKFYVE selective functionality in microtubule-based endosome-to-TGN trafficking (By similarity). {ECO:0000250|UniProtKB:Q58A65, ECO:0000269|PubMed:14743216, ECO:0000269|PubMed:29146937}. |
O60664 | PLIN3 | S91 | ochoa | Perilipin-3 (47 kDa mannose 6-phosphate receptor-binding protein) (47 kDa MPR-binding protein) (Cargo selection protein TIP47) (Mannose-6-phosphate receptor-binding protein 1) (Placental protein 17) (PP17) | Structural component of lipid droplets, which is required for the formation and maintenance of lipid storage droplets (PubMed:34077757). Required for the transport of mannose 6-phosphate receptors (MPR) from endosomes to the trans-Golgi network (PubMed:9590177). {ECO:0000269|PubMed:34077757, ECO:0000269|PubMed:9590177}. |
O60664 | PLIN3 | S187 | ochoa | Perilipin-3 (47 kDa mannose 6-phosphate receptor-binding protein) (47 kDa MPR-binding protein) (Cargo selection protein TIP47) (Mannose-6-phosphate receptor-binding protein 1) (Placental protein 17) (PP17) | Structural component of lipid droplets, which is required for the formation and maintenance of lipid storage droplets (PubMed:34077757). Required for the transport of mannose 6-phosphate receptors (MPR) from endosomes to the trans-Golgi network (PubMed:9590177). {ECO:0000269|PubMed:34077757, ECO:0000269|PubMed:9590177}. |
O60784 | TOM1 | S405 | ochoa | Target of Myb1 membrane trafficking protein (Target of Myb protein 1) | Adapter protein that plays a role in the intracellular membrane trafficking of ubiquitinated proteins, thereby participating in autophagy, ubiquitination-dependent signaling and receptor recycling pathways (PubMed:14563850, PubMed:15047686, PubMed:23023224, PubMed:25588840, PubMed:26320582, PubMed:31371777). Acts as a MYO6/Myosin VI adapter protein that targets MYO6 to endocytic structures (PubMed:23023224). Together with MYO6, required for autophagosomal delivery of endocytic cargo, the maturation of autophagosomes and their fusion with lysosomes (PubMed:23023224). MYO6 links TOM1 with autophagy receptors, such as TAX1BP1; CALCOCO2/NDP52 and OPTN (PubMed:31371777). Binds to polyubiquitinated proteins via its GAT domain (PubMed:14563850). In a complex with TOLLIP, recruits ubiquitin-conjugated proteins onto early endosomes (PubMed:15047686). The Tom1-Tollip complex may regulate endosomal trafficking by linking polyubiquitinated proteins to clathrin (PubMed:14563850, PubMed:15047686). Mediates clathrin recruitment to early endosomes by ZFYVE16 (PubMed:15657082). Modulates binding of TOLLIP to phosphatidylinositol 3-phosphate (PtdIns(3)P) via binding competition; the association with TOLLIP may favor the release of TOLLIP from endosomal membranes, allowing TOLLIP to commit to cargo trafficking (PubMed:26320582). Acts as a phosphatidylinositol 5-phosphate (PtdIns(5)P) effector by binding to PtdIns(5)P, thereby regulating endosomal maturation (PubMed:25588840). PtdIns(5)P-dependent recruitment to signaling endosomes may block endosomal maturation (PubMed:25588840). Also inhibits Toll-like receptor (TLR) signaling and participates in immune receptor recycling (PubMed:15047686, PubMed:26320582). {ECO:0000269|PubMed:14563850, ECO:0000269|PubMed:15047686, ECO:0000269|PubMed:15657082, ECO:0000269|PubMed:23023224, ECO:0000269|PubMed:25588840, ECO:0000269|PubMed:26320582, ECO:0000269|PubMed:31371777}. |
O75110 | ATP9A | S629 | ochoa | Probable phospholipid-transporting ATPase IIA (EC 7.6.2.1) (ATPase class II type 9A) | Plays a role in regulating membrane trafficking of cargo proteins, namely endosome to plasma membrane recycling, probably acting through RAB5 and RAB11 activation (PubMed:27733620, PubMed:30213940, PubMed:36604604). Also involved in endosome to trans-Golgi network retrograde transport (PubMed:27733620, PubMed:30213940). In complex with MON2 and DOP1B, regulates SNX3 retromer-mediated endosomal sorting of WLS, a transporter of Wnt morphogens in developing tissues. Participates in the formation of endosomal carriers that direct WLS trafficking back to Golgi, away from lysosomal degradation (PubMed:30213940). Appears to be implicated in intercellular communication by negatively regulating the release of exosomes (PubMed:30947313). The flippase activity towards membrane lipids and its role in membrane asymmetry remains to be proved (PubMed:30947313). Required for the maintenance of neurite morphology and synaptic transmission (By similarity). {ECO:0000250|UniProtKB:O70228, ECO:0000269|PubMed:27733620, ECO:0000269|PubMed:30213940, ECO:0000269|PubMed:30947313, ECO:0000269|PubMed:36604604}. |
O75460 | ERN1 | S724 | ochoa|psp | Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (hIRE1p) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)] | Serine/threonine-protein kinase and endoribonuclease that acts as a key sensor for the endoplasmic reticulum unfolded protein response (UPR) (PubMed:11175748, PubMed:11779464, PubMed:12637535, PubMed:19328063, PubMed:21317875, PubMed:28128204, PubMed:30118681, PubMed:36739529, PubMed:9637683). In unstressed cells, the endoplasmic reticulum luminal domain is maintained in its inactive monomeric state by binding to the endoplasmic reticulum chaperone HSPA5/BiP (PubMed:21317875). Accumulation of misfolded proteins in the endoplasmic reticulum causes release of HSPA5/BiP, allowing the luminal domain to homodimerize, promoting autophosphorylation of the kinase domain and subsequent activation of the endoribonuclease activity (PubMed:21317875). The endoribonuclease activity is specific for XBP1 mRNA and excises 26 nucleotides from XBP1 mRNA (PubMed:11779464, PubMed:21317875, PubMed:24508390). The resulting spliced transcript of XBP1 encodes a transcriptional activator protein that up-regulates expression of UPR target genes (PubMed:11779464, PubMed:21317875, PubMed:24508390). Acts as an upstream signal for ER stress-induced GORASP2-mediated unconventional (ER/Golgi-independent) trafficking of CFTR to cell membrane by modulating the expression and localization of SEC16A (PubMed:21884936, PubMed:28067262). {ECO:0000269|PubMed:11175748, ECO:0000269|PubMed:11779464, ECO:0000269|PubMed:12637535, ECO:0000269|PubMed:19328063, ECO:0000269|PubMed:21317875, ECO:0000269|PubMed:21884936, ECO:0000269|PubMed:28067262, ECO:0000269|PubMed:28128204, ECO:0000269|PubMed:30118681, ECO:0000269|PubMed:36739529, ECO:0000269|PubMed:9637683, ECO:0000305|PubMed:24508390}. |
O75469 | NR1I2 | S221 | psp | Nuclear receptor subfamily 1 group I member 2 (Orphan nuclear receptor PAR1) (Orphan nuclear receptor PXR) (Pregnane X receptor) (Steroid and xenobiotic receptor) (SXR) | Nuclear receptor that binds and is activated by variety of endogenous and xenobiotic compounds. Transcription factor that activates the transcription of multiple genes involved in the metabolism and secretion of potentially harmful xenobiotics, drugs and endogenous compounds. Activated by the antibiotic rifampicin and various plant metabolites, such as hyperforin, guggulipid, colupulone, and isoflavones. Response to specific ligands is species-specific. Activated by naturally occurring steroids, such as pregnenolone and progesterone. Binds to a response element in the promoters of the CYP3A4 and ABCB1/MDR1 genes. {ECO:0000269|PubMed:11297522, ECO:0000269|PubMed:11668216, ECO:0000269|PubMed:12578355, ECO:0000269|PubMed:18768384, ECO:0000269|PubMed:19297428, ECO:0000269|PubMed:9727070}. |
O75665 | OFD1 | S63 | ochoa | Centriole and centriolar satellite protein OFD1 (Oral-facial-digital syndrome 1 protein) (Protein 71-7A) | Component of the centrioles controlling mother and daughter centrioles length. Recruits to the centriole IFT88 and centriole distal appendage-specific proteins including CEP164 (By similarity). Involved in the biogenesis of the cilium, a centriole-associated function. The cilium is a cell surface projection found in many vertebrate cells required to transduce signals important for development and tissue homeostasis (PubMed:33934390). Plays an important role in development by regulating Wnt signaling and the specification of the left-right axis. Only OFD1 localized at the centriolar satellites is removed by autophagy, which is an important step in the ciliogenesis regulation (By similarity). {ECO:0000250|UniProtKB:Q80Z25, ECO:0000269|PubMed:33934390}. |
O94823 | ATP10B | S984 | ochoa | Phospholipid-transporting ATPase VB (EC 7.6.2.1) (ATPase class V type 10B) (P4-ATPase flippase complex alpha subunit ATP10B) | Catalytic component of a P4-ATPase flippase complex, which catalyzes the hydrolysis of ATP coupled to the transport of glucosylceramide (GlcCer) from the outer to the inner leaflet of lysosome membranes. Plays an important role in the maintenance of lysosome membrane integrity and function in cortical neurons. {ECO:0000269|PubMed:32172343}. |
O94916 | NFAT5 | S433 | ochoa | Nuclear factor of activated T-cells 5 (NF-AT5) (T-cell transcription factor NFAT5) (Tonicity-responsive enhancer-binding protein) (TonE-binding protein) (TonEBP) | Transcription factor involved, among others, in the transcriptional regulation of osmoprotective and inflammatory genes. Binds the DNA consensus sequence 5'-[ACT][AG]TGGAAA[CAT]A[TA][ATC][CA][ATG][GT][GAC][CG][CT]-3' (PubMed:10377394). Mediates the transcriptional response to hypertonicity (PubMed:10051678). Positively regulates the transcription of LCN2 and S100A4 genes; optimal transactivation of these genes requires the presence of DDX5/DDX17 (PubMed:22266867). Also involved in the DNA damage response by preventing formation of R-loops; R-loops are composed of a DNA:RNA hybrid and the associated non-template single-stranded DNA (PubMed:34049076). {ECO:0000269|PubMed:10051678, ECO:0000269|PubMed:10377394, ECO:0000269|PubMed:22266867, ECO:0000269|PubMed:34049076}. |
O95490 | ADGRL2 | S1400 | ochoa | Adhesion G protein-coupled receptor L2 (Calcium-independent alpha-latrotoxin receptor 2) (CIRL-2) (Latrophilin homolog 1) (Latrophilin-2) (Lectomedin-1) | Orphan adhesion G-protein coupled receptor (aGPCR), which mediates synapse specificity (By similarity). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors (By similarity). Following G-protein coupled receptor activation, associates with cell adhesion molecules that are expressed at the surface of adjacent cells to direct synapse specificity. Specifically mediates the establishment of perforant-path synapses on CA1-region pyramidal neurons in the hippocampus. Localizes to postsynaptic spines in excitatory synapses in the S.lacunosum-moleculare and interacts with presynaptic cell adhesion molecules, such as teneurins, promoting synapse formation (By similarity). {ECO:0000250|UniProtKB:Q80TS3, ECO:0000250|UniProtKB:Q8JZZ7}. |
O96013 | PAK4 | S243 | ochoa | Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) | Serine/threonine-protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell adhesion turnover, cell migration, growth, proliferation or cell survival (PubMed:26598620). Activation by various effectors including growth factor receptors or active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Phosphorylates and inactivates the protein phosphatase SSH1, leading to increased inhibitory phosphorylation of the actin binding/depolymerizing factor cofilin. Decreased cofilin activity may lead to stabilization of actin filaments. Phosphorylates LIMK1, a kinase that also inhibits the activity of cofilin. Phosphorylates integrin beta5/ITGB5 and thus regulates cell motility. Phosphorylates ARHGEF2 and activates the downstream target RHOA that plays a role in the regulation of assembly of focal adhesions and actin stress fibers. Stimulates cell survival by phosphorylating the BCL2 antagonist of cell death BAD. Alternatively, inhibits apoptosis by preventing caspase-8 binding to death domain receptors in a kinase independent manner. Plays a role in cell-cycle progression by controlling levels of the cell-cycle regulatory protein CDKN1A and by phosphorylating RAN. Promotes kinase-independent stabilization of RHOU, thereby contributing to focal adhesion disassembly during cell migration (PubMed:26598620). {ECO:0000269|PubMed:11278822, ECO:0000269|PubMed:11313478, ECO:0000269|PubMed:14560027, ECO:0000269|PubMed:15660133, ECO:0000269|PubMed:20507994, ECO:0000269|PubMed:20631255, ECO:0000269|PubMed:20805321, ECO:0000269|PubMed:26598620, ECO:0000269|PubMed:26607847}. |
P04035 | HMGCR | S356 | ochoa | 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34) | Catalyzes the conversion of (3S)-hydroxy-3-methylglutaryl-CoA (HMG-CoA) to mevalonic acid, the rate-limiting step in the synthesis of cholesterol and other isoprenoids, thus plays a critical role in cellular cholesterol homeostasis (PubMed:21357570, PubMed:2991281, PubMed:36745799, PubMed:6995544). HMGCR is the main target of statins, a class of cholesterol-lowering drugs (PubMed:11349148, PubMed:18540668, PubMed:36745799). {ECO:0000269|PubMed:11349148, ECO:0000269|PubMed:18540668, ECO:0000269|PubMed:21357570, ECO:0000269|PubMed:2991281, ECO:0000269|PubMed:36745799, ECO:0000269|PubMed:6995544}. |
P04350 | TUBB4A | T221 | ochoa | Tubulin beta-4A chain (Tubulin 5 beta) (Tubulin beta-4 chain) | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
P04350 | TUBB4A | S234 | ochoa | Tubulin beta-4A chain (Tubulin 5 beta) (Tubulin beta-4 chain) | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
P04839 | CYBB | S486 | psp | NADPH oxidase 2 (EC 1.6.3.-) (CGD91-phox) (Cytochrome b(558) subunit beta) (Cytochrome b558 subunit beta) (Cytochrome b-245 heavy chain) (Heme-binding membrane glycoprotein gp91phox) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome) | Catalytic subunit of the phagocyte NADPH oxidase complex that mediates the transfer of electrons from cytosolic NADPH to O2 to produce the superoxide anion (O2(-)) (PubMed:15338276, PubMed:36241643, PubMed:36413210, PubMed:38355798). In the activated complex, electrons are first transferred from NADPH to flavin adenine dinucleotide (FAD) and subsequently transferred via two heme molecules to molecular oxygen, producing superoxide through an outer-sphere reaction (Probable) (PubMed:38355798). Activation of the NADPH oxidase complex is initiated by the assembly of cytosolic subunits of the NADPH oxidase complex with the core NADPH oxidase complex to form a complex at the plasma membrane or phagosomal membrane (PubMed:19028840, PubMed:38355798). This activation process is initiated by phosphorylation dependent binding of the cytosolic NCF1/p47-phox subunit to the C-terminus of CYBA/p22-phox (By similarity). NADPH oxidase complex assembly is impaired through interaction with NRROS (By similarity). {ECO:0000250|UniProtKB:P13498, ECO:0000250|UniProtKB:Q61093, ECO:0000269|PubMed:15338276, ECO:0000269|PubMed:19028840, ECO:0000269|PubMed:36241643, ECO:0000269|PubMed:36413210, ECO:0000269|PubMed:38355798, ECO:0000305|PubMed:36241643}. |
P05090 | APOD | S169 | ochoa | Apolipoprotein D (Apo-D) (ApoD) | APOD occurs in the macromolecular complex with lecithin-cholesterol acyltransferase. It is probably involved in the transport and binding of bilin. Appears to be able to transport a variety of ligands in a number of different contexts. |
P05783 | KRT18 | S305 | ochoa | Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18) (CK-18) (Keratin-18) (K18) | Involved in the uptake of thrombin-antithrombin complexes by hepatic cells (By similarity). When phosphorylated, plays a role in filament reorganization. Involved in the delivery of mutated CFTR to the plasma membrane. Together with KRT8, is involved in interleukin-6 (IL-6)-mediated barrier protection. {ECO:0000250, ECO:0000269|PubMed:15529338, ECO:0000269|PubMed:16424149, ECO:0000269|PubMed:17213200, ECO:0000269|PubMed:7523419, ECO:0000269|PubMed:8522591, ECO:0000269|PubMed:9298992, ECO:0000269|PubMed:9524113}. |
P06239 | LCK | S42 | ochoa|psp | Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK) | Non-receptor tyrosine-protein kinase that plays an essential role in the selection and maturation of developing T-cells in the thymus and in the function of mature T-cells. Plays a key role in T-cell antigen receptor (TCR)-linked signal transduction pathways. Constitutively associated with the cytoplasmic portions of the CD4 and CD8 surface receptors. Association of the TCR with a peptide antigen-bound MHC complex facilitates the interaction of CD4 and CD8 with MHC class II and class I molecules, respectively, thereby recruiting the associated LCK protein to the vicinity of the TCR/CD3 complex. LCK then phosphorylates tyrosine residues within the immunoreceptor tyrosine-based activation motifs (ITAM) of the cytoplasmic tails of the TCR-gamma chains and CD3 subunits, initiating the TCR/CD3 signaling pathway. Once stimulated, the TCR recruits the tyrosine kinase ZAP70, that becomes phosphorylated and activated by LCK. Following this, a large number of signaling molecules are recruited, ultimately leading to lymphokine production. LCK also contributes to signaling by other receptor molecules. Associates directly with the cytoplasmic tail of CD2, which leads to hyperphosphorylation and activation of LCK. Also plays a role in the IL2 receptor-linked signaling pathway that controls the T-cell proliferative response. Binding of IL2 to its receptor results in increased activity of LCK. Is expressed at all stages of thymocyte development and is required for the regulation of maturation events that are governed by both pre-TCR and mature alpha beta TCR. Phosphorylates other substrates including RUNX3, PTK2B/PYK2, the microtubule-associated protein MAPT, RHOH or TYROBP. Interacts with FYB2 (PubMed:27335501). {ECO:0000269|PubMed:16339550, ECO:0000269|PubMed:16709819, ECO:0000269|PubMed:20028775, ECO:0000269|PubMed:20100835, ECO:0000269|PubMed:20851766, ECO:0000269|PubMed:21269457, ECO:0000269|PubMed:22080863, ECO:0000269|PubMed:27335501, ECO:0000269|PubMed:38614099}. |
P06400 | RB1 | S567 | psp | Retinoblastoma-associated protein (p105-Rb) (p110-RB1) (pRb) (Rb) (pp110) | Tumor suppressor that is a key regulator of the G1/S transition of the cell cycle (PubMed:10499802). The hypophosphorylated form binds transcription regulators of the E2F family, preventing transcription of E2F-responsive genes (PubMed:10499802). Both physically blocks E2Fs transactivating domain and recruits chromatin-modifying enzymes that actively repress transcription (PubMed:10499802). Cyclin and CDK-dependent phosphorylation of RB1 induces its dissociation from E2Fs, thereby activating transcription of E2F responsive genes and triggering entry into S phase (PubMed:10499802). RB1 also promotes the G0-G1 transition upon phosphorylation and activation by CDK3/cyclin-C (PubMed:15084261). Directly involved in heterochromatin formation by maintaining overall chromatin structure and, in particular, that of constitutive heterochromatin by stabilizing histone methylation. Recruits and targets histone methyltransferases SUV39H1, KMT5B and KMT5C, leading to epigenetic transcriptional repression. Controls histone H4 'Lys-20' trimethylation. Inhibits the intrinsic kinase activity of TAF1. Mediates transcriptional repression by SMARCA4/BRG1 by recruiting a histone deacetylase (HDAC) complex to the c-FOS promoter. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex (By similarity). {ECO:0000250|UniProtKB:P13405, ECO:0000250|UniProtKB:P33568, ECO:0000269|PubMed:10499802, ECO:0000269|PubMed:15084261}.; FUNCTION: (Microbial infection) In case of viral infections, interactions with SV40 large T antigen, HPV E7 protein or adenovirus E1A protein induce the disassembly of RB1-E2F1 complex thereby disrupting RB1's activity. {ECO:0000269|PubMed:1316611, ECO:0000269|PubMed:17974914, ECO:0000269|PubMed:18701596, ECO:0000269|PubMed:2839300, ECO:0000269|PubMed:8892909}. |
P06576 | ATP5F1B | S415 | ochoa | ATP synthase F(1) complex subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta) | Catalytic subunit beta, of the mitochondrial membrane ATP synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain (Probable) (PubMed:37244256). ATP synthase complex consist of a soluble F(1) head domain - the catalytic core - and a membrane F(1) domain - the membrane proton channel (PubMed:37244256). These two domains are linked by a central stalk rotating inside the F(1) region and a stationary peripheral stalk (PubMed:37244256). During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation (Probable). In vivo, can only synthesize ATP although its ATP hydrolase activity can be activated artificially in vitro (By similarity). With the subunit alpha (ATP5F1A), forms the catalytic core in the F(1) domain (PubMed:37244256). {ECO:0000250|UniProtKB:P19483, ECO:0000269|PubMed:37244256, ECO:0000305|PubMed:25168243, ECO:0000305|PubMed:36239646, ECO:0000305|PubMed:37244256}. |
P07355 | ANXA2 | Y109 | ochoa | Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36) | Calcium-regulated membrane-binding protein whose affinity for calcium is greatly enhanced by anionic phospholipids. It binds two calcium ions with high affinity. May be involved in heat-stress response. Inhibits PCSK9-enhanced LDLR degradation, probably reduces PCSK9 protein levels via a translational mechanism but also competes with LDLR for binding with PCSK9 (PubMed:18799458, PubMed:22848640, PubMed:24808179). Binds to endosomes damaged by phagocytosis of particulate wear debris and participates in endosomal membrane stabilization, thereby limiting NLRP3 inflammasome activation (By similarity). Required for endothelial cell surface plasmin generation and may support fibrinolytic surveillance and neoangiogenesis (By similarity). {ECO:0000250|UniProtKB:P07356, ECO:0000269|PubMed:18799458, ECO:0000269|PubMed:22848640, ECO:0000269|PubMed:24808179}.; FUNCTION: (Microbial infection) Binds M.pneumoniae CARDS toxin, probably serves as one receptor for this pathogen. When ANXA2 is down-regulated by siRNA, less toxin binds to human cells and less vacuolization (a symptom of M.pneumoniae infection) is seen. {ECO:0000269|PubMed:25139904}. |
P07437 | TUBB | T221 | ochoa | Tubulin beta chain (Tubulin beta-5 chain) | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
P07437 | TUBB | S234 | ochoa | Tubulin beta chain (Tubulin beta-5 chain) | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
P08670 | VIM | S409 | psp | Vimentin | Vimentins are class-III intermediate filaments found in various non-epithelial cells, especially mesenchymal cells. Vimentin is attached to the nucleus, endoplasmic reticulum, and mitochondria, either laterally or terminally. Plays a role in cell directional movement, orientation, cell sheet organization and Golgi complex polarization at the cell migration front (By similarity). Protects SCRIB from proteasomal degradation and facilitates its localization to intermediate filaments in a cell contact-mediated manner (By similarity). {ECO:0000250|UniProtKB:A0A8C0N8E3, ECO:0000250|UniProtKB:P31000}.; FUNCTION: Involved with LARP6 in the stabilization of type I collagen mRNAs for CO1A1 and CO1A2. {ECO:0000269|PubMed:21746880}. |
P08697 | SERPINF2 | S450 | ochoa | Alpha-2-antiplasmin (Alpha-2-AP) (Alpha-2-plasmin inhibitor) (Alpha-2-PI) (Serpin F2) | Serine protease inhibitor. The major targets of this inhibitor are plasmin and trypsin, but it also inactivates matriptase-3/TMPRSS7 and chymotrypsin. {ECO:0000269|PubMed:15853774}. |
P09327 | VIL1 | S261 | ochoa | Villin-1 | Epithelial cell-specific Ca(2+)-regulated actin-modifying protein that modulates the reorganization of microvillar actin filaments. Plays a role in the actin nucleation, actin filament bundle assembly, actin filament capping and severing. Binds phosphatidylinositol 4,5-bisphosphate (PIP2) and lysophosphatidic acid (LPA); binds LPA with higher affinity than PIP2. Binding to LPA increases its phosphorylation by SRC and inhibits all actin-modifying activities. Binding to PIP2 inhibits actin-capping and -severing activities but enhances actin-bundling activity. Regulates the intestinal epithelial cell morphology, cell invasion, cell migration and apoptosis. Protects against apoptosis induced by dextran sodium sulfate (DSS) in the gastrointestinal epithelium. Appears to regulate cell death by maintaining mitochondrial integrity. Enhances hepatocyte growth factor (HGF)-induced epithelial cell motility, chemotaxis and wound repair. Upon S.flexneri cell infection, its actin-severing activity enhances actin-based motility of the bacteria and plays a role during the dissemination. {ECO:0000269|PubMed:11500485, ECO:0000269|PubMed:14594952, ECO:0000269|PubMed:15084600, ECO:0000269|PubMed:15272027, ECO:0000269|PubMed:15342783, ECO:0000269|PubMed:16921170, ECO:0000269|PubMed:17182858, ECO:0000269|PubMed:17229814, ECO:0000269|PubMed:17606613, ECO:0000269|PubMed:18054784, ECO:0000269|PubMed:18198174, ECO:0000269|PubMed:19808673, ECO:0000269|PubMed:3087992}. |
P0DMV8 | HSPA1A | S340 | ochoa | Heat shock 70 kDa protein 1A (Heat shock 70 kDa protein 1) (HSP70-1) (HSP70.1) (Heat shock protein family A member 1A) | Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The co-chaperones have been shown to not only regulate different steps of the ATPase cycle, but they also have an individual specificity such that one co-chaperone may promote folding of a substrate while another may promote degradation. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. The co-chaperones are of three types: J-domain co-chaperones such as HSP40s (stimulate ATPase hydrolysis by HSP70), the nucleotide exchange factors (NEF) such as BAG1/2/3 (facilitate conversion of HSP70 from the ADP-bound to the ATP-bound state thereby promoting substrate release), and the TPR domain chaperones such as HOPX and STUB1 (PubMed:24012426, PubMed:24318877, PubMed:26865365). Maintains protein homeostasis during cellular stress through two opposing mechanisms: protein refolding and degradation. Its acetylation/deacetylation state determines whether it functions in protein refolding or protein degradation by controlling the competitive binding of co-chaperones HOPX and STUB1. During the early stress response, the acetylated form binds to HOPX which assists in chaperone-mediated protein refolding, thereafter, it is deacetylated and binds to ubiquitin ligase STUB1 that promotes ubiquitin-mediated protein degradation (PubMed:27708256). Regulates centrosome integrity during mitosis, and is required for the maintenance of a functional mitotic centrosome that supports the assembly of a bipolar mitotic spindle (PubMed:27137183). Enhances STUB1-mediated SMAD3 ubiquitination and degradation and facilitates STUB1-mediated inhibition of TGF-beta signaling (PubMed:24613385). Essential for STUB1-mediated ubiquitination and degradation of FOXP3 in regulatory T-cells (Treg) during inflammation (PubMed:23973223). Required as a co-chaperone for optimal STUB1/CHIP ubiquitination of NFATC3 (By similarity). Negatively regulates heat shock-induced HSF1 transcriptional activity during the attenuation and recovery phase period of the heat shock response (PubMed:9499401). Involved in the clearance of misfolded PRDM1/Blimp-1 proteins. Sequesters them in the cytoplasm and promotes their association with SYNV1/HRD1, leading to proteasomal degradation (PubMed:28842558). {ECO:0000250|UniProtKB:P0DMW0, ECO:0000269|PubMed:22528486, ECO:0000269|PubMed:23973223, ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:27137183, ECO:0000269|PubMed:27708256, ECO:0000269|PubMed:28842558, ECO:0000269|PubMed:9499401, ECO:0000303|PubMed:24012426, ECO:0000303|PubMed:26865365}.; FUNCTION: (Microbial infection) In case of rotavirus A infection, serves as a post-attachment receptor for the virus to facilitate entry into the cell. {ECO:0000269|PubMed:16537599}. |
P0DMV9 | HSPA1B | S340 | ochoa | Heat shock 70 kDa protein 1B (Heat shock 70 kDa protein 2) (HSP70-2) (HSP70.2) (Heat shock protein family A member 1B) | Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The co-chaperones have been shown to not only regulate different steps of the ATPase cycle, but they also have an individual specificity such that one co-chaperone may promote folding of a substrate while another may promote degradation. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. The co-chaperones are of three types: J-domain co-chaperones such as HSP40s (stimulate ATPase hydrolysis by HSP70), the nucleotide exchange factors (NEF) such as BAG1/2/3 (facilitate conversion of HSP70 from the ADP-bound to the ATP-bound state thereby promoting substrate release), and the TPR domain chaperones such as HOPX and STUB1 (PubMed:24012426, PubMed:24318877, PubMed:26865365). Maintains protein homeostasis during cellular stress through two opposing mechanisms: protein refolding and degradation. Its acetylation/deacetylation state determines whether it functions in protein refolding or protein degradation by controlling the competitive binding of co-chaperones HOPX and STUB1. During the early stress response, the acetylated form binds to HOPX which assists in chaperone-mediated protein refolding, thereafter, it is deacetylated and binds to ubiquitin ligase STUB1 that promotes ubiquitin-mediated protein degradation (PubMed:27708256). Regulates centrosome integrity during mitosis, and is required for the maintenance of a functional mitotic centrosome that supports the assembly of a bipolar mitotic spindle (PubMed:27137183). Enhances STUB1-mediated SMAD3 ubiquitination and degradation and facilitates STUB1-mediated inhibition of TGF-beta signaling (PubMed:24613385). Essential for STUB1-mediated ubiquitination and degradation of FOXP3 in regulatory T-cells (Treg) during inflammation (PubMed:23973223). {ECO:0000269|PubMed:22528486, ECO:0000269|PubMed:23973223, ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:27137183, ECO:0000269|PubMed:27708256, ECO:0000303|PubMed:24012426, ECO:0000303|PubMed:26865365}.; FUNCTION: (Microbial infection) In case of rotavirus A infection, serves as a post-attachment receptor for the virus to facilitate entry into the cell. {ECO:0000269|PubMed:16537599}. |
P0DPH7 | TUBA3C | T223 | ochoa | Tubulin alpha-3C chain (EC 3.6.5.-) (Alpha-tubulin 2) (Alpha-tubulin 3C) (Tubulin alpha-2 chain) [Cleaved into: Detyrosinated tubulin alpha-3C chain] | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
P0DPH8 | TUBA3D | T223 | ochoa | Tubulin alpha-3D chain (EC 3.6.5.-) (Alpha-tubulin 3D) [Cleaved into: Detyrosinated tubulin alpha-3D chain] | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
P10809 | HSPD1 | S252 | ochoa | 60 kDa heat shock protein, mitochondrial (EC 5.6.1.7) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) (Heat shock protein family D member 1) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein) | Chaperonin implicated in mitochondrial protein import and macromolecular assembly. Together with Hsp10, facilitates the correct folding of imported proteins. May also prevent misfolding and promote the refolding and proper assembly of unfolded polypeptides generated under stress conditions in the mitochondrial matrix (PubMed:11422376, PubMed:1346131). The functional units of these chaperonins consist of heptameric rings of the large subunit Hsp60, which function as a back-to-back double ring. In a cyclic reaction, Hsp60 ring complexes bind one unfolded substrate protein per ring, followed by the binding of ATP and association with 2 heptameric rings of the co-chaperonin Hsp10. This leads to sequestration of the substrate protein in the inner cavity of Hsp60 where, for a certain period of time, it can fold undisturbed by other cell components. Synchronous hydrolysis of ATP in all Hsp60 subunits results in the dissociation of the chaperonin rings and the release of ADP and the folded substrate protein (Probable). {ECO:0000269|PubMed:11422376, ECO:0000269|PubMed:1346131, ECO:0000305|PubMed:25918392}. |
P13010 | XRCC5 | S175 | ochoa | X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (86 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 2) (ATP-dependent DNA helicase II 80 kDa subunit) (CTC box-binding factor 85 kDa subunit) (CTC85) (CTCBF) (DNA repair protein XRCC5) (Ku80) (Ku86) (Lupus Ku autoantigen protein p86) (Nuclear factor IV) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)) | Single-stranded DNA-dependent ATP-dependent helicase that plays a key role in DNA non-homologous end joining (NHEJ) by recruiting DNA-PK to DNA (PubMed:11493912, PubMed:12145306, PubMed:7957065, PubMed:8621488). Required for double-strand break repair and V(D)J recombination (PubMed:11493912, PubMed:12145306, PubMed:7957065, PubMed:8621488). Also has a role in chromosome translocation (PubMed:11493912, PubMed:12145306, PubMed:7957065, PubMed:8621488). The DNA helicase II complex binds preferentially to fork-like ends of double-stranded DNA in a cell cycle-dependent manner (PubMed:11493912, PubMed:12145306, PubMed:7957065, PubMed:8621488). It works in the 3'-5' direction (PubMed:11493912, PubMed:12145306, PubMed:7957065, PubMed:8621488). During NHEJ, the XRCC5-XRRC6 dimer performs the recognition step: it recognizes and binds to the broken ends of the DNA and protects them from further resection (PubMed:11493912, PubMed:12145306, PubMed:7957065, PubMed:8621488). Binding to DNA may be mediated by XRCC6 (PubMed:11493912, PubMed:12145306, PubMed:7957065, PubMed:8621488). The XRCC5-XRRC6 dimer acts as a regulatory subunit of the DNA-dependent protein kinase complex DNA-PK by increasing the affinity of the catalytic subunit PRKDC to DNA by 100-fold (PubMed:11493912, PubMed:12145306, PubMed:20383123, PubMed:7957065, PubMed:8621488). The XRCC5-XRRC6 dimer is probably involved in stabilizing broken DNA ends and bringing them together (PubMed:12145306, PubMed:20383123, PubMed:7957065, PubMed:8621488). The assembly of the DNA-PK complex to DNA ends is required for the NHEJ ligation step (PubMed:12145306, PubMed:20383123, PubMed:7957065, PubMed:8621488). The XRCC5-XRRC6 dimer probably also acts as a 5'-deoxyribose-5-phosphate lyase (5'-dRP lyase), by catalyzing the beta-elimination of the 5' deoxyribose-5-phosphate at an abasic site near double-strand breaks (PubMed:20383123). XRCC5 probably acts as the catalytic subunit of 5'-dRP activity, and allows to 'clean' the termini of abasic sites, a class of nucleotide damage commonly associated with strand breaks, before such broken ends can be joined (PubMed:20383123). The XRCC5-XRRC6 dimer together with APEX1 acts as a negative regulator of transcription (PubMed:8621488). In association with NAA15, the XRCC5-XRRC6 dimer binds to the osteocalcin promoter and activates osteocalcin expression (PubMed:12145306). As part of the DNA-PK complex, involved in the early steps of ribosome assembly by promoting the processing of precursor rRNA into mature 18S rRNA in the small-subunit processome (PubMed:32103174). Binding to U3 small nucleolar RNA, recruits PRKDC and XRCC5/Ku86 to the small-subunit processome (PubMed:32103174). Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (PubMed:28712728). {ECO:0000269|PubMed:11493912, ECO:0000269|PubMed:12145306, ECO:0000269|PubMed:20383123, ECO:0000269|PubMed:28712728, ECO:0000269|PubMed:32103174, ECO:0000269|PubMed:7957065, ECO:0000269|PubMed:8621488}. |
P15336 | ATF2 | S90 | ochoa|psp | Cyclic AMP-dependent transcription factor ATF-2 (cAMP-dependent transcription factor ATF-2) (Activating transcription factor 2) (Cyclic AMP-responsive element-binding protein 2) (CREB-2) (cAMP-responsive element-binding protein 2) (HB16) (cAMP response element-binding protein CRE-BP1) | Transcriptional activator which regulates the transcription of various genes, including those involved in anti-apoptosis, cell growth, and DNA damage response. Dependent on its binding partner, binds to CRE (cAMP response element) consensus sequences (5'-TGACGTCA-3') or to AP-1 (activator protein 1) consensus sequences (5'-TGACTCA-3'). In the nucleus, contributes to global transcription and the DNA damage response, in addition to specific transcriptional activities that are related to cell development, proliferation and death. In the cytoplasm, interacts with and perturbs HK1- and VDAC1-containing complexes at the mitochondrial outer membrane, thereby impairing mitochondrial membrane potential, inducing mitochondrial leakage and promoting cell death. The phosphorylated form (mediated by ATM) plays a role in the DNA damage response and is involved in the ionizing radiation (IR)-induced S phase checkpoint control and in the recruitment of the MRN complex into the IR-induced foci (IRIF). Exhibits histone acetyltransferase (HAT) activity which specifically acetylates histones H2B and H4 in vitro (PubMed:10821277). In concert with CUL3 and RBX1, promotes the degradation of KAT5 thereby attenuating its ability to acetylate and activate ATM. Can elicit oncogenic or tumor suppressor activities depending on the tissue or cell type. {ECO:0000269|PubMed:10821277, ECO:0000269|PubMed:15916964, ECO:0000269|PubMed:18397884, ECO:0000269|PubMed:22304920}. |
P16066 | NPR1 | S505 | psp | Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) | Receptor for the atrial natriuretic peptide NPPA/ANP and the brain natriuretic peptide NPPB/BNP which are potent vasoactive hormones playing a key role in cardiovascular homeostasis (PubMed:39543315). Plays an essential role in the regulation of endothelial cell senescence and vascular aging (PubMed:36016499). Upon activation by ANP or BNP, stimulates the production of cyclic guanosine monophosphate (cGMP) that promotes vascular tone and volume homeostasis by activation of protein kinase cGMP-dependent 1/PRKG1 and subsequently PRKAA1, thereby controlling blood pressure and maintaining cardiovascular homeostasis (PubMed:36016499). {ECO:0000269|PubMed:1672777, ECO:0000269|PubMed:36016499, ECO:0000269|PubMed:39543315}. |
P16144 | ITGB4 | S1360 | psp | Integrin beta-4 (GP150) (CD antigen CD104) | Integrin alpha-6/beta-4 is a receptor for laminin. Plays a critical structural role in the hemidesmosome of epithelial cells. Is required for the regulation of keratinocyte polarity and motility. ITGA6:ITGB4 binds to NRG1 (via EGF domain) and this binding is essential for NRG1-ERBB signaling (PubMed:20682778). ITGA6:ITGB4 binds to IGF1 and this binding is essential for IGF1 signaling (PubMed:22351760). ITGA6:ITGB4 binds to IGF2 and this binding is essential for IGF2 signaling (PubMed:28873464). {ECO:0000269|PubMed:12482924, ECO:0000269|PubMed:19403692, ECO:0000269|PubMed:20682778, ECO:0000269|PubMed:22351760, ECO:0000269|PubMed:28873464}. |
P16144 | ITGB4 | S1494 | ochoa|psp | Integrin beta-4 (GP150) (CD antigen CD104) | Integrin alpha-6/beta-4 is a receptor for laminin. Plays a critical structural role in the hemidesmosome of epithelial cells. Is required for the regulation of keratinocyte polarity and motility. ITGA6:ITGB4 binds to NRG1 (via EGF domain) and this binding is essential for NRG1-ERBB signaling (PubMed:20682778). ITGA6:ITGB4 binds to IGF1 and this binding is essential for IGF1 signaling (PubMed:22351760). ITGA6:ITGB4 binds to IGF2 and this binding is essential for IGF2 signaling (PubMed:28873464). {ECO:0000269|PubMed:12482924, ECO:0000269|PubMed:19403692, ECO:0000269|PubMed:20682778, ECO:0000269|PubMed:22351760, ECO:0000269|PubMed:28873464}. |
P17661 | DES | S358 | ochoa | Desmin | Muscle-specific type III intermediate filament essential for proper muscular structure and function. Plays a crucial role in maintaining the structure of sarcomeres, inter-connecting the Z-disks and forming the myofibrils, linking them not only to the sarcolemmal cytoskeleton, but also to the nucleus and mitochondria, thus providing strength for the muscle fiber during activity (PubMed:25358400). In adult striated muscle they form a fibrous network connecting myofibrils to each other and to the plasma membrane from the periphery of the Z-line structures (PubMed:24200904, PubMed:25394388, PubMed:26724190). May act as a sarcomeric microtubule-anchoring protein: specifically associates with detyrosinated tubulin-alpha chains, leading to buckled microtubules and mechanical resistance to contraction. Required for nuclear membrane integrity, via anchoring at the cell tip and nuclear envelope, resulting in maintenance of microtubule-derived intracellular mechanical forces (By similarity). Contributes to the transcriptional regulation of the NKX2-5 gene in cardiac progenitor cells during a short period of cardiomyogenesis and in cardiac side population stem cells in the adult. Plays a role in maintaining an optimal conformation of nebulette (NEB) on heart muscle sarcomeres to bind and recruit cardiac alpha-actin (By similarity). {ECO:0000250|UniProtKB:P31001, ECO:0000269|PubMed:24200904, ECO:0000269|PubMed:25394388, ECO:0000269|PubMed:26724190, ECO:0000303|PubMed:25358400}. |
P17844 | DDX5 | S338 | ochoa | Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box protein 5) (RNA helicase p68) | Involved in the alternative regulation of pre-mRNA splicing; its RNA helicase activity is necessary for increasing tau exon 10 inclusion and occurs in a RBM4-dependent manner. Binds to the tau pre-mRNA in the stem-loop region downstream of exon 10. The rate of ATP hydrolysis is highly stimulated by single-stranded RNA. Involved in transcriptional regulation; the function is independent of the RNA helicase activity. Transcriptional coactivator for androgen receptor AR but probably not ESR1. Synergizes with DDX17 and SRA1 RNA to activate MYOD1 transcriptional activity and involved in skeletal muscle differentiation. Transcriptional coactivator for p53/TP53 and involved in p53/TP53 transcriptional response to DNA damage and p53/TP53-dependent apoptosis. Transcriptional coactivator for RUNX2 and involved in regulation of osteoblast differentiation. Acts as a transcriptional repressor in a promoter-specific manner; the function probably involves association with histone deacetylases, such as HDAC1. As component of a large PER complex is involved in the inhibition of 3' transcriptional termination of circadian target genes such as PER1 and NR1D1 and the control of the circadian rhythms. {ECO:0000269|PubMed:12527917, ECO:0000269|PubMed:15298701, ECO:0000269|PubMed:15660129, ECO:0000269|PubMed:17011493, ECO:0000269|PubMed:17960593, ECO:0000269|PubMed:18829551, ECO:0000269|PubMed:19718048, ECO:0000269|PubMed:21343338}. |
P19429 | TNNI3 | S150 | psp | Troponin I, cardiac muscle (Cardiac troponin I) | Troponin I is the inhibitory subunit of troponin, the thin filament regulatory complex which confers calcium-sensitivity to striated muscle actomyosin ATPase activity. |
P22314 | UBA1 | S820 | ochoa | Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Protein A1S9) (Ubiquitin-activating enzyme E1) | Catalyzes the first step in ubiquitin conjugation to mark cellular proteins for degradation through the ubiquitin-proteasome system (PubMed:1447181, PubMed:1606621, PubMed:33108101). Activates ubiquitin by first adenylating its C-terminal glycine residue with ATP, and thereafter linking this residue to the side chain of a cysteine residue in E1, yielding a ubiquitin-E1 thioester and free AMP (PubMed:1447181). Essential for the formation of radiation-induced foci, timely DNA repair and for response to replication stress. Promotes the recruitment of TP53BP1 and BRCA1 at DNA damage sites (PubMed:22456334). {ECO:0000269|PubMed:1447181, ECO:0000269|PubMed:1606621, ECO:0000269|PubMed:22456334, ECO:0000269|PubMed:33108101}. |
P23634 | ATP2B4 | S238 | ochoa | Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4) | Calcium/calmodulin-regulated and magnesium-dependent enzyme that catalyzes the hydrolysis of ATP coupled with the transport of calcium out of the cell (PubMed:8530416). By regulating sperm cell calcium homeostasis, may play a role in sperm motility (By similarity). {ECO:0000250|UniProtKB:Q6Q477, ECO:0000269|PubMed:8530416}. |
P25786 | PSMA1 | S114 | ochoa | Proteasome subunit alpha type-1 (30 kDa prosomal protein) (PROS-30) (Macropain subunit C2) (Multicatalytic endopeptidase complex subunit C2) (Proteasome component C2) (Proteasome nu chain) (Proteasome subunit alpha-6) (alpha-6) | Component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles. Associated with two 19S regulatory particles, forms the 26S proteasome and thus participates in the ATP-dependent degradation of ubiquitinated proteins. The 26S proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions, and by removing proteins whose functions are no longer required. Associated with the PA200 or PA28, the 20S proteasome mediates ubiquitin-independent protein degradation. This type of proteolysis is required in several pathways including spermatogenesis (20S-PA200 complex) or generation of a subset of MHC class I-presented antigenic peptides (20S-PA28 complex). {ECO:0000269|PubMed:15244466, ECO:0000269|PubMed:27176742, ECO:0000269|PubMed:8610016}. |
P28290 | ITPRID2 | S99 | ochoa | Protein ITPRID2 (Cleavage signal-1 protein) (CS-1) (ITPR-interacting domain-containing protein 2) (Ki-ras-induced actin-interacting protein) (Sperm-specific antigen 2) | None |
P30260 | CDC27 | S154 | psp | Cell division cycle protein 27 homolog (Anaphase-promoting complex subunit 3) (APC3) (CDC27 homolog) (CDC27Hs) (H-NUC) | Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle (PubMed:18485873). The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains (PubMed:18485873). The APC/C complex catalyzes assembly of branched 'Lys-11'-/'Lys-48'-linked branched ubiquitin chains on target proteins (PubMed:29033132). {ECO:0000269|PubMed:18485873, ECO:0000269|PubMed:29033132}. |
P31150 | GDI1 | S222 | ochoa | Rab GDP dissociation inhibitor alpha (Rab GDI alpha) (Guanosine diphosphate dissociation inhibitor 1) (GDI-1) (Oligophrenin-2) (Protein XAP-4) | Regulates the GDP/GTP exchange reaction of most Rab proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP to them. Promotes the dissociation of GDP-bound Rab proteins from the membrane and inhibits their activation. Promotes the dissociation of RAB1A, RAB3A, RAB5A and RAB10 from membranes. {ECO:0000269|PubMed:23815289}. |
P33981 | TTK | S345 | psp | Dual specificity protein kinase TTK (EC 2.7.12.1) (Phosphotyrosine picked threonine-protein kinase) (PYT) | Involved in mitotic spindle assembly checkpoint signaling, a process that delays anaphase until chromosomes are bioriented on the spindle, and in the repair of incorrect mitotic kinetochore-spindle microtubule attachments (PubMed:18243099, PubMed:28441529, PubMed:29162720). Phosphorylates MAD1L1 to promote the mitotic spindle assembly checkpoint (PubMed:18243099, PubMed:29162720). Phosphorylates CDCA8/Borealin leading to enhanced AURKB activity at the kinetochore (PubMed:18243099). Phosphorylates SKA3 at 'Ser-34' leading to dissociation of the SKA complex from microtubules and destabilization of microtubule-kinetochore attachments (PubMed:28441529). Phosphorylates KNL1, KNTC1 and autophosphorylates (PubMed:28441529). Phosphorylates MCRS1 which enhances recruitment of KIF2A to the minus end of spindle microtubules and promotes chromosome alignment (PubMed:30785839). {ECO:0000269|PubMed:18243099, ECO:0000269|PubMed:28441529, ECO:0000269|PubMed:29162720, ECO:0000269|PubMed:30785839}. |
P33991 | MCM4 | S131 | ochoa | DNA replication licensing factor MCM4 (EC 3.6.4.12) (CDC21 homolog) (P1-CDC21) | Acts as a component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. Core component of CDC45-MCM-GINS (CMG) helicase, the molecular machine that unwinds template DNA during replication, and around which the replisome is built (PubMed:16899510, PubMed:25661590, PubMed:32453425, PubMed:34694004, PubMed:34700328, PubMed:35585232, PubMed:9305914). The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity (PubMed:16899510, PubMed:25661590, PubMed:32453425, PubMed:9305914). {ECO:0000269|PubMed:16899510, ECO:0000269|PubMed:25661590, ECO:0000269|PubMed:32453425, ECO:0000269|PubMed:34694004, ECO:0000269|PubMed:34700328, ECO:0000269|PubMed:35585232, ECO:0000269|PubMed:9305914}. |
P35232 | PHB1 | S151 | psp | Prohibitin 1 | Protein with pleiotropic attributes mediated in a cell-compartment- and tissue-specific manner, which include the plasma membrane-associated cell signaling functions, mitochondrial chaperone, and transcriptional co-regulator of transcription factors in the nucleus (PubMed:11302691, PubMed:20959514, PubMed:28017329, PubMed:31522117). Plays a role in adipose tissue and glucose homeostasis in a sex-specific manner (By similarity). Contributes to pulmonary vascular remodeling by accelerating proliferation of pulmonary arterial smooth muscle cells (By similarity). {ECO:0000250|UniProtKB:P67778, ECO:0000250|UniProtKB:P67779, ECO:0000269|PubMed:11302691, ECO:0000269|PubMed:20959514, ECO:0000269|PubMed:28017329, ECO:0000269|PubMed:31522117}.; FUNCTION: In the mitochondria, together with PHB2, forms large ring complexes (prohibitin complexes) in the inner mitochondrial membrane (IMM) and functions as a chaperone protein that stabilizes mitochondrial respiratory enzymes and maintains mitochondrial integrity in the IMM, which is required for mitochondrial morphogenesis, neuronal survival, and normal lifespan (Probable). The prohibitin complex, with DNAJC19, regulates cardiolipin remodeling and the protein turnover of OMA1 in a cardiolipin-binding manner (By similarity). Regulates mitochondrial respiration activity playing a role in cellular aging (PubMed:11302691). The prohibitin complex plays a role of mitophagy receptor involved in targeting mitochondria for autophagic degradation (PubMed:28017329). Involved in mitochondrial-mediated antiviral innate immunity, activates RIG-I-mediated signal transduction and production of IFNB1 and pro-inflammatory cytokine IL6 (PubMed:31522117). {ECO:0000250|UniProtKB:P67778, ECO:0000269|PubMed:11302691, ECO:0000269|PubMed:28017329, ECO:0000269|PubMed:31522117, ECO:0000305}.; FUNCTION: In the nucleus, acts as a transcription coregulator, enhances promoter binding by TP53, a transcription factor it activates, but reduces the promoter binding by E2F1, a transcription factor it represses (PubMed:14500729). Interacts with STAT3 to affect IL17 secretion in T-helper Th17 cells (PubMed:31899195). {ECO:0000269|PubMed:14500729, ECO:0000269|PubMed:31899195}.; FUNCTION: In the plasma membrane, cooperates with CD86 to mediate CD86-signaling in B lymphocytes that regulates the level of IgG1 produced through the activation of distal signaling intermediates (By similarity). Upon CD40 engagement, required to activate NF-kappa-B signaling pathway via phospholipase C and protein kinase C activation (By similarity). {ECO:0000250|UniProtKB:P67778}. |
P35749 | MYH11 | S1189 | ochoa | Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, smooth muscle isoform) (SMMHC) | Muscle contraction. |
P35869 | AHR | S723 | psp | Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76) | Ligand-activated transcription factor that enables cells to adapt to changing conditions by sensing compounds from the environment, diet, microbiome and cellular metabolism, and which plays important roles in development, immunity and cancer (PubMed:23275542, PubMed:30373764, PubMed:32818467, PubMed:7961644). Upon ligand binding, translocates into the nucleus, where it heterodimerizes with ARNT and induces transcription by binding to xenobiotic response elements (XRE) (PubMed:23275542, PubMed:30373764, PubMed:7961644). Regulates a variety of biological processes, including angiogenesis, hematopoiesis, drug and lipid metabolism, cell motility and immune modulation (PubMed:12213388). Xenobiotics can act as ligands: upon xenobiotic-binding, activates the expression of multiple phase I and II xenobiotic chemical metabolizing enzyme genes (such as the CYP1A1 gene) (PubMed:7961644, PubMed:33193710). Mediates biochemical and toxic effects of halogenated aromatic hydrocarbons (PubMed:34521881, PubMed:7961644). Next to xenobiotics, natural ligands derived from plants, microbiota, and endogenous metabolism are potent AHR agonists (PubMed:18076143). Tryptophan (Trp) derivatives constitute an important class of endogenous AHR ligands (PubMed:32818467, PubMed:32866000). Acts as a negative regulator of anti-tumor immunity: indoles and kynurenic acid generated by Trp catabolism act as ligand and activate AHR, thereby promoting AHR-driven cancer cell motility and suppressing adaptive immunity (PubMed:32818467). Regulates the circadian clock by inhibiting the basal and circadian expression of the core circadian component PER1 (PubMed:28602820). Inhibits PER1 by repressing the CLOCK-BMAL1 heterodimer mediated transcriptional activation of PER1 (PubMed:28602820). The heterodimer ARNT:AHR binds to core DNA sequence 5'-TGCGTG-3' within the dioxin response element (DRE) of target gene promoters and activates their transcription (PubMed:28602820). {ECO:0000269|PubMed:23275542, ECO:0000269|PubMed:28602820, ECO:0000269|PubMed:30373764, ECO:0000269|PubMed:32818467, ECO:0000269|PubMed:32866000, ECO:0000269|PubMed:33193710, ECO:0000269|PubMed:34521881, ECO:0000269|PubMed:7961644, ECO:0000303|PubMed:12213388, ECO:0000303|PubMed:18076143}. |
P36873 | PPP1CC | S182 | ochoa | Serine/threonine-protein phosphatase PP1-gamma catalytic subunit (PP-1G) (EC 3.1.3.16) (Protein phosphatase 1C catalytic subunit) | Protein phosphatase that associates with over 200 regulatory proteins to form highly specific holoenzymes which dephosphorylate hundreds of biological targets (PubMed:17936702, PubMed:25012651). Protein phosphatase 1 (PP1) is essential for cell division, and participates in the regulation of glycogen metabolism, muscle contractility and protein synthesis. Dephosphorylates RPS6KB1 (PubMed:17936702). Involved in regulation of ionic conductances and long-term synaptic plasticity. May play an important role in dephosphorylating substrates such as the postsynaptic density-associated Ca(2+)/calmodulin dependent protein kinase II. Component of the PTW/PP1 phosphatase complex, which plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase (PubMed:20516061). In balance with CSNK1D and CSNK1E, determines the circadian period length, through the regulation of the speed and rhythmicity of PER1 and PER2 phosphorylation (PubMed:21712997). May dephosphorylate CSNK1D and CSNK1E (By similarity). Regulates the recruitment of the SKA complex to kinetochores (PubMed:28982702). Dephosphorylates the 'Ser-418' residue of FOXP3 in regulatory T-cells (Treg) from patients with rheumatoid arthritis, thereby inactivating FOXP3 and rendering Treg cells functionally defective (PubMed:23396208). Together with PPP1CA (PP1-alpha subunit), dephosphorylates IFIH1/MDA5 and RIG-I leading to their activation and a functional innate immune response (PubMed:23499489). Core component of the SHOC2-MRAS-PP1c (SMP) holophosphatase complex that regulates the MAPK pathway activation (PubMed:35768504, PubMed:35831509). The SMP complex specifically dephosphorylates the inhibitory phosphorylation at 'Ser-259' of RAF1 kinase, 'Ser-365' of BRAF kinase and 'Ser-214' of ARAF kinase, stimulating their kinase activities (PubMed:35768504, PubMed:35831509). Dephosphorylates MKI67 at the onset of anaphase (PubMed:25012651). The SMP complex enhances the dephosphorylation activity and substrate specificity of PP1c (PubMed:35768504, PubMed:35831509). {ECO:0000250|UniProtKB:P63087, ECO:0000269|PubMed:17936702, ECO:0000269|PubMed:20516061, ECO:0000269|PubMed:21712997, ECO:0000269|PubMed:23396208, ECO:0000269|PubMed:23499489, ECO:0000269|PubMed:25012651, ECO:0000269|PubMed:28982702, ECO:0000269|PubMed:35768504, ECO:0000269|PubMed:35831509}. |
P38398 | BRCA1 | S1266 | ochoa | Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) | E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage (PubMed:10500182, PubMed:12887909, PubMed:12890688, PubMed:14976165, PubMed:16818604, PubMed:17525340, PubMed:19261748). It is unclear whether it also mediates the formation of other types of polyubiquitin chains (PubMed:12890688). The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability (PubMed:12890688, PubMed:14976165, PubMed:20351172). Regulates centrosomal microtubule nucleation (PubMed:18056443). Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle (PubMed:10724175, PubMed:11836499, PubMed:12183412, PubMed:19261748). Required for FANCD2 targeting to sites of DNA damage (PubMed:12887909). Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation (PubMed:16326698). Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks (PubMed:19369211). Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8 (PubMed:16818604). Acts as a transcriptional activator (PubMed:20160719). {ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11836499, ECO:0000269|PubMed:12183412, ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172}. |
P43119 | PTGIR | S366 | ochoa | Prostacyclin receptor (Prostaglandin I2 receptor) (PGI receptor) (PGI2 receptor) (Prostanoid IP receptor) | Receptor for prostacyclin (prostaglandin I2 or PGI2). The activity of this receptor is mediated by G(s) proteins which activate adenylate cyclase. |
P43243 | MATR3 | S509 | ochoa | Matrin-3 | May play a role in transcription or may interact with other nuclear matrix proteins to form the internal fibrogranular network. In association with the SFPQ-NONO heteromer may play a role in nuclear retention of defective RNAs. Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (PubMed:28712728). Binds to N6-methyladenosine (m6A)-containing mRNAs and contributes to MYC stability by binding to m6A-containing MYC mRNAs (PubMed:32245947). May bind to specific miRNA hairpins (PubMed:28431233). {ECO:0000269|PubMed:11525732, ECO:0000269|PubMed:28431233, ECO:0000269|PubMed:28712728, ECO:0000269|PubMed:32245947}. |
P46013 | MKI67 | S2837 | ochoa | Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67) | Protein that associates with the surface of mitotic chromosomes and acts both as a chromosome repellent during early mitosis and chromosome attractant during late mitosis (PubMed:27362226, PubMed:32879492, PubMed:35513709, PubMed:39153474). Required to maintain individual mitotic chromosomes dispersed in the cytoplasm following nuclear envelope disassembly (PubMed:27362226). During early mitosis, relocalizes from nucleoli to the chromosome surface where it forms extended brush structures that cover a substantial fraction of the chromosome surface (PubMed:27362226). The MKI67 brush structure prevents chromosomes from collapsing into a single chromatin mass by forming a steric and electrostatic charge barrier: the protein has a high net electrical charge and acts as a surfactant, dispersing chromosomes and enabling independent chromosome motility (PubMed:27362226). During mitotic anaphase, the MKI67 brush structure collapses and MKI67 switches from a chromosome repellent to a chromosome attractant to promote chromosome clustering and facilitate the exclusion of large cytoplasmic particles from the future nuclear space (PubMed:32879492, PubMed:39153474). Mechanistically, dephosphorylation during mitotic exit and simultaneous exposure of a conserved basic patch induce the RNA-dependent formation of a liquid-like condensed phase on the chromosome surface, promoting coalescence of neighboring chromosome surfaces and clustering of chromosomes (PubMed:39153474). Binds premature ribosomal RNAs during anaphase; promoting liquid-liquid phase separation (PubMed:28935370, PubMed:39153474). Binds DNA, with a preference for supercoiled DNA and AT-rich DNA (PubMed:10878551). Does not contribute to the internal structure of mitotic chromosomes (By similarity). May play a role in chromatin organization; it is however unclear whether it plays a direct role in chromatin organization or whether it is an indirect consequence of its function in mitotic chromosome (PubMed:24867636). {ECO:0000250|UniProtKB:E9PVX6, ECO:0000269|PubMed:10878551, ECO:0000269|PubMed:24867636, ECO:0000269|PubMed:27362226, ECO:0000269|PubMed:28935370, ECO:0000269|PubMed:32879492, ECO:0000269|PubMed:35513709, ECO:0000269|PubMed:39153474}. |
P47974 | ZFP36L2 | S470 | ochoa | mRNA decay activator protein ZFP36L2 (Butyrate response factor 2) (EGF-response factor 2) (ERF-2) (TPA-induced sequence 11d) (Zinc finger protein 36, C3H1 type-like 2) (ZFP36-like 2) | Zinc-finger RNA-binding protein that destabilizes several cytoplasmic AU-rich element (ARE)-containing mRNA transcripts by promoting their poly(A) tail removal or deadenylation, and hence provide a mechanism for attenuating protein synthesis (PubMed:14981510, PubMed:25106868, PubMed:34611029). Acts as a 3'-untranslated region (UTR) ARE mRNA-binding adapter protein to communicate signaling events to the mRNA decay machinery (PubMed:25106868). Functions by recruiting the CCR4-NOT deadenylase complex and probably other components of the cytoplasmic RNA decay machinery to the bound ARE-containing mRNAs, and hence promotes ARE-mediated mRNA deadenylation and decay processes (PubMed:25106868). Binds to 3'-UTR ARE of numerous mRNAs (PubMed:14981510, PubMed:20506496, PubMed:25106868). Promotes ARE-containing mRNA decay of the low-density lipoprotein (LDL) receptor (LDLR) mRNA in response to phorbol 12-myristate 13-acetate (PMA) treatment in a p38 MAPK-dependent manner (PubMed:25106868). Positively regulates early adipogenesis by promoting ARE-mediated mRNA decay of immediate early genes (IEGs). Plays a role in mature peripheral neuron integrity by promoting ARE-containing mRNA decay of the transcriptional repressor REST mRNA. Plays a role in ovulation and oocyte meiotic maturation by promoting ARE-mediated mRNA decay of the luteinizing hormone receptor LHCGR mRNA. Acts as a negative regulator of erythroid cell differentiation: promotes glucocorticoid-induced self-renewal of erythroid cells by binding mRNAs that are induced or highly expressed during terminal erythroid differentiation and promotes their degradation, preventing erythroid cell differentiation. In association with ZFP36L1 maintains quiescence on developing B lymphocytes by promoting ARE-mediated decay of several mRNAs encoding cell cycle regulators that help B cells progress through the cell cycle, and hence ensuring accurate variable-diversity-joining (VDJ) recombination process and functional immune cell formation. Together with ZFP36L1 is also necessary for thymocyte development and prevention of T-cell acute lymphoblastic leukemia (T-ALL) transformation by promoting ARE-mediated mRNA decay of the oncogenic transcription factor NOTCH1 mRNA. {ECO:0000250|UniProtKB:P23949, ECO:0000269|PubMed:14981510, ECO:0000269|PubMed:20506496, ECO:0000269|PubMed:25106868, ECO:0000269|PubMed:34611029}. |
P48047 | ATP5PO | S163 | ochoa | ATP synthase peripheral stalk subunit OSCP, mitochondrial (ATP synthase subunit O) (Oligomycin sensitivity conferral protein) (OSCP) | Subunit OSCP, of the mitochondrial membrane ATP synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain (PubMed:37244256). ATP synthase complex consist of a soluble F(1) head domain - the catalytic core - and a membrane F(1) domain - the membrane proton channel (PubMed:37244256). These two domains are linked by a central stalk rotating inside the F(1) region and a stationary peripheral stalk (PubMed:37244256). During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation (Probable). In vivo, can only synthesize ATP although its ATP hydrolase activity can be activated artificially in vitro (By similarity). Part of the complex F(0) domain (PubMed:37244256). Part of the complex F(0) domain and the peripheric stalk, which acts as a stator to hold the catalytic alpha(3)beta(3) subcomplex and subunit a/ATP6 static relative to the rotary elements (By similarity). {ECO:0000250|UniProtKB:P13621, ECO:0000250|UniProtKB:P19483, ECO:0000269|PubMed:37244256, ECO:0000305|PubMed:37244256}. |
P48643 | CCT5 | S154 | ochoa | T-complex protein 1 subunit epsilon (TCP-1-epsilon) (EC 3.6.1.-) (CCT-epsilon) (Chaperonin containing T-complex polypeptide 1 subunit 5) | Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of actin, tubulin and other proteins upon ATP hydrolysis (PubMed:25467444, PubMed:36493755, PubMed:35449234, PubMed:37193829). The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance (PubMed:25467444). As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia (PubMed:20080638). {ECO:0000269|PubMed:20080638, ECO:0000269|PubMed:25467444, ECO:0000269|PubMed:35449234, ECO:0000269|PubMed:36493755, ECO:0000269|PubMed:37193829}. |
P49327 | FASN | S63 | ochoa | Fatty acid synthase (EC 2.3.1.85) (Type I fatty acid synthase) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Acyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)] | Fatty acid synthetase is a multifunctional enzyme that catalyzes the de novo biosynthesis of long-chain saturated fatty acids starting from acetyl-CoA and malonyl-CoA in the presence of NADPH. This multifunctional protein contains 7 catalytic activities and a site for the binding of the prosthetic group 4'-phosphopantetheine of the acyl carrier protein ([ACP]) domain. {ECO:0000269|PubMed:16215233, ECO:0000269|PubMed:16969344, ECO:0000269|PubMed:26851298, ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}.; FUNCTION: (Microbial infection) Fatty acid synthetase activity is required for SARS coronavirus-2/SARS-CoV-2 replication. {ECO:0000269|PubMed:34320401}. |
P49796 | RGS3 | S943 | ochoa|psp | Regulator of G-protein signaling 3 (RGP3) (RGS3) | Down-regulates signaling from heterotrimeric G-proteins by increasing the GTPase activity of the alpha subunits, thereby driving them into their inactive GDP-bound form. Down-regulates G-protein-mediated release of inositol phosphates and activation of MAP kinases. {ECO:0000269|PubMed:10749886, ECO:0000269|PubMed:11294858, ECO:0000269|PubMed:8602223, ECO:0000269|PubMed:9858594}. |
P49815 | TSC2 | S1259 | ochoa | Tuberin (Tuberous sclerosis 2 protein) | Catalytic component of the TSC-TBC complex, a multiprotein complex that acts as a negative regulator of the canonical mTORC1 complex, an evolutionarily conserved central nutrient sensor that stimulates anabolic reactions and macromolecule biosynthesis to promote cellular biomass generation and growth (PubMed:12172553, PubMed:12271141, PubMed:12842888, PubMed:12906785, PubMed:15340059, PubMed:22819219, PubMed:24529379, PubMed:28215400, PubMed:33436626, PubMed:35772404). Within the TSC-TBC complex, TSC2 acts as a GTPase-activating protein (GAP) for the small GTPase RHEB, a direct activator of the protein kinase activity of mTORC1 (PubMed:12172553, PubMed:12820960, PubMed:12842888, PubMed:12906785, PubMed:15340059, PubMed:22819219, PubMed:24529379, PubMed:33436626). In absence of nutrients, the TSC-TBC complex inhibits mTORC1, thereby preventing phosphorylation of ribosomal protein S6 kinase (RPS6KB1 and RPS6KB2) and EIF4EBP1 (4E-BP1) by the mTORC1 signaling (PubMed:12172553, PubMed:12271141, PubMed:12842888, PubMed:12906785, PubMed:22819219, PubMed:24529379, PubMed:28215400, PubMed:35772404). The TSC-TBC complex is inactivated in response to nutrients, relieving inhibition of mTORC1 (PubMed:12172553, PubMed:24529379). Involved in microtubule-mediated protein transport via its ability to regulate mTORC1 signaling (By similarity). Also stimulates the intrinsic GTPase activity of the Ras-related proteins RAP1A and RAB5 (By similarity). {ECO:0000250|UniProtKB:P49816, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12271141, ECO:0000269|PubMed:12820960, ECO:0000269|PubMed:12842888, ECO:0000269|PubMed:12906785, ECO:0000269|PubMed:15340059, ECO:0000269|PubMed:22819219, ECO:0000269|PubMed:24529379, ECO:0000269|PubMed:28215400, ECO:0000269|PubMed:33436626, ECO:0000269|PubMed:35772404}. |
P50395 | GDI2 | S222 | ochoa | Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2) | GDP-dissociation inhibitor preventing the GDP to GTP exchange of most Rab proteins. By keeping these small GTPases in their inactive GDP-bound form regulates intracellular membrane trafficking (PubMed:25860027). Negatively regulates protein transport to the cilium and ciliogenesis through the inhibition of RAB8A (PubMed:25860027). {ECO:0000269|PubMed:25860027}. |
P50851 | LRBA | S1015 | ochoa | Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) (CDC4-like protein) | Involved in coupling signal transduction and vesicle trafficking to enable polarized secretion and/or membrane deposition of immune effector molecules (By similarity). Involved in phagophore growth during mitophagy by regulating ATG9A trafficking to mitochondria (PubMed:33773106). {ECO:0000250|UniProtKB:Q9ESE1, ECO:0000269|PubMed:33773106}. |
P52333 | JAK3 | S783 | ochoa | Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3) (Leukocyte janus kinase) (L-JAK) | Non-receptor tyrosine kinase involved in various processes such as cell growth, development, or differentiation. Mediates essential signaling events in both innate and adaptive immunity and plays a crucial role in hematopoiesis during T-cells development. In the cytoplasm, plays a pivotal role in signal transduction via its association with type I receptors sharing the common subunit gamma such as IL2R, IL4R, IL7R, IL9R, IL15R and IL21R. Following ligand binding to cell surface receptors, phosphorylates specific tyrosine residues on the cytoplasmic tails of the receptor, creating docking sites for STATs proteins. Subsequently, phosphorylates the STATs proteins once they are recruited to the receptor. Phosphorylated STATs then form homodimer or heterodimers and translocate to the nucleus to activate gene transcription. For example, upon IL2R activation by IL2, JAK1 and JAK3 molecules bind to IL2R beta (IL2RB) and gamma chain (IL2RG) subunits inducing the tyrosine phosphorylation of both receptor subunits on their cytoplasmic domain. Then, STAT5A and STAT5B are recruited, phosphorylated and activated by JAK1 and JAK3. Once activated, dimerized STAT5 translocates to the nucleus and promotes the transcription of specific target genes in a cytokine-specific fashion. {ECO:0000269|PubMed:11909529, ECO:0000269|PubMed:20440074, ECO:0000269|PubMed:7662955, ECO:0000269|PubMed:8022485}. |
P54821 | PRRX1 | S21 | ochoa | Paired mesoderm homeobox protein 1 (Homeobox protein PHOX1) (Paired-related homeobox protein 1) (PRX-1) | Master transcription factor of stromal fibroblasts for myofibroblastic lineage progression. Orchestrates the functional drift of fibroblasts into myofibroblastic phenotype via TGF-beta signaling by remodeling a super-enhancer landscape. Through this function, plays an essential role in wound healing process (PubMed:35589735). Acts as a transcriptional regulator of muscle creatine kinase (MCK) and so has a role in the establishment of diverse mesodermal muscle types. The protein binds to an A/T-rich element in the muscle creatine enhancer (By similarity). May play a role in homeostasis and regeneration of bone, white adipose tissue and derm (By similarity). {ECO:0000250|UniProtKB:P63013, ECO:0000269|PubMed:35589735}.; FUNCTION: [Isoform 1]: Transcriptional activator, when transfected in fibroblastic or myoblastic cell lines. This activity may be masked by the C-terminal OAR domain. {ECO:0000250|UniProtKB:P63013}.; FUNCTION: [Isoform 2]: Transcriptional repressor, when transfected in fibroblastic or myoblastic cell lines. {ECO:0000250|UniProtKB:P63013}. |
P55196 | AFDN | S1083 | ochoa | Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6) (Afadin adherens junction formation factor) | Belongs to an adhesion system, probably together with the E-cadherin-catenin system, which plays a role in the organization of homotypic, interneuronal and heterotypic cell-cell adherens junctions (AJs) (By similarity). Nectin- and actin-filament-binding protein that connects nectin to the actin cytoskeleton (PubMed:11024295). May play a key role in the organization of epithelial structures of the embryonic ectoderm (By similarity). Essential for the organization of adherens junctions (PubMed:30463011). {ECO:0000250|UniProtKB:O35889, ECO:0000250|UniProtKB:Q9QZQ1, ECO:0000269|PubMed:11024295, ECO:0000269|PubMed:30463011}. |
P57740 | NUP107 | S86 | ochoa | Nuclear pore complex protein Nup107 (107 kDa nucleoporin) (Nucleoporin Nup107) | Plays a role in the nuclear pore complex (NPC) assembly and/or maintenance (PubMed:12552102, PubMed:15229283, PubMed:30179222). Required for the assembly of peripheral proteins into the NPC (PubMed:12552102, PubMed:15229283). May anchor NUP62 to the NPC (PubMed:15229283). Involved in nephrogenesis (PubMed:30179222). {ECO:0000269|PubMed:12552102, ECO:0000269|PubMed:15229283, ECO:0000269|PubMed:30179222}. |
P62136 | PPP1CA | S182 | ochoa | Serine/threonine-protein phosphatase PP1-alpha catalytic subunit (PP-1A) (EC 3.1.3.16) | Protein phosphatase that associates with over 200 regulatory proteins to form highly specific holoenzymes which dephosphorylate hundreds of biological targets (PubMed:28216226, PubMed:30158517, PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670, PubMed:39603239, PubMed:39603240). Protein phosphatase 1 (PP1) is essential for cell division, transcription elongation, and participates in the regulation of glycogen metabolism, muscle contractility and protein synthesis (PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670, PubMed:39603239, PubMed:39603240). Involved in regulation of ionic conductances and long-term synaptic plasticity. May play an important role in dephosphorylating substrates such as the postsynaptic density-associated Ca(2+)/calmodulin dependent protein kinase II. Catalytic component of the PNUTS-PP1 protein phosphatase complex, a protein phosphatase 1 (PP1) complex that promotes RNA polymerase II transcription pause-release, allowing transcription elongation: the PNUTS-PP1 complex mediates the release of RNA polymerase II from promoter-proximal region of genes by catalyzing dephosphorylation of proteins involved in transcription, such as AFF4, CDK9, MEPCE, INTS12, NCBP1, POLR2M/GDOWN1 and SUPT6H (PubMed:39603239, PubMed:39603240). The PNUTS-PP1 complex also regulates transcription termination by mediating dephosphorylation of SUPT5H in termination zones downstream of poly(A) sites, thereby promoting deceleration of RNA polymerase II transcription (PubMed:31677974). PNUTS-PP1 complex is also involved in the response to replication stress by mediating dephosphorylation of POLR2A at 'Ser-5' of the CTD, promoting RNA polymerase II degradation (PubMed:33264625). PNUTS-PP1 also plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase (PubMed:20516061). Regulates NEK2 function in terms of kinase activity and centrosome number and splitting, both in the presence and absence of radiation-induced DNA damage (PubMed:17283141). Regulator of neural tube and optic fissure closure, and enteric neural crest cell (ENCCs) migration during development (By similarity). In balance with CSNK1D and CSNK1E, determines the circadian period length, through the regulation of the speed and rhythmicity of PER1 and PER2 phosphorylation (PubMed:21712997). May dephosphorylate CSNK1D and CSNK1E (PubMed:21712997). Dephosphorylates the 'Ser-418' residue of FOXP3 in regulatory T-cells (Treg) from patients with rheumatoid arthritis, thereby inactivating FOXP3 and rendering Treg cells functionally defective (PubMed:23396208). Dephosphorylates CENPA (PubMed:25556658). Dephosphorylates the 'Ser-139' residue of ATG16L1 causing dissociation of ATG12-ATG5-ATG16L1 complex, thereby inhibiting autophagy (PubMed:26083323). Together with PPP1CC (PP1-gamma subunit), dephosphorylates IFIH1/MDA5 and RIG-I leading to their activation and a functional innate immune response (PubMed:23499489). Core component of the SHOC2-MRAS-PP1c (SMP) holophosphatase complex that regulates the MAPK pathway activation (PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670). The SMP complex specifically dephosphorylates the inhibitory phosphorylation at 'Ser-259' of RAF1 kinase, 'Ser-365' of BRAF kinase and 'Ser-214' of ARAF kinase, stimulating their kinase activities (PubMed:35768504, PubMed:35830882, PubMed:35831509, PubMed:36175670). The SMP complex enhances the dephosphorylation activity and substrate specificity of PP1c (PubMed:35768504, PubMed:36175670). {ECO:0000250|UniProtKB:P62137, ECO:0000269|PubMed:17283141, ECO:0000269|PubMed:20516061, ECO:0000269|PubMed:21712997, ECO:0000269|PubMed:23396208, ECO:0000269|PubMed:23499489, ECO:0000269|PubMed:25556658, ECO:0000269|PubMed:26083323, ECO:0000269|PubMed:28216226, ECO:0000269|PubMed:30158517, ECO:0000269|PubMed:31677974, ECO:0000269|PubMed:33264625, ECO:0000269|PubMed:35768504, ECO:0000269|PubMed:35830882, ECO:0000269|PubMed:35831509, ECO:0000269|PubMed:36175670, ECO:0000269|PubMed:39603239, ECO:0000269|PubMed:39603240}.; FUNCTION: (Microbial infection) Necessary for alphaviruses replication. {ECO:0000269|PubMed:29769351}. |
P62140 | PPP1CB | S181 | ochoa | Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PP-1B) (PPP1CD) (EC 3.1.3.16) (EC 3.1.3.53) | Protein phosphatase that associates with over 200 regulatory proteins to form highly specific holoenzymes which dephosphorylate hundreds of biological targets. Protein phosphatase (PP1) is essential for cell division, it participates in the regulation of glycogen metabolism, muscle contractility and protein synthesis. Involved in regulation of ionic conductances and long-term synaptic plasticity. Component of the PTW/PP1 phosphatase complex, which plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase. In balance with CSNK1D and CSNK1E, determines the circadian period length, through the regulation of the speed and rhythmicity of PER1 and PER2 phosphorylation. May dephosphorylate CSNK1D and CSNK1E. Dephosphorylates the 'Ser-418' residue of FOXP3 in regulatory T-cells (Treg) from patients with rheumatoid arthritis, thereby inactivating FOXP3 and rendering Treg cells functionally defective (PubMed:23396208). Core component of the SHOC2-MRAS-PP1c (SMP) holophosphatase complex that regulates the MAPK pathway activation (PubMed:35768504, PubMed:35831509, PubMed:36175670). The SMP complex specifically dephosphorylates the inhibitory phosphorylation at 'Ser-259' of RAF1 kinase, 'Ser-365' of BRAF kinase and 'Ser-214' of ARAF kinase, stimulating their kinase activities (PubMed:35768504, PubMed:35831509, PubMed:36175670). The SMP complex enhances the dephosphorylation activity and substrate specificity of PP1c (PubMed:35768504, PubMed:36175670). {ECO:0000269|PubMed:20516061, ECO:0000269|PubMed:21712997, ECO:0000269|PubMed:23396208, ECO:0000269|PubMed:35768504, ECO:0000269|PubMed:35831509, ECO:0000269|PubMed:36175670}. |
P68363 | TUBA1B | T223 | ochoa | Tubulin alpha-1B chain (EC 3.6.5.-) (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain] | Tubulin is the major constituent of microtubules, protein filaments consisting of alpha- and beta-tubulin heterodimers (PubMed:38305685, PubMed:34996871, PubMed:38609661). Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms (PubMed:38305685, PubMed:34996871, PubMed:38609661). Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin (PubMed:34996871, PubMed:38609661). {ECO:0000269|PubMed:34996871, ECO:0000269|PubMed:38305685, ECO:0000269|PubMed:38609661}. |
P68366 | TUBA4A | T223 | ochoa | Tubulin alpha-4A chain (EC 3.6.5.-) (Alpha-tubulin 1) (Testis-specific alpha-tubulin) (Tubulin H2-alpha) (Tubulin alpha-1 chain) | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
P68371 | TUBB4B | T221 | ochoa | Tubulin beta-4B chain (Tubulin beta-2 chain) (Tubulin beta-2C chain) | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
P68371 | TUBB4B | S234 | ochoa | Tubulin beta-4B chain (Tubulin beta-2 chain) (Tubulin beta-2C chain) | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
P78527 | PRKDC | S3366 | ochoa | DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1) (DNPK1) (Ser-473 kinase) (S473K) (p460) | Serine/threonine-protein kinase that acts as a molecular sensor for DNA damage (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:33854234). Involved in DNA non-homologous end joining (NHEJ) required for double-strand break (DSB) repair and V(D)J recombination (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:33854234, PubMed:34352203). Must be bound to DNA to express its catalytic properties (PubMed:11955432). Promotes processing of hairpin DNA structures in V(D)J recombination by activation of the hairpin endonuclease artemis (DCLRE1C) (PubMed:11955432). Recruited by XRCC5 and XRCC6 to DNA ends and is required to (1) protect and align broken ends of DNA, thereby preventing their degradation, (2) and sequester the DSB for repair by NHEJ (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:15574326, PubMed:33854234). Acts as a scaffold protein to aid the localization of DNA repair proteins to the site of damage (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:15574326). The assembly of the DNA-PK complex at DNA ends is also required for the NHEJ ligation step (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:15574326). Found at the ends of chromosomes, suggesting a further role in the maintenance of telomeric stability and the prevention of chromosomal end fusion (By similarity). Also involved in modulation of transcription (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:15574326). As part of the DNA-PK complex, involved in the early steps of ribosome assembly by promoting the processing of precursor rRNA into mature 18S rRNA in the small-subunit processome (PubMed:32103174). Binding to U3 small nucleolar RNA, recruits PRKDC and XRCC5/Ku86 to the small-subunit processome (PubMed:32103174). Recognizes the substrate consensus sequence [ST]-Q (PubMed:11955432, PubMed:12649176, PubMed:14734805, PubMed:15574326). Phosphorylates 'Ser-139' of histone variant H2AX, thereby regulating DNA damage response mechanism (PubMed:14627815, PubMed:16046194). Phosphorylates ASF1A, DCLRE1C, c-Abl/ABL1, histone H1, HSPCA, c-jun/JUN, p53/TP53, PARP1, POU2F1, DHX9, FH, SRF, NHEJ1/XLF, XRCC1, XRCC4, XRCC5, XRCC6, WRN, MYC and RFA2 (PubMed:10026262, PubMed:10467406, PubMed:11889123, PubMed:12509254, PubMed:14599745, PubMed:14612514, PubMed:14704337, PubMed:15177042, PubMed:1597196, PubMed:16397295, PubMed:18644470, PubMed:2247066, PubMed:2507541, PubMed:26237645, PubMed:26666690, PubMed:28712728, PubMed:29478807, PubMed:30247612, PubMed:8407951, PubMed:8464713, PubMed:9139719, PubMed:9362500). Can phosphorylate C1D not only in the presence of linear DNA but also in the presence of supercoiled DNA (PubMed:9679063). Ability to phosphorylate p53/TP53 in the presence of supercoiled DNA is dependent on C1D (PubMed:9363941). Acts as a regulator of the phosphatidylinositol 3-kinase/protein kinase B signal transduction by mediating phosphorylation of 'Ser-473' of protein kinase B (PKB/AKT1, PKB/AKT2, PKB/AKT3), promoting their activation (PubMed:15262962). Contributes to the determination of the circadian period length by antagonizing phosphorylation of CRY1 'Ser-588' and increasing CRY1 protein stability, most likely through an indirect mechanism (By similarity). Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (PubMed:28712728). Also regulates the cGAS-STING pathway by catalyzing phosphorylation of CGAS, thereby impairing CGAS oligomerization and activation (PubMed:33273464). Also regulates the cGAS-STING pathway by mediating phosphorylation of PARP1 (PubMed:35460603). {ECO:0000250|UniProtKB:P97313, ECO:0000269|PubMed:10026262, ECO:0000269|PubMed:10467406, ECO:0000269|PubMed:11889123, ECO:0000269|PubMed:11955432, ECO:0000269|PubMed:12509254, ECO:0000269|PubMed:12649176, ECO:0000269|PubMed:14599745, ECO:0000269|PubMed:14612514, ECO:0000269|PubMed:14627815, ECO:0000269|PubMed:14704337, ECO:0000269|PubMed:14734805, ECO:0000269|PubMed:15177042, ECO:0000269|PubMed:15262962, ECO:0000269|PubMed:15574326, ECO:0000269|PubMed:1597196, ECO:0000269|PubMed:16046194, ECO:0000269|PubMed:16397295, ECO:0000269|PubMed:18644470, ECO:0000269|PubMed:2247066, ECO:0000269|PubMed:2507541, ECO:0000269|PubMed:26237645, ECO:0000269|PubMed:26666690, ECO:0000269|PubMed:28712728, ECO:0000269|PubMed:29478807, ECO:0000269|PubMed:30247612, ECO:0000269|PubMed:32103174, ECO:0000269|PubMed:33273464, ECO:0000269|PubMed:33854234, ECO:0000269|PubMed:34352203, ECO:0000269|PubMed:35460603, ECO:0000269|PubMed:8407951, ECO:0000269|PubMed:8464713, ECO:0000269|PubMed:9139719, ECO:0000269|PubMed:9362500, ECO:0000269|PubMed:9363941, ECO:0000269|PubMed:9679063}. |
P98082 | DAB2 | S231 | ochoa | Disabled homolog 2 (Adaptor molecule disabled-2) (Differentially expressed in ovarian carcinoma 2) (DOC-2) (Differentially-expressed protein 2) | Adapter protein that functions as a clathrin-associated sorting protein (CLASP) required for clathrin-mediated endocytosis of selected cargo proteins. Can bind and assemble clathrin, and binds simultaneously to phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) and cargos containing non-phosphorylated NPXY internalization motifs, such as the LDL receptor, to recruit them to clathrin-coated pits. Can function in clathrin-mediated endocytosis independently of the AP-2 complex. Involved in endocytosis of integrin beta-1; this function seems to redundant with the AP-2 complex and seems to require DAB2 binding to endocytosis accessory EH domain-containing proteins such as EPS15, EPS15L1 and ITSN1. Involved in endocytosis of cystic fibrosis transmembrane conductance regulator/CFTR. Involved in endocytosis of megalin/LRP2 lipoprotein receptor during embryonal development. Required for recycling of the TGF-beta receptor. Involved in CFTR trafficking to the late endosome. Involved in several receptor-mediated signaling pathways. Involved in TGF-beta receptor signaling and facilitates phosphorylation of the signal transducer SMAD2. Mediates TFG-beta-stimulated JNK activation. May inhibit the canoniocal Wnt/beta-catenin signaling pathway by stabilizing the beta-catenin destruction complex through a competing association with axin preventing its dephosphorylation through protein phosphatase 1 (PP1). Sequesters LRP6 towards clathrin-mediated endocytosis, leading to inhibition of Wnt/beta-catenin signaling. May activate non-canonical Wnt signaling. In cell surface growth factor/Ras signaling pathways proposed to inhibit ERK activation by interrupting the binding of GRB2 to SOS1 and to inhibit SRC by preventing its activating phosphorylation at 'Tyr-419'. Proposed to be involved in modulation of androgen receptor (AR) signaling mediated by SRC activation; seems to compete with AR for interaction with SRC. Plays a role in the CSF-1 signal transduction pathway. Plays a role in cellular differentiation. Involved in cell positioning and formation of visceral endoderm (VE) during embryogenesis and proposed to be required in the VE to respond to Nodal signaling coming from the epiblast. Required for the epithelial to mesenchymal transition, a process necessary for proper embryonic development. May be involved in myeloid cell differentiation and can induce macrophage adhesion and spreading. May act as a tumor suppressor. {ECO:0000269|PubMed:11387212, ECO:0000269|PubMed:12805222, ECO:0000269|PubMed:16267015, ECO:0000269|PubMed:16984970, ECO:0000269|PubMed:19306879, ECO:0000269|PubMed:21995445, ECO:0000269|PubMed:22323290, ECO:0000269|PubMed:22491013}. |
P98168 | ZXDA | S714 | ochoa | Zinc finger X-linked protein ZXDA | Cooperates with CIITA to promote transcription of MHC class I and MHC class II genes. {ECO:0000269|PubMed:17493635}. |
P98169 | ZXDB | S718 | ochoa | Zinc finger X-linked protein ZXDB | Cooperates with CIITA to promote transcription of MHC class I and MHC class II genes. {ECO:0000250}. |
Q00341 | HDLBP | S35 | ochoa | Vigilin (High density lipoprotein-binding protein) (HDL-binding protein) | Appears to play a role in cell sterol metabolism. It may function to protect cells from over-accumulation of cholesterol. |
Q01094 | E2F1 | S364 | psp | Transcription factor E2F1 (E2F-1) (PBR3) (Retinoblastoma-associated protein 1) (RBAP-1) (Retinoblastoma-binding protein 3) (RBBP-3) (pRB-binding protein E2F-1) | Transcription activator that binds DNA cooperatively with DP proteins through the E2 recognition site, 5'-TTTC[CG]CGC-3' found in the promoter region of a number of genes whose products are involved in cell cycle regulation or in DNA replication (PubMed:10675335, PubMed:12717439, PubMed:17050006, PubMed:17704056, PubMed:18625225, PubMed:28992046). The DRTF1/E2F complex functions in the control of cell-cycle progression from G1 to S phase (PubMed:10675335, PubMed:12717439, PubMed:17704056). E2F1 binds preferentially RB1 in a cell-cycle dependent manner (PubMed:10675335, PubMed:12717439, PubMed:17704056). It can mediate both cell proliferation and TP53/p53-dependent apoptosis (PubMed:8170954). Blocks adipocyte differentiation by binding to specific promoters repressing CEBPA binding to its target gene promoters (PubMed:20176812). Directly activates transcription of PEG10 (PubMed:17050006, PubMed:18625225, PubMed:28992046). Positively regulates transcription of RRP1B (PubMed:20040599). {ECO:0000269|PubMed:10675335, ECO:0000269|PubMed:12717439, ECO:0000269|PubMed:17050006, ECO:0000269|PubMed:17704056, ECO:0000269|PubMed:18625225, ECO:0000269|PubMed:20040599, ECO:0000269|PubMed:20176812, ECO:0000269|PubMed:28992046, ECO:0000269|PubMed:8170954}. |
Q01362 | MS4A2 | S19 | ochoa | High affinity immunoglobulin epsilon receptor subunit beta (FcERI) (Fc epsilon receptor I beta-chain) (IgE Fc receptor subunit beta) (Membrane-spanning 4-domains subfamily A member 2) | High affinity receptor that binds to the Fc region of immunoglobulins epsilon. Aggregation of FCER1 by multivalent antigens is required for the full mast cell response, including the release of preformed mediators (such as histamine) by degranulation and de novo production of lipid mediators and cytokines. Also mediates the secretion of important lymphokines. Binding of allergen to receptor-bound IgE leads to cell activation and the release of mediators responsible for the manifestations of allergy. |
Q03001 | DST | S2239 | ochoa | Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) | Cytoskeletal linker protein. Acts as an integrator of intermediate filaments, actin and microtubule cytoskeleton networks. Required for anchoring either intermediate filaments to the actin cytoskeleton in neural and muscle cells or keratin-containing intermediate filaments to hemidesmosomes in epithelial cells. The proteins may self-aggregate to form filaments or a two-dimensional mesh. Regulates the organization and stability of the microtubule network of sensory neurons to allow axonal transport. Mediates docking of the dynein/dynactin motor complex to vesicle cargos for retrograde axonal transport through its interaction with TMEM108 and DCTN1 (By similarity). {ECO:0000250|UniProtKB:Q91ZU6}.; FUNCTION: [Isoform 3]: Plays a structural role in the assembly of hemidesmosomes of epithelial cells; anchors keratin-containing intermediate filaments to the inner plaque of hemidesmosomes. Required for the regulation of keratinocyte polarity and motility; mediates integrin ITGB4 regulation of RAC1 activity.; FUNCTION: [Isoform 6]: Required for bundling actin filaments around the nucleus. {ECO:0000250, ECO:0000269|PubMed:10428034, ECO:0000269|PubMed:12482924, ECO:0000269|PubMed:19403692}.; FUNCTION: [Isoform 7]: Regulates the organization and stability of the microtubule network of sensory neurons to allow axonal transport. |
Q06187 | BTK | Y134 | ochoa | Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase) | Non-receptor tyrosine kinase indispensable for B lymphocyte development, differentiation and signaling (PubMed:19290921). Binding of antigen to the B-cell antigen receptor (BCR) triggers signaling that ultimately leads to B-cell activation (PubMed:19290921). After BCR engagement and activation at the plasma membrane, phosphorylates PLCG2 at several sites, igniting the downstream signaling pathway through calcium mobilization, followed by activation of the protein kinase C (PKC) family members (PubMed:11606584). PLCG2 phosphorylation is performed in close cooperation with the adapter protein B-cell linker protein BLNK (PubMed:11606584). BTK acts as a platform to bring together a diverse array of signaling proteins and is implicated in cytokine receptor signaling pathways (PubMed:16517732, PubMed:17932028). Plays an important role in the function of immune cells of innate as well as adaptive immunity, as a component of the Toll-like receptors (TLR) pathway (PubMed:16517732). The TLR pathway acts as a primary surveillance system for the detection of pathogens and are crucial to the activation of host defense (PubMed:16517732). Especially, is a critical molecule in regulating TLR9 activation in splenic B-cells (PubMed:16517732, PubMed:17932028). Within the TLR pathway, induces tyrosine phosphorylation of TIRAP which leads to TIRAP degradation (PubMed:16415872). BTK also plays a critical role in transcription regulation (PubMed:19290921). Induces the activity of NF-kappa-B, which is involved in regulating the expression of hundreds of genes (PubMed:19290921). BTK is involved on the signaling pathway linking TLR8 and TLR9 to NF-kappa-B (PubMed:19290921). Acts as an activator of NLRP3 inflammasome assembly by mediating phosphorylation of NLRP3 (PubMed:34554188). Transiently phosphorylates transcription factor GTF2I on tyrosine residues in response to BCR (PubMed:9012831). GTF2I then translocates to the nucleus to bind regulatory enhancer elements to modulate gene expression (PubMed:9012831). ARID3A and NFAT are other transcriptional target of BTK (PubMed:16738337). BTK is required for the formation of functional ARID3A DNA-binding complexes (PubMed:16738337). There is however no evidence that BTK itself binds directly to DNA (PubMed:16738337). BTK has a dual role in the regulation of apoptosis (PubMed:9751072). Plays a role in STING1-mediated induction of type I interferon (IFN) response by phosphorylating DDX41 (PubMed:25704810). {ECO:0000269|PubMed:11606584, ECO:0000269|PubMed:16415872, ECO:0000269|PubMed:16517732, ECO:0000269|PubMed:16738337, ECO:0000269|PubMed:17932028, ECO:0000269|PubMed:25704810, ECO:0000269|PubMed:34554188, ECO:0000269|PubMed:9012831, ECO:0000303|PubMed:19290921, ECO:0000303|PubMed:9751072}. |
Q07065 | CKAP4 | S461 | ochoa | Cytoskeleton-associated protein 4 (63-kDa cytoskeleton-linking membrane protein) (Climp-63) (p63) | Mediates the anchoring of the endoplasmic reticulum to microtubules. {ECO:0000269|PubMed:15703217}.; FUNCTION: High-affinity epithelial cell surface receptor for the FZD8-related low molecular weight sialoglycopeptide APF/antiproliferative factor. Mediates the APF antiproliferative signaling within cells. {ECO:0000269|PubMed:17030514, ECO:0000269|PubMed:19144824}. |
Q09472 | EP300 | S2039 | psp | Histone acetyltransferase p300 (p300 HAT) (EC 2.3.1.48) (E1A-associated protein p300) (Histone butyryltransferase p300) (EC 2.3.1.-) (Histone crotonyltransferase p300) (EC 2.3.1.-) (Protein 2-hydroxyisobutyryltransferase p300) (EC 2.3.1.-) (Protein lactyltransferas p300) (EC 2.3.1.-) (Protein propionyltransferase p300) (EC 2.3.1.-) | Functions as a histone acetyltransferase and regulates transcription via chromatin remodeling (PubMed:23415232, PubMed:23934153, PubMed:8945521). Acetylates all four core histones in nucleosomes (PubMed:23415232, PubMed:23934153, PubMed:8945521). Histone acetylation gives an epigenetic tag for transcriptional activation (PubMed:23415232, PubMed:23934153, PubMed:8945521). Mediates acetylation of histone H3 at 'Lys-122' (H3K122ac), a modification that localizes at the surface of the histone octamer and stimulates transcription, possibly by promoting nucleosome instability (PubMed:23415232). Mediates acetylation of histone H3 at 'Lys-18' and 'Lys-27' (H3K18ac and H3K27ac, respectively) (PubMed:21131905, PubMed:23911289). Also able to acetylate histone lysine residues that are already monomethylated on the same side chain to form N6-acetyl-N6-methyllysine (Kacme), an epigenetic mark of active chromatin associated with increased transcriptional initiation (PubMed:37731000). Catalyzes formation of histone H4 acetyl-methylated at 'Lys-5' and 'Lys-12' (H4K5acme and H4K12acme, respectively) (PubMed:37731000). Also functions as acetyltransferase for non-histone targets, such as ALX1, HDAC1, PRMT1, SIRT2, STAT3 or GLUL (PubMed:12929931, PubMed:15653507, PubMed:16285960, PubMed:16762839, PubMed:18722353, PubMed:18782771, PubMed:26990986). Acetylates 'Lys-131' of ALX1 and acts as its coactivator (PubMed:12929931). Acetylates SIRT2 and is proposed to indirectly increase the transcriptional activity of p53/TP53 through acetylation and subsequent attenuation of SIRT2 deacetylase function (PubMed:18722353). Following DNA damage, forms a stress-responsive p53/TP53 coactivator complex with JMY which mediates p53/TP53 acetylation, thereby increasing p53/TP53-dependent transcription and apoptosis (PubMed:11511361, PubMed:15448695). Promotes chromatin acetylation in heat shock responsive HSP genes during the heat shock response (HSR), thereby stimulating HSR transcription (PubMed:18451878). Acetylates HDAC1 leading to its inactivation and modulation of transcription (PubMed:16762839). Acetylates 'Lys-247' of EGR2 (By similarity). Acts as a TFAP2A-mediated transcriptional coactivator in presence of CITED2 (PubMed:12586840). Plays a role as a coactivator of NEUROD1-dependent transcription of the secretin and p21 genes and controls terminal differentiation of cells in the intestinal epithelium. Promotes cardiac myocyte enlargement (PubMed:14752053). Can also mediate transcriptional repression. Acetylates FOXO1 and enhances its transcriptional activity (PubMed:15890677). Acetylates STAT3 at different sites, promoting both STAT3 dimerization and activation and recruitment to chromatin (PubMed:15653507, PubMed:16285960, PubMed:18782771). Acetylates BCL6 which disrupts its ability to recruit histone deacetylases and hinders its transcriptional repressor activity (PubMed:12402037). Participates in CLOCK or NPAS2-regulated rhythmic gene transcription; exhibits a circadian association with CLOCK or NPAS2, correlating with increase in PER1/2 mRNA and histone H3 acetylation on the PER1/2 promoter (PubMed:14645221). Acetylates MTA1 at 'Lys-626' which is essential for its transcriptional coactivator activity (PubMed:16617102). Acetylates XBP1 isoform 2; acetylation increases protein stability of XBP1 isoform 2 and enhances its transcriptional activity (PubMed:20955178). Acetylates PCNA; acetylation promotes removal of chromatin-bound PCNA and its degradation during nucleotide excision repair (NER) (PubMed:24939902). Acetylates MEF2D (PubMed:21030595). Acetylates and stabilizes ZBTB7B protein by antagonizing ubiquitin conjugation and degradation, this mechanism may be involved in CD4/CD8 lineage differentiation (PubMed:20810990). Acetylates GABPB1, impairing GABPB1 heterotetramerization and activity (By similarity). Acetylates PCK1 and promotes PCK1 anaplerotic activity (PubMed:30193097). Acetylates RXRA and RXRG (PubMed:17761950). Acetylates isoform M2 of PKM (PKM2), promoting its homodimerization and conversion into a protein kinase (PubMed:24120661). Acetylates RPTOR in response to leucine, leading to activation of the mTORC1 complex (PubMed:30197302, PubMed:32561715). Acetylates RICTOR, leading to activation of the mTORC2 complex (PubMed:22084251). Mediates cAMP-gene regulation by binding specifically to phosphorylated CREBBP (PubMed:8917528). In addition to protein acetyltransferase, can use different acyl-CoA substrates, such as (2E)-butenoyl-CoA (crotonyl-CoA), butanoyl-CoA (butyryl-CoA), 2-hydroxyisobutanoyl-CoA (2-hydroxyisobutyryl-CoA), lactoyl-CoA or propanoyl-CoA (propionyl-CoA), and is able to mediate protein crotonylation, butyrylation, 2-hydroxyisobutyrylation, lactylation or propionylation, respectively (PubMed:17267393, PubMed:25818647, PubMed:29775581, PubMed:31645732). Acts as a histone crotonyltransferase; crotonylation marks active promoters and enhancers and confers resistance to transcriptional repressors (PubMed:25818647). Histone crotonyltransferase activity is dependent on the concentration of (2E)-butenoyl-CoA (crotonyl-CoA) substrate and such activity is weak when (2E)-butenoyl-CoA (crotonyl-CoA) concentration is low (PubMed:25818647). Also acts as a histone butyryltransferase; butyrylation marks active promoters (PubMed:17267393). Catalyzes histone lactylation in macrophages by using lactoyl-CoA directly derived from endogenous or exogenous lactate, leading to stimulates gene transcription (PubMed:31645732). Acts as a protein-lysine 2-hydroxyisobutyryltransferase; regulates glycolysis by mediating 2-hydroxyisobutyrylation of glycolytic enzymes (PubMed:29775581). Functions as a transcriptional coactivator for SMAD4 in the TGF-beta signaling pathway (PubMed:25514493). {ECO:0000250|UniProtKB:B2RWS6, ECO:0000269|PubMed:10733570, ECO:0000269|PubMed:11430825, ECO:0000269|PubMed:11511361, ECO:0000269|PubMed:11701890, ECO:0000269|PubMed:12402037, ECO:0000269|PubMed:12586840, ECO:0000269|PubMed:12929931, ECO:0000269|PubMed:14645221, ECO:0000269|PubMed:14752053, ECO:0000269|PubMed:15186775, ECO:0000269|PubMed:15448695, ECO:0000269|PubMed:15653507, ECO:0000269|PubMed:15890677, ECO:0000269|PubMed:16285960, ECO:0000269|PubMed:16617102, ECO:0000269|PubMed:16762839, ECO:0000269|PubMed:17267393, ECO:0000269|PubMed:17761950, ECO:0000269|PubMed:18451878, ECO:0000269|PubMed:18722353, ECO:0000269|PubMed:18782771, ECO:0000269|PubMed:18995842, ECO:0000269|PubMed:20810990, ECO:0000269|PubMed:21030595, ECO:0000269|PubMed:21131905, ECO:0000269|PubMed:22084251, ECO:0000269|PubMed:23415232, ECO:0000269|PubMed:23911289, ECO:0000269|PubMed:23934153, ECO:0000269|PubMed:24120661, ECO:0000269|PubMed:24939902, ECO:0000269|PubMed:25514493, ECO:0000269|PubMed:25818647, ECO:0000269|PubMed:26990986, ECO:0000269|PubMed:29775581, ECO:0000269|PubMed:30193097, ECO:0000269|PubMed:30197302, ECO:0000269|PubMed:31645732, ECO:0000269|PubMed:32561715, ECO:0000269|PubMed:37731000, ECO:0000269|PubMed:8917528, ECO:0000269|PubMed:8945521, ECO:0000305|PubMed:20955178}.; FUNCTION: (Microbial infection) In case of HIV-1 infection, it is recruited by the viral protein Tat. Regulates Tat's transactivating activity and may help inducing chromatin remodeling of proviral genes. Binds to and may be involved in the transforming capacity of the adenovirus E1A protein. {ECO:0000269|PubMed:10545121, ECO:0000269|PubMed:11080476}. |
Q09666 | AHNAK | S5310 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S5589 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q12802 | AKAP13 | S1168 | ochoa | A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47) | Scaffold protein that plays an important role in assembling signaling complexes downstream of several types of G protein-coupled receptors. Activates RHOA in response to signaling via G protein-coupled receptors via its function as Rho guanine nucleotide exchange factor (PubMed:11546812, PubMed:15229649, PubMed:23090968, PubMed:24993829, PubMed:25186459). May also activate other Rho family members (PubMed:11546812). Part of a kinase signaling complex that links ADRA1A and ADRA1B adrenergic receptor signaling to the activation of downstream p38 MAP kinases, such as MAPK11 and MAPK14 (PubMed:17537920, PubMed:21224381, PubMed:23716597). Part of a signaling complex that links ADRA1B signaling to the activation of RHOA and IKBKB/IKKB, leading to increased NF-kappa-B transcriptional activity (PubMed:23090968). Part of a RHOA-dependent signaling cascade that mediates responses to lysophosphatidic acid (LPA), a signaling molecule that activates G-protein coupled receptors and potentiates transcriptional activation of the glucocorticoid receptor NR3C1 (PubMed:16469733). Part of a signaling cascade that stimulates MEF2C-dependent gene expression in response to lysophosphatidic acid (LPA) (By similarity). Part of a signaling pathway that activates MAPK11 and/or MAPK14 and leads to increased transcription activation of the estrogen receptors ESR1 and ESR2 (PubMed:11579095, PubMed:9627117). Part of a signaling cascade that links cAMP and EGFR signaling to BRAF signaling and to PKA-mediated phosphorylation of KSR1, leading to the activation of downstream MAP kinases, such as MAPK1 or MAPK3 (PubMed:21102438). Functions as a scaffold protein that anchors cAMP-dependent protein kinase (PKA) and PRKD1. This promotes activation of PRKD1, leading to increased phosphorylation of HDAC5 and ultimately cardiomyocyte hypertrophy (By similarity). Has no guanine nucleotide exchange activity on CDC42, Ras or Rac (PubMed:11546812). Required for normal embryonic heart development, and in particular for normal sarcomere formation in the developing cardiomyocytes (By similarity). Plays a role in cardiomyocyte growth and cardiac hypertrophy in response to activation of the beta-adrenergic receptor by phenylephrine or isoproterenol (PubMed:17537920, PubMed:23090968). Required for normal adaptive cardiac hypertrophy in response to pressure overload (PubMed:23716597). Plays a role in osteogenesis (By similarity). {ECO:0000250|UniProtKB:E9Q394, ECO:0000269|PubMed:11546812, ECO:0000269|PubMed:11579095, ECO:0000269|PubMed:17537920, ECO:0000269|PubMed:21224381, ECO:0000269|PubMed:23716597, ECO:0000269|PubMed:24993829, ECO:0000269|PubMed:25186459, ECO:0000269|PubMed:9627117, ECO:0000269|PubMed:9891067}. |
Q12912 | IRAG2 | S345 | ochoa | Inositol 1,4,5-triphosphate receptor associated 2 (Lymphoid-restricted membrane protein) (Protein Jaw1) [Cleaved into: Processed inositol 1,4,5-triphosphate receptor associated 2] | Plays a role in the delivery of peptides to major histocompatibility complex (MHC) class I molecules; this occurs in a transporter associated with antigen processing (TAP)-independent manner. May play a role in taste signal transduction via ITPR3. May play a role during fertilization in pronucleus congression and fusion. Plays a role in maintaining nuclear shape, maybe as a component of the LINC complex and through interaction with microtubules. Plays a role in the regulation of cellular excitability by regulating the hyperpolarization-activated cyclic nucleotide-gated HCN4 channel activity (By similarity). {ECO:0000250|UniProtKB:Q60664}. |
Q12923 | PTPN13 | S502 | ochoa | Tyrosine-protein phosphatase non-receptor type 13 (EC 3.1.3.48) (Fas-associated protein-tyrosine phosphatase 1) (FAP-1) (PTP-BAS) (Protein-tyrosine phosphatase 1E) (PTP-E1) (hPTPE1) (Protein-tyrosine phosphatase PTPL1) | Tyrosine phosphatase which negatively regulates FAS-induced apoptosis and NGFR-mediated pro-apoptotic signaling (PubMed:15611135). May regulate phosphoinositide 3-kinase (PI3K) signaling through dephosphorylation of PIK3R2 (PubMed:23604317). {ECO:0000269|PubMed:15611135, ECO:0000269|PubMed:23604317}. |
Q13085 | ACACA | S48 | ochoa | Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (Acetyl-Coenzyme A carboxylase alpha) (ACC-alpha) | Cytosolic enzyme that catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, the first and rate-limiting step of de novo fatty acid biosynthesis (PubMed:20457939, PubMed:20952656, PubMed:29899443). This is a 2 steps reaction starting with the ATP-dependent carboxylation of the biotin carried by the biotin carboxyl carrier (BCC) domain followed by the transfer of the carboxyl group from carboxylated biotin to acetyl-CoA (PubMed:20457939, PubMed:20952656, PubMed:29899443). {ECO:0000269|PubMed:20457939, ECO:0000269|PubMed:20952656, ECO:0000269|PubMed:29899443}. |
Q13085 | ACACA | S1203 | ochoa | Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (Acetyl-Coenzyme A carboxylase alpha) (ACC-alpha) | Cytosolic enzyme that catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, the first and rate-limiting step of de novo fatty acid biosynthesis (PubMed:20457939, PubMed:20952656, PubMed:29899443). This is a 2 steps reaction starting with the ATP-dependent carboxylation of the biotin carried by the biotin carboxyl carrier (BCC) domain followed by the transfer of the carboxyl group from carboxylated biotin to acetyl-CoA (PubMed:20457939, PubMed:20952656, PubMed:29899443). {ECO:0000269|PubMed:20457939, ECO:0000269|PubMed:20952656, ECO:0000269|PubMed:29899443}. |
Q13190 | STX5 | S264 | ochoa | Syntaxin-5 | Mediates endoplasmic reticulum to Golgi transport. Together with p115/USO1 and GM130/GOLGA2, involved in vesicle tethering and fusion at the cis-Golgi membrane to maintain the stacked and inter-connected structure of the Golgi apparatus. {ECO:0000250|UniProtKB:Q08851}.; FUNCTION: [Isoform 2]: Required for Golgi to endoplasmic reticulum retrogade transport, and for intra-Golgi transport. {ECO:0000269|PubMed:34711829}.; FUNCTION: (Microbial infection) Required for the efficient production of infectious virion during human cytomegalovirus infection. Mechanistically, participates in the formation of the cytoplasmic viral assembly compartment where tegument acquisition and envelopment occur. {ECO:0000269|PubMed:27795424}. |
Q13330 | MTA1 | S522 | ochoa|psp | Metastasis-associated protein MTA1 | Transcriptional coregulator which can act as both a transcriptional corepressor and coactivator (PubMed:16617102, PubMed:17671180, PubMed:17922032, PubMed:21965678, PubMed:24413532). Acts as a component of the histone deacetylase NuRD complex which participates in the remodeling of chromatin (PubMed:16428440, PubMed:28977666). In the NuRD complex, regulates transcription of its targets by modifying the acetylation status of the target chromatin and cofactor accessibility to the target DNA (PubMed:17671180). In conjunction with other components of NuRD, acts as a transcriptional corepressor of BRCA1, ESR1, TFF1 and CDKN1A (PubMed:17922032, PubMed:24413532). Acts as a transcriptional coactivator of BCAS3, and SUMO2, independent of the NuRD complex (PubMed:16617102, PubMed:17671180, PubMed:21965678). Stimulates the expression of WNT1 by inhibiting the expression of its transcriptional corepressor SIX3 (By similarity). Regulates p53-dependent and -independent DNA repair processes following genotoxic stress (PubMed:19837670). Regulates the stability and function of p53/TP53 by inhibiting its ubiquitination by COP1 and MDM2 thereby regulating the p53-dependent DNA repair (PubMed:19837670). Plays a role in the regulation of the circadian clock and is essential for the generation and maintenance of circadian rhythms under constant light and for normal entrainment of behavior to light-dark (LD) cycles (By similarity). Positively regulates the CLOCK-BMAL1 heterodimer mediated transcriptional activation of its own transcription and the transcription of CRY1 (By similarity). Regulates deacetylation of BMAL1 by regulating SIRT1 expression, resulting in derepressing CRY1-mediated transcription repression (By similarity). With TFCP2L1, promotes establishment and maintenance of pluripotency in embryonic stem cells (ESCs) and inhibits endoderm differentiation (By similarity). {ECO:0000250|UniProtKB:Q8K4B0, ECO:0000269|PubMed:16428440, ECO:0000269|PubMed:16617102, ECO:0000269|PubMed:17671180, ECO:0000269|PubMed:17922032, ECO:0000269|PubMed:19837670, ECO:0000269|PubMed:21965678, ECO:0000269|PubMed:24413532}.; FUNCTION: [Isoform Short]: Binds to ESR1 and sequesters it in the cytoplasm and enhances its non-genomic responses. {ECO:0000269|PubMed:15077195}. |
Q13885 | TUBB2A | T221 | ochoa | Tubulin beta-2A chain (Tubulin beta class IIa) | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
Q13885 | TUBB2A | S234 | ochoa | Tubulin beta-2A chain (Tubulin beta class IIa) | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
Q13950 | RUNX2 | S451 | psp | Runt-related transcription factor 2 (Acute myeloid leukemia 3 protein) (Core-binding factor subunit alpha-1) (CBF-alpha-1) (Oncogene AML-3) (Osteoblast-specific transcription factor 2) (OSF-2) (Polyomavirus enhancer-binding protein 2 alpha A subunit) (PEA2-alpha A) (PEBP2-alpha A) (SL3-3 enhancer factor 1 alpha A subunit) (SL3/AKV core-binding factor alpha A subunit) | Transcription factor involved in osteoblastic differentiation and skeletal morphogenesis (PubMed:28505335, PubMed:28703881, PubMed:28738062). Essential for the maturation of osteoblasts and both intramembranous and endochondral ossification. CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, osteocalcin, osteopontin, bone sialoprotein, alpha 1(I) collagen, LCK, IL-3 and GM-CSF promoters. In osteoblasts, supports transcription activation: synergizes with SPEN/MINT to enhance FGFR2-mediated activation of the osteocalcin FGF-responsive element (OCFRE) (By similarity). Inhibits KAT6B-dependent transcriptional activation. {ECO:0000250, ECO:0000269|PubMed:11965546, ECO:0000269|PubMed:28505335, ECO:0000269|PubMed:28703881, ECO:0000269|PubMed:28738062}. |
Q14676 | MDC1 | S422 | ochoa | Mediator of DNA damage checkpoint protein 1 (Nuclear factor with BRCT domains 1) | Histone reader protein required for checkpoint-mediated cell cycle arrest in response to DNA damage within both the S phase and G2/M phases of the cell cycle (PubMed:12475977, PubMed:12499369, PubMed:12551934, PubMed:12607003, PubMed:12607004, PubMed:12607005, PubMed:12611903, PubMed:14695167, PubMed:15201865, PubMed:15377652, PubMed:16049003, PubMed:16377563, PubMed:30898438). Specifically recognizes and binds histone H2AX phosphorylated at 'Ser-139', a marker of DNA damage, serving as a scaffold for the recruitment of DNA repair and signal transduction proteins to discrete foci of DNA damage sites (PubMed:12607005, PubMed:15201865, PubMed:16049003, PubMed:16377563, PubMed:30898438). Also required for downstream events subsequent to the recruitment of these proteins (PubMed:12607005, PubMed:15201865, PubMed:16049003, PubMed:16377563, PubMed:18582474). These include phosphorylation and activation of the ATM, CHEK1 and CHEK2 kinases, and stabilization of TP53/p53 and apoptosis (PubMed:12499369, PubMed:12551934, PubMed:12607004). ATM and CHEK2 may also be activated independently by a parallel pathway mediated by TP53BP1 (PubMed:12499369, PubMed:12551934, PubMed:12607004). Required for chromosomal stability during mitosis by promoting recruitment of TOPBP1 to DNA double strand breaks (DSBs): TOPBP1 forms filamentous assemblies that bridge MDC1 and tether broken chromosomes during mitosis (PubMed:30898438). Required for the repair of DSBs via homologous recombination by promoting recruitment of NBN component of the MRN complex to DSBs (PubMed:18411307, PubMed:18582474, PubMed:18583988, PubMed:18678890). {ECO:0000269|PubMed:12475977, ECO:0000269|PubMed:12499369, ECO:0000269|PubMed:12551934, ECO:0000269|PubMed:12607003, ECO:0000269|PubMed:12607004, ECO:0000269|PubMed:12607005, ECO:0000269|PubMed:12611903, ECO:0000269|PubMed:14695167, ECO:0000269|PubMed:15201865, ECO:0000269|PubMed:15377652, ECO:0000269|PubMed:16049003, ECO:0000269|PubMed:16377563, ECO:0000269|PubMed:18411307, ECO:0000269|PubMed:18582474, ECO:0000269|PubMed:18583988, ECO:0000269|PubMed:18678890, ECO:0000269|PubMed:30898438}. |
Q14980 | NUMA1 | S1278 | ochoa | Nuclear mitotic apparatus protein 1 (Nuclear matrix protein-22) (NMP-22) (Nuclear mitotic apparatus protein) (NuMA protein) (SP-H antigen) | Microtubule (MT)-binding protein that plays a role in the formation and maintenance of the spindle poles and the alignement and the segregation of chromosomes during mitotic cell division (PubMed:17172455, PubMed:19255246, PubMed:24996901, PubMed:26195665, PubMed:27462074, PubMed:7769006). Functions to tether the minus ends of MTs at the spindle poles, which is critical for the establishment and maintenance of the spindle poles (PubMed:11956313, PubMed:12445386). Plays a role in the establishment of the mitotic spindle orientation during metaphase and elongation during anaphase in a dynein-dynactin-dependent manner (PubMed:23870127, PubMed:24109598, PubMed:24996901, PubMed:26765568). In metaphase, part of a ternary complex composed of GPSM2 and G(i) alpha proteins, that regulates the recruitment and anchorage of the dynein-dynactin complex in the mitotic cell cortex regions situated above the two spindle poles, and hence regulates the correct oritentation of the mitotic spindle (PubMed:22327364, PubMed:23027904, PubMed:23921553). During anaphase, mediates the recruitment and accumulation of the dynein-dynactin complex at the cell membrane of the polar cortical region through direct association with phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), and hence participates in the regulation of the spindle elongation and chromosome segregation (PubMed:22327364, PubMed:23921553, PubMed:24371089, PubMed:24996901). Also binds to other polyanionic phosphoinositides, such as phosphatidylinositol 3-phosphate (PIP), lysophosphatidic acid (LPA) and phosphatidylinositol triphosphate (PIP3), in vitro (PubMed:24371089, PubMed:24996901). Also required for proper orientation of the mitotic spindle during asymmetric cell divisions (PubMed:21816348). Plays a role in mitotic MT aster assembly (PubMed:11163243, PubMed:11229403, PubMed:12445386). Involved in anastral spindle assembly (PubMed:25657325). Positively regulates TNKS protein localization to spindle poles in mitosis (PubMed:16076287). Highly abundant component of the nuclear matrix where it may serve a non-mitotic structural role, occupies the majority of the nuclear volume (PubMed:10075938). Required for epidermal differentiation and hair follicle morphogenesis (By similarity). {ECO:0000250|UniProtKB:E9Q7G0, ECO:0000269|PubMed:11163243, ECO:0000269|PubMed:11229403, ECO:0000269|PubMed:11956313, ECO:0000269|PubMed:12445386, ECO:0000269|PubMed:16076287, ECO:0000269|PubMed:17172455, ECO:0000269|PubMed:19255246, ECO:0000269|PubMed:22327364, ECO:0000269|PubMed:23027904, ECO:0000269|PubMed:23870127, ECO:0000269|PubMed:23921553, ECO:0000269|PubMed:24109598, ECO:0000269|PubMed:24371089, ECO:0000269|PubMed:24996901, ECO:0000269|PubMed:25657325, ECO:0000269|PubMed:26195665, ECO:0000269|PubMed:26765568, ECO:0000269|PubMed:27462074, ECO:0000269|PubMed:7769006, ECO:0000305|PubMed:10075938, ECO:0000305|PubMed:21816348}. |
Q15042 | RAB3GAP1 | S676 | ochoa | Rab3 GTPase-activating protein catalytic subunit (RAB3 GTPase-activating protein 130 kDa subunit) (Rab3-GAP p130) (Rab3-GAP) | Catalytic subunit of the Rab3 GTPase-activating (Rab3GAP) complex composed of RAB3GAP1 and RAB3GAP2, which has GTPase-activating protein (GAP) activity towards various Rab3 subfamily members (RAB3A, RAB3B, RAB3C and RAB3D), RAB5A and RAB43, and guanine nucleotide exchange factor (GEF) activity towards RAB18 (PubMed:10859313, PubMed:24891604, PubMed:9030515). As part of the Rab3GAP complex, acts as a GAP for Rab3 proteins by converting active RAB3-GTP to the inactive form RAB3-GDP (PubMed:10859313). Rab3 proteins are involved in regulated exocytosis of neurotransmitters and hormones (PubMed:15696165). The Rab3GAP complex, acts as a GEF for RAB18 by promoting the conversion of inactive RAB18-GDP to the active form RAB18-GTP (PubMed:24891604). Recruits and stabilizes RAB18 at the cis-Golgi membrane in fibroblasts where RAB18 is most likely activated (PubMed:26063829). Also involved in RAB18 recruitment at the endoplasmic reticulum (ER) membrane where it maintains proper ER structure (PubMed:24891604). Required for normal eye and brain development (PubMed:15696165, PubMed:23420520). May participate in neurodevelopmental processes such as proliferation, migration and differentiation before synapse formation, and non-synaptic vesicular release of neurotransmitters (PubMed:9030515, PubMed:9852129). {ECO:0000269|PubMed:10859313, ECO:0000269|PubMed:15696165, ECO:0000269|PubMed:23420520, ECO:0000269|PubMed:24891604, ECO:0000269|PubMed:26063829, ECO:0000269|PubMed:9030515, ECO:0000269|PubMed:9852129}. |
Q15149 | PLEC | S3900 | ochoa | Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) | Interlinks intermediate filaments with microtubules and microfilaments and anchors intermediate filaments to desmosomes or hemidesmosomes. Could also bind muscle proteins such as actin to membrane complexes in muscle. May be involved not only in the filaments network, but also in the regulation of their dynamics. Structural component of muscle. Isoform 9 plays a major role in the maintenance of myofiber integrity. {ECO:0000269|PubMed:12482924, ECO:0000269|PubMed:21109228}. |
Q15672 | TWIST1 | S144 | psp | Twist-related protein 1 (Class A basic helix-loop-helix protein 38) (bHLHa38) (H-twist) | Acts as a transcriptional regulator. Inhibits myogenesis by sequestrating E proteins, inhibiting trans-activation by MEF2, and inhibiting DNA-binding by MYOD1 through physical interaction. This interaction probably involves the basic domains of both proteins. Also represses expression of pro-inflammatory cytokines such as TNFA and IL1B. Regulates cranial suture patterning and fusion. Activates transcription as a heterodimer with E proteins. Regulates gene expression differentially, depending on dimer composition. Homodimers induce expression of FGFR2 and POSTN while heterodimers repress FGFR2 and POSTN expression and induce THBS1 expression. Heterodimerization is also required for osteoblast differentiation. Represses the activity of the circadian transcriptional activator: NPAS2-BMAL1 heterodimer (By similarity). {ECO:0000250|UniProtKB:P26687, ECO:0000269|PubMed:12553906, ECO:0000269|PubMed:25981568}. |
Q15717 | ELAVL1 | S42 | ochoa | ELAV-like protein 1 (Hu-antigen R) (HuR) | RNA-binding protein that binds to the 3'-UTR region of mRNAs and increases their stability (PubMed:14517288, PubMed:18285462, PubMed:31358969). Involved in embryonic stem cell (ESC) differentiation: preferentially binds mRNAs that are not methylated by N6-methyladenosine (m6A), stabilizing them, promoting ESC differentiation (By similarity). Has also been shown to be capable of binding to m6A-containing mRNAs and contributes to MYC stability by binding to m6A-containing MYC mRNAs (PubMed:32245947). Binds to poly-U elements and AU-rich elements (AREs) in the 3'-UTR of target mRNAs (PubMed:14731398, PubMed:17632515, PubMed:18285462, PubMed:23519412, PubMed:8626503). Binds avidly to the AU-rich element in FOS and IL3/interleukin-3 mRNAs. In the case of the FOS AU-rich element, binds to a core element of 27 nucleotides that contain AUUUA, AUUUUA, and AUUUUUA motifs. Binds preferentially to the 5'-UUUU[AG]UUU-3' motif in vitro (PubMed:8626503). With ZNF385A, binds the 3'-UTR of p53/TP53 mRNA to control their nuclear export induced by CDKN2A. Hence, may regulate p53/TP53 expression and mediate in part the CDKN2A anti-proliferative activity. May also bind with ZNF385A the CCNB1 mRNA (By similarity). Increases the stability of the leptin mRNA harboring an AU-rich element (ARE) in its 3' UTR (PubMed:29180010). {ECO:0000250|UniProtKB:P70372, ECO:0000269|PubMed:14517288, ECO:0000269|PubMed:14731398, ECO:0000269|PubMed:17632515, ECO:0000269|PubMed:18285462, ECO:0000269|PubMed:19029303, ECO:0000269|PubMed:23519412, ECO:0000269|PubMed:29180010, ECO:0000269|PubMed:31358969, ECO:0000269|PubMed:32245947, ECO:0000269|PubMed:8626503}. |
Q15785 | TOMM34 | S231 | ochoa | Mitochondrial import receptor subunit TOM34 (hTom34) (Translocase of outer membrane 34 kDa subunit) | Plays a role in the import of cytosolically synthesized preproteins into mitochondria. Binds the mature portion of precursor proteins. Interacts with cellular components, and possesses weak ATPase activity. May be a chaperone-like protein that helps to keep newly synthesized precursors in an unfolded import compatible state. {ECO:0000269|PubMed:10101285, ECO:0000269|PubMed:11913975, ECO:0000269|PubMed:9324309}. |
Q16363 | LAMA4 | S953 | ochoa | Laminin subunit alpha-4 (Laminin-14 subunit alpha) (Laminin-8 subunit alpha) (Laminin-9 subunit alpha) | Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. |
Q16572 | SLC18A3 | S480 | ochoa | Vesicular acetylcholine transporter (VAChT) (Solute carrier family 18 member 3) | Electrogenic antiporter that exchanges one cholinergic neurotransmitter, acetylcholine or choline, with two intravesicular protons across the membrane of synaptic vesicles. Uses the electrochemical proton gradient established by the V-type proton-pump ATPase to store neurotransmitters inside the vesicles prior to their release via exocytosis (By similarity) (PubMed:20225888, PubMed:8910293). Determines cholinergic vesicular quantal size at presynaptic nerve terminals in developing neuro-muscular junctions with an impact on motor neuron differentiation and innervation pattern (By similarity). Part of forebrain cholinergic system, regulates hippocampal synapse transmissions that underlie spatial memory formation (By similarity). Can transport serotonin. {ECO:0000250|UniProtKB:O35304, ECO:0000250|UniProtKB:Q62666, ECO:0000269|PubMed:20225888, ECO:0000269|PubMed:25355561, ECO:0000269|PubMed:8910293}. |
Q17R91 | DIAPH2 | S196 | psp | Protein diaphanous homolog 2 (Diaphanous-related formin-2) | None |
Q2M2I8 | AAK1 | S846 | ochoa | AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1) | Regulates clathrin-mediated endocytosis by phosphorylating the AP2M1/mu2 subunit of the adaptor protein complex 2 (AP-2) which ensures high affinity binding of AP-2 to cargo membrane proteins during the initial stages of endocytosis (PubMed:11877457, PubMed:11877461, PubMed:12952931, PubMed:14617351, PubMed:17494869, PubMed:25653444). Isoform 1 and isoform 2 display similar levels of kinase activity towards AP2M1 (PubMed:17494869). Preferentially, may phosphorylate substrates on threonine residues (PubMed:11877457, PubMed:18657069). Regulates phosphorylation of other AP-2 subunits as well as AP-2 localization and AP-2-mediated internalization of ligand complexes (PubMed:12952931). Phosphorylates NUMB and regulates its cellular localization, promoting NUMB localization to endosomes (PubMed:18657069). Binds to and stabilizes the activated form of NOTCH1, increases its localization in endosomes and regulates its transcriptional activity (PubMed:21464124). {ECO:0000269|PubMed:11877457, ECO:0000269|PubMed:11877461, ECO:0000269|PubMed:12952931, ECO:0000269|PubMed:14617351, ECO:0000269|PubMed:17494869, ECO:0000269|PubMed:18657069, ECO:0000269|PubMed:21464124, ECO:0000269|PubMed:25653444}.; FUNCTION: (Microbial infection) By regulating clathrin-mediated endocytosis, AAK1 plays a role in the entry of hepatitis C virus as well as for the lifecycle of other viruses such as Ebola and Dengue. {ECO:0000269|PubMed:25653444, ECO:0000305|PubMed:31136173}. |
Q3MIX3 | ADCK5 | S42 | ochoa | Uncharacterized aarF domain-containing protein kinase 5 (EC 2.7.11.-) | The function of this protein is not yet clear. It is not known if it has protein kinase activity and what type of substrate it would phosphorylate (Ser, Thr or Tyr). |
Q53GA4 | PHLDA2 | S19 | ochoa | Pleckstrin homology-like domain family A member 2 (Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene C protein) (Imprinted in placenta and liver protein) (Tumor-suppressing STF cDNA 3 protein) (Tumor-suppressing subchromosomal transferable fragment candidate gene 3 protein) (p17-Beckwith-Wiedemann region 1 C) (p17-BWR1C) | Plays a role in regulating placenta growth. May act via its PH domain that competes with other PH domain-containing proteins, thereby preventing their binding to membrane lipids (By similarity). {ECO:0000250}. |
Q5BKX5 | ACTMAP | S318 | ochoa | Actin maturation protease (EC 3.4.11.-) (Actin aminopeptidase ACTMAP) | Actin maturation protease that specifically mediates the cleavage of immature acetylated N-terminal actin, thereby contributing to actin maturation (PubMed:36173861). Cleaves N-terminal acetylated methionine of immature cytoplasmic beta- and gamma-actins ACTB and ACTG1 after translation (PubMed:36173861). Cleaves N-terminal acetylated cysteine of muscle alpha-actins ACTA1, ACTC1 and ACTA2 after canonical removal of N-terminal methionine (By similarity). {ECO:0000250|UniProtKB:J3QPC3, ECO:0000269|PubMed:36173861}. |
Q5GLZ8 | HERC4 | S830 | ochoa | Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4) | Probable E3 ubiquitin-protein ligase involved in either protein trafficking or in the distribution of cellular structures. Required for spermatozoon maturation and fertility, and for the removal of the cytoplasmic droplet of the spermatozoon. E3 ubiquitin-protein ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfer it to targeted substrates. {ECO:0000250|UniProtKB:Q6PAV2}. |
Q5HYC2 | BRD10 | S1816 | ochoa | Uncharacterized bromodomain-containing protein 10 | None |
Q5HYI8 | RABL3 | Y130 | ochoa | Rab-like protein 3 | Required for KRAS signaling regulation and modulation of cell proliferation (PubMed:31406347). Regulator of KRAS prenylation, and probably prenylation of other small GTPases (PubMed:31406347). Required for lymphocyte development and function (By similarity). Not required for myeloid cell development (By similarity). {ECO:0000250|UniProtKB:Q9D4V7, ECO:0000269|PubMed:31406347}. |
Q5JSZ5 | PRRC2B | S765 | ochoa | Protein PRRC2B (HLA-B-associated transcript 2-like 1) (Proline-rich coiled-coil protein 2B) | None |
Q5T0Z8 | C6orf132 | S576 | ochoa | Uncharacterized protein C6orf132 | None |
Q5THK1 | PRR14L | S1641 | ochoa | Protein PRR14L (Proline rich 14-like protein) | None |
Q5VT06 | CEP350 | S2295 | ochoa | Centrosome-associated protein 350 (Cep350) (Centrosome-associated protein of 350 kDa) | Plays an essential role in centriole growth by stabilizing a procentriolar seed composed of at least, SASS6 and CPAP (PubMed:19052644). Required for anchoring microtubules to the centrosomes and for the integrity of the microtubule network (PubMed:16314388, PubMed:17878239, PubMed:28659385). Recruits PPARA to discrete subcellular compartments and thereby modulates PPARA activity (PubMed:15615782). Required for ciliation (PubMed:28659385). {ECO:0000269|PubMed:15615782, ECO:0000269|PubMed:16314388, ECO:0000269|PubMed:17878239, ECO:0000269|PubMed:19052644, ECO:0000269|PubMed:28659385}. |
Q5VT25 | CDC42BPA | S855 | ochoa | Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha) | Serine/threonine-protein kinase which is an important downstream effector of CDC42 and plays a role in the regulation of cytoskeleton reorganization and cell migration (PubMed:15723050, PubMed:9092543, PubMed:9418861). Regulates actin cytoskeletal reorganization via phosphorylation of PPP1R12C and MYL9/MLC2 (PubMed:21457715). In concert with MYO18A and LURAP1, is involved in modulating lamellar actomyosin retrograde flow that is crucial to cell protrusion and migration (PubMed:18854160). Phosphorylates: PPP1R12A, LIMK1 and LIMK2 (PubMed:11340065, PubMed:11399775). May play a role in TFRC-mediated iron uptake (PubMed:20188707). In concert with FAM89B/LRAP25 mediates the targeting of LIMK1 to the lamellipodium resulting in its activation and subsequent phosphorylation of CFL1 which is important for lamellipodial F-actin regulation (By similarity). Triggers the formation of an extrusion apical actin ring required for epithelial extrusion of apoptotic cells (PubMed:29162624). {ECO:0000250|UniProtKB:Q3UU96, ECO:0000269|PubMed:11340065, ECO:0000269|PubMed:11399775, ECO:0000269|PubMed:15723050, ECO:0000269|PubMed:18854160, ECO:0000269|PubMed:20188707, ECO:0000269|PubMed:21457715, ECO:0000269|PubMed:29162624, ECO:0000269|PubMed:9092543, ECO:0000269|PubMed:9418861}. |
Q5VV42 | CDKAL1 | S528 | ochoa | Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.8.4.5) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase) | Catalyzes the methylthiolation of N6-threonylcarbamoyladenosine (t(6)A), leading to the formation of 2-methylthio-N6-threonylcarbamoyladenosine (ms(2)t(6)A) at position 37 in tRNAs that read codons beginning with adenine. {ECO:0000250|UniProtKB:Q91WE6}. |
Q5VWN6 | TASOR2 | S601 | ochoa | Protein TASOR 2 | None |
Q5W0B1 | OBI1 | S595 | ochoa | ORC ubiquitin ligase 1 (OBI1) (EC 2.3.2.27) (RING finger protein 219) | E3 ubiquitin ligase essential for DNA replication origin activation during S phase (PubMed:31160578). Acts as a replication origin selector which selects the origins to be fired and catalyzes the multi-mono-ubiquitination of a subset of chromatin-bound ORC3 and ORC5 during S-phase (PubMed:31160578). {ECO:0000269|PubMed:31160578}. |
Q659C4 | LARP1B | S348 | ochoa | La-related protein 1B (La ribonucleoprotein domain family member 1B) (La ribonucleoprotein domain family member 2) (La-related protein 2) | None |
Q68DK7 | MSL1 | S213 | ochoa | Male-specific lethal 1 homolog (MSL-1) (Male-specific lethal 1-like 1) (MSL1-like 1) (Male-specific lethal-1 homolog 1) | Non-catalytic component of the MSL histone acetyltransferase complex, a multiprotein complex that mediates the majority of histone H4 acetylation at 'Lys-16' (H4K16ac), an epigenetic mark that prevents chromatin compaction (PubMed:16227571, PubMed:16543150, PubMed:33837287). The MSL complex is required for chromosome stability and genome integrity by maintaining homeostatic levels of H4K16ac (PubMed:33837287). The MSL complex is also involved in gene dosage by promoting up-regulation of genes expressed by the X chromosome (By similarity). X up-regulation is required to compensate for autosomal biallelic expression (By similarity). The MSL complex also participates in gene dosage compensation by promoting expression of Tsix non-coding RNA (By similarity). Within the MSL complex, acts as a scaffold to tether MSL3 and KAT8 together for enzymatic activity regulation (PubMed:22547026). Greatly enhances MSL2 E3 ubiquitin ligase activity, promoting monoubiquitination of histone H2B at 'Lys-34' (H2BK34Ub) (PubMed:21726816, PubMed:30930284). This modification in turn stimulates histone H3 methylation at 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me) and leads to gene activation, including that of HOXA9 and MEIS1 (PubMed:21726816). {ECO:0000250|UniProtKB:Q6PDM1, ECO:0000269|PubMed:16227571, ECO:0000269|PubMed:16543150, ECO:0000269|PubMed:21726816, ECO:0000269|PubMed:22547026, ECO:0000269|PubMed:30930284, ECO:0000269|PubMed:33837287}. |
Q6IBW4 | NCAPH2 | S385 | psp | Condensin-2 complex subunit H2 (Chromosome-associated protein H2) (hCAP-H2) (Kleisin-beta) (Non-SMC condensin II complex subunit H2) | Regulatory subunit of the condensin-2 complex, a complex that seems to provide chromosomes with an additional level of organization and rigidity and in establishing mitotic chromosome architecture (PubMed:14532007). May promote the resolution of double-strand DNA catenanes (intertwines) between sister chromatids. Condensin-mediated compaction likely increases tension in catenated sister chromatids, providing directionality for type II topoisomerase-mediated strand exchanges toward chromatid decatenation. Required for decatenation of chromatin bridges at anaphase. Early in neurogenesis, may play an essential role to ensure accurate mitotic chromosome condensation in neuron stem cells, ultimately affecting neuron pool and cortex size (By similarity). Seems to have lineage-specific role in T-cell development (PubMed:14532007). {ECO:0000250|UniProtKB:Q8BSP2, ECO:0000269|PubMed:14532007}. |
Q6PEY2 | TUBA3E | T223 | ochoa | Tubulin alpha-3E chain (EC 3.6.5.-) (Alpha-tubulin 3E) [Cleaved into: Detyrosinated tubulin alpha-3E chain] | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
Q6PJT7 | ZC3H14 | S475 | ochoa | Zinc finger CCCH domain-containing protein 14 (Mammalian suppressor of tau pathology-2) (MSUT-2) (Renal carcinoma antigen NY-REN-37) | RNA-binding protein involved in the biogenesis of circular RNAs (circRNAs), which are produced by back-splicing circularization of pre-mRNAs (PubMed:39461343). Acts by binding to both exon-intron boundary and 3'-UTR of pre-mRNAs to promote circRNA biogenesis through dimerization and the association with the spliceosome (PubMed:39461343). Required for spermatogenesis via involvement in circRNA biogenesis (PubMed:39461343). Regulates the pre-mRNA processing of ATP5MC1; preventing its degradation (PubMed:27563065). Also binds the poly(A) tail of mRNAs; controlling poly(A) length in neuronal cells (PubMed:17630287, PubMed:24671764). {ECO:0000269|PubMed:17630287, ECO:0000269|PubMed:24671764, ECO:0000269|PubMed:27563065, ECO:0000269|PubMed:39461343}. |
Q6PJT7 | ZC3H14 | S579 | ochoa | Zinc finger CCCH domain-containing protein 14 (Mammalian suppressor of tau pathology-2) (MSUT-2) (Renal carcinoma antigen NY-REN-37) | RNA-binding protein involved in the biogenesis of circular RNAs (circRNAs), which are produced by back-splicing circularization of pre-mRNAs (PubMed:39461343). Acts by binding to both exon-intron boundary and 3'-UTR of pre-mRNAs to promote circRNA biogenesis through dimerization and the association with the spliceosome (PubMed:39461343). Required for spermatogenesis via involvement in circRNA biogenesis (PubMed:39461343). Regulates the pre-mRNA processing of ATP5MC1; preventing its degradation (PubMed:27563065). Also binds the poly(A) tail of mRNAs; controlling poly(A) length in neuronal cells (PubMed:17630287, PubMed:24671764). {ECO:0000269|PubMed:17630287, ECO:0000269|PubMed:24671764, ECO:0000269|PubMed:27563065, ECO:0000269|PubMed:39461343}. |
Q6ZNL6 | FGD5 | S552 | ochoa | FYVE, RhoGEF and PH domain-containing protein 5 (Zinc finger FYVE domain-containing protein 23) | Activates CDC42, a member of the Ras-like family of Rho- and Rac proteins, by exchanging bound GDP for free GTP. Mediates VEGF-induced CDC42 activation. May regulate proangiogenic action of VEGF in vascular endothelial cells, including network formation, directional movement and proliferation. May play a role in regulating the actin cytoskeleton and cell shape. {ECO:0000269|PubMed:22328776}. |
Q6ZVM7 | TOM1L2 | S423 | ochoa | TOM1-like protein 2 (Target of Myb-like protein 2) | Acts as a MYO6/Myosin VI adapter protein that targets myosin VI to endocytic structures (PubMed:23023224). May also play a role in recruiting clathrin to endosomes (PubMed:16412388). May regulate growth factor-induced mitogenic signaling (PubMed:16479011). {ECO:0000269|PubMed:16412388, ECO:0000269|PubMed:16479011, ECO:0000269|PubMed:23023224}. |
Q71U36 | TUBA1A | T223 | ochoa | Tubulin alpha-1A chain (EC 3.6.5.-) (Alpha-tubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain] | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
Q76I76 | SSH2 | S1187 | ochoa | Protein phosphatase Slingshot homolog 2 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 2) (SSH-2L) (hSSH-2L) | Protein phosphatase which regulates actin filament dynamics. Dephosphorylates and activates the actin binding/depolymerizing factor cofilin, which subsequently binds to actin filaments and stimulates their disassembly. Inhibitory phosphorylation of cofilin is mediated by LIMK1, which may also be dephosphorylated and inactivated by this protein (PubMed:11832213). Required for spermatogenesis (By similarity). Involved in acrosome biogenesis, probably by regulating cofilin-mediated actin cytoskeleton remodeling during proacrosomal vesicle fusion and/or Golgi to perinuclear vesicle trafficking (By similarity). {ECO:0000250|UniProtKB:Q5SW75, ECO:0000269|PubMed:11832213}. |
Q7L2E3 | DHX30 | S225 | ochoa | ATP-dependent RNA helicase DHX30 (EC 3.6.4.13) (DEAH box protein 30) | RNA-dependent helicase (PubMed:29100085). Plays an important role in the assembly of the mitochondrial large ribosomal subunit (PubMed:25683715, PubMed:29100085). Required for optimal function of the zinc-finger antiviral protein ZC3HAV1 (By similarity). Associates with mitochondrial DNA (PubMed:18063578). Involved in nervous system development and differentiation through its involvement in the up-regulation of a number of genes which are required for neurogenesis, including GSC, NCAM1, neurogenin, and NEUROD (By similarity). {ECO:0000250|UniProtKB:Q5BJS0, ECO:0000250|UniProtKB:Q99PU8, ECO:0000269|PubMed:18063578, ECO:0000269|PubMed:25683715, ECO:0000269|PubMed:29100085}. |
Q7Z2W4 | ZC3HAV1 | Y299 | ochoa | Zinc finger CCCH-type antiviral protein 1 (ADP-ribosyltransferase diphtheria toxin-like 13) (ARTD13) (Inactive Poly [ADP-ribose] polymerase 13) (PARP13) (Zinc finger CCCH domain-containing protein 2) (Zinc finger antiviral protein) (ZAP) | Antiviral protein which inhibits the replication of viruses by recruiting the cellular RNA degradation machineries to degrade the viral mRNAs. Binds to a ZAP-responsive element (ZRE) present in the target viral mRNA, recruits cellular poly(A)-specific ribonuclease PARN to remove the poly(A) tail, and the 3'-5' exoribonuclease complex exosome to degrade the RNA body from the 3'-end. It also recruits the decapping complex DCP1-DCP2 through RNA helicase p72 (DDX17) to remove the cap structure of the viral mRNA to initiate its degradation from the 5'-end. Its target viruses belong to families which include retroviridae: human immunodeficiency virus type 1 (HIV-1), moloney and murine leukemia virus (MoMLV) and xenotropic MuLV-related virus (XMRV), filoviridae: ebola virus (EBOV) and marburg virus (MARV), togaviridae: sindbis virus (SINV) and Ross river virus (RRV). Specifically targets the multiply spliced but not unspliced or singly spliced HIV-1 mRNAs for degradation. Isoform 1 is a more potent viral inhibitor than isoform 2. Isoform 2 acts as a positive regulator of RIGI signaling resulting in activation of the downstream effector IRF3 leading to the expression of type I IFNs and IFN stimulated genes (ISGs). {ECO:0000269|PubMed:18225958, ECO:0000269|PubMed:21102435, ECO:0000269|PubMed:21876179, ECO:0000269|PubMed:22720057}. |
Q7Z3T8 | ZFYVE16 | S142 | ochoa | Zinc finger FYVE domain-containing protein 16 (Endofin) (Endosome-associated FYVE domain protein) | May be involved in regulating membrane trafficking in the endosomal pathway. Overexpression induces endosome aggregation. Required to target TOM1 to endosomes. {ECO:0000269|PubMed:11546807, ECO:0000269|PubMed:14613930}. |
Q7Z418 | KCNK18 | S264 | psp | Potassium channel subfamily K member 18 (TWIK-related individual potassium channel) (TWIK-related spinal cord potassium channel) | K(+) channel that conducts outward and inward rectifying currents at depolarized and hyperpolarized membrane potentials, respectively. The outward rectifying currents are voltage-dependent, coupled to K(+) electrochemical gradient across the membrane, whereas the inward currents can be induced in response to activation of Ca(2+)-mobilizing receptors (PubMed:12754259, PubMed:15562060, PubMed:20871611, PubMed:22355750, PubMed:26919430, PubMed:30573346). Homo- and heterodimerizes to form functional channels with distinct regulatory and gating properties. In trigeminal ganglia sensory neurons, the heterodimers of KCNK18/TRESK and KCNK2/TREK-1 or KCNK10/TREK-2 inhibit neuronal firing and neurogenic inflammation by stabilizing the resting membrane potential at K(+) equilibrium potential as well as by regulating the threshold of action potentials and the spike frequency (By similarity). In thymocytes, conducts K(+) currents upon T cell receptor (TCR) signaling leading to sustained Ca(2+) influx and NF-kappa-B activation, FOXP3 transcription and positive selection of regulatory T cell (Treg) progenitor subsets (PubMed:34702947). Appears to mediate the analgesics effects of hydroxy-alpha-sanshool, a metabolite naturally present in Schezuan pepper and other Xanthoxylum plants (By similarity). {ECO:0000250|UniProtKB:Q6VV64, ECO:0000269|PubMed:12754259, ECO:0000269|PubMed:15562060, ECO:0000269|PubMed:20871611, ECO:0000269|PubMed:22355750, ECO:0000269|PubMed:26919430, ECO:0000269|PubMed:30573346, ECO:0000269|PubMed:34702947}. |
Q7Z5L9 | IRF2BP2 | S318 | ochoa | Interferon regulatory factor 2-binding protein 2 (IRF-2-binding protein 2) (IRF-2BP2) | Acts as a transcriptional corepressor in a IRF2-dependent manner; this repression is not mediated by histone deacetylase activities (PubMed:12799427). Represses the NFAT1-dependent transactivation of NFAT-responsive promoters (PubMed:21576369). Acts as a coactivator of VEGFA expression in cardiac and skeletal muscles (PubMed:20702774). Plays a role in immature B-cell differentiation (PubMed:27016798). {ECO:0000269|PubMed:12799427, ECO:0000269|PubMed:20702774, ECO:0000269|PubMed:21576369, ECO:0000269|PubMed:27016798}. |
Q7Z6Z7 | HUWE1 | S2388 | ochoa | E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1) | E3 ubiquitin-protein ligase which mediates ubiquitination and subsequent proteasomal degradation of target proteins (PubMed:15567145, PubMed:15767685, PubMed:15989957, PubMed:17567951, PubMed:18488021, PubMed:19037095, PubMed:19713937, PubMed:20534529, PubMed:30217973). Regulates apoptosis by catalyzing the polyubiquitination and degradation of MCL1 (PubMed:15989957). Mediates monoubiquitination of DNA polymerase beta (POLB) at 'Lys-41', 'Lys-61' and 'Lys-81', thereby playing a role in base-excision repair (PubMed:19713937). Also ubiquitinates the p53/TP53 tumor suppressor and core histones including H1, H2A, H2B, H3 and H4 (PubMed:15567145, PubMed:15767685, PubMed:15989956). Ubiquitinates MFN2 to negatively regulate mitochondrial fusion in response to decreased stearoylation of TFRC (PubMed:26214738). Ubiquitination of MFN2 also takes place following induction of mitophagy; AMBRA1 acts as a cofactor for HUWE1-mediated ubiquitination (PubMed:30217973). Regulates neural differentiation and proliferation by catalyzing the polyubiquitination and degradation of MYCN (PubMed:18488021). May regulate abundance of CDC6 after DNA damage by polyubiquitinating and targeting CDC6 to degradation (PubMed:17567951). Mediates polyubiquitination of isoform 2 of PA2G4 (PubMed:19037095). Acts in concert with MYCBP2 to regulate the circadian clock gene expression by promoting the lithium-induced ubiquination and degradation of NR1D1 (PubMed:20534529). Binds to an upstream initiator-like sequence in the preprodynorphin gene (By similarity). Mediates HAPSTR1 degradation, but is also a required cofactor in the pathway by which HAPSTR1 governs stress signaling (PubMed:35776542). Acts as a regulator of the JNK and NF-kappa-B signaling pathways by mediating assembly of heterotypic 'Lys-63'-/'Lys-48'-linked branched ubiquitin chains that are then recognized by TAB2: HUWE1 mediates branching of 'Lys-48'-linked chains of substrates initially modified with 'Lys-63'-linked conjugates by TRAF6 (PubMed:27746020). 'Lys-63'-/'Lys-48'-linked branched ubiquitin chains protect 'Lys-63'-linkages from CYLD deubiquitination (PubMed:27746020). Ubiquitinates PPARA in hepatocytes (By similarity). {ECO:0000250|UniProtKB:P51593, ECO:0000250|UniProtKB:Q7TMY8, ECO:0000269|PubMed:15567145, ECO:0000269|PubMed:15767685, ECO:0000269|PubMed:15989956, ECO:0000269|PubMed:15989957, ECO:0000269|PubMed:17567951, ECO:0000269|PubMed:18488021, ECO:0000269|PubMed:19037095, ECO:0000269|PubMed:19713937, ECO:0000269|PubMed:20534529, ECO:0000269|PubMed:26214738, ECO:0000269|PubMed:27746020, ECO:0000269|PubMed:30217973, ECO:0000269|PubMed:35776542}. |
Q7Z6Z7 | HUWE1 | S2534 | ochoa | E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1) | E3 ubiquitin-protein ligase which mediates ubiquitination and subsequent proteasomal degradation of target proteins (PubMed:15567145, PubMed:15767685, PubMed:15989957, PubMed:17567951, PubMed:18488021, PubMed:19037095, PubMed:19713937, PubMed:20534529, PubMed:30217973). Regulates apoptosis by catalyzing the polyubiquitination and degradation of MCL1 (PubMed:15989957). Mediates monoubiquitination of DNA polymerase beta (POLB) at 'Lys-41', 'Lys-61' and 'Lys-81', thereby playing a role in base-excision repair (PubMed:19713937). Also ubiquitinates the p53/TP53 tumor suppressor and core histones including H1, H2A, H2B, H3 and H4 (PubMed:15567145, PubMed:15767685, PubMed:15989956). Ubiquitinates MFN2 to negatively regulate mitochondrial fusion in response to decreased stearoylation of TFRC (PubMed:26214738). Ubiquitination of MFN2 also takes place following induction of mitophagy; AMBRA1 acts as a cofactor for HUWE1-mediated ubiquitination (PubMed:30217973). Regulates neural differentiation and proliferation by catalyzing the polyubiquitination and degradation of MYCN (PubMed:18488021). May regulate abundance of CDC6 after DNA damage by polyubiquitinating and targeting CDC6 to degradation (PubMed:17567951). Mediates polyubiquitination of isoform 2 of PA2G4 (PubMed:19037095). Acts in concert with MYCBP2 to regulate the circadian clock gene expression by promoting the lithium-induced ubiquination and degradation of NR1D1 (PubMed:20534529). Binds to an upstream initiator-like sequence in the preprodynorphin gene (By similarity). Mediates HAPSTR1 degradation, but is also a required cofactor in the pathway by which HAPSTR1 governs stress signaling (PubMed:35776542). Acts as a regulator of the JNK and NF-kappa-B signaling pathways by mediating assembly of heterotypic 'Lys-63'-/'Lys-48'-linked branched ubiquitin chains that are then recognized by TAB2: HUWE1 mediates branching of 'Lys-48'-linked chains of substrates initially modified with 'Lys-63'-linked conjugates by TRAF6 (PubMed:27746020). 'Lys-63'-/'Lys-48'-linked branched ubiquitin chains protect 'Lys-63'-linkages from CYLD deubiquitination (PubMed:27746020). Ubiquitinates PPARA in hepatocytes (By similarity). {ECO:0000250|UniProtKB:P51593, ECO:0000250|UniProtKB:Q7TMY8, ECO:0000269|PubMed:15567145, ECO:0000269|PubMed:15767685, ECO:0000269|PubMed:15989956, ECO:0000269|PubMed:15989957, ECO:0000269|PubMed:17567951, ECO:0000269|PubMed:18488021, ECO:0000269|PubMed:19037095, ECO:0000269|PubMed:19713937, ECO:0000269|PubMed:20534529, ECO:0000269|PubMed:26214738, ECO:0000269|PubMed:27746020, ECO:0000269|PubMed:30217973, ECO:0000269|PubMed:35776542}. |
Q86T24 | ZBTB33 | S264 | ochoa | Transcriptional regulator Kaiso (Zinc finger and BTB domain-containing protein 33) | Transcriptional regulator with bimodal DNA-binding specificity. Binds to methylated CpG dinucleotides in the consensus sequence 5'-CGCG-3' and also binds to the non-methylated consensus sequence 5'-CTGCNA-3' also known as the consensus kaiso binding site (KBS). Recruits the N-CoR repressor complex to promote histone deacetylation and the formation of repressive chromatin structures in target gene promoters. May contribute to the repression of target genes of the Wnt signaling pathway. May also activate transcription of a subset of target genes by the recruitment of CTNND2. Represses expression of MMP7 in conjunction with transcriptional corepressors CBFA2T3, CBFA2T2 and RUNX1T1 (PubMed:23251453). {ECO:0000269|PubMed:11445535, ECO:0000269|PubMed:14527417, ECO:0000269|PubMed:15548582, ECO:0000269|PubMed:15817151, ECO:0000269|PubMed:16354688, ECO:0000269|PubMed:23251453}. |
Q86TB9 | PATL1 | S120 | ochoa | Protein PAT1 homolog 1 (PAT1-like protein 1) (Protein PAT1 homolog b) (Pat1b) (hPat1b) | RNA-binding protein involved in deadenylation-dependent decapping of mRNAs, leading to the degradation of mRNAs (PubMed:17936923, PubMed:20543818, PubMed:20584987, PubMed:20852261). Acts as a scaffold protein that connects deadenylation and decapping machinery (PubMed:17936923, PubMed:20543818, PubMed:20584987, PubMed:20852261). Required for cytoplasmic mRNA processing body (P-body) assembly (PubMed:17936923, PubMed:20543818, PubMed:20584987, PubMed:20852261). {ECO:0000269|PubMed:17936923, ECO:0000269|PubMed:20543818, ECO:0000269|PubMed:20584987, ECO:0000269|PubMed:20852261}.; FUNCTION: (Microbial infection) In case of infection, required for translation and replication of hepatitis C virus (HCV). {ECO:0000269|PubMed:19628699}. |
Q86VW1 | SLC22A16 | S482 | ochoa | Solute carrier family 22 member 16 (Carnitine transporter 2) (CT2) (Fly-like putative transporter 2) (FLIPT2) (Flipt 2) (Organic cation transporter OKB1) (Organic cation/carnitine transporter 6) | Facilitative organic cation transporter that mediates the transport of carnitine as well as the polyamine spermidine (PubMed:12089149, PubMed:20037140). Mediates the partially Na(+)-dependent bidirectional transport of carnitine (PubMed:12089149). May mediate L-carnitine secretion from testis epididymal epithelium into the lumen which is involved in the maturation of spermatozoa (PubMed:12089149). {ECO:0000269|PubMed:12089149, ECO:0000269|PubMed:20037140}. |
Q86X02 | CDR2L | S344 | ochoa | Cerebellar degeneration-related protein 2-like (Paraneoplastic 62 kDa antigen) | None |
Q8IUD2 | ERC1 | S251 | ochoa | ELKS/Rab6-interacting/CAST family member 1 (ERC-1) (Rab6-interacting protein 2) | Regulatory subunit of the IKK complex. Probably recruits IkappaBalpha/NFKBIA to the complex. May be involved in the organization of the cytomatrix at the nerve terminals active zone (CAZ) which regulates neurotransmitter release. May be involved in vesicle trafficking at the CAZ. May be involved in Rab-6 regulated endosomes to Golgi transport. {ECO:0000269|PubMed:15218148}. |
Q8IVF2 | AHNAK2 | S1707 | ochoa | Protein AHNAK2 | None |
Q8IVF2 | AHNAK2 | S4182 | ochoa | Protein AHNAK2 | None |
Q8IWB9 | TEX2 | S388 | ochoa | Testis-expressed protein 2 (Transmembrane protein 96) | During endoplasmic reticulum (ER) stress or when cellular ceramide levels increase, may induce contacts between the ER and medial-Golgi complex to facilitate non-vesicular transport of ceramides from the ER to the Golgi complex where they are converted to complex sphingolipids, preventing toxic ceramide accumulation. {ECO:0000269|PubMed:28011845}. |
Q8IWU2 | LMTK2 | S788 | ochoa | Serine/threonine-protein kinase LMTK2 (EC 2.7.11.1) (Apoptosis-associated tyrosine kinase 2) (Brain-enriched kinase) (hBREK) (CDK5/p35-regulated kinase) (CPRK) (Kinase/phosphatase/inhibitor 2) (Lemur tyrosine kinase 2) (Serine/threonine-protein kinase KPI-2) | Phosphorylates PPP1C, phosphorylase b and CFTR. |
Q8IWY8 | ZSCAN29 | S137 | ochoa | Zinc finger and SCAN domain-containing protein 29 (Zinc finger protein 690) | May be involved in transcriptional regulation. |
Q8IWY9 | CDAN1 | S285 | ochoa | Codanin-1 | May act as a negative regulator of ASF1 in chromatin assembly. {ECO:0000269|PubMed:22407294}. |
Q8IYD8 | FANCM | S948 | ochoa | Fanconi anemia group M protein (Protein FACM) (EC 3.6.4.13) (ATP-dependent RNA helicase FANCM) (Fanconi anemia-associated polypeptide of 250 kDa) (FAAP250) (Protein Hef ortholog) | DNA-dependent ATPase component of the Fanconi anemia (FA) core complex (PubMed:16116422). Required for the normal activation of the FA pathway, leading to monoubiquitination of the FANCI-FANCD2 complex in response to DNA damage, cellular resistance to DNA cross-linking drugs, and prevention of chromosomal breakage (PubMed:16116422, PubMed:19423727, PubMed:20347428, PubMed:20347429, PubMed:29231814). In complex with CENPS and CENPX, binds double-stranded DNA (dsDNA), fork-structured DNA (fsDNA) and Holliday junction substrates (PubMed:20347428, PubMed:20347429). Its ATP-dependent DNA branch migration activity can process branched DNA structures such as a movable replication fork. This activity is strongly stimulated in the presence of CENPS and CENPX (PubMed:20347429). In complex with FAAP24, efficiently binds to single-strand DNA (ssDNA), splayed-arm DNA, and 3'-flap substrates (PubMed:17289582). In vitro, on its own, strongly binds ssDNA oligomers and weakly fsDNA, but does not bind to dsDNA (PubMed:16116434). {ECO:0000269|PubMed:16116422, ECO:0000269|PubMed:16116434, ECO:0000269|PubMed:17289582, ECO:0000269|PubMed:19423727, ECO:0000269|PubMed:20347428, ECO:0000269|PubMed:20347429, ECO:0000269|PubMed:29231814}. |
Q8IYD8 | FANCM | S1158 | ochoa | Fanconi anemia group M protein (Protein FACM) (EC 3.6.4.13) (ATP-dependent RNA helicase FANCM) (Fanconi anemia-associated polypeptide of 250 kDa) (FAAP250) (Protein Hef ortholog) | DNA-dependent ATPase component of the Fanconi anemia (FA) core complex (PubMed:16116422). Required for the normal activation of the FA pathway, leading to monoubiquitination of the FANCI-FANCD2 complex in response to DNA damage, cellular resistance to DNA cross-linking drugs, and prevention of chromosomal breakage (PubMed:16116422, PubMed:19423727, PubMed:20347428, PubMed:20347429, PubMed:29231814). In complex with CENPS and CENPX, binds double-stranded DNA (dsDNA), fork-structured DNA (fsDNA) and Holliday junction substrates (PubMed:20347428, PubMed:20347429). Its ATP-dependent DNA branch migration activity can process branched DNA structures such as a movable replication fork. This activity is strongly stimulated in the presence of CENPS and CENPX (PubMed:20347429). In complex with FAAP24, efficiently binds to single-strand DNA (ssDNA), splayed-arm DNA, and 3'-flap substrates (PubMed:17289582). In vitro, on its own, strongly binds ssDNA oligomers and weakly fsDNA, but does not bind to dsDNA (PubMed:16116434). {ECO:0000269|PubMed:16116422, ECO:0000269|PubMed:16116434, ECO:0000269|PubMed:17289582, ECO:0000269|PubMed:19423727, ECO:0000269|PubMed:20347428, ECO:0000269|PubMed:20347429, ECO:0000269|PubMed:29231814}. |
Q8IYI6 | EXOC8 | S19 | ochoa | Exocyst complex component 8 (Exocyst complex 84 kDa subunit) | Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane. |
Q8N163 | CCAR2 | S808 | ochoa|psp | Cell cycle and apoptosis regulator protein 2 (Cell division cycle and apoptosis regulator protein 2) (DBIRD complex subunit KIAA1967) (Deleted in breast cancer gene 1 protein) (DBC-1) (DBC.1) (NET35) (p30 DBC) | Core component of the DBIRD complex, a multiprotein complex that acts at the interface between core mRNP particles and RNA polymerase II (RNAPII) and integrates transcript elongation with the regulation of alternative splicing: the DBIRD complex affects local transcript elongation rates and alternative splicing of a large set of exons embedded in (A + T)-rich DNA regions (PubMed:22446626). Inhibits SIRT1 deacetylase activity leading to increasing levels of p53/TP53 acetylation and p53-mediated apoptosis (PubMed:18235501, PubMed:18235502, PubMed:23352644). Inhibits SUV39H1 methyltransferase activity (PubMed:19218236). Mediates ligand-dependent transcriptional activation by nuclear hormone receptors (PubMed:19131338). Plays a critical role in maintaining genomic stability and cellular integrity following UV-induced genotoxic stress (PubMed:23398316). Regulates the circadian expression of the core clock components NR1D1 and BMAL1 (PubMed:23398316). Enhances the transcriptional repressor activity of NR1D1 through stabilization of NR1D1 protein levels by preventing its ubiquitination and subsequent degradation (PubMed:23398316). Represses the ligand-dependent transcriptional activation function of ESR2 (PubMed:20074560). Acts as a regulator of PCK1 expression and gluconeogenesis by a mechanism that involves, at least in part, both NR1D1 and SIRT1 (PubMed:24415752). Negatively regulates the deacetylase activity of HDAC3 and can alter its subcellular localization (PubMed:21030595). Positively regulates the beta-catenin pathway (canonical Wnt signaling pathway) and is required for MCC-mediated repression of the beta-catenin pathway (PubMed:24824780). Represses ligand-dependent transcriptional activation function of NR1H2 and NR1H3 and inhibits the interaction of SIRT1 with NR1H3 (PubMed:25661920). Plays an important role in tumor suppression through p53/TP53 regulation; stabilizes p53/TP53 by affecting its interaction with ubiquitin ligase MDM2 (PubMed:25732823). Represses the transcriptional activator activity of BRCA1 (PubMed:20160719). Inhibits SIRT1 in a CHEK2 and PSEM3-dependent manner and inhibits the activity of CHEK2 in vitro (PubMed:25361978). {ECO:0000269|PubMed:18235501, ECO:0000269|PubMed:18235502, ECO:0000269|PubMed:19131338, ECO:0000269|PubMed:19218236, ECO:0000269|PubMed:20074560, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:21030595, ECO:0000269|PubMed:22446626, ECO:0000269|PubMed:23352644, ECO:0000269|PubMed:23398316, ECO:0000269|PubMed:24415752, ECO:0000269|PubMed:24824780, ECO:0000269|PubMed:25361978, ECO:0000269|PubMed:25661920, ECO:0000269|PubMed:25732823}. |
Q8N3K9 | CMYA5 | S2479 | ochoa | Cardiomyopathy-associated protein 5 (Dystrobrevin-binding protein 2) (Genethonin-3) (Myospryn) (SPRY domain-containing protein 2) (Tripartite motif-containing protein 76) | May serve as an anchoring protein that mediates the subcellular compartmentation of protein kinase A (PKA) via binding to PRKAR2A (By similarity). May function as a repressor of calcineurin-mediated transcriptional activity. May attenuate calcineurin ability to induce slow-fiber gene program in muscle and may negatively modulate skeletal muscle regeneration (By similarity). Plays a role in the assembly of ryanodine receptor (RYR2) clusters in striated muscle (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:Q70KF4}. |
Q8N4N8 | KIF2B | S204 | psp | Kinesin-like protein KIF2B | Plus end-directed microtubule-dependent motor required for spindle assembly and chromosome movement. Has microtubule depolymerization activity (PubMed:17538014). Plays a role in chromosome congression (PubMed:23891108). {ECO:0000269|PubMed:17538014, ECO:0000269|PubMed:23891108}. |
Q8N5G2 | MACO1 | S228 | ochoa | Macoilin (Macoilin-1) (Transmembrane protein 57) | Plays a role in the regulation of neuronal activity. {ECO:0000269|PubMed:21589894}. |
Q8NB16 | MLKL | S358 | psp | Mixed lineage kinase domain-like protein (hMLKL) | Pseudokinase that plays a key role in TNF-induced necroptosis, a programmed cell death process (PubMed:22265413, PubMed:22265414, PubMed:22421439, PubMed:24316671). Does not have protein kinase activity (PubMed:22265413, PubMed:22265414, PubMed:22421439, PubMed:24316671). Activated following phosphorylation by RIPK3, leading to homotrimerization, localization to the plasma membrane and execution of programmed necrosis characterized by calcium influx and plasma membrane damage (PubMed:22265413, PubMed:22265414, PubMed:22421439, PubMed:24316671). In addition to TNF-induced necroptosis, necroptosis can also take place in the nucleus in response to orthomyxoviruses infection: following activation by ZBP1, MLKL is phosphorylated by RIPK3 in the nucleus, triggering disruption of the nuclear envelope and leakage of cellular DNA into the cytosol.following ZBP1 activation, which senses double-stranded Z-RNA structures, nuclear RIPK3 catalyzes phosphorylation and activation of MLKL, promoting disruption of the nuclear envelope and leakage of cellular DNA into the cytosol (By similarity). Binds to highly phosphorylated inositol phosphates such as inositolhexakisphosphate (InsP6) which is essential for its necroptotic function (PubMed:29883610). {ECO:0000250|UniProtKB:Q9D2Y4, ECO:0000269|PubMed:22265413, ECO:0000269|PubMed:22265414, ECO:0000269|PubMed:22421439, ECO:0000269|PubMed:24316671, ECO:0000269|PubMed:29883610}. |
Q8ND24 | RNF214 | S150 | ochoa | RING finger protein 214 | None |
Q8NG08 | HELB | S708 | ochoa | DNA helicase B (hDHB) (EC 3.6.4.12) | 5'-3' DNA helicase involved in DNA damage response by acting as an inhibitor of DNA end resection (PubMed:25617833, PubMed:26774285). Recruitment to single-stranded DNA (ssDNA) following DNA damage leads to inhibit the nucleases catalyzing resection, such as EXO1, BLM and DNA2, possibly via the 5'-3' ssDNA translocase activity of HELB (PubMed:26774285). As cells approach S phase, DNA end resection is promoted by the nuclear export of HELB following phosphorylation (PubMed:26774285). Acts independently of TP53BP1 (PubMed:26774285). Unwinds duplex DNA with 5'-3' polarity. Has single-strand DNA-dependent ATPase and DNA helicase activities. Prefers ATP and dATP as substrates (PubMed:12181327). During S phase, may facilitate cellular recovery from replication stress (PubMed:22194613). {ECO:0000269|PubMed:12181327, ECO:0000269|PubMed:22194613, ECO:0000269|PubMed:25617833, ECO:0000269|PubMed:26774285}. |
Q8NI08 | NCOA7 | S595 | ochoa | Nuclear receptor coactivator 7 (140 kDa estrogen receptor-associated protein) (Estrogen nuclear receptor coactivator 1) | Enhances the transcriptional activities of several nuclear receptors. Involved in the coactivation of different nuclear receptors, such as ESR1, THRB, PPARG and RARA. {ECO:0000269|PubMed:11971969}. |
Q8TD16 | BICD2 | S343 | ochoa | Protein bicaudal D homolog 2 (Bic-D 2) | Acts as an adapter protein linking the dynein motor complex to various cargos and converts dynein from a non-processive to a highly processive motor in the presence of dynactin. Facilitates and stabilizes the interaction between dynein and dynactin and activates dynein processivity (the ability to move along a microtubule for a long distance without falling off the track) (PubMed:25814576). Facilitates the binding of RAB6A to the Golgi by stabilizing its GTP-bound form. Regulates coat complex coatomer protein I (COPI)-independent Golgi-endoplasmic reticulum transport via its interaction with RAB6A and recruitment of the dynein-dynactin motor complex (PubMed:25962623). Contributes to nuclear and centrosomal positioning prior to mitotic entry through regulation of both dynein and kinesin-1. During G2 phase of the cell cycle, associates with RANBP2 at the nuclear pores and recruits dynein and dynactin to the nuclear envelope to ensure proper positioning of the nucleus relative to centrosomes prior to the onset of mitosis (By similarity). {ECO:0000250|UniProtKB:Q921C5, ECO:0000269|PubMed:25814576, ECO:0000269|PubMed:25962623}. |
Q8TD43 | TRPM4 | S839 | psp | Transient receptor potential cation channel subfamily M member 4 (hTRPM4) (Calcium-activated non-selective cation channel 1) (Long transient receptor potential channel 4) (LTrpC-4) (LTrpC4) (Melastatin-4) | Calcium-activated selective cation channel that mediates membrane depolarization (PubMed:12015988, PubMed:12842017, PubMed:29211723, PubMed:30528822). While it is activated by increase in intracellular Ca(2+), it is impermeable to it (PubMed:12015988). Mediates transport of monovalent cations (Na(+) > K(+) > Cs(+) > Li(+)), leading to depolarize the membrane (PubMed:12015988). It thereby plays a central role in cadiomyocytes, neurons from entorhinal cortex, dorsal root and vomeronasal neurons, endocrine pancreas cells, kidney epithelial cells, cochlea hair cells etc. Participates in T-cell activation by modulating Ca(2+) oscillations after T lymphocyte activation, which is required for NFAT-dependent IL2 production. Involved in myogenic constriction of cerebral arteries. Controls insulin secretion in pancreatic beta-cells. May also be involved in pacemaking or could cause irregular electrical activity under conditions of Ca(2+) overload. Affects T-helper 1 (Th1) and T-helper 2 (Th2) cell motility and cytokine production through differential regulation of calcium signaling and NFATC1 localization. Enhances cell proliferation through up-regulation of the beta-catenin signaling pathway. Plays a role in keratinocyte differentiation (PubMed:30528822). {ECO:0000269|PubMed:11535825, ECO:0000269|PubMed:12015988, ECO:0000269|PubMed:12799367, ECO:0000269|PubMed:12842017, ECO:0000269|PubMed:14758478, ECO:0000269|PubMed:15121803, ECO:0000269|PubMed:15331675, ECO:0000269|PubMed:15472118, ECO:0000269|PubMed:15550671, ECO:0000269|PubMed:15590641, ECO:0000269|PubMed:15845551, ECO:0000269|PubMed:16186107, ECO:0000269|PubMed:16407466, ECO:0000269|PubMed:16424899, ECO:0000269|PubMed:16806463, ECO:0000269|PubMed:20625999, ECO:0000269|PubMed:20656926, ECO:0000269|PubMed:29211723, ECO:0000269|PubMed:30528822}.; FUNCTION: [Isoform 2]: Lacks channel activity. {ECO:0000269|PubMed:12842017}. |
Q8TEA7 | TBCK | S409 | ochoa | TBC domain-containing protein kinase-like protein (FERRY endosomal RAB5 effector complex subunit 1) (Fy-1) | Component of the FERRY complex (Five-subunit Endosomal Rab5 and RNA/ribosome intermediary) (PubMed:37267905). The FERRY complex directly interacts with mRNAs and RAB5A, and functions as a RAB5A effector involved in the localization and the distribution of specific mRNAs most likely by mediating their endosomal transport. The complex recruits mRNAs and ribosomes to early endosomes through direct mRNA-interaction (PubMed:37267905). Also involved in the modulation of mTOR signaling and expression of mTOR complex components (PubMed:23977024, PubMed:27040691). Involved in the control of actin-cytoskeleton organization (PubMed:23977024). {ECO:0000269|PubMed:23977024, ECO:0000269|PubMed:24576458, ECO:0000269|PubMed:27040691, ECO:0000269|PubMed:37267905}. |
Q8TER5 | ARHGEF40 | S1443 | ochoa | Rho guanine nucleotide exchange factor 40 (Protein SOLO) | May act as a guanine nucleotide exchange factor (GEF). {ECO:0000250}. |
Q8WTQ7 | GRK7 | S23 | psp | Rhodopsin kinase GRK7 (EC 2.7.11.14) (G protein-coupled receptor kinase 7) (G protein-coupled receptor kinase GRK7) | Retina-specific kinase involved in the shutoff of the photoresponse and adaptation to changing light conditions via cone opsin phosphorylation, including rhodopsin (RHO). {ECO:0000269|PubMed:15946941}. |
Q8WVM8 | SCFD1 | S252 | ochoa | Sec1 family domain-containing protein 1 (SLY1 homolog) (Sly1p) (Syntaxin-binding protein 1-like 2) | Plays a role in SNARE-pin assembly and Golgi-to-ER retrograde transport via its interaction with COG4. Involved in vesicular transport between the endoplasmic reticulum and the Golgi (By similarity). {ECO:0000250}. |
Q8WWW8 | GAB3 | S344 | ochoa | GRB2-associated-binding protein 3 (GRB2-associated binder 3) (Growth factor receptor bound protein 2-associated protein 3) | None |
Q92945 | KHSRP | S480 | ochoa | Far upstream element-binding protein 2 (FUSE-binding protein 2) (KH type-splicing regulatory protein) (KSRP) (p75) | Binds to the dendritic targeting element and may play a role in mRNA trafficking (By similarity). Part of a ternary complex that binds to the downstream control sequence (DCS) of the pre-mRNA. Mediates exon inclusion in transcripts that are subject to tissue-specific alternative splicing. May interact with single-stranded DNA from the far-upstream element (FUSE). May activate gene expression. Also involved in degradation of inherently unstable mRNAs that contain AU-rich elements (AREs) in their 3'-UTR, possibly by recruiting degradation machinery to ARE-containing mRNAs. {ECO:0000250, ECO:0000269|PubMed:11003644, ECO:0000269|PubMed:8940189, ECO:0000269|PubMed:9136930}. |
Q969J3 | BORCS5 | S75 | ochoa | BLOC-1-related complex subunit 5 (Loss of heterozygosity 12 chromosomal region 1) (Myristoylated lysosomal protein) (Myrlysin) | As part of the BORC complex may play a role in lysosomes movement and localization at the cell periphery. Associated with the cytosolic face of lysosomes, the BORC complex may recruit ARL8B and couple lysosomes to microtubule plus-end-directed kinesin motor. Thereby, it may indirectly play a role in cell spreading and motility. {ECO:0000269|PubMed:25898167}. |
Q96A65 | EXOC4 | S248 | ochoa | Exocyst complex component 4 (Exocyst complex component Sec8) | Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane. {ECO:0000250|UniProtKB:Q62824}. |
Q96J84 | KIRREL1 | S562 | ochoa | Kin of IRRE-like protein 1 (Kin of irregular chiasm-like protein 1) (Nephrin-like protein 1) | Required for proper function of the glomerular filtration barrier. It is involved in the maintenance of a stable podocyte architecture with interdigitating foot processes connected by specialized cell-cell junctions, known as the slit diaphragm (PubMed:31472902). It is a signaling protein that needs the presence of TEC kinases to fully trans-activate the transcription factor AP-1 (By similarity). {ECO:0000250, ECO:0000269|PubMed:31472902}. |
Q96KB5 | PBK | S19 | ochoa | Lymphokine-activated killer T-cell-originated protein kinase (EC 2.7.12.2) (Cancer/testis antigen 84) (CT84) (MAPKK-like protein kinase) (Nori-3) (PDZ-binding kinase) (Spermatogenesis-related protein kinase) (SPK) (T-LAK cell-originated protein kinase) | Phosphorylates MAP kinase p38. Seems to be active only in mitosis. May also play a role in the activation of lymphoid cells. When phosphorylated, forms a complex with TP53, leading to TP53 destabilization and attenuation of G2/M checkpoint during doxorubicin-induced DNA damage. {ECO:0000269|PubMed:10781613, ECO:0000269|PubMed:17482142}. |
Q96P20 | NLRP3 | S806 | psp | NACHT, LRR and PYD domains-containing protein 3 (EC 3.6.4.-) (Angiotensin/vasopressin receptor AII/AVP-like) (Caterpiller protein 1.1) (CLR1.1) (Cold-induced autoinflammatory syndrome 1 protein) (Cryopyrin) (PYRIN-containing APAF1-like protein 1) | Sensor component of the NLRP3 inflammasome, which mediates inflammasome activation in response to defects in membrane integrity, leading to secretion of inflammatory cytokines IL1B and IL18 and pyroptosis (PubMed:16407889, PubMed:18403674, PubMed:18604214, PubMed:23582325, PubMed:25686105, PubMed:27929086, PubMed:28656979, PubMed:28847925, PubMed:30487600, PubMed:30612879, PubMed:31086327, PubMed:31086329, PubMed:31189953, PubMed:33231615, PubMed:34133077, PubMed:34341353, PubMed:34512673, PubMed:36442502). In response to pathogens and other damage-associated signals that affect the integrity of membranes, initiates the formation of the inflammasome polymeric complex composed of NLRP3, CASP1 and PYCARD/ASC (PubMed:16407889, PubMed:18403674, PubMed:27432880, PubMed:28847925, PubMed:31189953, PubMed:33231615, PubMed:34133077, PubMed:34341353, PubMed:36142182, PubMed:36442502). Recruitment of pro-caspase-1 (proCASP1) to the NLRP3 inflammasome promotes caspase-1 (CASP1) activation, which subsequently cleaves and activates inflammatory cytokines IL1B and IL18 and gasdermin-D (GSDMD), promoting cytokine secretion and pyroptosis (PubMed:23582325, PubMed:28847925, PubMed:31189953, PubMed:33231615, PubMed:34133077, PubMed:34341353). Activation of NLRP3 inflammasome is also required for HMGB1 secretion; stimulating inflammatory responses (PubMed:22801494). Under resting conditions, ADP-bound NLRP3 is autoinhibited (PubMed:35114687). NLRP3 activation stimuli include extracellular ATP, nigericin, reactive oxygen species, crystals of monosodium urate or cholesterol, amyloid-beta fibers, environmental or industrial particles and nanoparticles, such as asbestos, silica, aluminum salts, cytosolic dsRNA, etc (PubMed:16407889, PubMed:18403674, PubMed:18604214, PubMed:19414800, PubMed:23871209). Almost all stimuli trigger intracellular K(+) efflux (By similarity). These stimuli lead to membrane perturbation and activation of NLRP3 (By similarity). Upon activation, NLRP3 is transported to microtubule organizing center (MTOC), where it is unlocked by NEK7, leading to its relocalization to dispersed trans-Golgi network (dTGN) vesicle membranes and formation of an active inflammasome complex (PubMed:36442502, PubMed:39173637). Associates with dTGN vesicle membranes by binding to phosphatidylinositol 4-phosphate (PtdIns4P) (PubMed:30487600, PubMed:34554188). Shows ATPase activity (PubMed:17483456). {ECO:0000250|UniProtKB:Q8R4B8, ECO:0000269|PubMed:16407889, ECO:0000269|PubMed:17483456, ECO:0000269|PubMed:18403674, ECO:0000269|PubMed:18604214, ECO:0000269|PubMed:19414800, ECO:0000269|PubMed:22801494, ECO:0000269|PubMed:23582325, ECO:0000269|PubMed:23871209, ECO:0000269|PubMed:25686105, ECO:0000269|PubMed:27432880, ECO:0000269|PubMed:27929086, ECO:0000269|PubMed:28656979, ECO:0000269|PubMed:28847925, ECO:0000269|PubMed:30487600, ECO:0000269|PubMed:30612879, ECO:0000269|PubMed:31086327, ECO:0000269|PubMed:31086329, ECO:0000269|PubMed:31189953, ECO:0000269|PubMed:33231615, ECO:0000269|PubMed:34133077, ECO:0000269|PubMed:34341353, ECO:0000269|PubMed:34554188, ECO:0000269|PubMed:35114687, ECO:0000269|PubMed:36142182, ECO:0000269|PubMed:36442502, ECO:0000269|PubMed:39173637}.; FUNCTION: Independently of inflammasome activation, regulates the differentiation of T helper 2 (Th2) cells and has a role in Th2 cell-dependent asthma and tumor growth (By similarity). During Th2 differentiation, required for optimal IRF4 binding to IL4 promoter and for IRF4-dependent IL4 transcription (By similarity). Binds to the consensus DNA sequence 5'-GRRGGNRGAG-3' (By similarity). May also participate in the transcription of IL5, IL13, GATA3, CCR3, CCR4 and MAF (By similarity). {ECO:0000250|UniProtKB:Q8R4B8}. |
Q96P48 | ARAP1 | S1428 | ochoa | Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1 (Centaurin-delta-2) (Cnt-d2) | Phosphatidylinositol 3,4,5-trisphosphate-dependent GTPase-activating protein that modulates actin cytoskeleton remodeling by regulating ARF and RHO family members (PubMed:11804590, PubMed:19666464). Activated by phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) binding and, to a lesser extent, by phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) binding (PubMed:11804590). Has a preference for ARF1 and ARF5 (PubMed:11804590, PubMed:19666464). Positively regulates the ring size of circular dorsal ruffles and promotes macropinocytosis (PubMed:22573888). Acts as a bridging factor in osteoclasts to control actin and membrane dynamics (By similarity). Regulates the condensing of osteoclast podosomes into sealing zones which segregate the bone-facing membrane from other membrane domains and are required for osteoclast resorption activity (By similarity). Also regulates recruitment of the AP-3 complex to endosomal membranes and trafficking of lysosomal membrane proteins to the ruffled membrane border of osteoclasts to modulate bone resorption (By similarity). Regulates the endocytic trafficking of EGFR (PubMed:18764928, PubMed:18939958, PubMed:21275903). Regulates the incorporation of CD63 and CD9 into multivesicular bodies (PubMed:38682696). Required in the retinal pigment epithelium (RPE) for photoreceptor survival due to its role in promoting RPE phagocytosis (By similarity). {ECO:0000250|UniProtKB:Q4LDD4, ECO:0000269|PubMed:11804590, ECO:0000269|PubMed:18764928, ECO:0000269|PubMed:18939958, ECO:0000269|PubMed:19666464, ECO:0000269|PubMed:21275903, ECO:0000269|PubMed:22573888, ECO:0000269|PubMed:38682696}. |
Q96PP8 | GBP5 | S157 | ochoa | Guanylate-binding protein 5 (EC 3.6.5.-) (GBP-TA antigen) (GTP-binding protein 5) (GBP-5) (Guanine nucleotide-binding protein 5) | Interferon (IFN)-inducible GTPase that plays important roles in innate immunity against a diverse range of bacterial, viral and protozoan pathogens (By similarity). Hydrolyzes GTP, but in contrast to other family members, does not produce GMP (PubMed:20180847). Following infection, recruited to the pathogen-containing vacuoles or vacuole-escaped bacteria and acts as a positive regulator of inflammasome assembly by promoting the release of inflammasome ligands from bacteria (By similarity). Acts by promoting lysis of pathogen-containing vacuoles, releasing pathogens into the cytosol (By similarity). Following pathogen release in the cytosol, promotes recruitment of proteins that mediate bacterial cytolysis: this liberates ligands that are detected by inflammasomes, such as lipopolysaccharide (LPS) that activates the non-canonical CASP4/CASP11 inflammasome or double-stranded DNA (dsDNA) that activates the AIM2 inflammasome (By similarity). As an activator of NLRP3 inflammasome assembly: promotes selective NLRP3 inflammasome assembly in response to microbial and soluble, but not crystalline, agents (PubMed:22461501). Independently of its GTPase activity, acts as an inhibitor of various viruses infectivity, such as HIV-1, Zika and influenza A viruses, by inhibiting FURIN-mediated maturation of viral envelope proteins (PubMed:26996307, PubMed:31091448). {ECO:0000250|UniProtKB:Q8CFB4, ECO:0000269|PubMed:20180847, ECO:0000269|PubMed:22461501, ECO:0000269|PubMed:26996307, ECO:0000269|PubMed:31091448}.; FUNCTION: Antigenic tumor-specific truncated splice form. {ECO:0000269|PubMed:15175044}. |
Q96Q89 | KIF20B | S442 | ochoa | Kinesin-like protein KIF20B (Cancer/testis antigen 90) (CT90) (Kinesin family member 20B) (Kinesin-related motor interacting with PIN1) (M-phase phosphoprotein 1) (MPP1) | Plus-end-directed motor enzyme that is required for completion of cytokinesis (PubMed:11470801, PubMed:12740395). Required for proper midbody organization and abscission in polarized cortical stem cells. Plays a role in the regulation of neuronal polarization by mediating the transport of specific cargos. Participates in the mobilization of SHTN1 and in the accumulation of PIP3 in the growth cone of primary hippocampal neurons in a tubulin and actin-dependent manner. In the developing telencephalon, cooperates with SHTN1 to promote both the transition from the multipolar to the bipolar stage and the radial migration of cortical neurons from the ventricular zone toward the superficial layer of the neocortex. Involved in cerebral cortex growth (By similarity). Acts as an oncogene for promoting bladder cancer cells proliferation, apoptosis inhibition and carcinogenic progression (PubMed:17409436). {ECO:0000250|UniProtKB:Q80WE4, ECO:0000269|PubMed:11470801, ECO:0000269|PubMed:12740395, ECO:0000269|PubMed:17409436}. |
Q96QT4 | TRPM7 | S1255 | ochoa|psp | Transient receptor potential cation channel subfamily M member 7 (EC 2.7.11.1) (Channel-kinase 1) (Long transient receptor potential channel 7) (LTrpC-7) (LTrpC7) [Cleaved into: TRPM7 kinase, cleaved form (M7CK); TRPM7 channel, cleaved form] | Bifunctional protein that combines an ion channel with an intrinsic kinase domain, enabling it to modulate cellular functions either by conducting ions through the pore or by phosphorylating downstream proteins via its kinase domain. The channel is highly permeable to divalent cations, specifically calcium (Ca2+), magnesium (Mg2+) and zinc (Zn2+) and mediates their influx (PubMed:11385574, PubMed:12887921, PubMed:15485879, PubMed:24316671, PubMed:35561741, PubMed:36027648). Controls a wide range of biological processes such as Ca2(+), Mg(2+) and Zn(2+) homeostasis, vesicular Zn(2+) release channel and intracellular Ca(2+) signaling, embryonic development, immune responses, cell motility, proliferation and differentiation (By similarity). The C-terminal alpha-kinase domain autophosphorylates cytoplasmic residues of TRPM7 (PubMed:18365021). In vivo, TRPM7 phosphorylates SMAD2, suggesting that TRPM7 kinase may play a role in activating SMAD signaling pathways. In vitro, TRPM7 kinase phosphorylates ANXA1 (annexin A1), myosin II isoforms and a variety of proteins with diverse cellular functions (PubMed:15485879, PubMed:18394644). {ECO:0000250|UniProtKB:Q923J1, ECO:0000269|PubMed:11385574, ECO:0000269|PubMed:12887921, ECO:0000269|PubMed:15485879, ECO:0000269|PubMed:18365021, ECO:0000269|PubMed:18394644, ECO:0000269|PubMed:24316671, ECO:0000269|PubMed:35561741, ECO:0000269|PubMed:36027648}.; FUNCTION: [TRPM7 channel, cleaved form]: The cleaved channel exhibits substantially higher current and potentiates Fas receptor signaling. {ECO:0000250|UniProtKB:Q923J1}.; FUNCTION: [TRPM7 kinase, cleaved form]: The C-terminal kinase domain can be cleaved from the channel segment in a cell-type-specific fashion. In immune cells, the TRPM7 kinase domain is clipped from the channel domain by caspases in response to Fas-receptor stimulation. The cleaved kinase fragments can translocate to the nucleus, and bind chromatin-remodeling complex proteins in a Zn(2+)-dependent manner to ultimately phosphorylate specific Ser/Thr residues of histones known to be functionally important for cell differentiation and embryonic development. {ECO:0000250|UniProtKB:Q923J1}. |
Q96S38 | RPS6KC1 | S596 | ochoa | Ribosomal protein S6 kinase delta-1 (S6K-delta-1) (EC 2.7.11.1) (52 kDa ribosomal protein S6 kinase) (Ribosomal S6 kinase-like protein with two PSK domains 118 kDa protein) (SPHK1-binding protein) | May be involved in transmitting sphingosine-1 phosphate (SPP)-mediated signaling into the cell (PubMed:12077123). Plays a role in the recruitment of PRDX3 to early endosomes (PubMed:15750338). {ECO:0000269|PubMed:12077123, ECO:0000269|PubMed:15750338}. |
Q99459 | CDC5L | S228 | ochoa | Cell division cycle 5-like protein (Cdc5-like protein) (Pombe cdc5-related protein) | DNA-binding protein involved in cell cycle control. May act as a transcription activator. Plays a role in pre-mRNA splicing as core component of precatalytic, catalytic and postcatalytic spliceosomal complexes (PubMed:11991638, PubMed:20176811, PubMed:28076346, PubMed:28502770, PubMed:29301961, PubMed:29360106, PubMed:29361316, PubMed:30705154, PubMed:30728453). Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. The PRP19-CDC5L complex may also play a role in the response to DNA damage (DDR) (PubMed:20176811). As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:10570151, ECO:0000269|PubMed:11082045, ECO:0000269|PubMed:11101529, ECO:0000269|PubMed:11544257, ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:12927788, ECO:0000269|PubMed:18583928, ECO:0000269|PubMed:20176811, ECO:0000269|PubMed:24332808, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:30728453, ECO:0000269|PubMed:9038199, ECO:0000269|PubMed:9468527, ECO:0000269|PubMed:9632794, ECO:0000305|PubMed:33509932}. |
Q99956 | DUSP9 | S325 | ochoa | Dual specificity protein phosphatase 9 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 4) (MAP kinase phosphatase 4) (MKP-4) | Inactivates MAP kinases. Has a specificity for the ERK family. |
Q9BQE3 | TUBA1C | T223 | ochoa | Tubulin alpha-1C chain (EC 3.6.5.-) (Alpha-tubulin 6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain] | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
Q9BUE0 | MED18 | S66 | ochoa | Mediator of RNA polymerase II transcription subunit 18 (Mediator complex subunit 18) (p28b) | Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. |
Q9BUL8 | PDCD10 | S39 | psp | Programmed cell death protein 10 (Cerebral cavernous malformations 3 protein) (TF-1 cell apoptosis-related protein 15) | Promotes cell proliferation. Modulates apoptotic pathways. Increases mitogen-activated protein kinase activity and STK26 activity (PubMed:27807006). Important for cell migration, and for normal structure and assembly of the Golgi complex (PubMed:27807006). Part of the striatin-interacting phosphatase and kinase (STRIPAK) complexes. STRIPAK complexes have critical roles in protein (de)phosphorylation and are regulators of multiple signaling pathways including Hippo, MAPK, nuclear receptor and cytoskeleton remodeling. Different types of STRIPAK complexes are involved in a variety of biological processes such as cell growth, differentiation, apoptosis, metabolism and immune regulation (PubMed:18782753). Important for KDR/VEGFR2 signaling. Increases the stability of KDR/VEGFR2 and prevents its breakdown. Required for normal cardiovascular development. Required for normal angiogenesis, vasculogenesis and hematopoiesis during embryonic development (By similarity). {ECO:0000250|UniProtKB:Q8VE70, ECO:0000269|PubMed:15543491, ECO:0000269|PubMed:17360971, ECO:0000269|PubMed:18782753, ECO:0000269|PubMed:20332113, ECO:0000269|PubMed:27807006}. |
Q9BUU2 | METTL22 | S40 | ochoa | Methyltransferase-like protein 22 (EC 2.1.1.-) | Protein N-lysine methyltransferase. Trimethylates KIN at Lys-135 (in vitro). {ECO:0000269|PubMed:23349634}. |
Q9BVA1 | TUBB2B | T221 | ochoa | Tubulin beta-2B chain | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers (PubMed:23001566, PubMed:26732629, PubMed:28013290). Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. Plays a critical role in proper axon guidance in both central and peripheral axon tracts (PubMed:23001566). Implicated in neuronal migration (PubMed:19465910). {ECO:0000269|PubMed:19465910, ECO:0000269|PubMed:23001566, ECO:0000269|PubMed:26732629, ECO:0000269|PubMed:28013290}. |
Q9BVA1 | TUBB2B | S234 | ochoa | Tubulin beta-2B chain | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers (PubMed:23001566, PubMed:26732629, PubMed:28013290). Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. Plays a critical role in proper axon guidance in both central and peripheral axon tracts (PubMed:23001566). Implicated in neuronal migration (PubMed:19465910). {ECO:0000269|PubMed:19465910, ECO:0000269|PubMed:23001566, ECO:0000269|PubMed:26732629, ECO:0000269|PubMed:28013290}. |
Q9BXK5 | BCL2L13 | S37 | ochoa | Bcl-2-like protein 13 (Bcl2-L-13) (Bcl-rambo) (Protein Mil1) | May promote the activation of caspase-3 and apoptosis. |
Q9BXM7 | PINK1 | S284 | psp | Serine/threonine-protein kinase PINK1, mitochondrial (EC 2.7.11.1) (BRPK) (PTEN-induced putative kinase protein 1) | Serine/threonine-protein kinase which acts as a sensor of mitochondrial damage and protects against mitochondrial dysfunction during cellular stress. It phosphorylates mitochondrial proteins to coordinate mitochondrial quality control mechanisms that remove and replace dysfunctional mitochondrial components (PubMed:14607334, PubMed:15087508, PubMed:18443288, PubMed:18957282, PubMed:19229105, PubMed:19966284, PubMed:20404107, PubMed:20547144, PubMed:20798600, PubMed:22396657, PubMed:23620051, PubMed:23754282, PubMed:23933751, PubMed:24660806, PubMed:24751536, PubMed:24784582, PubMed:24896179, PubMed:24898855, PubMed:25527291, PubMed:32484300). Depending on the severity of mitochondrial damage, activity ranges from preventing apoptosis and stimulating mitochondrial biogenesis to eliminating severely damaged mitochondria via PINK1-PRKN-dependent mitophagy (PubMed:14607334, PubMed:15087508, PubMed:18443288, PubMed:19966284, PubMed:20404107, PubMed:20798600, PubMed:22396657, PubMed:23620051, PubMed:23933751, PubMed:24898855, PubMed:32047033, PubMed:32484300). When cellular stress results in irreversible mitochondrial damage, PINK1 accumulates at the outer mitochondrial membrane (OMM) where it phosphorylates pre-existing polyubiquitin chains at 'Ser-65', recruits PRKN from the cytosol to the OMM and activates PRKN by phosphorylation at 'Ser-65'; activated PRKN then ubiquinates VDAC1 and other OMM proteins to initiate mitophagy (PubMed:14607334, PubMed:15087508, PubMed:19966284, PubMed:20404107, PubMed:20798600, PubMed:23754282, PubMed:23933751, PubMed:24660806, PubMed:24751536, PubMed:24784582, PubMed:25474007, PubMed:25527291, PubMed:32047033). The PINK1-PRKN pathway also promotes fission of damaged mitochondria through phosphorylation and PRKN-dependent degradation of mitochondrial proteins involved in fission such as MFN2 (PubMed:18443288, PubMed:23620051, PubMed:24898855). This prevents the refusion of unhealthy mitochondria with the mitochondrial network or initiates mitochondrial fragmentation facilitating their later engulfment by autophagosomes (PubMed:18443288, PubMed:23620051). Also promotes mitochondrial fission independently of PRKN and ATG7-mediated mitophagy, via the phosphorylation and activation of DNM1L (PubMed:18443288, PubMed:32484300). Regulates motility of damaged mitochondria by promoting the ubiquitination and subsequent degradation of MIRO1 and MIRO2; in motor neurons, this likely inhibits mitochondrial intracellular anterograde transport along the axons which probably increases the chance of the mitochondria undergoing mitophagy in the soma (PubMed:22396657). Required for ubiquinone reduction by mitochondrial complex I by mediating phosphorylation of complex I subunit NDUFA10 (By similarity). Phosphorylates LETM1, positively regulating its mitochondrial calcium transport activity (PubMed:29123128). {ECO:0000250|UniProtKB:Q99MQ3, ECO:0000269|PubMed:14607334, ECO:0000269|PubMed:15087508, ECO:0000269|PubMed:18443288, ECO:0000269|PubMed:18957282, ECO:0000269|PubMed:19229105, ECO:0000269|PubMed:19966284, ECO:0000269|PubMed:20404107, ECO:0000269|PubMed:20547144, ECO:0000269|PubMed:20798600, ECO:0000269|PubMed:22396657, ECO:0000269|PubMed:23620051, ECO:0000269|PubMed:23754282, ECO:0000269|PubMed:23933751, ECO:0000269|PubMed:24660806, ECO:0000269|PubMed:24751536, ECO:0000269|PubMed:24784582, ECO:0000269|PubMed:24896179, ECO:0000269|PubMed:24898855, ECO:0000269|PubMed:25474007, ECO:0000269|PubMed:25527291, ECO:0000269|PubMed:29123128, ECO:0000269|PubMed:32047033, ECO:0000269|PubMed:32484300}. |
Q9BXW9 | FANCD2 | S126 | psp | Fanconi anemia group D2 protein (Protein FACD2) | Required for maintenance of chromosomal stability (PubMed:11239453, PubMed:14517836). Promotes accurate and efficient pairing of homologs during meiosis (PubMed:14517836). Involved in the repair of DNA double-strand breaks, both by homologous recombination and single-strand annealing (PubMed:15671039, PubMed:15650050, PubMed:30335751, PubMed:36385258). The FANCI-FANCD2 complex binds and scans double-stranded DNA (dsDNA) for DNA damage; this complex stalls at DNA junctions between double-stranded DNA and single-stranded DNA (By similarity). May participate in S phase and G2 phase checkpoint activation upon DNA damage (PubMed:15377654). Plays a role in preventing breakage and loss of missegregating chromatin at the end of cell division, particularly after replication stress (PubMed:15454491, PubMed:15661754). Required for the targeting, or stabilization, of BLM to non-centromeric abnormal structures induced by replicative stress (PubMed:15661754, PubMed:19465921). Promotes BRCA2/FANCD1 loading onto damaged chromatin (PubMed:11239454, PubMed:12239151, PubMed:12086603, PubMed:15115758, PubMed:15199141, PubMed:15671039, PubMed:18212739). May also be involved in B-cell immunoglobulin isotype switching. {ECO:0000250|UniProtKB:Q68Y81, ECO:0000269|PubMed:11239453, ECO:0000269|PubMed:11239454, ECO:0000269|PubMed:12086603, ECO:0000269|PubMed:12239151, ECO:0000269|PubMed:14517836, ECO:0000269|PubMed:15115758, ECO:0000269|PubMed:15314022, ECO:0000269|PubMed:15377654, ECO:0000269|PubMed:15454491, ECO:0000269|PubMed:15650050, ECO:0000269|PubMed:15661754, ECO:0000269|PubMed:15671039, ECO:0000269|PubMed:19465921, ECO:0000269|PubMed:30335751, ECO:0000269|PubMed:36385258}. |
Q9BXW9 | FANCD2 | S705 | psp | Fanconi anemia group D2 protein (Protein FACD2) | Required for maintenance of chromosomal stability (PubMed:11239453, PubMed:14517836). Promotes accurate and efficient pairing of homologs during meiosis (PubMed:14517836). Involved in the repair of DNA double-strand breaks, both by homologous recombination and single-strand annealing (PubMed:15671039, PubMed:15650050, PubMed:30335751, PubMed:36385258). The FANCI-FANCD2 complex binds and scans double-stranded DNA (dsDNA) for DNA damage; this complex stalls at DNA junctions between double-stranded DNA and single-stranded DNA (By similarity). May participate in S phase and G2 phase checkpoint activation upon DNA damage (PubMed:15377654). Plays a role in preventing breakage and loss of missegregating chromatin at the end of cell division, particularly after replication stress (PubMed:15454491, PubMed:15661754). Required for the targeting, or stabilization, of BLM to non-centromeric abnormal structures induced by replicative stress (PubMed:15661754, PubMed:19465921). Promotes BRCA2/FANCD1 loading onto damaged chromatin (PubMed:11239454, PubMed:12239151, PubMed:12086603, PubMed:15115758, PubMed:15199141, PubMed:15671039, PubMed:18212739). May also be involved in B-cell immunoglobulin isotype switching. {ECO:0000250|UniProtKB:Q68Y81, ECO:0000269|PubMed:11239453, ECO:0000269|PubMed:11239454, ECO:0000269|PubMed:12086603, ECO:0000269|PubMed:12239151, ECO:0000269|PubMed:14517836, ECO:0000269|PubMed:15115758, ECO:0000269|PubMed:15314022, ECO:0000269|PubMed:15377654, ECO:0000269|PubMed:15454491, ECO:0000269|PubMed:15650050, ECO:0000269|PubMed:15661754, ECO:0000269|PubMed:15671039, ECO:0000269|PubMed:19465921, ECO:0000269|PubMed:30335751, ECO:0000269|PubMed:36385258}. |
Q9C026 | TRIM9 | S44 | ochoa | E3 ubiquitin-protein ligase TRIM9 (EC 2.3.2.27) (RING finger protein 91) (RING-type E3 ubiquitin transferase TRIM9) (Tripartite motif-containing protein 9) | E3 ubiquitin-protein ligase which ubiquitinates itself in cooperation with an E2 enzyme UBE2D2/UBC4 and serves as a targeting signal for proteasomal degradation. May play a role in regulation of neuronal functions and may also participate in the formation or breakdown of abnormal inclusions in neurodegenerative disorders. May act as a regulator of synaptic vesicle exocytosis by controlling the availability of SNAP25 for the SNARE complex formation. {ECO:0000269|PubMed:20085810}. |
Q9C0D2 | CEP295 | S938 | ochoa | Centrosomal protein of 295 kDa | Centriole-enriched microtubule-binding protein involved in centriole biogenesis (PubMed:20844083, PubMed:25131205, PubMed:27185865, PubMed:38154379). Essential for the generation of the distal portion of new-born centrioles in a CPAP- and CEP120-mediated elongation dependent manner during the cell cycle S/G2 phase after formation of the initiating cartwheel structure (PubMed:27185865). Required for the recruitment of centriolar proteins, such as POC1B, POC5 and CEP135, into the distal portion of centrioles (PubMed:27185865). Also required for centriole-to-centrosome conversion during mitotic progression, but is dispensable for cartwheel removal or centriole disengagement (PubMed:25131205). Binds to and stabilizes centriolar microtubule (PubMed:27185865). May be involved in ciliogenesis (PubMed:38154379). {ECO:0000269|PubMed:20844083, ECO:0000269|PubMed:25131205, ECO:0000269|PubMed:27185865, ECO:0000269|PubMed:32060285, ECO:0000269|PubMed:38154379}. |
Q9H0H5 | RACGAP1 | S600 | ochoa | Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) | Component of the centralspindlin complex that serves as a microtubule-dependent and Rho-mediated signaling required for the myosin contractile ring formation during the cell cycle cytokinesis. Required for proper attachment of the midbody to the cell membrane during cytokinesis. Sequentially binds to ECT2 and RAB11FIP3 which regulates cleavage furrow ingression and abscission during cytokinesis (PubMed:18511905). Plays key roles in controlling cell growth and differentiation of hematopoietic cells through mechanisms other than regulating Rac GTPase activity (PubMed:10979956). Has a critical role in erythropoiesis (PubMed:34818416). Also involved in the regulation of growth-related processes in adipocytes and myoblasts. May be involved in regulating spermatogenesis and in the RACGAP1 pathway in neuronal proliferation. Shows strong GAP (GTPase activation) activity towards CDC42 and RAC1 and less towards RHOA. Essential for the early stages of embryogenesis. May play a role in regulating cortical activity through RHOA during cytokinesis. May participate in the regulation of sulfate transport in male germ cells. {ECO:0000269|PubMed:10979956, ECO:0000269|PubMed:11085985, ECO:0000269|PubMed:11278976, ECO:0000269|PubMed:11782313, ECO:0000269|PubMed:14729465, ECO:0000269|PubMed:15642749, ECO:0000269|PubMed:16103226, ECO:0000269|PubMed:16129829, ECO:0000269|PubMed:16236794, ECO:0000269|PubMed:18511905, ECO:0000269|PubMed:19468300, ECO:0000269|PubMed:19468302, ECO:0000269|PubMed:23235882, ECO:0000269|PubMed:9497316}. |
Q9H1A4 | ANAPC1 | S547 | ochoa | Anaphase-promoting complex subunit 1 (APC1) (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein) | Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle (PubMed:18485873). The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains (PubMed:18485873). The APC/C complex catalyzes assembly of branched 'Lys-11'-/'Lys-48'-linked branched ubiquitin chains on target proteins (PubMed:29033132). {ECO:0000269|PubMed:18485873, ECO:0000269|PubMed:29033132}. |
Q9H4M9 | EHD1 | S284 | ochoa | EH domain-containing protein 1 (PAST homolog 1) (hPAST1) (Testilin) | ATP- and membrane-binding protein that controls membrane reorganization/tubulation upon ATP hydrolysis. In vitro causes vesiculation of endocytic membranes (PubMed:24019528). Acts in early endocytic membrane fusion and membrane trafficking of recycling endosomes (PubMed:15020713, PubMed:17233914, PubMed:20801876). Recruited to endosomal membranes upon nerve growth factor stimulation, indirectly regulates neurite outgrowth (By similarity). Plays a role in myoblast fusion (By similarity). Involved in the unidirectional retrograde dendritic transport of endocytosed BACE1 and in efficient sorting of BACE1 to axons implicating a function in neuronal APP processing (By similarity). Plays a role in the formation of the ciliary vesicle (CV), an early step in cilium biogenesis (PubMed:31615969). Proposed to be required for the fusion of distal appendage vesicles (DAVs) to form the CV by recruiting SNARE complex component SNAP29. Is required for recruitment of transition zone proteins CEP290, RPGRIP1L, TMEM67 and B9D2, and of IFT20 following DAV reorganization before Rab8-dependent ciliary membrane extension. Required for the loss of CCP110 form the mother centriole essential for the maturation of the basal body during ciliogenesis (PubMed:25686250). {ECO:0000250|UniProtKB:Q641Z6, ECO:0000250|UniProtKB:Q9WVK4, ECO:0000269|PubMed:15020713, ECO:0000269|PubMed:17233914, ECO:0000269|PubMed:20801876, ECO:0000269|PubMed:24019528, ECO:0000269|PubMed:25686250, ECO:0000269|PubMed:31615969}. |
Q9H6B4 | CLMP | S334 | ochoa | CXADR-like membrane protein (Adipocyte adhesion molecule) (Coxsackie- and adenovirus receptor-like membrane protein) (CAR-like membrane protein) | May be involved in the cell-cell adhesion. May play a role in adipocyte differentiation and development of obesity. Is required for normal small intestine development. {ECO:0000269|PubMed:14573622, ECO:0000269|PubMed:15563274, ECO:0000269|PubMed:22155368}. |
Q9HC52 | CBX8 | S256 | ochoa | Chromobox protein homolog 8 (Polycomb 3 homolog) (Pc3) (hPc3) (Rectachrome 1) | Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility. {ECO:0000269|PubMed:21282530}. |
Q9HD26 | GOPC | S86 | ochoa | Golgi-associated PDZ and coiled-coil motif-containing protein (CFTR-associated ligand) (Fused in glioblastoma) (PDZ protein interacting specifically with TC10) (PIST) | Plays a role in intracellular protein trafficking and degradation (PubMed:11707463, PubMed:14570915, PubMed:15358775). May regulate CFTR chloride currents and acid-induced ASIC3 currents by modulating cell surface expression of both channels (By similarity). May also regulate the intracellular trafficking of the ADR1B receptor (PubMed:15358775). May play a role in autophagy (By similarity). Together with MARCHF2 mediates the ubiquitination and lysosomal degradation of CFTR (PubMed:23818989). Overexpression results in CFTR intracellular retention and lysosomaldegradation in the lysosomes (PubMed:11707463, PubMed:14570915). {ECO:0000250|UniProtKB:Q8BH60, ECO:0000269|PubMed:11707463, ECO:0000269|PubMed:14570915, ECO:0000269|PubMed:15358775, ECO:0000269|PubMed:23818989}. |
Q9NS62 | THSD1 | S477 | ochoa | Thrombospondin type-1 domain-containing protein 1 (Transmembrane molecule with thrombospondin module) | Is a positive regulator of nascent focal adhesion assembly, involved in the modulation of endothelial cell attachment to the extracellular matrix. {ECO:0000269|PubMed:27895300, ECO:0000269|PubMed:29069646}. |
Q9NSA2 | KCND1 | S568 | psp | A-type voltage-gated potassium channel KCND1 (Potassium voltage-gated channel subfamily D member 1) (Shal-type potassium channel KCND1) (Voltage-gated potassium channel subunit Kv4.1) | A-type voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes in the brain (PubMed:15454437). Mediates A-type current I(SA) in suprachiasmatic nucleus (SCN) neurons. Exhibits a low-threshold A-type current with a hyperpolarized steady-state inactivation midpoint and the recovery process was steeply voltage-dependent, with recovery being markedly faster at more negative potentials. May regulates repetitive firing rates in the suprachiasmatic nucleus (SCN) neurons and circadian rhythms in neuronal excitability and behavior. Contributes to the regulation of the circadian rhythm of action potential firing in suprachiasmatic nucleus neurons, which regulates the circadian rhythm of locomotor activity. The regulatory subunit KCNIP1 modulates the kinetics of channel inactivation, increases the current amplitudes and accelerates recovery from inactivation, shifts activation in a depolarizing direction (By similarity). The regulatory subunit DPP10 decreases the voltage sensitivity of the inactivation channel gating (PubMed:15454437). {ECO:0000250|UniProtKB:Q03719, ECO:0000269|PubMed:15454437}. |
Q9NUQ9 | CYRIB | S117 | ochoa | CYFIP-related Rac1 interactor B (L1) | Negatively regulates RAC1 signaling and RAC1-driven cytoskeletal remodeling (PubMed:30250061, PubMed:31285585). Regulates chemotaxis, cell migration and epithelial polarization by controlling the polarity, plasticity, duration and extent of protrusions. Limits Rac1 mediated activation of the Scar/WAVE complex, focuses protrusion signals and regulates pseudopod complexity by inhibiting Scar/WAVE-induced actin polymerization (PubMed:30250061). Protects against Salmonella bacterial infection. Attenuates processes such as macropinocytosis, phagocytosis and cell migration and restrict sopE-mediated bacterial entry (PubMed:31285585). Also restricts infection mediated by Mycobacterium tuberculosis and Listeria monocytogenes (By similarity). Involved in the regulation of mitochondrial dynamics and oxidative stress (PubMed:29059164). {ECO:0000250|UniProtKB:Q921M7, ECO:0000269|PubMed:29059164, ECO:0000269|PubMed:30250061, ECO:0000269|PubMed:31285585}. |
Q9NXG2 | THUMPD1 | S270 | ochoa | THUMP domain-containing protein 1 | Functions as a tRNA-binding adapter to mediate NAT10-dependent tRNA acetylation modifying cytidine to N4-acetylcytidine (ac4C) (PubMed:25653167, PubMed:35196516). {ECO:0000269|PubMed:25653167, ECO:0000269|PubMed:35196516}. |
Q9NY65 | TUBA8 | T223 | ochoa | Tubulin alpha-8 chain (EC 3.6.5.-) (Alpha-tubulin 8) (Tubulin alpha chain-like 2) [Cleaved into: Dephenylalaninated tubulin alpha-8 chain] | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
Q9NYL2 | MAP3K20 | S275 | ochoa | Mitogen-activated protein kinase kinase kinase 20 (EC 2.7.11.25) (Human cervical cancer suppressor gene 4 protein) (HCCS-4) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mitogen-activated protein kinase kinase kinase MLT) (Mixed lineage kinase 7) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK) | Stress-activated component of a protein kinase signal transduction cascade that promotes programmed cell death in response to various stress, such as ribosomal stress, osmotic shock and ionizing radiation (PubMed:10924358, PubMed:11836244, PubMed:12220515, PubMed:14521931, PubMed:15350844, PubMed:15737997, PubMed:18331592, PubMed:20559024, PubMed:26999302, PubMed:32289254, PubMed:32610081, PubMed:35857590). Acts by catalyzing phosphorylation of MAP kinase kinases, leading to activation of the JNK (MAPK8/JNK1, MAPK9/JNK2 and/or MAPK10/JNK3) and MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) pathways (PubMed:11042189, PubMed:11836244, PubMed:12220515, PubMed:14521931, PubMed:15172994, PubMed:15737997, PubMed:32289254, PubMed:32610081, PubMed:35857590). Activates JNK through phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7, and MAP kinase p38 gamma (MAPK12) via phosphorylation of MAP2K3/MKK3 and MAP2K6/MKK6 (PubMed:11836244, PubMed:12220515). Involved in stress associated with adrenergic stimulation: contributes to cardiac decompensation during periods of acute cardiac stress (PubMed:15350844, PubMed:21224381, PubMed:27859413). May be involved in regulation of S and G2 cell cycle checkpoint by mediating phosphorylation of CHEK2 (PubMed:15342622). {ECO:0000269|PubMed:10924358, ECO:0000269|PubMed:11042189, ECO:0000269|PubMed:11836244, ECO:0000269|PubMed:12220515, ECO:0000269|PubMed:14521931, ECO:0000269|PubMed:15172994, ECO:0000269|PubMed:15342622, ECO:0000269|PubMed:15350844, ECO:0000269|PubMed:15737997, ECO:0000269|PubMed:18331592, ECO:0000269|PubMed:20559024, ECO:0000269|PubMed:21224381, ECO:0000269|PubMed:26999302, ECO:0000269|PubMed:27859413, ECO:0000269|PubMed:32289254, ECO:0000269|PubMed:32610081, ECO:0000269|PubMed:35857590}.; FUNCTION: [Isoform ZAKalpha]: Key component of the stress-activated protein kinase signaling cascade in response to ribotoxic stress or UV-B irradiation (PubMed:32289254, PubMed:32610081, PubMed:35857590). Acts as the proximal sensor of ribosome collisions during the ribotoxic stress response (RSR): directly binds to the ribosome by inserting its flexible C-terminus into the ribosomal intersubunit space, thereby acting as a sentinel for colliding ribosomes (PubMed:32289254, PubMed:32610081). Upon ribosome collisions, activates either the stress-activated protein kinase signal transduction cascade or the integrated stress response (ISR), leading to programmed cell death or cell survival, respectively (PubMed:32610081). Dangerous levels of ribosome collisions trigger the autophosphorylation and activation of MAP3K20, which dissociates from colliding ribosomes and phosphorylates MAP kinase kinases, leading to activation of the JNK and MAP kinase p38 pathways that promote programmed cell death (PubMed:32289254, PubMed:32610081). Less dangerous levels of ribosome collisions trigger the integrated stress response (ISR): MAP3K20 activates EIF2AK4/GCN2 independently of its protein-kinase activity, promoting EIF2AK4/GCN2-mediated phosphorylation of EIF2S1/eIF-2-alpha (PubMed:32610081). Also part of the stress-activated protein kinase signaling cascade triggering the NLRP1 inflammasome in response to UV-B irradiation: ribosome collisions activate MAP3K20, which directly phosphorylates NLRP1, leading to activation of the NLRP1 inflammasome and subsequent pyroptosis (PubMed:35857590). NLRP1 is also phosphorylated by MAP kinase p38 downstream of MAP3K20 (PubMed:35857590). Also acts as a histone kinase by phosphorylating histone H3 at 'Ser-28' (H3S28ph) (PubMed:15684425). {ECO:0000269|PubMed:15684425, ECO:0000269|PubMed:32289254, ECO:0000269|PubMed:32610081, ECO:0000269|PubMed:35857590}.; FUNCTION: [Isoform ZAKbeta]: Isoform that lacks the C-terminal region that mediates ribosome-binding: does not act as a sensor of ribosome collisions in response to ribotoxic stress (PubMed:32289254, PubMed:32610081, PubMed:35857590). May act as an antagonist of isoform ZAKalpha: interacts with isoform ZAKalpha, leading to decrease the expression of isoform ZAKalpha (PubMed:27859413). {ECO:0000269|PubMed:27859413, ECO:0000269|PubMed:32289254, ECO:0000269|PubMed:32610081, ECO:0000269|PubMed:35857590}. |
Q9NYY8 | FASTKD2 | S126 | ochoa | FAST kinase domain-containing protein 2, mitochondrial | Plays an important role in assembly of the mitochondrial large ribosomal subunit (PubMed:25683715). As a component of a functional protein-RNA module, consisting of RCC1L, NGRN, RPUSD3, RPUSD4, TRUB2, FASTKD2 and 16S mitochondrial ribosomal RNA (16S mt-rRNA), controls 16S mt-rRNA abundance and is required for intra-mitochondrial translation (PubMed:25683715, PubMed:26370583, PubMed:27667664). May play a role in mitochondrial apoptosis. {ECO:0000269|PubMed:18771761, ECO:0000269|PubMed:25683715, ECO:0000269|PubMed:26370583, ECO:0000269|PubMed:27667664}. |
Q9NZN3 | EHD3 | S284 | ochoa | EH domain-containing protein 3 (PAST homolog 3) | ATP- and membrane-binding protein that controls membrane reorganization/tubulation upon ATP hydrolysis (PubMed:25686250). In vitro causes tubulation of endocytic membranes (PubMed:24019528). Binding to phosphatidic acid induces its membrane tubulation activity (By similarity). Plays a role in endocytic transport. Involved in early endosome to recycling endosome compartment (ERC), retrograde early endosome to Golgi, and endosome to plasma membrane (rapid recycling) protein transport. Involved in the regulation of Golgi maintenance and morphology (PubMed:16251358, PubMed:17233914, PubMed:19139087, PubMed:23781025). Involved in the recycling of internalized D1 dopamine receptor (PubMed:21791287). Plays a role in cardiac protein trafficking probably implicating ANK2 (PubMed:20489164). Involved in the ventricular membrane targeting of SLC8A1 and CACNA1C and probably the atrial membrane localization of CACNA1GG and CACNA1H implicated in the regulation of atrial myocyte excitability and cardiac conduction (By similarity). In conjunction with EHD4 may be involved in endocytic trafficking of KDR/VEGFR2 implicated in control of glomerular function (By similarity). Involved in the rapid recycling of integrin beta-3 implicated in cell adhesion maintenance (PubMed:23781025). Involved in the unidirectional retrograde dendritic transport of endocytosed BACE1 and in efficient sorting of BACE1 to axons implicating a function in neuronal APP processing (By similarity). Plays a role in the formation of the ciliary vesicle, an early step in cilium biogenesis; possibly sharing redundant functions with EHD1 (PubMed:25686250). {ECO:0000250|UniProtKB:Q9QXY6, ECO:0000269|PubMed:16251358, ECO:0000269|PubMed:17233914, ECO:0000269|PubMed:19139087, ECO:0000269|PubMed:21791287, ECO:0000269|PubMed:23781025, ECO:0000269|PubMed:24019528, ECO:0000269|PubMed:25686250, ECO:0000305|PubMed:20489164}. |
Q9P107 | GMIP | S480 | ochoa | GEM-interacting protein (GMIP) | Stimulates, in vitro and in vivo, the GTPase activity of RhoA. {ECO:0000269|PubMed:12093360}. |
Q9P270 | SLAIN2 | S391 | ochoa | SLAIN motif-containing protein 2 | Binds to the plus end of microtubules and regulates microtubule dynamics and microtubule organization. Promotes cytoplasmic microtubule nucleation and elongation. Required for normal structure of the microtubule cytoskeleton during interphase. {ECO:0000269|PubMed:21646404}. |
Q9P2G1 | ANKIB1 | S891 | ochoa | Ankyrin repeat and IBR domain-containing protein 1 (EC 2.3.2.31) | Might act as an E3 ubiquitin-protein ligase, or as part of E3 complex, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes and then transfers it to substrates. {ECO:0000250}. |
Q9UIF8 | BAZ2B | S335 | ochoa | Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) | Regulatory subunit of the ATP-dependent BRF-1 and BRF-5 ISWI chromatin remodeling complexes, which form ordered nucleosome arrays on chromatin and facilitate access to DNA during DNA-templated processes such as DNA replication, transcription, and repair (PubMed:28801535). Both complexes regulate the spacing of nucleosomes along the chromatin and have the ability to slide mononucleosomes to the center of a DNA template (PubMed:28801535). The BRF-1 ISWI chromatin remodeling complex has a lower ATP hydrolysis rate than the BRF-5 ISWI chromatin remodeling complex (PubMed:28801535). Chromatin reader protein, which may play a role in transcriptional regulation via interaction with ISWI (By similarity) (PubMed:10662543). Involved in positively modulating the rate of age-related behavioral deterioration (By similarity). Represses the expression of mitochondrial function-related genes, perhaps by occupying their promoter regions, working in concert with histone methyltransferase EHMT1 (By similarity). {ECO:0000250|UniProtKB:A2AUY4, ECO:0000269|PubMed:28801535, ECO:0000303|PubMed:10662543}. |
Q9UKA2 | FBXL4 | S268 | ochoa | F-box/LRR-repeat protein 4 (F-box and leucine-rich repeat protein 4) (F-box protein FBL4/FBL5) | Substrate-recognition component of the mitochondria-localized SCF-FBXL4 ubiquitin E3 ligase complex that plays a role in the restriction of mitophagy by controlling the degradation of BNIP3 and NIX mitophagy receptors (PubMed:36896912, PubMed:38992176). Rescues also mitochondrial injury through reverting hyperactivation of DRP1-mediated mitochondrial fission (By similarity). {ECO:0000250|UniProtKB:Q8BH70, ECO:0000269|PubMed:36896912, ECO:0000269|PubMed:38992176}. |
Q9UMS6 | SYNPO2 | S717 | ochoa | Synaptopodin-2 (Genethonin-2) (Myopodin) | Has an actin-binding and actin-bundling activity. Can induce the formation of F-actin networks in an isoform-specific manner (PubMed:23225103, PubMed:24005909). At the sarcomeric Z lines is proposed to act as adapter protein that links nascent myofibers to the sarcolemma via ZYX and may play a role in early assembly and stabilization of the Z lines. Involved in autophagosome formation. May play a role in chaperone-assisted selective autophagy (CASA) involved in Z lines maintenance in striated muscle under mechanical tension; may link the client-processing CASA chaperone machinery to a membrane-tethering and fusion complex providing autophagosome membranes (By similarity). Involved in regulation of cell migration (PubMed:22915763, PubMed:25883213). May be a tumor suppressor (PubMed:16885336). {ECO:0000250|UniProtKB:D4A702, ECO:0000250|UniProtKB:Q91YE8, ECO:0000269|PubMed:22915763, ECO:0000269|PubMed:23225103, ECO:0000269|PubMed:24005909, ECO:0000269|PubMed:25883213, ECO:0000305|PubMed:16885336, ECO:0000305|PubMed:20554076}.; FUNCTION: [Isoform 1]: Involved in regulation of cell migration. Can induce formation of thick, irregular actin bundles in the cell body. {ECO:0000269|PubMed:22915763, ECO:0000269|PubMed:24005909}.; FUNCTION: [Isoform 2]: Involved in regulation of cell migration. Can induce long, well-organized actin bundles frequently orientated in parallel along the long axis of the cell showing characteristics of contractile ventral stress fibers. {ECO:0000269|PubMed:22915763, ECO:0000269|PubMed:24005909}.; FUNCTION: [Isoform 3]: Involved in regulation of cell migration. Can induce an amorphous actin meshwork throughout the cell body containing a mixture of long and short, randomly organized thick and thin actin bundles. {ECO:0000269|PubMed:22915763, ECO:0000269|PubMed:24005909}.; FUNCTION: [Isoform 4]: Can induce long, well-organized actin bundles frequently orientated in parallel along the long axis of the cell showing characteristics of contractile ventral stress fibers. {ECO:0000269|PubMed:24005909}.; FUNCTION: [Isoform 5]: Involved in regulation of cell migration in part dependent on the Rho-ROCK cascade; can promote formation of nascent focal adhesions, actin bundles at the leading cell edge and lamellipodia (PubMed:22915763, PubMed:25883213). Can induce formation of thick, irregular actin bundles in the cell body; the induced actin network is associated with enhanced cell migration in vitro. {ECO:0000269|PubMed:22915763, ECO:0000269|PubMed:24005909, ECO:0000269|PubMed:25883213}. |
Q9UMZ2 | SYNRG | S821 | ochoa | Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin) | Plays a role in endocytosis and/or membrane trafficking at the trans-Golgi network (TGN) (PubMed:15758025). May act by linking the adapter protein complex AP-1 to other proteins (Probable). Component of clathrin-coated vesicles (PubMed:15758025). Component of the aftiphilin/p200/gamma-synergin complex, which plays roles in AP1G1/AP-1-mediated protein trafficking including the trafficking of transferrin from early to recycling endosomes, and the membrane trafficking of furin and the lysosomal enzyme cathepsin D between the trans-Golgi network (TGN) and endosomes (PubMed:15758025). {ECO:0000269|PubMed:15758025, ECO:0000305|PubMed:12538641}. |
Q9UNY4 | TTF2 | S235 | ochoa | Transcription termination factor 2 (EC 3.6.4.-) (Lodestar homolog) (RNA polymerase II termination factor) (Transcription release factor 2) (F2) (HuF2) | DsDNA-dependent ATPase which acts as a transcription termination factor by coupling ATP hydrolysis with removal of RNA polymerase II from the DNA template. May contribute to mitotic transcription repression. May also be involved in pre-mRNA splicing. {ECO:0000269|PubMed:10455150, ECO:0000269|PubMed:12927788, ECO:0000269|PubMed:15125840, ECO:0000269|PubMed:9748214}. |
Q9UPU9 | SAMD4A | S272 | ochoa | Protein Smaug homolog 1 (Smaug 1) (hSmaug1) (Sterile alpha motif domain-containing protein 4A) (SAM domain-containing protein 4A) | Acts as a translational repressor of SRE-containing messengers. {ECO:0000269|PubMed:16221671}. |
Q9Y2H5 | PLEKHA6 | S591 | ochoa | Pleckstrin homology domain-containing family A member 6 (PH domain-containing family A member 6) (Phosphoinositol 3-phosphate-binding protein 3) (PEPP-3) | None |
Q9Y448 | KNSTRN | S232 | ochoa | Small kinetochore-associated protein (SKAP) (Kinetochore-localized astrin-binding protein) (Kinastrin) (Kinetochore-localized astrin/SPAG5-binding protein) (TRAF4-associated factor 1) | Essential component of the mitotic spindle required for faithful chromosome segregation and progression into anaphase (PubMed:19667759). Promotes the metaphase-to-anaphase transition and is required for chromosome alignment, normal timing of sister chromatid segregation, and maintenance of spindle pole architecture (PubMed:19667759, PubMed:22110139). The astrin (SPAG5)-kinastrin (SKAP) complex promotes stable microtubule-kinetochore attachments (PubMed:21402792). Required for kinetochore oscillations and dynamics of microtubule plus-ends during live cell mitosis, possibly by forming a link between spindle microtubule plus-ends and mitotic chromosomes to achieve faithful cell division (PubMed:23035123). May be involved in UV-induced apoptosis via its interaction with PRPF19; however, these results need additional evidences (PubMed:24718257). {ECO:0000269|PubMed:19667759, ECO:0000269|PubMed:21402792, ECO:0000269|PubMed:22110139, ECO:0000269|PubMed:23035123, ECO:0000305|PubMed:24718257}. |
Q9Y490 | TLN1 | S604 | ochoa | Talin-1 | High molecular weight cytoskeletal protein concentrated at regions of cell-matrix and cell-cell contacts. Involved in connections of major cytoskeletal structures to the plasma membrane. With KANK1 co-organize the assembly of cortical microtubule stabilizing complexes (CMSCs) positioned to control microtubule-actin crosstalk at focal adhesions (FAs) rims. {ECO:0000250|UniProtKB:P26039}. |
Q9Y6R4 | MAP3K4 | S503 | ochoa | Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) | Component of a protein kinase signal transduction cascade. Activates the CSBP2, P38 and JNK MAPK pathways, but not the ERK pathway. Specifically phosphorylates and activates MAP2K4 and MAP2K6. {ECO:0000269|PubMed:12052864, ECO:0000269|PubMed:9305639}. |
P27986 | PIK3R1 | S155 | Sugiyama | Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha) | Binds to activated (phosphorylated) protein-Tyr kinases, through its SH2 domain, and acts as an adapter, mediating the association of the p110 catalytic unit to the plasma membrane. Necessary for the insulin-stimulated increase in glucose uptake and glycogen synthesis in insulin-sensitive tissues. Plays an important role in signaling in response to FGFR1, FGFR2, FGFR3, FGFR4, KITLG/SCF, KIT, PDGFRA and PDGFRB. Likewise, plays a role in ITGB2 signaling (PubMed:17626883, PubMed:19805105, PubMed:7518429). Modulates the cellular response to ER stress by promoting nuclear translocation of XBP1 isoform 2 in a ER stress- and/or insulin-dependent manner during metabolic overloading in the liver and hence plays a role in glucose tolerance improvement (PubMed:20348923). {ECO:0000269|PubMed:17626883, ECO:0000269|PubMed:19805105, ECO:0000269|PubMed:20348923, ECO:0000269|PubMed:7518429}. |
O43324 | EEF1E1 | S100 | Sugiyama | Eukaryotic translation elongation factor 1 epsilon-1 (Aminoacyl tRNA synthetase complex-interacting multifunctional protein 3) (Elongation factor p18) (Multisynthase complex auxiliary component p18) | Positive modulator of ATM response to DNA damage. {ECO:0000250|UniProtKB:Q9D1M4}. |
Q8N5N7 | MRPL50 | S72 | Sugiyama | Large ribosomal subunit protein mL50 (39S ribosomal protein L50, mitochondrial) (L50mt) (MRP-L50) | None |
Q9NTJ3 | SMC4 | S964 | Sugiyama | Structural maintenance of chromosomes protein 4 (SMC protein 4) (SMC-4) (Chromosome-associated polypeptide C) (hCAP-C) (XCAP-C homolog) | Central component of the condensin complex, a complex required for conversion of interphase chromatin into mitotic-like condense chromosomes. The condensin complex probably introduces positive supercoils into relaxed DNA in the presence of type I topoisomerases and converts nicked DNA into positive knotted forms in the presence of type II topoisomerases. {ECO:0000269|PubMed:11136719}. |
P49327 | FASN | S519 | Sugiyama | Fatty acid synthase (EC 2.3.1.85) (Type I fatty acid synthase) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Acyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)] | Fatty acid synthetase is a multifunctional enzyme that catalyzes the de novo biosynthesis of long-chain saturated fatty acids starting from acetyl-CoA and malonyl-CoA in the presence of NADPH. This multifunctional protein contains 7 catalytic activities and a site for the binding of the prosthetic group 4'-phosphopantetheine of the acyl carrier protein ([ACP]) domain. {ECO:0000269|PubMed:16215233, ECO:0000269|PubMed:16969344, ECO:0000269|PubMed:26851298, ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}.; FUNCTION: (Microbial infection) Fatty acid synthetase activity is required for SARS coronavirus-2/SARS-CoV-2 replication. {ECO:0000269|PubMed:34320401}. |
Q16658 | FSCN1 | S237 | Sugiyama | Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55) | Actin-binding protein that contains 2 major actin binding sites (PubMed:21685497, PubMed:23184945). Organizes filamentous actin into parallel bundles (PubMed:20393565, PubMed:21685497, PubMed:23184945). Plays a role in the organization of actin filament bundles and the formation of microspikes, membrane ruffles, and stress fibers (PubMed:22155786). Important for the formation of a diverse set of cell protrusions, such as filopodia, and for cell motility and migration (PubMed:20393565, PubMed:21685497, PubMed:23184945). Mediates reorganization of the actin cytoskeleton and axon growth cone collapse in response to NGF (PubMed:22155786). {ECO:0000269|PubMed:20137952, ECO:0000269|PubMed:20393565, ECO:0000269|PubMed:21685497, ECO:0000269|PubMed:22155786, ECO:0000269|PubMed:23184945, ECO:0000269|PubMed:9362073, ECO:0000269|PubMed:9571235}. |
P41091 | EIF2S3 | S410 | Sugiyama | Eukaryotic translation initiation factor 2 subunit 3 (EC 3.6.5.3) (Eukaryotic translation initiation factor 2 subunit gamma X) (eIF2-gamma X) (eIF2gX) | Member of the eIF2 complex that functions in the early steps of protein synthesis by forming a ternary complex with GTP and initiator tRNA (PubMed:31836389). This complex binds to a 40S ribosomal subunit, followed by mRNA binding to form the 43S pre-initiation complex (43S PIC) (By similarity). Junction of the 60S ribosomal subunit to form the 80S initiation complex is preceded by hydrolysis of the GTP bound to eIF2 and release of an eIF2-GDP binary complex (By similarity). In order for eIF2 to recycle and catalyze another round of initiation, the GDP bound to eIF2 must exchange with GTP by way of a reaction catalyzed by eIF-2B (By similarity). {ECO:0000250|UniProtKB:P05198, ECO:0000269|PubMed:31836389}. |
Q2VIR3 | EIF2S3B | S410 | Sugiyama | Eukaryotic translation initiation factor 2 subunit 3B (EC 3.6.5.3) (Eukaryotic translation initiation factor 2 subunit gamma A) (eIF-2-gamma A) (eIF-2gA) | Member of the eIF2 complex that functions in the early steps of protein synthesis by forming a ternary complex with GTP and initiator tRNA. This complex binds to a 40S ribosomal subunit, followed by mRNA binding to form the 43S pre-initiation complex (43S PIC). Junction of the 60S ribosomal subunit to form the 80S initiation complex is preceded by hydrolysis of the GTP bound to eIF2 and release of an eIF2-GDP binary complex. In order for eIF2 to recycle and catalyze another round of initiation, the GDP bound to eIF2 must exchange with GTP by way of a reaction catalyzed by eIF-2B (By similarity). {ECO:0000250|UniProtKB:P05198}. |
P28329 | CHAT | S464 | SIGNOR|EPSD | Choline O-acetyltransferase (CHOACTase) (ChAT) (Choline acetylase) (EC 2.3.1.6) | Catalyzes the reversible synthesis of acetylcholine (ACh) from acetyl CoA and choline at cholinergic synapses. {ECO:0000269|PubMed:17144655}. |
O96004 | HAND1 | S98 | ELM | Heart- and neural crest derivatives-expressed protein 1 (Class A basic helix-loop-helix protein 27) (bHLHa27) (Extraembryonic tissues, heart, autonomic nervous system and neural crest derivatives-expressed protein 1) (eHAND) | Transcription factor that plays an essential role in both trophoblast giant cell differentiation and in cardiac morphogenesis (By similarity). Binds the DNA sequence 5'-NRTCTG-3' (non-canonical E-box) (By similarity). Acts as a transcriptional repressor of SOX15 (By similarity). In the adult, could be required for ongoing expression of cardiac-specific genes (PubMed:9931445). {ECO:0000250|UniProtKB:Q64279, ECO:0000269|PubMed:9931445}. |
P15735 | PHKG2 | S175 | Sugiyama | Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (PSK-C3) (Phosphorylase kinase subunit gamma-2) | Catalytic subunit of the phosphorylase b kinase (PHK), which mediates the neural and hormonal regulation of glycogen breakdown (glycogenolysis) by phosphorylating and thereby activating glycogen phosphorylase. May regulate glycogeneolysis in the testis. In vitro, phosphorylates PYGM (PubMed:35549678). {ECO:0000250|UniProtKB:P31325, ECO:0000269|PubMed:10487978, ECO:0000269|PubMed:35549678}. |
Q99615 | DNAJC7 | S88 | Sugiyama | DnaJ homolog subfamily C member 7 (Tetratricopeptide repeat protein 2) (TPR repeat protein 2) | Acts as a co-chaperone regulating the molecular chaperones HSP70 and HSP90 in folding of steroid receptors, such as the glucocorticoid receptor and the progesterone receptor. Proposed to act as a recycling chaperone by facilitating the return of chaperone substrates to early stages of chaperoning if further folding is required. In vitro, induces ATP-independent dissociation of HSP90 but not of HSP70 from the chaperone-substrate complexes. Recruits NR1I3 to the cytoplasm (By similarity). {ECO:0000250, ECO:0000269|PubMed:12853476, ECO:0000269|PubMed:18620420}. |
O60941 | DTNB | S465 | Sugiyama | Dystrobrevin beta (DTN-B) (Beta-dystrobrevin) | Scaffolding protein that assembles DMD and SNTA1 molecules to the basal membrane of kidney cells and liver sinusoids (By similarity). May function as a repressor of the SYN1 promoter through the binding of repressor element-1 (RE-1), in turn regulates SYN1 expression and may be involved in cell proliferation regulation during the early phase of neural differentiation (PubMed:27223470). May be required for proper maturation and function of a subset of inhibitory synapses (By similarity). {ECO:0000250|UniProtKB:O70585, ECO:0000269|PubMed:27223470}. |
Q9Y4J8 | DTNA | S501 | Sugiyama | Dystrobrevin alpha (DTN-A) (Alpha-dystrobrevin) (Dystrophin-related protein 3) | May be involved in the formation and stability of synapses as well as being involved in the clustering of nicotinic acetylcholine receptors. |
Q96QK1 | VPS35 | S760 | Sugiyama | Vacuolar protein sorting-associated protein 35 (hVPS35) (Maternal-embryonic 3) (Vesicle protein sorting 35) | Acts as a component of the retromer cargo-selective complex (CSC). The CSC is believed to be the core functional component of retromer or respective retromer complex variants acting to prevent missorting of selected transmembrane cargo proteins into the lysosomal degradation pathway. The recruitment of the CSC to the endosomal membrane involves RAB7A and SNX3. The CSC seems to associate with the cytoplasmic domain of cargo proteins predominantly via VPS35; however, these interactions seem to be of low affinity and retromer SNX proteins may also contribute to cargo selectivity thus questioning the classical function of the CSC. The SNX-BAR retromer mediates retrograde transport of cargo proteins from endosomes to the trans-Golgi network (TGN) and is involved in endosome-to-plasma membrane transport for cargo protein recycling. The SNX3-retromer mediates the retrograde endosome-to-TGN transport of WLS distinct from the SNX-BAR retromer pathway (PubMed:30213940). The SNX27-retromer is believed to be involved in endosome-to-plasma membrane trafficking and recycling of a broad spectrum of cargo proteins. The CSC seems to act as recruitment hub for other proteins, such as the WASH complex and TBC1D5 (Probable). Required for retrograde transport of lysosomal enzyme receptor IGF2R and SLC11A2. Required to regulate transcytosis of the polymeric immunoglobulin receptor (pIgR-pIgA) (PubMed:15078903, PubMed:15247922, PubMed:20164305). Required for endosomal localization of WASHC2C (PubMed:22070227, PubMed:28892079). Mediates the association of the CSC with the WASH complex via WASHC2 (PubMed:22070227, PubMed:24819384, PubMed:24980502). Required for the endosomal localization of TBC1D5 (PubMed:20923837). {ECO:0000269|PubMed:15078903, ECO:0000269|PubMed:15247922, ECO:0000269|PubMed:20164305, ECO:0000269|PubMed:20923837, ECO:0000269|PubMed:22070227, ECO:0000269|PubMed:23395371, ECO:0000269|PubMed:24819384, ECO:0000269|PubMed:24980502, ECO:0000269|PubMed:28892079, ECO:0000269|PubMed:30213940, ECO:0000303|PubMed:21725319, ECO:0000303|PubMed:22070227, ECO:0000303|PubMed:22513087, ECO:0000303|PubMed:23563491}.; FUNCTION: (Microbial infection) The heterotrimeric retromer cargo-selective complex (CSC) mediates the exit of human papillomavirus from the early endosome and the delivery to the Golgi apparatus. {ECO:0000269|PubMed:25693203, ECO:0000269|PubMed:30122350}. |
P53634 | CTSC | S343 | Sugiyama | Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)] | Thiol protease (PubMed:1586157). Has dipeptidylpeptidase activity (PubMed:1586157). Active against a broad range of dipeptide substrates composed of both polar and hydrophobic amino acids (PubMed:1586157). Proline cannot occupy the P1 position and arginine cannot occupy the P2 position of the substrate (PubMed:1586157). Can act as both an exopeptidase and endopeptidase (PubMed:1586157). Activates serine proteases such as elastase, cathepsin G and granzymes A and B (PubMed:8428921). {ECO:0000269|PubMed:1586157, ECO:0000269|PubMed:8428921}. |
P33993 | MCM7 | Y539 | Sugiyama | DNA replication licensing factor MCM7 (EC 3.6.4.12) (CDC47 homolog) (P1.1-MCM3) | Acts as a component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. Core component of CDC45-MCM-GINS (CMG) helicase, the molecular machine that unwinds template DNA during replication, and around which the replisome is built (PubMed:25661590, PubMed:32453425, PubMed:34694004, PubMed:34700328, PubMed:35585232, PubMed:9305914). The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity (PubMed:32453425). Required for S-phase checkpoint activation upon UV-induced damage. {ECO:0000269|PubMed:15210935, ECO:0000269|PubMed:15538388, ECO:0000269|PubMed:25661590, ECO:0000269|PubMed:32453425, ECO:0000269|PubMed:34694004, ECO:0000269|PubMed:34700328, ECO:0000269|PubMed:35585232, ECO:0000269|PubMed:9305914}. |
P20020 | ATP2B1 | S52 | Sugiyama | Plasma membrane calcium-transporting ATPase 1 (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 1) (PMCA1) (Plasma membrane calcium pump isoform 1) | Catalyzes the hydrolysis of ATP coupled with the transport of calcium from the cytoplasm to the extracellular space thereby maintaining intracellular calcium homeostasis (PubMed:35358416). Plays a role in blood pressure regulation through regulation of intracellular calcium concentration and nitric oxide production leading to regulation of vascular smooth muscle cells vasoconstriction. Positively regulates bone mineralization through absorption of calcium from the intestine. Plays dual roles in osteoclast differentiation and survival by regulating RANKL-induced calcium oscillations in preosteoclasts and mediating calcium extrusion in mature osteoclasts (By similarity). Regulates insulin sensitivity through calcium/calmodulin signaling pathway by regulating AKT1 activation and NOS3 activation in endothelial cells (PubMed:29104511). May play a role in synaptic transmission by modulating calcium and proton dynamics at the synaptic vesicles. {ECO:0000250|UniProtKB:G5E829, ECO:0000269|PubMed:29104511, ECO:0000269|PubMed:35358416}. |
O15156 | ZBTB7B | S342 | Sugiyama | Zinc finger and BTB domain-containing protein 7B (Krueppel-related zinc finger protein cKrox) (hcKrox) (T-helper-inducing POZ/Krueppel-like factor) (Zinc finger and BTB domain-containing protein 15) (Zinc finger protein 67 homolog) (Zfp-67) (Zinc finger protein 857B) (Zinc finger protein Th-POK) | Transcription regulator that acts as a key regulator of lineage commitment of immature T-cell precursors. Exerts distinct biological functions in the mammary epithelial cells and T cells in a tissue-specific manner. Necessary and sufficient for commitment of CD4 lineage, while its absence causes CD8 commitment. Development of immature T-cell precursors (thymocytes) to either the CD4 helper or CD8 killer T-cell lineages correlates precisely with their T-cell receptor specificity for major histocompatibility complex class II or class I molecules, respectively. Cross-antagonism between ZBTB7B and CBF complexes are determinative to CD4 versus CD8 cell fate decision. Suppresses RUNX3 expression and imposes CD4+ lineage fate by inducing the SOCS suppressors of cytokine signaling. induces, as a transcriptional activator, SOCS genes expression which represses RUNX3 expression and promotes the CD4+ lineage fate. During CD4 lineage commitment, associates with multiple sites at the CD8 locus, acting as a negative regulator of the CD8 promoter and enhancers by epigenetic silencing through the recruitment of class II histone deacetylases, such as HDAC4 and HDAC5, to these loci. Regulates the development of IL17-producing CD1d-restricted naural killer (NK) T cells. Also functions as an important metabolic regulator in the lactating mammary glands. Critical feed-forward regulator of insulin signaling in mammary gland lactation, directly regulates expression of insulin receptor substrate-1 (IRS-1) and insulin-induced Akt-mTOR-SREBP signaling (By similarity). Transcriptional repressor of the collagen COL1A1 and COL1A2 genes. May also function as a repressor of fibronectin and possibly other extracellular matrix genes (PubMed:9370309). Potent driver of brown fat development, thermogenesis and cold-induced beige fat formation. Recruits the brown fat lncRNA 1 (Blnc1):HNRNPU ribonucleoprotein complex to activate thermogenic gene expression in brown and beige adipocytes (By similarity). {ECO:0000250|UniProtKB:Q64321, ECO:0000269|PubMed:9370309}. |
Q4V328 | GRIPAP1 | S291 | Sugiyama | GRIP1-associated protein 1 (GRASP-1) [Cleaved into: GRASP-1 C-terminal chain (30kDa C-terminus form)] | Regulates the endosomal recycling back to the neuronal plasma membrane, possibly by connecting early and late recycling endosomal domains and promoting segregation of recycling endosomes from early endosomal membranes. Involved in the localization of recycling endosomes to dendritic spines, thereby playing a role in the maintenance of dendritic spine morphology. Required for the activity-induced AMPA receptor recycling to dendrite membranes and for long-term potentiation and synaptic plasticity (By similarity). {ECO:0000250|UniProtKB:Q9JHZ4}.; FUNCTION: [GRASP-1 C-terminal chain]: Functions as a scaffold protein to facilitate MAP3K1/MEKK1-mediated activation of the JNK1 kinase by phosphorylation, possibly by bringing MAP3K1/MEKK1 and JNK1 in close proximity. {ECO:0000269|PubMed:17761173}. |
Q15303 | ERBB4 | S1228 | Sugiyama | Receptor tyrosine-protein kinase erbB-4 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain (4ICD) (E4ICD) (s80HER4)] | Tyrosine-protein kinase that plays an essential role as cell surface receptor for neuregulins and EGF family members and regulates development of the heart, the central nervous system and the mammary gland, gene transcription, cell proliferation, differentiation, migration and apoptosis. Required for normal cardiac muscle differentiation during embryonic development, and for postnatal cardiomyocyte proliferation. Required for normal development of the embryonic central nervous system, especially for normal neural crest cell migration and normal axon guidance. Required for mammary gland differentiation, induction of milk proteins and lactation. Acts as cell-surface receptor for the neuregulins NRG1, NRG2, NRG3 and NRG4 and the EGF family members BTC, EREG and HBEGF. Ligand binding triggers receptor dimerization and autophosphorylation at specific tyrosine residues that then serve as binding sites for scaffold proteins and effectors. Ligand specificity and signaling is modulated by alternative splicing, proteolytic processing, and by the formation of heterodimers with other ERBB family members, thereby creating multiple combinations of intracellular phosphotyrosines that trigger ligand- and context-specific cellular responses. Mediates phosphorylation of SHC1 and activation of the MAP kinases MAPK1/ERK2 and MAPK3/ERK1. Isoform JM-A CYT-1 and isoform JM-B CYT-1 phosphorylate PIK3R1, leading to the activation of phosphatidylinositol 3-kinase and AKT1 and protect cells against apoptosis. Isoform JM-A CYT-1 and isoform JM-B CYT-1 mediate reorganization of the actin cytoskeleton and promote cell migration in response to NRG1. Isoform JM-A CYT-2 and isoform JM-B CYT-2 lack the phosphotyrosine that mediates interaction with PIK3R1, and hence do not phosphorylate PIK3R1, do not protect cells against apoptosis, and do not promote reorganization of the actin cytoskeleton and cell migration. Proteolytic processing of isoform JM-A CYT-1 and isoform JM-A CYT-2 gives rise to the corresponding soluble intracellular domains (4ICD) that translocate to the nucleus, promote nuclear import of STAT5A, activation of STAT5A, mammary epithelium differentiation, cell proliferation and activation of gene expression. The ERBB4 soluble intracellular domains (4ICD) colocalize with STAT5A at the CSN2 promoter to regulate transcription of milk proteins during lactation. The ERBB4 soluble intracellular domains can also translocate to mitochondria and promote apoptosis. {ECO:0000269|PubMed:10348342, ECO:0000269|PubMed:10353604, ECO:0000269|PubMed:10358079, ECO:0000269|PubMed:10722704, ECO:0000269|PubMed:10867024, ECO:0000269|PubMed:11178955, ECO:0000269|PubMed:11390655, ECO:0000269|PubMed:12807903, ECO:0000269|PubMed:15534001, ECO:0000269|PubMed:15746097, ECO:0000269|PubMed:16251361, ECO:0000269|PubMed:16778220, ECO:0000269|PubMed:16837552, ECO:0000269|PubMed:17486069, ECO:0000269|PubMed:17638867, ECO:0000269|PubMed:19098003, ECO:0000269|PubMed:20858735, ECO:0000269|PubMed:8383326, ECO:0000269|PubMed:8617750, ECO:0000269|PubMed:9135143, ECO:0000269|PubMed:9168115, ECO:0000269|PubMed:9334263}. |
Q09472 | EP300 | S24 | GPS6|ELM|EPSD | Histone acetyltransferase p300 (p300 HAT) (EC 2.3.1.48) (E1A-associated protein p300) (Histone butyryltransferase p300) (EC 2.3.1.-) (Histone crotonyltransferase p300) (EC 2.3.1.-) (Protein 2-hydroxyisobutyryltransferase p300) (EC 2.3.1.-) (Protein lactyltransferas p300) (EC 2.3.1.-) (Protein propionyltransferase p300) (EC 2.3.1.-) | Functions as a histone acetyltransferase and regulates transcription via chromatin remodeling (PubMed:23415232, PubMed:23934153, PubMed:8945521). Acetylates all four core histones in nucleosomes (PubMed:23415232, PubMed:23934153, PubMed:8945521). Histone acetylation gives an epigenetic tag for transcriptional activation (PubMed:23415232, PubMed:23934153, PubMed:8945521). Mediates acetylation of histone H3 at 'Lys-122' (H3K122ac), a modification that localizes at the surface of the histone octamer and stimulates transcription, possibly by promoting nucleosome instability (PubMed:23415232). Mediates acetylation of histone H3 at 'Lys-18' and 'Lys-27' (H3K18ac and H3K27ac, respectively) (PubMed:21131905, PubMed:23911289). Also able to acetylate histone lysine residues that are already monomethylated on the same side chain to form N6-acetyl-N6-methyllysine (Kacme), an epigenetic mark of active chromatin associated with increased transcriptional initiation (PubMed:37731000). Catalyzes formation of histone H4 acetyl-methylated at 'Lys-5' and 'Lys-12' (H4K5acme and H4K12acme, respectively) (PubMed:37731000). Also functions as acetyltransferase for non-histone targets, such as ALX1, HDAC1, PRMT1, SIRT2, STAT3 or GLUL (PubMed:12929931, PubMed:15653507, PubMed:16285960, PubMed:16762839, PubMed:18722353, PubMed:18782771, PubMed:26990986). Acetylates 'Lys-131' of ALX1 and acts as its coactivator (PubMed:12929931). Acetylates SIRT2 and is proposed to indirectly increase the transcriptional activity of p53/TP53 through acetylation and subsequent attenuation of SIRT2 deacetylase function (PubMed:18722353). Following DNA damage, forms a stress-responsive p53/TP53 coactivator complex with JMY which mediates p53/TP53 acetylation, thereby increasing p53/TP53-dependent transcription and apoptosis (PubMed:11511361, PubMed:15448695). Promotes chromatin acetylation in heat shock responsive HSP genes during the heat shock response (HSR), thereby stimulating HSR transcription (PubMed:18451878). Acetylates HDAC1 leading to its inactivation and modulation of transcription (PubMed:16762839). Acetylates 'Lys-247' of EGR2 (By similarity). Acts as a TFAP2A-mediated transcriptional coactivator in presence of CITED2 (PubMed:12586840). Plays a role as a coactivator of NEUROD1-dependent transcription of the secretin and p21 genes and controls terminal differentiation of cells in the intestinal epithelium. Promotes cardiac myocyte enlargement (PubMed:14752053). Can also mediate transcriptional repression. Acetylates FOXO1 and enhances its transcriptional activity (PubMed:15890677). Acetylates STAT3 at different sites, promoting both STAT3 dimerization and activation and recruitment to chromatin (PubMed:15653507, PubMed:16285960, PubMed:18782771). Acetylates BCL6 which disrupts its ability to recruit histone deacetylases and hinders its transcriptional repressor activity (PubMed:12402037). Participates in CLOCK or NPAS2-regulated rhythmic gene transcription; exhibits a circadian association with CLOCK or NPAS2, correlating with increase in PER1/2 mRNA and histone H3 acetylation on the PER1/2 promoter (PubMed:14645221). Acetylates MTA1 at 'Lys-626' which is essential for its transcriptional coactivator activity (PubMed:16617102). Acetylates XBP1 isoform 2; acetylation increases protein stability of XBP1 isoform 2 and enhances its transcriptional activity (PubMed:20955178). Acetylates PCNA; acetylation promotes removal of chromatin-bound PCNA and its degradation during nucleotide excision repair (NER) (PubMed:24939902). Acetylates MEF2D (PubMed:21030595). Acetylates and stabilizes ZBTB7B protein by antagonizing ubiquitin conjugation and degradation, this mechanism may be involved in CD4/CD8 lineage differentiation (PubMed:20810990). Acetylates GABPB1, impairing GABPB1 heterotetramerization and activity (By similarity). Acetylates PCK1 and promotes PCK1 anaplerotic activity (PubMed:30193097). Acetylates RXRA and RXRG (PubMed:17761950). Acetylates isoform M2 of PKM (PKM2), promoting its homodimerization and conversion into a protein kinase (PubMed:24120661). Acetylates RPTOR in response to leucine, leading to activation of the mTORC1 complex (PubMed:30197302, PubMed:32561715). Acetylates RICTOR, leading to activation of the mTORC2 complex (PubMed:22084251). Mediates cAMP-gene regulation by binding specifically to phosphorylated CREBBP (PubMed:8917528). In addition to protein acetyltransferase, can use different acyl-CoA substrates, such as (2E)-butenoyl-CoA (crotonyl-CoA), butanoyl-CoA (butyryl-CoA), 2-hydroxyisobutanoyl-CoA (2-hydroxyisobutyryl-CoA), lactoyl-CoA or propanoyl-CoA (propionyl-CoA), and is able to mediate protein crotonylation, butyrylation, 2-hydroxyisobutyrylation, lactylation or propionylation, respectively (PubMed:17267393, PubMed:25818647, PubMed:29775581, PubMed:31645732). Acts as a histone crotonyltransferase; crotonylation marks active promoters and enhancers and confers resistance to transcriptional repressors (PubMed:25818647). Histone crotonyltransferase activity is dependent on the concentration of (2E)-butenoyl-CoA (crotonyl-CoA) substrate and such activity is weak when (2E)-butenoyl-CoA (crotonyl-CoA) concentration is low (PubMed:25818647). Also acts as a histone butyryltransferase; butyrylation marks active promoters (PubMed:17267393). Catalyzes histone lactylation in macrophages by using lactoyl-CoA directly derived from endogenous or exogenous lactate, leading to stimulates gene transcription (PubMed:31645732). Acts as a protein-lysine 2-hydroxyisobutyryltransferase; regulates glycolysis by mediating 2-hydroxyisobutyrylation of glycolytic enzymes (PubMed:29775581). Functions as a transcriptional coactivator for SMAD4 in the TGF-beta signaling pathway (PubMed:25514493). {ECO:0000250|UniProtKB:B2RWS6, ECO:0000269|PubMed:10733570, ECO:0000269|PubMed:11430825, ECO:0000269|PubMed:11511361, ECO:0000269|PubMed:11701890, ECO:0000269|PubMed:12402037, ECO:0000269|PubMed:12586840, ECO:0000269|PubMed:12929931, ECO:0000269|PubMed:14645221, ECO:0000269|PubMed:14752053, ECO:0000269|PubMed:15186775, ECO:0000269|PubMed:15448695, ECO:0000269|PubMed:15653507, ECO:0000269|PubMed:15890677, ECO:0000269|PubMed:16285960, ECO:0000269|PubMed:16617102, ECO:0000269|PubMed:16762839, ECO:0000269|PubMed:17267393, ECO:0000269|PubMed:17761950, ECO:0000269|PubMed:18451878, ECO:0000269|PubMed:18722353, ECO:0000269|PubMed:18782771, ECO:0000269|PubMed:18995842, ECO:0000269|PubMed:20810990, ECO:0000269|PubMed:21030595, ECO:0000269|PubMed:21131905, ECO:0000269|PubMed:22084251, ECO:0000269|PubMed:23415232, ECO:0000269|PubMed:23911289, ECO:0000269|PubMed:23934153, ECO:0000269|PubMed:24120661, ECO:0000269|PubMed:24939902, ECO:0000269|PubMed:25514493, ECO:0000269|PubMed:25818647, ECO:0000269|PubMed:26990986, ECO:0000269|PubMed:29775581, ECO:0000269|PubMed:30193097, ECO:0000269|PubMed:30197302, ECO:0000269|PubMed:31645732, ECO:0000269|PubMed:32561715, ECO:0000269|PubMed:37731000, ECO:0000269|PubMed:8917528, ECO:0000269|PubMed:8945521, ECO:0000305|PubMed:20955178}.; FUNCTION: (Microbial infection) In case of HIV-1 infection, it is recruited by the viral protein Tat. Regulates Tat's transactivating activity and may help inducing chromatin remodeling of proviral genes. Binds to and may be involved in the transforming capacity of the adenovirus E1A protein. {ECO:0000269|PubMed:10545121, ECO:0000269|PubMed:11080476}. |
Q6XQN6 | NAPRT | S102 | Sugiyama | Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21) (FHA-HIT-interacting protein) (Nicotinate phosphoribosyltransferase domain-containing protein 1) | Catalyzes the first step in the biosynthesis of NAD from nicotinic acid, the ATP-dependent synthesis of beta-nicotinate D-ribonucleotide from nicotinate and 5-phospho-D-ribose 1-phosphate (PubMed:17604275, PubMed:21742010, PubMed:26042198). Helps prevent cellular oxidative stress via its role in NAD biosynthesis (PubMed:17604275). {ECO:0000269|PubMed:17604275, ECO:0000269|PubMed:21742010, ECO:0000269|PubMed:26042198}. |
Q8IY84 | NIM1K | S124 | Sugiyama | Serine/threonine-protein kinase NIM1 (EC 2.7.11.1) (NIM1 serine/threonine-protein kinase) | None |
P05362 | ICAM1 | S51 | Sugiyama | Intercellular adhesion molecule 1 (ICAM-1) (Major group rhinovirus receptor) (CD antigen CD54) | ICAM proteins are ligands for the leukocyte adhesion protein LFA-1 (integrin alpha-L/beta-2). During leukocyte trans-endothelial migration, ICAM1 engagement promotes the assembly of endothelial apical cups through ARHGEF26/SGEF and RHOG activation. {ECO:0000269|PubMed:11173916, ECO:0000269|PubMed:17875742}.; FUNCTION: (Microbial infection) Acts as a receptor for major receptor group rhinovirus A-B capsid proteins. {ECO:0000269|PubMed:1968231, ECO:0000269|PubMed:2538243}.; FUNCTION: (Microbial infection) Acts as a receptor for Coxsackievirus A21 capsid proteins. {ECO:0000269|PubMed:11160747, ECO:0000269|PubMed:16004874, ECO:0000269|PubMed:9539703}.; FUNCTION: (Microbial infection) Upon Kaposi's sarcoma-associated herpesvirus/HHV-8 infection, is degraded by viral E3 ubiquitin ligase MIR2, presumably to prevent lysis of infected cells by cytotoxic T-lymphocytes and NK cell. {ECO:0000269|PubMed:11413168}. |
P15121 | AKR1B1 | S264 | Sugiyama | Aldo-keto reductase family 1 member B1 (EC 1.1.1.21) (EC 1.1.1.300) (EC 1.1.1.372) (EC 1.1.1.54) (Aldehyde reductase) (Aldose reductase) (AR) | Catalyzes the NADPH-dependent reduction of a wide variety of carbonyl-containing compounds to their corresponding alcohols. Displays enzymatic activity towards endogenous metabolites such as aromatic and aliphatic aldehydes, ketones, monosacharides, bile acids and xenobiotics substrates. Key enzyme in the polyol pathway, catalyzes reduction of glucose to sorbitol during hyperglycemia (PubMed:1936586). Reduces steroids and their derivatives and prostaglandins. Displays low enzymatic activity toward all-trans-retinal, 9-cis-retinal, and 13-cis-retinal (PubMed:12732097, PubMed:19010934, PubMed:8343525). Catalyzes the reduction of diverse phospholipid aldehydes such as 1-palmitoyl-2-(5-oxovaleroyl)-sn -glycero-3-phosphoethanolamin (POVPC) and related phospholipid aldehydes that are generated from the oxydation of phosphotidylcholine and phosphatdyleethanolamides (PubMed:17381426). Plays a role in detoxifying dietary and lipid-derived unsaturated carbonyls, such as crotonaldehyde, 4-hydroxynonenal, trans-2-hexenal, trans-2,4-hexadienal and their glutathione-conjugates carbonyls (GS-carbonyls) (PubMed:21329684). {ECO:0000269|PubMed:12732097, ECO:0000269|PubMed:17381426, ECO:0000269|PubMed:19010934, ECO:0000269|PubMed:1936586, ECO:0000269|PubMed:21329684, ECO:0000269|PubMed:8343525}. |
Q92900 | UPF1 | S274 | Sugiyama | Regulator of nonsense transcripts 1 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (hUpf1) | RNA-dependent helicase required for nonsense-mediated decay (NMD) of aberrant mRNAs containing premature stop codons and modulates the expression level of normal mRNAs (PubMed:11163187, PubMed:16086026, PubMed:18172165, PubMed:21145460, PubMed:21419344, PubMed:24726324). Is recruited to mRNAs upon translation termination and undergoes a cycle of phosphorylation and dephosphorylation; its phosphorylation appears to be a key step in NMD (PubMed:11544179, PubMed:25220460). Recruited by release factors to stalled ribosomes together with the SMG1C protein kinase complex to form the transient SURF (SMG1-UPF1-eRF1-eRF3) complex (PubMed:19417104). In EJC-dependent NMD, the SURF complex associates with the exon junction complex (EJC) (located 50-55 or more nucleotides downstream from the termination codon) through UPF2 and allows the formation of an UPF1-UPF2-UPF3 surveillance complex which is believed to activate NMD (PubMed:21419344). Phosphorylated UPF1 is recognized by EST1B/SMG5, SMG6 and SMG7 which are thought to provide a link to the mRNA degradation machinery involving exonucleolytic and endonucleolytic pathways, and to serve as adapters to protein phosphatase 2A (PP2A), thereby triggering UPF1 dephosphorylation and allowing the recycling of NMD factors (PubMed:12554878). UPF1 can also activate NMD without UPF2 or UPF3, and in the absence of the NMD-enhancing downstream EJC indicative for alternative NMD pathways (PubMed:18447585). Plays a role in replication-dependent histone mRNA degradation at the end of phase S; the function is independent of UPF2 (PubMed:16086026, PubMed:18172165). For the recognition of premature termination codons (PTC) and initiation of NMD a competitive interaction between UPF1 and PABPC1 with the ribosome-bound release factors is proposed (PubMed:18447585, PubMed:25220460). The ATPase activity of UPF1 is required for disassembly of mRNPs undergoing NMD (PubMed:21145460). Together with UPF2 and dependent on TDRD6, mediates the degradation of mRNA harboring long 3'UTR by inducing the NMD machinery (By similarity). Also capable of unwinding double-stranded DNA and translocating on single-stranded DNA (PubMed:30218034). {ECO:0000250|UniProtKB:Q9EPU0, ECO:0000269|PubMed:11163187, ECO:0000269|PubMed:11544179, ECO:0000269|PubMed:12554878, ECO:0000269|PubMed:16086026, ECO:0000269|PubMed:18172165, ECO:0000269|PubMed:18447585, ECO:0000269|PubMed:19417104, ECO:0000269|PubMed:21145460, ECO:0000269|PubMed:21419344, ECO:0000269|PubMed:24726324, ECO:0000269|PubMed:25220460, ECO:0000269|PubMed:30218034}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-190840 | Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | 1.332268e-15 | 14.875 |
R-HSA-190872 | Transport of connexons to the plasma membrane | 2.331468e-15 | 14.632 |
R-HSA-389960 | Formation of tubulin folding intermediates by CCT/TriC | 6.428191e-14 | 13.192 |
R-HSA-983189 | Kinesins | 6.039613e-14 | 13.219 |
R-HSA-389977 | Post-chaperonin tubulin folding pathway | 1.829648e-13 | 12.738 |
R-HSA-9619483 | Activation of AMPK downstream of NMDARs | 3.053113e-13 | 12.515 |
R-HSA-389958 | Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 8.701928e-13 | 12.060 |
R-HSA-9646399 | Aggrephagy | 1.022182e-12 | 11.990 |
R-HSA-9668328 | Sealing of the nuclear envelope (NE) by ESCRT-III | 1.666778e-12 | 11.778 |
R-HSA-6811436 | COPI-independent Golgi-to-ER retrograde traffic | 3.638645e-12 | 11.439 |
R-HSA-190828 | Gap junction trafficking | 3.861245e-12 | 11.413 |
R-HSA-190861 | Gap junction assembly | 3.085199e-12 | 11.511 |
R-HSA-9833482 | PKR-mediated signaling | 3.422262e-12 | 11.466 |
R-HSA-5620920 | Cargo trafficking to the periciliary membrane | 7.482570e-12 | 11.126 |
R-HSA-1445148 | Translocation of SLC2A4 (GLUT4) to the plasma membrane | 1.078349e-11 | 10.967 |
R-HSA-157858 | Gap junction trafficking and regulation | 1.280775e-11 | 10.893 |
R-HSA-3371568 | Attenuation phase | 1.642497e-11 | 10.784 |
R-HSA-9609736 | Assembly and cell surface presentation of NMDA receptors | 2.727907e-11 | 10.564 |
R-HSA-3371497 | HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of lig... | 4.847456e-11 | 10.314 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 5.343914e-11 | 10.272 |
R-HSA-6811434 | COPI-dependent Golgi-to-ER retrograde traffic | 6.836920e-11 | 10.165 |
R-HSA-8955332 | Carboxyterminal post-translational modifications of tubulin | 1.104465e-10 | 9.957 |
R-HSA-437239 | Recycling pathway of L1 | 1.104465e-10 | 9.957 |
R-HSA-2467813 | Separation of Sister Chromatids | 1.319751e-10 | 9.880 |
R-HSA-438064 | Post NMDA receptor activation events | 1.260970e-10 | 9.899 |
R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes | 1.462868e-10 | 9.835 |
R-HSA-9663891 | Selective autophagy | 1.462868e-10 | 9.835 |
R-HSA-8852276 | The role of GTSE1 in G2/M progression after G2 checkpoint | 1.816494e-10 | 9.741 |
R-HSA-8856688 | Golgi-to-ER retrograde transport | 1.789323e-10 | 9.747 |
R-HSA-3371571 | HSF1-dependent transactivation | 2.568170e-10 | 9.590 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 3.009529e-10 | 9.522 |
R-HSA-68877 | Mitotic Prometaphase | 3.380497e-10 | 9.471 |
R-HSA-389957 | Prefoldin mediated transfer of substrate to CCT/TriC | 4.559937e-10 | 9.341 |
R-HSA-453274 | Mitotic G2-G2/M phases | 1.277747e-09 | 8.894 |
R-HSA-442755 | Activation of NMDA receptors and postsynaptic events | 1.276436e-09 | 8.894 |
R-HSA-69278 | Cell Cycle, Mitotic | 1.660210e-09 | 8.780 |
R-HSA-983231 | Factors involved in megakaryocyte development and platelet production | 2.440534e-09 | 8.613 |
R-HSA-2995410 | Nuclear Envelope (NE) Reassembly | 3.279998e-09 | 8.484 |
R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic | 3.389801e-09 | 8.470 |
R-HSA-6807878 | COPI-mediated anterograde transport | 4.804210e-09 | 8.318 |
R-HSA-3371453 | Regulation of HSF1-mediated heat shock response | 9.819138e-09 | 8.008 |
R-HSA-68882 | Mitotic Anaphase | 1.213873e-08 | 7.916 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 1.241409e-08 | 7.906 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 1.303818e-08 | 7.885 |
R-HSA-1640170 | Cell Cycle | 1.371534e-08 | 7.863 |
R-HSA-3371556 | Cellular response to heat stress | 1.503080e-08 | 7.823 |
R-HSA-2132295 | MHC class II antigen presentation | 1.837236e-08 | 7.736 |
R-HSA-3371511 | HSF1 activation | 1.846484e-08 | 7.734 |
R-HSA-1632852 | Macroautophagy | 2.135001e-08 | 7.671 |
R-HSA-2262752 | Cellular responses to stress | 2.433719e-08 | 7.614 |
R-HSA-69275 | G2/M Transition | 3.254678e-08 | 7.487 |
R-HSA-68886 | M Phase | 3.559983e-08 | 7.449 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 3.952657e-08 | 7.403 |
R-HSA-390466 | Chaperonin-mediated protein folding | 7.618232e-08 | 7.118 |
R-HSA-9612973 | Autophagy | 8.344938e-08 | 7.079 |
R-HSA-8953897 | Cellular responses to stimuli | 1.193571e-07 | 6.923 |
R-HSA-391251 | Protein folding | 1.511423e-07 | 6.821 |
R-HSA-5620924 | Intraflagellar transport | 2.078433e-07 | 6.682 |
R-HSA-5617833 | Cilium Assembly | 2.182839e-07 | 6.661 |
R-HSA-199991 | Membrane Trafficking | 1.156521e-06 | 5.937 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 1.201261e-06 | 5.920 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 2.157932e-06 | 5.666 |
R-HSA-373760 | L1CAM interactions | 2.188970e-06 | 5.660 |
R-HSA-5610787 | Hedgehog 'off' state | 2.460289e-06 | 5.609 |
R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | 9.125984e-06 | 5.040 |
R-HSA-163765 | ChREBP activates metabolic gene expression | 9.492705e-06 | 5.023 |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | 1.631418e-05 | 4.787 |
R-HSA-913531 | Interferon Signaling | 1.762145e-05 | 4.754 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 4.511755e-05 | 4.346 |
R-HSA-5358351 | Signaling by Hedgehog | 6.386170e-05 | 4.195 |
R-HSA-5653656 | Vesicle-mediated transport | 8.606067e-05 | 4.065 |
R-HSA-9609690 | HCMV Early Events | 9.989934e-05 | 4.000 |
R-HSA-112315 | Transmission across Chemical Synapses | 1.608058e-04 | 3.794 |
R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling | 2.974354e-04 | 3.527 |
R-HSA-9841251 | Mitochondrial unfolded protein response (UPRmt) | 5.122943e-04 | 3.290 |
R-HSA-2426168 | Activation of gene expression by SREBF (SREBP) | 5.380134e-04 | 3.269 |
R-HSA-112316 | Neuronal System | 6.709729e-04 | 3.173 |
R-HSA-9687139 | Aberrant regulation of mitotic cell cycle due to RB1 defects | 7.552123e-04 | 3.122 |
R-HSA-9609646 | HCMV Infection | 9.470695e-04 | 3.024 |
R-HSA-9675126 | Diseases of mitotic cell cycle | 9.591685e-04 | 3.018 |
R-HSA-109582 | Hemostasis | 1.124071e-03 | 2.949 |
R-HSA-9614657 | FOXO-mediated transcription of cell death genes | 1.136385e-03 | 2.944 |
R-HSA-446107 | Type I hemidesmosome assembly | 1.365146e-03 | 2.865 |
R-HSA-1253288 | Downregulation of ERBB4 signaling | 1.365146e-03 | 2.865 |
R-HSA-383280 | Nuclear Receptor transcription pathway | 1.612761e-03 | 2.792 |
R-HSA-1655829 | Regulation of cholesterol biosynthesis by SREBP (SREBF) | 1.720568e-03 | 2.764 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 2.346194e-03 | 2.630 |
R-HSA-380284 | Loss of proteins required for interphase microtubule organization from the centr... | 2.857864e-03 | 2.544 |
R-HSA-380259 | Loss of Nlp from mitotic centrosomes | 2.857864e-03 | 2.544 |
R-HSA-1280218 | Adaptive Immune System | 3.220762e-03 | 2.492 |
R-HSA-1250342 | PI3K events in ERBB4 signaling | 3.270216e-03 | 2.485 |
R-HSA-8854518 | AURKA Activation by TPX2 | 3.492738e-03 | 2.457 |
R-HSA-9931530 | Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | 3.912938e-03 | 2.407 |
R-HSA-9659787 | Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | 4.627391e-03 | 2.335 |
R-HSA-9661069 | Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | 4.627391e-03 | 2.335 |
R-HSA-9664565 | Signaling by ERBB2 KD Mutants | 5.088328e-03 | 2.293 |
R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes | 5.375800e-03 | 2.270 |
R-HSA-8847993 | ERBB2 Activates PTK6 Signaling | 5.415760e-03 | 2.266 |
R-HSA-1227990 | Signaling by ERBB2 in Cancer | 5.610679e-03 | 2.251 |
R-HSA-8941333 | RUNX2 regulates genes involved in differentiation of myeloid cells | 6.238620e-03 | 2.205 |
R-HSA-380287 | Centrosome maturation | 6.028960e-03 | 2.220 |
R-HSA-397014 | Muscle contraction | 6.211087e-03 | 2.207 |
R-HSA-168256 | Immune System | 5.893600e-03 | 2.230 |
R-HSA-6785631 | ERBB2 Regulates Cell Motility | 6.280022e-03 | 2.202 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 6.425227e-03 | 2.192 |
R-HSA-446203 | Asparagine N-linked glycosylation | 6.460581e-03 | 2.190 |
R-HSA-9687136 | Aberrant regulation of mitotic exit in cancer due to RB1 defects | 7.221957e-03 | 2.141 |
R-HSA-8941284 | RUNX2 regulates chondrocyte maturation | 8.384271e-03 | 2.077 |
R-HSA-68911 | G2 Phase | 8.384271e-03 | 2.077 |
R-HSA-1250347 | SHC1 events in ERBB4 signaling | 8.243156e-03 | 2.084 |
R-HSA-141430 | Inactivation of APC/C via direct inhibition of the APC/C complex | 8.243156e-03 | 2.084 |
R-HSA-141405 | Inhibition of the proteolytic activity of APC/C required for the onset of anapha... | 8.243156e-03 | 2.084 |
R-HSA-1963640 | GRB2 events in ERBB2 signaling | 8.243156e-03 | 2.084 |
R-HSA-9675108 | Nervous system development | 7.657516e-03 | 2.116 |
R-HSA-69620 | Cell Cycle Checkpoints | 8.847458e-03 | 2.053 |
R-HSA-1963642 | PI3K events in ERBB2 signaling | 9.345025e-03 | 2.029 |
R-HSA-6802957 | Oncogenic MAPK signaling | 1.018693e-02 | 1.992 |
R-HSA-163560 | Triglyceride catabolism | 1.028780e-02 | 1.988 |
R-HSA-8939902 | Regulation of RUNX2 expression and activity | 1.170668e-02 | 1.932 |
R-HSA-8953750 | Transcriptional Regulation by E2F6 | 1.288575e-02 | 1.890 |
R-HSA-5620912 | Anchoring of the basal body to the plasma membrane | 1.348703e-02 | 1.870 |
R-HSA-8869496 | TFAP2A acts as a transcriptional repressor during retinoic acid induced cell dif... | 1.351286e-02 | 1.869 |
R-HSA-1251985 | Nuclear signaling by ERBB4 | 1.383637e-02 | 1.859 |
R-HSA-179409 | APC-Cdc20 mediated degradation of Nek2A | 1.458147e-02 | 1.836 |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | 1.599228e-02 | 1.796 |
R-HSA-162582 | Signal Transduction | 1.475413e-02 | 1.831 |
R-HSA-422475 | Axon guidance | 1.546849e-02 | 1.811 |
R-HSA-9726840 | SHOC2 M1731 mutant abolishes MRAS complex function | 1.647298e-02 | 1.783 |
R-HSA-69242 | S Phase | 1.673557e-02 | 1.776 |
R-HSA-2173788 | Downregulation of TGF-beta receptor signaling | 1.770831e-02 | 1.752 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 1.809153e-02 | 1.743 |
R-HSA-9661070 | Defective translocation of RB1 mutants to the nucleus | 1.918937e-02 | 1.717 |
R-HSA-9660537 | Signaling by MRAS-complex mutants | 1.968232e-02 | 1.706 |
R-HSA-9726842 | Gain-of-function MRAS complexes activate RAF signaling | 1.968232e-02 | 1.706 |
R-HSA-9825895 | Regulation of MITF-M-dependent genes involved in DNA replication, damage repair ... | 1.968232e-02 | 1.706 |
R-HSA-8939246 | RUNX1 regulates transcription of genes involved in differentiation of myeloid ce... | 1.968232e-02 | 1.706 |
R-HSA-174143 | APC/C-mediated degradation of cell cycle proteins | 1.975554e-02 | 1.704 |
R-HSA-453276 | Regulation of mitotic cell cycle | 1.975554e-02 | 1.704 |
R-HSA-1236394 | Signaling by ERBB4 | 2.273548e-02 | 1.643 |
R-HSA-9924644 | Developmental Lineages of the Mammary Gland | 2.071859e-02 | 1.684 |
R-HSA-176974 | Unwinding of DNA | 2.313029e-02 | 1.636 |
R-HSA-69052 | Switching of origins to a post-replicative state | 2.171180e-02 | 1.663 |
R-HSA-9665686 | Signaling by ERBB2 TMD/JMD mutants | 2.117939e-02 | 1.674 |
R-HSA-264870 | Caspase-mediated cleavage of cytoskeletal proteins | 2.313029e-02 | 1.636 |
R-HSA-9620244 | Long-term potentiation | 2.304451e-02 | 1.637 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 2.440984e-02 | 1.612 |
R-HSA-3295583 | TRP channels | 2.499606e-02 | 1.602 |
R-HSA-5689901 | Metalloprotease DUBs | 2.499606e-02 | 1.602 |
R-HSA-9024446 | NR1H2 and NR1H3-mediated signaling | 2.599229e-02 | 1.585 |
R-HSA-9828806 | Maturation of hRSV A proteins | 2.703392e-02 | 1.568 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 2.762551e-02 | 1.559 |
R-HSA-449147 | Signaling by Interleukins | 2.815913e-02 | 1.550 |
R-HSA-8940973 | RUNX2 regulates osteoblast differentiation | 2.915787e-02 | 1.535 |
R-HSA-8941332 | RUNX2 regulates genes involved in cell migration | 3.070131e-02 | 1.513 |
R-HSA-9927432 | Developmental Lineage of Mammary Gland Myoepithelial Cells | 3.136761e-02 | 1.504 |
R-HSA-174184 | Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 3.032805e-02 | 1.518 |
R-HSA-179419 | APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of th... | 3.192843e-02 | 1.496 |
R-HSA-174178 | APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins ... | 3.192843e-02 | 1.496 |
R-HSA-176409 | APC/C:Cdc20 mediated degradation of mitotic proteins | 3.527545e-02 | 1.453 |
R-HSA-2424491 | DAP12 signaling | 3.366274e-02 | 1.473 |
R-HSA-9020558 | Interleukin-2 signaling | 3.070131e-02 | 1.513 |
R-HSA-113501 | Inhibition of replication initiation of damaged DNA by RB1/E2F1 | 3.480472e-02 | 1.458 |
R-HSA-1250196 | SHC1 events in ERBB2 signaling | 3.366274e-02 | 1.473 |
R-HSA-9734779 | Developmental Cell Lineages of the Integumentary System | 3.078901e-02 | 1.512 |
R-HSA-69239 | Synthesis of DNA | 2.974125e-02 | 1.527 |
R-HSA-418359 | Reduction of cytosolic Ca++ levels | 3.480472e-02 | 1.458 |
R-HSA-8863795 | Downregulation of ERBB2 signaling | 3.366274e-02 | 1.473 |
R-HSA-75205 | Dissolution of Fibrin Clot | 3.070131e-02 | 1.513 |
R-HSA-9913351 | Formation of the dystrophin-glycoprotein complex (DGC) | 3.604278e-02 | 1.443 |
R-HSA-176814 | Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 3.702232e-02 | 1.432 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 3.749219e-02 | 1.426 |
R-HSA-141424 | Amplification of signal from the kinetochores | 3.749219e-02 | 1.426 |
R-HSA-9699150 | Defective DNA double strand break response due to BARD1 loss of function | 3.801166e-02 | 1.420 |
R-HSA-1299344 | TWIK-related spinal cord K+ channel (TRESK) | 3.801166e-02 | 1.420 |
R-HSA-5602566 | TICAM1 deficiency - HSE | 3.801166e-02 | 1.420 |
R-HSA-9663199 | Defective DNA double strand break response due to BRCA1 loss of function | 3.801166e-02 | 1.420 |
R-HSA-69190 | DNA strand elongation | 3.850716e-02 | 1.414 |
R-HSA-9617629 | Regulation of FOXO transcriptional activity by acetylation | 3.910743e-02 | 1.408 |
R-HSA-5673001 | RAF/MAP kinase cascade | 4.050213e-02 | 1.393 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 4.240820e-02 | 1.373 |
R-HSA-8979227 | Triglyceride metabolism | 4.255716e-02 | 1.371 |
R-HSA-9029558 | NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | 4.360035e-02 | 1.361 |
R-HSA-9682706 | Replication of the SARS-CoV-1 genome | 4.360035e-02 | 1.361 |
R-HSA-390522 | Striated Muscle Contraction | 4.368629e-02 | 1.360 |
R-HSA-8878166 | Transcriptional regulation by RUNX2 | 4.663474e-02 | 1.331 |
R-HSA-8941326 | RUNX2 regulates bone development | 5.206926e-02 | 1.283 |
R-HSA-1227986 | Signaling by ERBB2 | 4.450022e-02 | 1.352 |
R-HSA-176408 | Regulation of APC/C activators between G1/S and early anaphase | 4.853331e-02 | 1.314 |
R-HSA-68867 | Assembly of the pre-replicative complex | 5.168399e-02 | 1.287 |
R-HSA-196780 | Biotin transport and metabolism | 5.312173e-02 | 1.275 |
R-HSA-3270619 | IRF3-mediated induction of type I IFN | 5.312173e-02 | 1.275 |
R-HSA-2219528 | PI3K/AKT Signaling in Cancer | 4.526585e-02 | 1.344 |
R-HSA-936837 | Ion transport by P-type ATPases | 5.276172e-02 | 1.278 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 4.618283e-02 | 1.336 |
R-HSA-5673000 | RAF activation | 4.639956e-02 | 1.333 |
R-HSA-2032785 | YAP1- and WWTR1 (TAZ)-stimulated gene expression | 4.827464e-02 | 1.316 |
R-HSA-2559585 | Oncogene Induced Senescence | 4.919418e-02 | 1.308 |
R-HSA-9679514 | SARS-CoV-1 Genome Replication and Transcription | 4.827464e-02 | 1.316 |
R-HSA-9006927 | Signaling by Non-Receptor Tyrosine Kinases | 5.062316e-02 | 1.296 |
R-HSA-8848021 | Signaling by PTK6 | 5.062316e-02 | 1.296 |
R-HSA-5683057 | MAPK family signaling cascades | 5.636463e-02 | 1.249 |
R-HSA-5602571 | TRAF3 deficiency - HSE | 5.647388e-02 | 1.248 |
R-HSA-176412 | Phosphorylation of the APC/C | 5.813333e-02 | 1.236 |
R-HSA-1362300 | Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL... | 5.813333e-02 | 1.236 |
R-HSA-6804116 | TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | 5.813333e-02 | 1.236 |
R-HSA-9824446 | Viral Infection Pathways | 5.987263e-02 | 1.223 |
R-HSA-201556 | Signaling by ALK | 6.116732e-02 | 1.213 |
R-HSA-9820965 | Respiratory syncytial virus (RSV) genome replication, transcription and translat... | 6.116732e-02 | 1.213 |
R-HSA-451927 | Interleukin-2 family signaling | 6.435408e-02 | 1.191 |
R-HSA-204005 | COPII-mediated vesicle transport | 6.660592e-02 | 1.176 |
R-HSA-1834949 | Cytosolic sensors of pathogen-associated DNA | 6.660592e-02 | 1.176 |
R-HSA-9607240 | FLT3 Signaling | 6.761600e-02 | 1.170 |
R-HSA-5576891 | Cardiac conduction | 6.849700e-02 | 1.164 |
R-HSA-176407 | Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | 6.861804e-02 | 1.164 |
R-HSA-9694686 | Replication of the SARS-CoV-2 genome | 6.861804e-02 | 1.164 |
R-HSA-174048 | APC/C:Cdc20 mediated degradation of Cyclin B | 7.966729e-02 | 1.099 |
R-HSA-9709603 | Impaired BRCA2 binding to PALB2 | 7.966729e-02 | 1.099 |
R-HSA-163210 | Formation of ATP by chemiosmotic coupling | 8.538542e-02 | 1.069 |
R-HSA-9701193 | Defective homologous recombination repair (HRR) due to PALB2 loss of function | 8.538542e-02 | 1.069 |
R-HSA-9704331 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of... | 8.538542e-02 | 1.069 |
R-HSA-9701192 | Defective homologous recombination repair (HRR) due to BRCA1 loss of function | 8.538542e-02 | 1.069 |
R-HSA-9704646 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of... | 8.538542e-02 | 1.069 |
R-HSA-174084 | Autodegradation of Cdh1 by Cdh1:APC/C | 8.869668e-02 | 1.052 |
R-HSA-174154 | APC/C:Cdc20 mediated degradation of Securin | 9.244950e-02 | 1.034 |
R-HSA-373753 | Nephrin family interactions | 8.538542e-02 | 1.069 |
R-HSA-2299718 | Condensation of Prophase Chromosomes | 8.869668e-02 | 1.052 |
R-HSA-264642 | Acetylcholine Neurotransmitter Release Cycle | 9.122331e-02 | 1.040 |
R-HSA-6798695 | Neutrophil degranulation | 8.462083e-02 | 1.073 |
R-HSA-450531 | Regulation of mRNA stability by proteins that bind AU-rich elements | 7.160068e-02 | 1.145 |
R-HSA-416572 | Sema4D induced cell migration and growth-cone collapse | 8.538542e-02 | 1.069 |
R-HSA-69002 | DNA Replication Pre-Initiation | 8.827217e-02 | 1.054 |
R-HSA-113510 | E2F mediated regulation of DNA replication | 7.966729e-02 | 1.099 |
R-HSA-9613829 | Chaperone Mediated Autophagy | 7.407580e-02 | 1.130 |
R-HSA-844456 | The NLRP3 inflammasome | 7.966729e-02 | 1.099 |
R-HSA-1362277 | Transcription of E2F targets under negative control by DREAM complex | 8.538542e-02 | 1.069 |
R-HSA-2172127 | DAP12 interactions | 8.139087e-02 | 1.089 |
R-HSA-416482 | G alpha (12/13) signalling events | 8.768881e-02 | 1.057 |
R-HSA-9909396 | Circadian clock | 7.025238e-02 | 1.153 |
R-HSA-3000171 | Non-integrin membrane-ECM interactions | 7.944062e-02 | 1.100 |
R-HSA-5620916 | VxPx cargo-targeting to cilium | 8.538542e-02 | 1.069 |
R-HSA-69231 | Cyclin D associated events in G1 | 8.139087e-02 | 1.089 |
R-HSA-69236 | G1 Phase | 8.139087e-02 | 1.089 |
R-HSA-1257604 | PIP3 activates AKT signaling | 8.913971e-02 | 1.050 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 9.349990e-02 | 1.029 |
R-HSA-75153 | Apoptotic execution phase | 8.869668e-02 | 1.052 |
R-HSA-9694682 | SARS-CoV-2 Genome Replication and Transcription | 7.966729e-02 | 1.099 |
R-HSA-8864260 | Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 8.139087e-02 | 1.089 |
R-HSA-1834941 | STING mediated induction of host immune responses | 7.966729e-02 | 1.099 |
R-HSA-2173789 | TGF-beta receptor signaling activates SMADs | 7.784059e-02 | 1.109 |
R-HSA-9725371 | Nuclear events stimulated by ALK signaling in cancer | 9.626709e-02 | 1.017 |
R-HSA-9734767 | Developmental Cell Lineages | 1.023408e-01 | 0.990 |
R-HSA-9670439 | Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT m... | 1.032319e-01 | 0.986 |
R-HSA-9669938 | Signaling by KIT in disease | 1.032319e-01 | 0.986 |
R-HSA-912526 | Interleukin receptor SHC signaling | 1.093899e-01 | 0.961 |
R-HSA-5674400 | Constitutive Signaling by AKT1 E17K in Cancer | 1.093899e-01 | 0.961 |
R-HSA-9013957 | TLR3-mediated TICAM1-dependent programmed cell death | 1.097681e-01 | 0.960 |
R-HSA-9818035 | NFE2L2 regulating ER-stress associated genes | 1.097681e-01 | 0.960 |
R-HSA-8952158 | RUNX3 regulates BCL2L11 (BIM) transcription | 1.097681e-01 | 0.960 |
R-HSA-165181 | Inhibition of TSC complex formation by PKB | 1.097681e-01 | 0.960 |
R-HSA-69200 | Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 ... | 1.097681e-01 | 0.960 |
R-HSA-111448 | Activation of NOXA and translocation to mitochondria | 1.097681e-01 | 0.960 |
R-HSA-9706374 | FLT3 signaling through SRC family kinases | 1.097681e-01 | 0.960 |
R-HSA-68949 | Orc1 removal from chromatin | 1.121566e-01 | 0.950 |
R-HSA-983712 | Ion channel transport | 1.124719e-01 | 0.949 |
R-HSA-445355 | Smooth Muscle Contraction | 1.162766e-01 | 0.935 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 1.176199e-01 | 0.930 |
R-HSA-69306 | DNA Replication | 1.176199e-01 | 0.930 |
R-HSA-9818026 | NFE2L2 regulating inflammation associated genes | 1.268574e-01 | 0.897 |
R-HSA-9652817 | Signaling by MAPK mutants | 1.436197e-01 | 0.843 |
R-HSA-5576894 | Phase 1 - inactivation of fast Na+ channels | 1.436197e-01 | 0.843 |
R-HSA-2562578 | TRIF-mediated programmed cell death | 1.761880e-01 | 0.754 |
R-HSA-72731 | Recycling of eIF2:GDP | 1.761880e-01 | 0.754 |
R-HSA-9828211 | Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | 1.920061e-01 | 0.717 |
R-HSA-196025 | Formation of annular gap junctions | 1.920061e-01 | 0.717 |
R-HSA-9028335 | Activated NTRK2 signals through PI3K | 1.920061e-01 | 0.717 |
R-HSA-9818032 | NFE2L2 regulating MDR associated enzymes | 2.075215e-01 | 0.683 |
R-HSA-450520 | HuR (ELAVL1) binds and stabilizes mRNA | 2.075215e-01 | 0.683 |
R-HSA-9613354 | Lipophagy | 2.075215e-01 | 0.683 |
R-HSA-190873 | Gap junction degradation | 2.075215e-01 | 0.683 |
R-HSA-9014325 | TICAM1,TRAF6-dependent induction of TAK1 complex | 2.227399e-01 | 0.652 |
R-HSA-164843 | 2-LTR circle formation | 2.227399e-01 | 0.652 |
R-HSA-390450 | Folding of actin by CCT/TriC | 2.227399e-01 | 0.652 |
R-HSA-416550 | Sema4D mediated inhibition of cell attachment and migration | 2.523083e-01 | 0.598 |
R-HSA-2514853 | Condensation of Prometaphase Chromosomes | 2.523083e-01 | 0.598 |
R-HSA-9824878 | Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | 2.523083e-01 | 0.598 |
R-HSA-5693554 | Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SD... | 1.219830e-01 | 0.914 |
R-HSA-9615710 | Late endosomal microautophagy | 1.481203e-01 | 0.829 |
R-HSA-69166 | Removal of the Flap Intermediate | 2.945716e-01 | 0.531 |
R-HSA-937072 | TRAF6-mediated induction of TAK1 complex within TLR4 complex | 3.081233e-01 | 0.511 |
R-HSA-8964315 | G beta:gamma signalling through BTK | 3.081233e-01 | 0.511 |
R-HSA-168927 | TICAM1, RIP1-mediated IKK complex recruitment | 3.081233e-01 | 0.511 |
R-HSA-450604 | KSRP (KHSRP) binds and destabilizes mRNA | 3.214155e-01 | 0.493 |
R-HSA-354194 | GRB2:SOS provides linkage to MAPK signaling for Integrins | 3.214155e-01 | 0.493 |
R-HSA-9927426 | Developmental Lineage of Mammary Gland Alveolar Cells | 1.890969e-01 | 0.723 |
R-HSA-430039 | mRNA decay by 5' to 3' exoribonuclease | 3.344531e-01 | 0.476 |
R-HSA-9912633 | Antigen processing: Ub, ATP-independent proteasomal degradation | 3.344531e-01 | 0.476 |
R-HSA-174437 | Removal of the Flap Intermediate from the C-strand | 3.472411e-01 | 0.459 |
R-HSA-372708 | p130Cas linkage to MAPK signaling for integrins | 3.472411e-01 | 0.459 |
R-HSA-5651801 | PCNA-Dependent Long Patch Base Excision Repair | 3.597841e-01 | 0.444 |
R-HSA-9927418 | Developmental Lineage of Mammary Gland Luminal Epithelial Cells | 2.527336e-01 | 0.597 |
R-HSA-9925563 | Developmental Lineage of Pancreatic Ductal Cells | 1.888158e-01 | 0.724 |
R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer | 1.450168e-01 | 0.839 |
R-HSA-5250924 | B-WICH complex positively regulates rRNA expression | 3.309430e-01 | 0.480 |
R-HSA-9818030 | NFE2L2 regulating tumorigenic genes | 2.807553e-01 | 0.552 |
R-HSA-68962 | Activation of the pre-replicative complex | 1.548220e-01 | 0.810 |
R-HSA-9013973 | TICAM1-dependent activation of IRF3/IRF7 | 2.523083e-01 | 0.598 |
R-HSA-936964 | Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | 3.344531e-01 | 0.476 |
R-HSA-6783310 | Fanconi Anemia Pathway | 2.741480e-01 | 0.562 |
R-HSA-69183 | Processive synthesis on the lagging strand | 3.081233e-01 | 0.511 |
R-HSA-8876198 | RAB GEFs exchange GTP for GDP on RABs | 2.749412e-01 | 0.561 |
R-HSA-389359 | CD28 dependent Vav1 pathway | 2.807553e-01 | 0.552 |
R-HSA-8983432 | Interleukin-15 signaling | 2.666693e-01 | 0.574 |
R-HSA-8937144 | Aryl hydrocarbon receptor signalling | 1.436197e-01 | 0.843 |
R-HSA-9020958 | Interleukin-21 signaling | 2.075215e-01 | 0.683 |
R-HSA-9675136 | Diseases of DNA Double-Strand Break Repair | 1.890969e-01 | 0.723 |
R-HSA-400685 | Sema4D in semaphorin signaling | 1.219830e-01 | 0.914 |
R-HSA-8951936 | RUNX3 regulates p14-ARF | 2.666693e-01 | 0.574 |
R-HSA-450408 | AUF1 (hnRNP D0) binds and destabilizes mRNA | 2.030843e-01 | 0.692 |
R-HSA-8941856 | RUNX3 regulates NOTCH signaling | 2.666693e-01 | 0.574 |
R-HSA-5250913 | Positive epigenetic regulation of rRNA expression | 1.985909e-01 | 0.702 |
R-HSA-6802955 | Paradoxical activation of RAF signaling by kinase inactive BRAF | 2.812833e-01 | 0.551 |
R-HSA-9649948 | Signaling downstream of RAS mutants | 2.812833e-01 | 0.551 |
R-HSA-6802946 | Signaling by moderate kinase activity BRAF mutants | 2.812833e-01 | 0.551 |
R-HSA-9931509 | Expression of BMAL (ARNTL), CLOCK, and NPAS2 | 2.242649e-01 | 0.649 |
R-HSA-69206 | G1/S Transition | 1.381197e-01 | 0.860 |
R-HSA-9614085 | FOXO-mediated transcription | 1.667366e-01 | 0.778 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 2.294841e-01 | 0.639 |
R-HSA-5685942 | HDR through Homologous Recombination (HRR) | 1.791708e-01 | 0.747 |
R-HSA-8985947 | Interleukin-9 signaling | 1.920061e-01 | 0.717 |
R-HSA-5693537 | Resolution of D-Loop Structures | 1.821545e-01 | 0.740 |
R-HSA-9614399 | Regulation of localization of FOXO transcription factors | 2.376670e-01 | 0.624 |
R-HSA-8949664 | Processing of SMDT1 | 2.807553e-01 | 0.552 |
R-HSA-8939243 | RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not kno... | 1.752515e-01 | 0.756 |
R-HSA-5693579 | Homologous DNA Pairing and Strand Exchange | 2.171829e-01 | 0.663 |
R-HSA-5693568 | Resolution of D-loop Structures through Holliday Junction Intermediates | 1.752515e-01 | 0.756 |
R-HSA-1234158 | Regulation of gene expression by Hypoxia-inducible Factor | 2.523083e-01 | 0.598 |
R-HSA-9027276 | Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | 2.666693e-01 | 0.574 |
R-HSA-5693538 | Homology Directed Repair | 2.543950e-01 | 0.594 |
R-HSA-6802949 | Signaling by RAS mutants | 2.812833e-01 | 0.551 |
R-HSA-9007101 | Rab regulation of trafficking | 2.502031e-01 | 0.602 |
R-HSA-3000157 | Laminin interactions | 1.219830e-01 | 0.914 |
R-HSA-9860927 | Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZ... | 1.960748e-01 | 0.708 |
R-HSA-1433557 | Signaling by SCF-KIT | 2.598705e-01 | 0.585 |
R-HSA-5652227 | Fructose biosynthesis | 1.920061e-01 | 0.717 |
R-HSA-9927354 | Co-stimulation by ICOS | 1.920061e-01 | 0.717 |
R-HSA-9818028 | NFE2L2 regulates pentose phosphate pathway genes | 2.523083e-01 | 0.598 |
R-HSA-8949613 | Cristae formation | 1.349075e-01 | 0.870 |
R-HSA-2559584 | Formation of Senescence-Associated Heterochromatin Foci (SAHF) | 2.807553e-01 | 0.552 |
R-HSA-804914 | Transport of fatty acids | 2.945716e-01 | 0.531 |
R-HSA-5576886 | Phase 4 - resting membrane potential | 3.214155e-01 | 0.493 |
R-HSA-9701190 | Defective homologous recombination repair (HRR) due to BRCA2 loss of function | 1.890969e-01 | 0.723 |
R-HSA-69017 | CDK-mediated phosphorylation and removal of Cdc6 | 1.204527e-01 | 0.919 |
R-HSA-389356 | Co-stimulation by CD28 | 2.955343e-01 | 0.529 |
R-HSA-5693616 | Presynaptic phase of homologous DNA pairing and strand exchange | 1.960748e-01 | 0.708 |
R-HSA-1839117 | Signaling by cytosolic FGFR1 fusion mutants | 3.597841e-01 | 0.444 |
R-HSA-139915 | Activation of PUMA and translocation to mitochondria | 1.761880e-01 | 0.754 |
R-HSA-8851907 | MET activates PI3K/AKT signaling | 1.761880e-01 | 0.754 |
R-HSA-9603381 | Activated NTRK3 signals through PI3K | 1.761880e-01 | 0.754 |
R-HSA-450341 | Activation of the AP-1 family of transcription factors | 2.075215e-01 | 0.683 |
R-HSA-198203 | PI3K/AKT activation | 2.227399e-01 | 0.652 |
R-HSA-168274 | Export of Viral Ribonucleoproteins from Nucleus | 2.812833e-01 | 0.551 |
R-HSA-9018519 | Estrogen-dependent gene expression | 1.779697e-01 | 0.750 |
R-HSA-1266695 | Interleukin-7 signaling | 1.219830e-01 | 0.914 |
R-HSA-1433559 | Regulation of KIT signaling | 2.945716e-01 | 0.531 |
R-HSA-5602358 | Diseases associated with the TLR signaling cascade | 2.313642e-01 | 0.636 |
R-HSA-5260271 | Diseases of Immune System | 2.313642e-01 | 0.636 |
R-HSA-1236973 | Cross-presentation of particulate exogenous antigens (phagosomes) | 2.227399e-01 | 0.652 |
R-HSA-9706019 | RHOBTB3 ATPase cycle | 2.376670e-01 | 0.624 |
R-HSA-168330 | Viral RNP Complexes in the Host Cell Nucleus | 2.523083e-01 | 0.598 |
R-HSA-6804760 | Regulation of TP53 Activity through Methylation | 3.597841e-01 | 0.444 |
R-HSA-8878159 | Transcriptional regulation by RUNX3 | 3.484344e-01 | 0.458 |
R-HSA-9837999 | Mitochondrial protein degradation | 3.274035e-01 | 0.485 |
R-HSA-68875 | Mitotic Prophase | 1.212221e-01 | 0.916 |
R-HSA-9818749 | Regulation of NFE2L2 gene expression | 1.600612e-01 | 0.796 |
R-HSA-622312 | Inflammasomes | 1.414805e-01 | 0.849 |
R-HSA-9673767 | Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | 3.081233e-01 | 0.511 |
R-HSA-9673770 | Signaling by PDGFRA extracellular domain mutants | 3.081233e-01 | 0.511 |
R-HSA-9820841 | M-decay: degradation of maternal mRNAs by maternally stored factors | 2.384775e-01 | 0.623 |
R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 2.755581e-01 | 0.560 |
R-HSA-381042 | PERK regulates gene expression | 1.960748e-01 | 0.708 |
R-HSA-918233 | TRAF3-dependent IRF activation pathway | 3.344531e-01 | 0.476 |
R-HSA-373755 | Semaphorin interactions | 1.603169e-01 | 0.795 |
R-HSA-8943724 | Regulation of PTEN gene transcription | 1.466042e-01 | 0.834 |
R-HSA-512988 | Interleukin-3, Interleukin-5 and GM-CSF signaling | 2.527336e-01 | 0.597 |
R-HSA-8939211 | ESR-mediated signaling | 2.336138e-01 | 0.632 |
R-HSA-9660826 | Purinergic signaling in leishmaniasis infection | 2.812833e-01 | 0.551 |
R-HSA-9664424 | Cell recruitment (pro-inflammatory response) | 2.812833e-01 | 0.551 |
R-HSA-1538133 | G0 and Early G1 | 1.683922e-01 | 0.774 |
R-HSA-9842640 | Signaling by LTK in cancer | 1.600612e-01 | 0.796 |
R-HSA-3371599 | Defective HLCS causes multiple carboxylase deficiency | 1.761880e-01 | 0.754 |
R-HSA-8849469 | PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | 1.920061e-01 | 0.717 |
R-HSA-198693 | AKT phosphorylates targets in the nucleus | 2.075215e-01 | 0.683 |
R-HSA-8866907 | Activation of the TFAP2 (AP-2) family of transcription factors | 2.075215e-01 | 0.683 |
R-HSA-428540 | Activation of RAC1 | 2.523083e-01 | 0.598 |
R-HSA-69091 | Polymerase switching | 2.666693e-01 | 0.574 |
R-HSA-69109 | Leading Strand Synthesis | 2.666693e-01 | 0.574 |
R-HSA-6811555 | PI5P Regulates TP53 Acetylation | 2.807553e-01 | 0.552 |
R-HSA-5694530 | Cargo concentration in the ER | 1.615808e-01 | 0.792 |
R-HSA-1810476 | RIP-mediated NFkB activation via ZBP1 | 3.081233e-01 | 0.511 |
R-HSA-9837092 | FASTK family proteins regulate processing and stability of mitochondrial RNAs | 3.081233e-01 | 0.511 |
R-HSA-210744 | Regulation of gene expression in late stage (branching morphogenesis) pancreatic... | 3.214155e-01 | 0.493 |
R-HSA-69481 | G2/M Checkpoints | 1.439724e-01 | 0.842 |
R-HSA-212436 | Generic Transcription Pathway | 2.183310e-01 | 0.661 |
R-HSA-5578775 | Ion homeostasis | 1.289672e-01 | 0.890 |
R-HSA-9686347 | Microbial modulation of RIPK1-mediated regulated necrosis | 1.761880e-01 | 0.754 |
R-HSA-2197563 | NOTCH2 intracellular domain regulates transcription | 2.666693e-01 | 0.574 |
R-HSA-389357 | CD28 dependent PI3K/Akt signaling | 1.349075e-01 | 0.870 |
R-HSA-176187 | Activation of ATR in response to replication stress | 1.752515e-01 | 0.756 |
R-HSA-8941858 | Regulation of RUNX3 expression and activity | 2.313642e-01 | 0.636 |
R-HSA-162592 | Integration of provirus | 2.523083e-01 | 0.598 |
R-HSA-9680350 | Signaling by CSF1 (M-CSF) in myeloid cells | 1.890969e-01 | 0.723 |
R-HSA-9675135 | Diseases of DNA repair | 2.812833e-01 | 0.551 |
R-HSA-3134973 | LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | 1.268574e-01 | 0.897 |
R-HSA-164944 | Nef and signal transduction | 1.600612e-01 | 0.796 |
R-HSA-8964011 | HDL clearance | 1.600612e-01 | 0.796 |
R-HSA-167590 | Nef Mediated CD4 Down-regulation | 1.761880e-01 | 0.754 |
R-HSA-9693928 | Defective RIPK1-mediated regulated necrosis | 2.227399e-01 | 0.652 |
R-HSA-5655291 | Signaling by FGFR4 in disease | 2.945716e-01 | 0.531 |
R-HSA-975163 | IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | 2.945716e-01 | 0.531 |
R-HSA-69202 | Cyclin E associated events during G1/S transition | 1.936878e-01 | 0.713 |
R-HSA-912446 | Meiotic recombination | 3.168277e-01 | 0.499 |
R-HSA-2559583 | Cellular Senescence | 1.916654e-01 | 0.717 |
R-HSA-199418 | Negative regulation of the PI3K/AKT network | 3.099639e-01 | 0.509 |
R-HSA-3214847 | HATs acetylate histones | 3.589283e-01 | 0.445 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 1.284462e-01 | 0.891 |
R-HSA-6804114 | TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | 3.344531e-01 | 0.476 |
R-HSA-180292 | GAB1 signalosome | 3.597841e-01 | 0.444 |
R-HSA-114608 | Platelet degranulation | 2.969993e-01 | 0.527 |
R-HSA-3323169 | Defects in biotin (Btn) metabolism | 2.075215e-01 | 0.683 |
R-HSA-9840373 | Cellular response to mitochondrial stress | 2.075215e-01 | 0.683 |
R-HSA-1296346 | Tandem pore domain potassium channels | 2.227399e-01 | 0.652 |
R-HSA-6793080 | rRNA modification in the mitochondrion | 2.807553e-01 | 0.552 |
R-HSA-5578768 | Physiological factors | 2.945716e-01 | 0.531 |
R-HSA-70370 | Galactose catabolism | 3.344531e-01 | 0.476 |
R-HSA-549127 | SLC-mediated transport of organic cations | 2.101215e-01 | 0.678 |
R-HSA-202424 | Downstream TCR signaling | 3.011131e-01 | 0.521 |
R-HSA-69656 | Cyclin A:Cdk2-associated events at S phase entry | 2.035236e-01 | 0.691 |
R-HSA-1989781 | PPARA activates gene expression | 2.462748e-01 | 0.609 |
R-HSA-1500931 | Cell-Cell communication | 1.212158e-01 | 0.916 |
R-HSA-9764790 | Positive Regulation of CDH1 Gene Transcription | 2.227399e-01 | 0.652 |
R-HSA-210990 | PECAM1 interactions | 2.376670e-01 | 0.624 |
R-HSA-9735871 | SARS-CoV-1 targets host intracellular signalling and regulatory pathways | 3.081233e-01 | 0.511 |
R-HSA-193648 | NRAGE signals death through JNK | 3.519569e-01 | 0.454 |
R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ | 3.273313e-01 | 0.485 |
R-HSA-156711 | Polo-like kinase mediated events | 3.597841e-01 | 0.444 |
R-HSA-9665348 | Signaling by ERBB2 ECD mutants | 3.597841e-01 | 0.444 |
R-HSA-400206 | Regulation of lipid metabolism by PPARalpha | 2.534651e-01 | 0.596 |
R-HSA-418360 | Platelet calcium homeostasis | 1.481203e-01 | 0.829 |
R-HSA-399955 | SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | 3.214155e-01 | 0.493 |
R-HSA-9764560 | Regulation of CDH1 Gene Transcription | 1.936878e-01 | 0.713 |
R-HSA-1660499 | Synthesis of PIPs at the plasma membrane | 1.557028e-01 | 0.808 |
R-HSA-114604 | GPVI-mediated activation cascade | 2.030843e-01 | 0.692 |
R-HSA-5357801 | Programmed Cell Death | 1.499608e-01 | 0.824 |
R-HSA-381070 | IRE1alpha activates chaperones | 3.116225e-01 | 0.506 |
R-HSA-430116 | GP1b-IX-V activation signalling | 2.075215e-01 | 0.683 |
R-HSA-391908 | Prostanoid ligand receptors | 2.376670e-01 | 0.624 |
R-HSA-198323 | AKT phosphorylates targets in the cytosol | 2.666693e-01 | 0.574 |
R-HSA-8876725 | Protein methylation | 3.081233e-01 | 0.511 |
R-HSA-140534 | Caspase activation via Death Receptors in the presence of ligand | 3.214155e-01 | 0.493 |
R-HSA-5637810 | Constitutive Signaling by EGFRvIII | 3.472411e-01 | 0.459 |
R-HSA-5637812 | Signaling by EGFRvIII in Cancer | 3.472411e-01 | 0.459 |
R-HSA-5358606 | Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | 3.472411e-01 | 0.459 |
R-HSA-1592230 | Mitochondrial biogenesis | 2.502031e-01 | 0.602 |
R-HSA-9031628 | NGF-stimulated transcription | 2.955343e-01 | 0.529 |
R-HSA-1912408 | Pre-NOTCH Transcription and Translation | 3.063660e-01 | 0.514 |
R-HSA-111465 | Apoptotic cleavage of cellular proteins | 1.683922e-01 | 0.774 |
R-HSA-9842663 | Signaling by LTK | 2.666693e-01 | 0.574 |
R-HSA-9029569 | NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflu... | 1.376884e-01 | 0.861 |
R-HSA-5358565 | Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | 3.472411e-01 | 0.459 |
R-HSA-446728 | Cell junction organization | 2.239916e-01 | 0.650 |
R-HSA-1266738 | Developmental Biology | 2.753476e-01 | 0.560 |
R-HSA-6791312 | TP53 Regulates Transcription of Cell Cycle Genes | 1.333027e-01 | 0.875 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 2.012776e-01 | 0.696 |
R-HSA-2151201 | Transcriptional activation of mitochondrial biogenesis | 2.490276e-01 | 0.604 |
R-HSA-9701898 | STAT3 nuclear events downstream of ALK signaling | 3.081233e-01 | 0.511 |
R-HSA-1606322 | ZBP1(DAI) mediated induction of type I IFNs | 3.597841e-01 | 0.444 |
R-HSA-381119 | Unfolded Protein Response (UPR) | 1.877300e-01 | 0.726 |
R-HSA-6807070 | PTEN Regulation | 3.578413e-01 | 0.446 |
R-HSA-9006925 | Intracellular signaling by second messengers | 1.685999e-01 | 0.773 |
R-HSA-9700206 | Signaling by ALK in cancer | 2.012776e-01 | 0.696 |
R-HSA-109581 | Apoptosis | 1.396242e-01 | 0.855 |
R-HSA-8853884 | Transcriptional Regulation by VENTX | 2.384775e-01 | 0.623 |
R-HSA-9733709 | Cardiogenesis | 1.752515e-01 | 0.756 |
R-HSA-9619665 | EGR2 and SOX10-mediated initiation of Schwann cell myelination | 1.821545e-01 | 0.740 |
R-HSA-9008059 | Interleukin-37 signaling | 1.548220e-01 | 0.810 |
R-HSA-210993 | Tie2 Signaling | 3.597841e-01 | 0.444 |
R-HSA-163685 | Integration of energy metabolism | 1.779697e-01 | 0.750 |
R-HSA-164938 | Nef-mediates down modulation of cell surface receptors by recruiting them to cla... | 3.472411e-01 | 0.459 |
R-HSA-264876 | Insulin processing | 1.349075e-01 | 0.870 |
R-HSA-5358508 | Mismatch Repair | 3.597841e-01 | 0.444 |
R-HSA-9006936 | Signaling by TGFB family members | 2.643465e-01 | 0.578 |
R-HSA-170834 | Signaling by TGF-beta Receptor Complex | 1.593704e-01 | 0.798 |
R-HSA-9820952 | Respiratory Syncytial Virus Infection Pathway | 1.812015e-01 | 0.742 |
R-HSA-8957322 | Metabolism of steroids | 2.266160e-01 | 0.645 |
R-HSA-2022090 | Assembly of collagen fibrils and other multimeric structures | 1.421227e-01 | 0.847 |
R-HSA-1474290 | Collagen formation | 3.274035e-01 | 0.485 |
R-HSA-9772572 | Early SARS-CoV-2 Infection Events | 3.658400e-01 | 0.437 |
R-HSA-5654710 | PI-3K cascade:FGFR3 | 3.720868e-01 | 0.429 |
R-HSA-392851 | Prostacyclin signalling through prostacyclin receptor | 3.720868e-01 | 0.429 |
R-HSA-937041 | IKK complex recruitment mediated by RIP1 | 3.720868e-01 | 0.429 |
R-HSA-912631 | Regulation of signaling by CBL | 3.720868e-01 | 0.429 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at... | 3.727390e-01 | 0.429 |
R-HSA-2559580 | Oxidative Stress Induced Senescence | 3.746224e-01 | 0.426 |
R-HSA-1483255 | PI Metabolism | 3.746224e-01 | 0.426 |
R-HSA-9764725 | Negative Regulation of CDH1 Gene Transcription | 3.796077e-01 | 0.421 |
R-HSA-5654720 | PI-3K cascade:FGFR4 | 3.841539e-01 | 0.415 |
R-HSA-9609523 | Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | 3.841539e-01 | 0.415 |
R-HSA-389513 | Co-inhibition by CTLA4 | 3.841539e-01 | 0.415 |
R-HSA-5620922 | BBSome-mediated cargo-targeting to cilium | 3.841539e-01 | 0.415 |
R-HSA-196108 | Pregnenolone biosynthesis | 3.841539e-01 | 0.415 |
R-HSA-1181150 | Signaling by NODAL | 3.841539e-01 | 0.415 |
R-HSA-391903 | Eicosanoid ligand-binding receptors | 3.841539e-01 | 0.415 |
R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis | 3.850441e-01 | 0.414 |
R-HSA-9860931 | Response of endothelial cells to shear stress | 3.850441e-01 | 0.414 |
R-HSA-9793380 | Formation of paraxial mesoderm | 3.864446e-01 | 0.413 |
R-HSA-1268020 | Mitochondrial protein import | 3.932486e-01 | 0.405 |
R-HSA-9616222 | Transcriptional regulation of granulopoiesis | 3.932486e-01 | 0.405 |
R-HSA-9707616 | Heme signaling | 3.932486e-01 | 0.405 |
R-HSA-5602498 | MyD88 deficiency (TLR2/4) | 3.959898e-01 | 0.402 |
R-HSA-69186 | Lagging Strand Synthesis | 3.959898e-01 | 0.402 |
R-HSA-9819196 | Zygotic genome activation (ZGA) | 3.959898e-01 | 0.402 |
R-HSA-9013695 | NOTCH4 Intracellular Domain Regulates Transcription | 3.959898e-01 | 0.402 |
R-HSA-5637815 | Signaling by Ligand-Responsive EGFR Variants in Cancer | 3.959898e-01 | 0.402 |
R-HSA-1236382 | Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 3.959898e-01 | 0.402 |
R-HSA-162594 | Early Phase of HIV Life Cycle | 3.959898e-01 | 0.402 |
R-HSA-73857 | RNA Polymerase II Transcription | 3.989700e-01 | 0.399 |
R-HSA-418346 | Platelet homeostasis | 4.005993e-01 | 0.397 |
R-HSA-168643 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signali... | 4.067525e-01 | 0.391 |
R-HSA-5696397 | Gap-filling DNA repair synthesis and ligation in GG-NER | 4.075989e-01 | 0.390 |
R-HSA-5603041 | IRAK4 deficiency (TLR2/4) | 4.075989e-01 | 0.390 |
R-HSA-9617828 | FOXO-mediated transcription of cell cycle genes | 4.075989e-01 | 0.390 |
R-HSA-8949215 | Mitochondrial calcium ion transport | 4.075989e-01 | 0.390 |
R-HSA-9671555 | Signaling by PDGFR in disease | 4.075989e-01 | 0.390 |
R-HSA-9034015 | Signaling by NTRK3 (TRKC) | 4.075989e-01 | 0.390 |
R-HSA-9679191 | Potential therapeutics for SARS | 4.100069e-01 | 0.387 |
R-HSA-1236975 | Antigen processing-Cross presentation | 4.109091e-01 | 0.386 |
R-HSA-2672351 | Stimuli-sensing channels | 4.109091e-01 | 0.386 |
R-HSA-6802952 | Signaling by BRAF and RAF1 fusions | 4.134501e-01 | 0.384 |
R-HSA-1234174 | Cellular response to hypoxia | 4.134501e-01 | 0.384 |
R-HSA-8950505 | Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulati... | 4.134501e-01 | 0.384 |
R-HSA-5654689 | PI-3K cascade:FGFR1 | 4.189856e-01 | 0.378 |
R-HSA-3238698 | WNT ligand biogenesis and trafficking | 4.189856e-01 | 0.378 |
R-HSA-5652084 | Fructose metabolism | 4.189856e-01 | 0.378 |
R-HSA-112409 | RAF-independent MAPK1/3 activation | 4.189856e-01 | 0.378 |
R-HSA-597592 | Post-translational protein modification | 4.209430e-01 | 0.376 |
R-HSA-202403 | TCR signaling | 4.211641e-01 | 0.376 |
R-HSA-5693606 | DNA Double Strand Break Response | 4.267314e-01 | 0.370 |
R-HSA-9648895 | Response of EIF2AK1 (HRI) to heme deficiency | 4.301542e-01 | 0.366 |
R-HSA-9634638 | Estrogen-dependent nuclear events downstream of ESR-membrane signaling | 4.301542e-01 | 0.366 |
R-HSA-9937008 | Mitochondrial mRNA modification | 4.301542e-01 | 0.366 |
R-HSA-164952 | The role of Nef in HIV-1 replication and disease pathogenesis | 4.301542e-01 | 0.366 |
R-HSA-200425 | Carnitine shuttle | 4.301542e-01 | 0.366 |
R-HSA-8854691 | Interleukin-20 family signaling | 4.301542e-01 | 0.366 |
R-HSA-3000170 | Syndecan interactions | 4.301542e-01 | 0.366 |
R-HSA-9662360 | Sensory processing of sound by inner hair cells of the cochlea | 4.333130e-01 | 0.363 |
R-HSA-1912422 | Pre-NOTCH Expression and Processing | 4.364323e-01 | 0.360 |
R-HSA-202430 | Translocation of ZAP-70 to Immunological synapse | 4.411087e-01 | 0.355 |
R-HSA-110314 | Recognition of DNA damage by PCNA-containing replication complex | 4.411087e-01 | 0.355 |
R-HSA-8862803 | Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's dis... | 4.411087e-01 | 0.355 |
R-HSA-8863678 | Neurodegenerative Diseases | 4.411087e-01 | 0.355 |
R-HSA-5621575 | CD209 (DC-SIGN) signaling | 4.411087e-01 | 0.355 |
R-HSA-9836573 | Mitochondrial RNA degradation | 4.411087e-01 | 0.355 |
R-HSA-9703648 | Signaling by FLT3 ITD and TKD mutants | 4.411087e-01 | 0.355 |
R-HSA-9855142 | Cellular responses to mechanical stimuli | 4.414887e-01 | 0.355 |
R-HSA-75105 | Fatty acyl-CoA biosynthesis | 4.463537e-01 | 0.350 |
R-HSA-877300 | Interferon gamma signaling | 4.485803e-01 | 0.348 |
R-HSA-5654695 | PI-3K cascade:FGFR2 | 4.518533e-01 | 0.345 |
R-HSA-174411 | Polymerase switching on the C-strand of the telomere | 4.518533e-01 | 0.345 |
R-HSA-9839394 | TGFBR3 expression | 4.518533e-01 | 0.345 |
R-HSA-70221 | Glycogen breakdown (glycogenolysis) | 4.518533e-01 | 0.345 |
R-HSA-9856649 | Transcriptional and post-translational regulation of MITF-M expression and activ... | 4.528110e-01 | 0.344 |
R-HSA-73894 | DNA Repair | 4.557869e-01 | 0.341 |
R-HSA-198725 | Nuclear Events (kinase and transcription factor activation) | 4.592254e-01 | 0.338 |
R-HSA-168249 | Innate Immune System | 4.608053e-01 | 0.336 |
R-HSA-9615933 | Postmitotic nuclear pore complex (NPC) reformation | 4.623920e-01 | 0.335 |
R-HSA-525793 | Myogenesis | 4.623920e-01 | 0.335 |
R-HSA-110373 | Resolution of AP sites via the multiple-nucleotide patch replacement pathway | 4.623920e-01 | 0.335 |
R-HSA-8874081 | MET activates PTK2 signaling | 4.623920e-01 | 0.335 |
R-HSA-9638630 | Attachment of bacteria to epithelial cells | 4.623920e-01 | 0.335 |
R-HSA-9703465 | Signaling by FLT3 fusion proteins | 4.623920e-01 | 0.335 |
R-HSA-1643713 | Signaling by EGFR in Cancer | 4.623920e-01 | 0.335 |
R-HSA-5357769 | Caspase activation via extrinsic apoptotic signalling pathway | 4.623920e-01 | 0.335 |
R-HSA-204998 | Cell death signalling via NRAGE, NRIF and NADE | 4.655959e-01 | 0.332 |
R-HSA-69473 | G2/M DNA damage checkpoint | 4.719220e-01 | 0.326 |
R-HSA-9013694 | Signaling by NOTCH4 | 4.719220e-01 | 0.326 |
R-HSA-174414 | Processive synthesis on the C-strand of the telomere | 4.727287e-01 | 0.325 |
R-HSA-202427 | Phosphorylation of CD3 and TCR zeta chains | 4.727287e-01 | 0.325 |
R-HSA-8866652 | Synthesis of active ubiquitin: roles of E1 and E2 enzymes | 4.727287e-01 | 0.325 |
R-HSA-9734009 | Defective Intrinsic Pathway for Apoptosis | 4.727287e-01 | 0.325 |
R-HSA-3928663 | EPHA-mediated growth cone collapse | 4.727287e-01 | 0.325 |
R-HSA-201451 | Signaling by BMP | 4.727287e-01 | 0.325 |
R-HSA-5655332 | Signaling by FGFR3 in disease | 4.727287e-01 | 0.325 |
R-HSA-9006115 | Signaling by NTRK2 (TRKB) | 4.727287e-01 | 0.325 |
R-HSA-8852135 | Protein ubiquitination | 4.782030e-01 | 0.320 |
R-HSA-5205685 | PINK1-PRKN Mediated Mitophagy | 4.828673e-01 | 0.316 |
R-HSA-380994 | ATF4 activates genes in response to endoplasmic reticulum stress | 4.828673e-01 | 0.316 |
R-HSA-9020591 | Interleukin-12 signaling | 4.844383e-01 | 0.315 |
R-HSA-418990 | Adherens junctions interactions | 4.897382e-01 | 0.310 |
R-HSA-9709570 | Impaired BRCA2 binding to RAD51 | 4.928115e-01 | 0.307 |
R-HSA-5654708 | Downstream signaling of activated FGFR3 | 4.928115e-01 | 0.307 |
R-HSA-5656169 | Termination of translesion DNA synthesis | 4.928115e-01 | 0.307 |
R-HSA-9006335 | Signaling by Erythropoietin | 4.928115e-01 | 0.307 |
R-HSA-450282 | MAPK targets/ Nuclear events mediated by MAP kinases | 4.928115e-01 | 0.307 |
R-HSA-180024 | DARPP-32 events | 4.928115e-01 | 0.307 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 4.958357e-01 | 0.305 |
R-HSA-6783783 | Interleukin-10 signaling | 4.967696e-01 | 0.304 |
R-HSA-191273 | Cholesterol biosynthesis | 4.967696e-01 | 0.304 |
R-HSA-162909 | Host Interactions of HIV factors | 5.006478e-01 | 0.300 |
R-HSA-5619107 | Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC... | 5.025651e-01 | 0.299 |
R-HSA-9933387 | RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | 5.025651e-01 | 0.299 |
R-HSA-5654716 | Downstream signaling of activated FGFR4 | 5.025651e-01 | 0.299 |
R-HSA-380972 | Energy dependent regulation of mTOR by LKB1-AMPK | 5.025651e-01 | 0.299 |
R-HSA-114452 | Activation of BH3-only proteins | 5.025651e-01 | 0.299 |
R-HSA-9013508 | NOTCH3 Intracellular Domain Regulates Transcription | 5.025651e-01 | 0.299 |
R-HSA-9659379 | Sensory processing of sound | 5.028645e-01 | 0.299 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 5.054762e-01 | 0.296 |
R-HSA-6806834 | Signaling by MET | 5.089118e-01 | 0.293 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 5.109221e-01 | 0.292 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 5.109221e-01 | 0.292 |
R-HSA-1855196 | IP3 and IP4 transport between cytosol and nucleus | 5.121318e-01 | 0.291 |
R-HSA-1855229 | IP6 and IP7 transport between cytosol and nucleus | 5.121318e-01 | 0.291 |
R-HSA-211733 | Regulation of activated PAK-2p34 by proteasome mediated degradation | 5.121318e-01 | 0.291 |
R-HSA-186763 | Downstream signal transduction | 5.121318e-01 | 0.291 |
R-HSA-9833109 | Evasion by RSV of host interferon responses | 5.121318e-01 | 0.291 |
R-HSA-5693607 | Processing of DNA double-strand break ends | 5.149109e-01 | 0.288 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 5.186729e-01 | 0.285 |
R-HSA-9678108 | SARS-CoV-1 Infection | 5.189996e-01 | 0.285 |
R-HSA-2559582 | Senescence-Associated Secretory Phenotype (SASP) | 5.208615e-01 | 0.283 |
R-HSA-350562 | Regulation of ornithine decarboxylase (ODC) | 5.215150e-01 | 0.283 |
R-HSA-1474244 | Extracellular matrix organization | 5.215443e-01 | 0.283 |
R-HSA-187037 | Signaling by NTRK1 (TRKA) | 5.243504e-01 | 0.280 |
R-HSA-1855170 | IPs transport between nucleus and cytosol | 5.307183e-01 | 0.275 |
R-HSA-159227 | Transport of the SLBP independent Mature mRNA | 5.307183e-01 | 0.275 |
R-HSA-5083635 | Defective B3GALTL causes PpS | 5.307183e-01 | 0.275 |
R-HSA-354192 | Integrin signaling | 5.307183e-01 | 0.275 |
R-HSA-5685938 | HDR through Single Strand Annealing (SSA) | 5.307183e-01 | 0.275 |
R-HSA-6804758 | Regulation of TP53 Activity through Acetylation | 5.307183e-01 | 0.275 |
R-HSA-5675482 | Regulation of necroptotic cell death | 5.307183e-01 | 0.275 |
R-HSA-1839124 | FGFR1 mutant receptor activation | 5.307183e-01 | 0.275 |
R-HSA-397795 | G-protein beta:gamma signalling | 5.307183e-01 | 0.275 |
R-HSA-69273 | Cyclin A/B1/B2 associated events during G2/M transition | 5.307183e-01 | 0.275 |
R-HSA-1500620 | Meiosis | 5.384187e-01 | 0.269 |
R-HSA-5687128 | MAPK6/MAPK4 signaling | 5.384187e-01 | 0.269 |
R-HSA-5663205 | Infectious disease | 5.395131e-01 | 0.268 |
R-HSA-159230 | Transport of the SLBP Dependant Mature mRNA | 5.397452e-01 | 0.268 |
R-HSA-390471 | Association of TriC/CCT with target proteins during biosynthesis | 5.397452e-01 | 0.268 |
R-HSA-9818027 | NFE2L2 regulating anti-oxidant/detoxification enzymes | 5.397452e-01 | 0.268 |
R-HSA-170822 | Regulation of Glucokinase by Glucokinase Regulatory Protein | 5.397452e-01 | 0.268 |
R-HSA-180534 | Vpu mediated degradation of CD4 | 5.397452e-01 | 0.268 |
R-HSA-199220 | Vitamin B5 (pantothenate) metabolism | 5.397452e-01 | 0.268 |
R-HSA-1643685 | Disease | 5.407542e-01 | 0.267 |
R-HSA-9843745 | Adipogenesis | 5.428622e-01 | 0.265 |
R-HSA-6814122 | Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | 5.485990e-01 | 0.261 |
R-HSA-5696400 | Dual Incision in GG-NER | 5.485990e-01 | 0.261 |
R-HSA-180746 | Nuclear import of Rev protein | 5.485990e-01 | 0.261 |
R-HSA-5205647 | Mitophagy | 5.485990e-01 | 0.261 |
R-HSA-349425 | Autodegradation of the E3 ubiquitin ligase COP1 | 5.485990e-01 | 0.261 |
R-HSA-75815 | Ubiquitin-dependent degradation of Cyclin D | 5.485990e-01 | 0.261 |
R-HSA-1980145 | Signaling by NOTCH2 | 5.485990e-01 | 0.261 |
R-HSA-381038 | XBP1(S) activates chaperone genes | 5.498753e-01 | 0.260 |
R-HSA-447115 | Interleukin-12 family signaling | 5.555284e-01 | 0.255 |
R-HSA-3301854 | Nuclear Pore Complex (NPC) Disassembly | 5.572830e-01 | 0.254 |
R-HSA-8854050 | FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | 5.572830e-01 | 0.254 |
R-HSA-174113 | SCF-beta-TrCP mediated degradation of Emi1 | 5.572830e-01 | 0.254 |
R-HSA-5654696 | Downstream signaling of activated FGFR2 | 5.572830e-01 | 0.254 |
R-HSA-5654687 | Downstream signaling of activated FGFR1 | 5.572830e-01 | 0.254 |
R-HSA-169911 | Regulation of Apoptosis | 5.572830e-01 | 0.254 |
R-HSA-3296482 | Defects in vitamin and cofactor metabolism | 5.572830e-01 | 0.254 |
R-HSA-9645723 | Diseases of programmed cell death | 5.611311e-01 | 0.251 |
R-HSA-74160 | Gene expression (Transcription) | 5.638435e-01 | 0.249 |
R-HSA-69205 | G1/S-Specific Transcription | 5.658004e-01 | 0.247 |
R-HSA-180585 | Vif-mediated degradation of APOBEC3G | 5.658004e-01 | 0.247 |
R-HSA-9682385 | FLT3 signaling in disease | 5.658004e-01 | 0.247 |
R-HSA-8853659 | RET signaling | 5.658004e-01 | 0.247 |
R-HSA-1236974 | ER-Phagosome pathway | 5.666833e-01 | 0.247 |
R-HSA-112310 | Neurotransmitter release cycle | 5.721849e-01 | 0.242 |
R-HSA-5173214 | O-glycosylation of TSR domain-containing proteins | 5.741545e-01 | 0.241 |
R-HSA-1296072 | Voltage gated Potassium channels | 5.741545e-01 | 0.241 |
R-HSA-6802948 | Signaling by high-kinase activity BRAF mutants | 5.741545e-01 | 0.241 |
R-HSA-180910 | Vpr-mediated nuclear import of PICs | 5.741545e-01 | 0.241 |
R-HSA-933541 | TRAF6 mediated IRF7 activation | 5.741545e-01 | 0.241 |
R-HSA-4641258 | Degradation of DVL | 5.741545e-01 | 0.241 |
R-HSA-4641257 | Degradation of AXIN | 5.741545e-01 | 0.241 |
R-HSA-9762114 | GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | 5.741545e-01 | 0.241 |
R-HSA-2173796 | SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 5.741545e-01 | 0.241 |
R-HSA-5213460 | RIPK1-mediated regulated necrosis | 5.823484e-01 | 0.235 |
R-HSA-165054 | Rev-mediated nuclear export of HIV RNA | 5.823484e-01 | 0.235 |
R-HSA-9931953 | Biofilm formation | 5.823484e-01 | 0.235 |
R-HSA-8875878 | MET promotes cell motility | 5.823484e-01 | 0.235 |
R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript | 5.903851e-01 | 0.229 |
R-HSA-1236978 | Cross-presentation of soluble exogenous antigens (endosomes) | 5.903851e-01 | 0.229 |
R-HSA-9725554 | Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | 5.903851e-01 | 0.229 |
R-HSA-168276 | NS1 Mediated Effects on Host Pathways | 5.903851e-01 | 0.229 |
R-HSA-9929356 | GSK3B-mediated proteasomal degradation of PD-L1(CD274) | 5.903851e-01 | 0.229 |
R-HSA-69541 | Stabilization of p53 | 5.903851e-01 | 0.229 |
R-HSA-8964043 | Plasma lipoprotein clearance | 5.903851e-01 | 0.229 |
R-HSA-983695 | Antigen activates B Cell Receptor (BCR) leading to generation of second messenge... | 5.936828e-01 | 0.226 |
R-HSA-159234 | Transport of Mature mRNAs Derived from Intronless Transcripts | 5.982677e-01 | 0.223 |
R-HSA-427389 | ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 5.982677e-01 | 0.223 |
R-HSA-9843743 | Transcriptional regulation of brown and beige adipocyte differentiation | 5.982677e-01 | 0.223 |
R-HSA-9844594 | Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | 5.982677e-01 | 0.223 |
R-HSA-177243 | Interactions of Rev with host cellular proteins | 5.982677e-01 | 0.223 |
R-HSA-176033 | Interactions of Vpr with host cellular proteins | 5.982677e-01 | 0.223 |
R-HSA-202433 | Generation of second messenger molecules | 5.982677e-01 | 0.223 |
R-HSA-9604323 | Negative regulation of NOTCH4 signaling | 5.982677e-01 | 0.223 |
R-HSA-8868766 | rRNA processing in the mitochondrion | 5.982677e-01 | 0.223 |
R-HSA-8982491 | Glycogen metabolism | 5.982677e-01 | 0.223 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 5.996770e-01 | 0.222 |
R-HSA-421270 | Cell-cell junction organization | 6.041067e-01 | 0.219 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 6.042351e-01 | 0.219 |
R-HSA-168271 | Transport of Ribonucleoproteins into the Host Nucleus | 6.059990e-01 | 0.218 |
R-HSA-9929491 | SPOP-mediated proteasomal degradation of PD-L1(CD274) | 6.059990e-01 | 0.218 |
R-HSA-5362768 | Hh mutants are degraded by ERAD | 6.059990e-01 | 0.218 |
R-HSA-73933 | Resolution of Abasic Sites (AP sites) | 6.059990e-01 | 0.218 |
R-HSA-5676590 | NIK-->noncanonical NF-kB signaling | 6.059990e-01 | 0.218 |
R-HSA-110313 | Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA templa... | 6.059990e-01 | 0.218 |
R-HSA-5674135 | MAP2K and MAPK activation | 6.135820e-01 | 0.212 |
R-HSA-9656223 | Signaling by RAF1 mutants | 6.135820e-01 | 0.212 |
R-HSA-174417 | Telomere C-strand (Lagging Strand) Synthesis | 6.135820e-01 | 0.212 |
R-HSA-6811438 | Intra-Golgi traffic | 6.135820e-01 | 0.212 |
R-HSA-9615017 | FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | 6.135820e-01 | 0.212 |
R-HSA-9932298 | Degradation of CRY and PER proteins | 6.135820e-01 | 0.212 |
R-HSA-5610780 | Degradation of GLI1 by the proteasome | 6.135820e-01 | 0.212 |
R-HSA-5655302 | Signaling by FGFR1 in disease | 6.135820e-01 | 0.212 |
R-HSA-5610783 | Degradation of GLI2 by the proteasome | 6.135820e-01 | 0.212 |
R-HSA-5610785 | GLI3 is processed to GLI3R by the proteasome | 6.135820e-01 | 0.212 |
R-HSA-5675221 | Negative regulation of MAPK pathway | 6.135820e-01 | 0.212 |
R-HSA-2730905 | Role of LAT2/NTAL/LAB on calcium mobilization | 6.143657e-01 | 0.212 |
R-HSA-381340 | Transcriptional regulation of white adipocyte differentiation | 6.143657e-01 | 0.212 |
R-HSA-1296071 | Potassium Channels | 6.143657e-01 | 0.212 |
R-HSA-379716 | Cytosolic tRNA aminoacylation | 6.210196e-01 | 0.207 |
R-HSA-73762 | RNA Polymerase I Transcription Initiation | 6.210196e-01 | 0.207 |
R-HSA-165159 | MTOR signalling | 6.210196e-01 | 0.207 |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | 6.247058e-01 | 0.204 |
R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade | 6.247941e-01 | 0.204 |
R-HSA-166520 | Signaling by NTRKs | 6.247941e-01 | 0.204 |
R-HSA-5654743 | Signaling by FGFR4 | 6.283144e-01 | 0.202 |
R-HSA-5387390 | Hh mutants abrogate ligand secretion | 6.283144e-01 | 0.202 |
R-HSA-8854214 | TBC/RABGAPs | 6.283144e-01 | 0.202 |
R-HSA-193704 | p75 NTR receptor-mediated signalling | 6.293438e-01 | 0.201 |
R-HSA-382556 | ABC-family proteins mediated transport | 6.342351e-01 | 0.198 |
R-HSA-9907900 | Proteasome assembly | 6.354693e-01 | 0.197 |
R-HSA-187577 | SCF(Skp2)-mediated degradation of p27/p21 | 6.354693e-01 | 0.197 |
R-HSA-5683826 | Surfactant metabolism | 6.354693e-01 | 0.197 |
R-HSA-9755511 | KEAP1-NFE2L2 pathway | 6.367746e-01 | 0.196 |
R-HSA-9009391 | Extra-nuclear estrogen signaling | 6.390760e-01 | 0.194 |
R-HSA-9820448 | Developmental Cell Lineages of the Exocrine Pancreas | 6.407085e-01 | 0.193 |
R-HSA-446652 | Interleukin-1 family signaling | 6.407085e-01 | 0.193 |
R-HSA-76009 | Platelet Aggregation (Plug Formation) | 6.424868e-01 | 0.192 |
R-HSA-168333 | NEP/NS2 Interacts with the Cellular Export Machinery | 6.424868e-01 | 0.192 |
R-HSA-5654741 | Signaling by FGFR3 | 6.424868e-01 | 0.192 |
R-HSA-4608870 | Asymmetric localization of PCP proteins | 6.424868e-01 | 0.192 |
R-HSA-5678895 | Defective CFTR causes cystic fibrosis | 6.424868e-01 | 0.192 |
R-HSA-5607761 | Dectin-1 mediated noncanonical NF-kB signaling | 6.424868e-01 | 0.192 |
R-HSA-69613 | p53-Independent G1/S DNA Damage Checkpoint | 6.424868e-01 | 0.192 |
R-HSA-69601 | Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | 6.424868e-01 | 0.192 |
R-HSA-9824272 | Somitogenesis | 6.424868e-01 | 0.192 |
R-HSA-9609507 | Protein localization | 6.446125e-01 | 0.191 |
R-HSA-72695 | Formation of the ternary complex, and subsequently, the 43S complex | 6.493697e-01 | 0.188 |
R-HSA-2514859 | Inactivation, recovery and regulation of the phototransduction cascade | 6.493697e-01 | 0.188 |
R-HSA-9839373 | Signaling by TGFBR3 | 6.493697e-01 | 0.188 |
R-HSA-9633012 | Response of EIF2AK4 (GCN2) to amino acid deficiency | 6.532971e-01 | 0.185 |
R-HSA-6811440 | Retrograde transport at the Trans-Golgi-Network | 6.561205e-01 | 0.183 |
R-HSA-1483191 | Synthesis of PC | 6.561205e-01 | 0.183 |
R-HSA-9711123 | Cellular response to chemical stress | 6.569969e-01 | 0.182 |
R-HSA-9833110 | RSV-host interactions | 6.579374e-01 | 0.182 |
R-HSA-9730414 | MITF-M-regulated melanocyte development | 6.619879e-01 | 0.179 |
R-HSA-168164 | Toll Like Receptor 3 (TLR3) Cascade | 6.625281e-01 | 0.179 |
R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | 6.636827e-01 | 0.178 |
R-HSA-9692914 | SARS-CoV-1-host interactions | 6.670692e-01 | 0.176 |
R-HSA-2122947 | NOTCH1 Intracellular Domain Regulates Transcription | 6.692359e-01 | 0.174 |
R-HSA-73893 | DNA Damage Bypass | 6.692359e-01 | 0.174 |
R-HSA-9766229 | Degradation of CDH1 | 6.692359e-01 | 0.174 |
R-HSA-69563 | p53-Dependent G1 DNA Damage Response | 6.692359e-01 | 0.174 |
R-HSA-69580 | p53-Dependent G1/S DNA damage checkpoint | 6.692359e-01 | 0.174 |
R-HSA-5658442 | Regulation of RAS by GAPs | 6.756053e-01 | 0.170 |
R-HSA-109704 | PI3K Cascade | 6.756053e-01 | 0.170 |
R-HSA-5655253 | Signaling by FGFR2 in disease | 6.756053e-01 | 0.170 |
R-HSA-975138 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 6.760037e-01 | 0.170 |
R-HSA-975155 | MyD88 dependent cascade initiated on endosome | 6.803976e-01 | 0.167 |
R-HSA-1169091 | Activation of NF-kappaB in B cells | 6.818526e-01 | 0.166 |
R-HSA-1234176 | Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 6.818526e-01 | 0.166 |
R-HSA-5358346 | Hedgehog ligand biogenesis | 6.818526e-01 | 0.166 |
R-HSA-2514856 | The phototransduction cascade | 6.818526e-01 | 0.166 |
R-HSA-166166 | MyD88-independent TLR4 cascade | 6.847428e-01 | 0.164 |
R-HSA-937061 | TRIF (TICAM1)-mediated TLR4 signaling | 6.847428e-01 | 0.164 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 6.864030e-01 | 0.163 |
R-HSA-8951664 | Neddylation | 6.874834e-01 | 0.163 |
R-HSA-9931269 | AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | 6.879798e-01 | 0.162 |
R-HSA-8866654 | E3 ubiquitin ligases ubiquitinate target proteins | 6.879798e-01 | 0.162 |
R-HSA-6794361 | Neurexins and neuroligins | 6.879798e-01 | 0.162 |
R-HSA-9692916 | SARS-CoV-1 activates/modulates innate immune responses | 6.879798e-01 | 0.162 |
R-HSA-1221632 | Meiotic synapsis | 6.939895e-01 | 0.159 |
R-HSA-8948751 | Regulation of PTEN stability and activity | 6.939895e-01 | 0.159 |
R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | 6.974890e-01 | 0.156 |
R-HSA-72649 | Translation initiation complex formation | 6.998837e-01 | 0.155 |
R-HSA-3214815 | HDACs deacetylate histones | 7.056648e-01 | 0.151 |
R-HSA-9012852 | Signaling by NOTCH3 | 7.056648e-01 | 0.151 |
R-HSA-162906 | HIV Infection | 7.056984e-01 | 0.151 |
R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | 7.098067e-01 | 0.149 |
R-HSA-72702 | Ribosomal scanning and start codon recognition | 7.113349e-01 | 0.148 |
R-HSA-6782210 | Gap-filling DNA repair synthesis and ligation in TC-NER | 7.113349e-01 | 0.148 |
R-HSA-5654736 | Signaling by FGFR1 | 7.113349e-01 | 0.148 |
R-HSA-9662361 | Sensory processing of sound by outer hair cells of the cochlea | 7.113349e-01 | 0.148 |
R-HSA-109606 | Intrinsic Pathway for Apoptosis | 7.113349e-01 | 0.148 |
R-HSA-3299685 | Detoxification of Reactive Oxygen Species | 7.113349e-01 | 0.148 |
R-HSA-177929 | Signaling by EGFR | 7.113349e-01 | 0.148 |
R-HSA-2173793 | Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 7.113349e-01 | 0.148 |
R-HSA-2871809 | FCERI mediated Ca+2 mobilization | 7.138186e-01 | 0.146 |
R-HSA-4420097 | VEGFA-VEGFR2 Pathway | 7.138186e-01 | 0.146 |
R-HSA-196849 | Metabolism of water-soluble vitamins and cofactors | 7.145140e-01 | 0.146 |
R-HSA-112399 | IRS-mediated signalling | 7.168961e-01 | 0.145 |
R-HSA-2980766 | Nuclear Envelope Breakdown | 7.168961e-01 | 0.145 |
R-HSA-9764561 | Regulation of CDH1 Function | 7.168961e-01 | 0.145 |
R-HSA-2980736 | Peptide hormone metabolism | 7.217033e-01 | 0.142 |
R-HSA-72662 | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and sub... | 7.223505e-01 | 0.141 |
R-HSA-6782135 | Dual incision in TC-NER | 7.223505e-01 | 0.141 |
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | 7.223505e-01 | 0.141 |
R-HSA-2029480 | Fcgamma receptor (FCGR) dependent phagocytosis | 7.229207e-01 | 0.141 |
R-HSA-3247509 | Chromatin modifying enzymes | 7.259660e-01 | 0.139 |
R-HSA-191859 | snRNP Assembly | 7.277001e-01 | 0.138 |
R-HSA-194441 | Metabolism of non-coding RNA | 7.277001e-01 | 0.138 |
R-HSA-180786 | Extension of Telomeres | 7.277001e-01 | 0.138 |
R-HSA-429914 | Deadenylation-dependent mRNA decay | 7.277001e-01 | 0.138 |
R-HSA-186712 | Regulation of beta-cell development | 7.277001e-01 | 0.138 |
R-HSA-166058 | MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 7.294045e-01 | 0.137 |
R-HSA-168188 | Toll Like Receptor TLR6:TLR2 Cascade | 7.294045e-01 | 0.137 |
R-HSA-9845323 | Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | 7.329470e-01 | 0.135 |
R-HSA-2644606 | Constitutive Signaling by NOTCH1 PEST Domain Mutants | 7.329470e-01 | 0.135 |
R-HSA-2894858 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 7.329470e-01 | 0.135 |
R-HSA-2894862 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 7.329470e-01 | 0.135 |
R-HSA-2644602 | Signaling by NOTCH1 PEST Domain Mutants in Cancer | 7.329470e-01 | 0.135 |
R-HSA-2644603 | Signaling by NOTCH1 in Cancer | 7.329470e-01 | 0.135 |
R-HSA-379724 | tRNA Aminoacylation | 7.329470e-01 | 0.135 |
R-HSA-351202 | Metabolism of polyamines | 7.329470e-01 | 0.135 |
R-HSA-9759194 | Nuclear events mediated by NFE2L2 | 7.369248e-01 | 0.133 |
R-HSA-168325 | Viral Messenger RNA Synthesis | 7.380931e-01 | 0.132 |
R-HSA-2428928 | IRS-related events triggered by IGF1R | 7.380931e-01 | 0.132 |
R-HSA-450294 | MAP kinase activation | 7.380931e-01 | 0.132 |
R-HSA-211976 | Endogenous sterols | 7.380931e-01 | 0.132 |
R-HSA-168179 | Toll Like Receptor TLR1:TLR2 Cascade | 7.406178e-01 | 0.130 |
R-HSA-181438 | Toll Like Receptor 2 (TLR2) Cascade | 7.406178e-01 | 0.130 |
R-HSA-157118 | Signaling by NOTCH | 7.425000e-01 | 0.129 |
R-HSA-6784531 | tRNA processing in the nucleus | 7.431403e-01 | 0.129 |
R-HSA-186797 | Signaling by PDGF | 7.431403e-01 | 0.129 |
R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | 7.431403e-01 | 0.129 |
R-HSA-6790901 | rRNA modification in the nucleus and cytosol | 7.480906e-01 | 0.126 |
R-HSA-69615 | G1/S DNA Damage Checkpoints | 7.480906e-01 | 0.126 |
R-HSA-2428924 | IGF1R signaling cascade | 7.529458e-01 | 0.123 |
R-HSA-74751 | Insulin receptor signalling cascade | 7.529458e-01 | 0.123 |
R-HSA-211981 | Xenobiotics | 7.529458e-01 | 0.123 |
R-HSA-9841922 | MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesi... | 7.549505e-01 | 0.122 |
R-HSA-9851695 | Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | 7.549505e-01 | 0.122 |
R-HSA-9818564 | Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | 7.549505e-01 | 0.122 |
R-HSA-194138 | Signaling by VEGF | 7.549505e-01 | 0.122 |
R-HSA-2404192 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 7.577077e-01 | 0.120 |
R-HSA-9909649 | Regulation of PD-L1(CD274) transcription | 7.623781e-01 | 0.118 |
R-HSA-6782315 | tRNA modification in the nucleus and cytosol | 7.623781e-01 | 0.118 |
R-HSA-392499 | Metabolism of proteins | 7.629618e-01 | 0.117 |
R-HSA-4839726 | Chromatin organization | 7.658691e-01 | 0.116 |
R-HSA-196807 | Nicotinate metabolism | 7.669588e-01 | 0.115 |
R-HSA-196071 | Metabolism of steroid hormones | 7.669588e-01 | 0.115 |
R-HSA-8936459 | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet fun... | 7.714514e-01 | 0.113 |
R-HSA-5218859 | Regulated Necrosis | 7.714514e-01 | 0.113 |
R-HSA-168898 | Toll-like Receptor Cascades | 7.737256e-01 | 0.111 |
R-HSA-1474165 | Reproduction | 7.751689e-01 | 0.111 |
R-HSA-9843940 | Regulation of endogenous retroelements by KRAB-ZFP proteins | 7.801793e-01 | 0.108 |
R-HSA-1168372 | Downstream signaling events of B Cell Receptor (BCR) | 7.801793e-01 | 0.108 |
R-HSA-448424 | Interleukin-17 signaling | 7.801793e-01 | 0.108 |
R-HSA-195253 | Degradation of beta-catenin by the destruction complex | 7.801793e-01 | 0.108 |
R-HSA-5688426 | Deubiquitination | 7.805115e-01 | 0.108 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 7.828803e-01 | 0.106 |
R-HSA-3906995 | Diseases associated with O-glycosylation of proteins | 7.844179e-01 | 0.105 |
R-HSA-5632684 | Hedgehog 'on' state | 7.844179e-01 | 0.105 |
R-HSA-3000178 | ECM proteoglycans | 7.844179e-01 | 0.105 |
R-HSA-9679506 | SARS-CoV Infections | 7.868071e-01 | 0.104 |
R-HSA-5578749 | Transcriptional regulation by small RNAs | 7.885750e-01 | 0.103 |
R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript | 7.926521e-01 | 0.101 |
R-HSA-1226099 | Signaling by FGFR in disease | 7.966509e-01 | 0.099 |
R-HSA-425397 | Transport of vitamins, nucleosides, and related molecules | 7.966509e-01 | 0.099 |
R-HSA-1222556 | ROS and RNS production in phagocytes | 7.966509e-01 | 0.099 |
R-HSA-389948 | Co-inhibition by PD-1 | 7.973916e-01 | 0.098 |
R-HSA-6781827 | Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 8.005729e-01 | 0.097 |
R-HSA-1169408 | ISG15 antiviral mechanism | 8.005729e-01 | 0.097 |
R-HSA-1980143 | Signaling by NOTCH1 | 8.044194e-01 | 0.095 |
R-HSA-5689603 | UCH proteinases | 8.044194e-01 | 0.095 |
R-HSA-73854 | RNA Polymerase I Promoter Clearance | 8.044194e-01 | 0.095 |
R-HSA-9664407 | Parasite infection | 8.084760e-01 | 0.092 |
R-HSA-9664417 | Leishmania phagocytosis | 8.084760e-01 | 0.092 |
R-HSA-9664422 | FCGR3A-mediated phagocytosis | 8.084760e-01 | 0.092 |
R-HSA-2029482 | Regulation of actin dynamics for phagocytic cup formation | 8.112756e-01 | 0.091 |
R-HSA-73864 | RNA Polymerase I Transcription | 8.118919e-01 | 0.091 |
R-HSA-5619084 | ABC transporter disorders | 8.118919e-01 | 0.091 |
R-HSA-4086400 | PCP/CE pathway | 8.118919e-01 | 0.091 |
R-HSA-216083 | Integrin cell surface interactions | 8.118919e-01 | 0.091 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 8.167658e-01 | 0.088 |
R-HSA-5654738 | Signaling by FGFR2 | 8.190799e-01 | 0.087 |
R-HSA-9856530 | High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR... | 8.190799e-01 | 0.087 |
R-HSA-2871837 | FCERI mediated NF-kB activation | 8.221131e-01 | 0.085 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 8.259940e-01 | 0.083 |
R-HSA-5668541 | TNFR2 non-canonical NF-kB pathway | 8.293517e-01 | 0.081 |
R-HSA-9707564 | Cytoprotection by HMOX1 | 8.293517e-01 | 0.081 |
R-HSA-5696399 | Global Genome Nucleotide Excision Repair (GG-NER) | 8.326447e-01 | 0.080 |
R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | 8.326447e-01 | 0.080 |
R-HSA-9758941 | Gastrulation | 8.348746e-01 | 0.078 |
R-HSA-9658195 | Leishmania infection | 8.357411e-01 | 0.078 |
R-HSA-9824443 | Parasitic Infection Pathways | 8.357411e-01 | 0.078 |
R-HSA-6794362 | Protein-protein interactions at synapses | 8.358745e-01 | 0.078 |
R-HSA-9856651 | MITF-M-dependent gene expression | 8.373258e-01 | 0.077 |
R-HSA-9909615 | Regulation of PD-L1(CD274) Post-translational modification | 8.390420e-01 | 0.076 |
R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | 8.421487e-01 | 0.075 |
R-HSA-9917777 | Epigenetic regulation by WDR5-containing histone modifying complexes | 8.468054e-01 | 0.072 |
R-HSA-73887 | Death Receptor Signaling | 8.468054e-01 | 0.072 |
R-HSA-162587 | HIV Life Cycle | 8.535835e-01 | 0.069 |
R-HSA-73884 | Base Excision Repair | 8.539889e-01 | 0.069 |
R-HSA-9711097 | Cellular response to starvation | 8.557815e-01 | 0.068 |
R-HSA-975956 | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 8.595727e-01 | 0.066 |
R-HSA-5633007 | Regulation of TP53 Activity | 8.600877e-01 | 0.065 |
R-HSA-1483257 | Phospholipid metabolism | 8.603568e-01 | 0.065 |
R-HSA-74752 | Signaling by Insulin receptor | 8.622842e-01 | 0.064 |
R-HSA-2682334 | EPH-Ephrin signaling | 8.622842e-01 | 0.064 |
R-HSA-174824 | Plasma lipoprotein assembly, remodeling, and clearance | 8.622842e-01 | 0.064 |
R-HSA-168928 | DDX58/IFIH1-mediated induction of interferon-alpha/beta | 8.701097e-01 | 0.060 |
R-HSA-9954709 | Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | 8.726184e-01 | 0.059 |
R-HSA-5389840 | Mitochondrial translation elongation | 8.750788e-01 | 0.058 |
R-HSA-5607764 | CLEC7A (Dectin-1) signaling | 8.750788e-01 | 0.058 |
R-HSA-157579 | Telomere Maintenance | 8.774919e-01 | 0.057 |
R-HSA-8957275 | Post-translational protein phosphorylation | 8.798585e-01 | 0.056 |
R-HSA-5368286 | Mitochondrial translation initiation | 8.798585e-01 | 0.056 |
R-HSA-190236 | Signaling by FGFR | 8.798585e-01 | 0.056 |
R-HSA-975871 | MyD88 cascade initiated on plasma membrane | 8.798585e-01 | 0.056 |
R-HSA-168142 | Toll Like Receptor 10 (TLR10) Cascade | 8.798585e-01 | 0.056 |
R-HSA-168176 | Toll Like Receptor 5 (TLR5) Cascade | 8.798585e-01 | 0.056 |
R-HSA-72306 | tRNA processing | 8.817402e-01 | 0.055 |
R-HSA-5621481 | C-type lectin receptors (CLRs) | 8.835473e-01 | 0.054 |
R-HSA-70171 | Glycolysis | 8.844558e-01 | 0.053 |
R-HSA-9909648 | Regulation of PD-L1(CD274) expression | 8.853289e-01 | 0.053 |
R-HSA-9020702 | Interleukin-1 signaling | 8.866882e-01 | 0.052 |
R-HSA-9842860 | Regulation of endogenous retroelements | 8.888777e-01 | 0.051 |
R-HSA-9937383 | Mitochondrial ribosome-associated quality control | 8.910250e-01 | 0.050 |
R-HSA-111885 | Opioid Signalling | 8.931309e-01 | 0.049 |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogen... | 8.951963e-01 | 0.048 |
R-HSA-5619507 | Activation of HOX genes during differentiation | 8.951963e-01 | 0.048 |
R-HSA-168255 | Influenza Infection | 8.971113e-01 | 0.047 |
R-HSA-5696398 | Nucleotide Excision Repair | 8.972218e-01 | 0.047 |
R-HSA-212165 | Epigenetic regulation of gene expression | 9.002702e-01 | 0.046 |
R-HSA-211000 | Gene Silencing by RNA | 9.011566e-01 | 0.045 |
R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit | 9.030674e-01 | 0.044 |
R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression | 9.030674e-01 | 0.044 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 9.033292e-01 | 0.044 |
R-HSA-5419276 | Mitochondrial translation termination | 9.049413e-01 | 0.043 |
R-HSA-8953854 | Metabolism of RNA | 9.056355e-01 | 0.043 |
R-HSA-6803157 | Antimicrobial peptides | 9.085814e-01 | 0.042 |
R-HSA-927802 | Nonsense-Mediated Decay (NMD) | 9.103491e-01 | 0.041 |
R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 9.103491e-01 | 0.041 |
R-HSA-1483249 | Inositol phosphate metabolism | 9.103491e-01 | 0.041 |
R-HSA-2871796 | FCERI mediated MAPK activation | 9.103491e-01 | 0.041 |
R-HSA-416476 | G alpha (q) signalling events | 9.136929e-01 | 0.039 |
R-HSA-381426 | Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-l... | 9.154502e-01 | 0.038 |
R-HSA-5628897 | TP53 Regulates Metabolic Genes | 9.170854e-01 | 0.038 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 9.186692e-01 | 0.037 |
R-HSA-2029485 | Role of phospholipids in phagocytosis | 9.186891e-01 | 0.037 |
R-HSA-72737 | Cap-dependent Translation Initiation | 9.202619e-01 | 0.036 |
R-HSA-72613 | Eukaryotic Translation Initiation | 9.202619e-01 | 0.036 |
R-HSA-70326 | Glucose metabolism | 9.218043e-01 | 0.035 |
R-HSA-382551 | Transport of small molecules | 9.229469e-01 | 0.035 |
R-HSA-73886 | Chromosome Maintenance | 9.276824e-01 | 0.033 |
R-HSA-9694516 | SARS-CoV-2 Infection | 9.279796e-01 | 0.032 |
R-HSA-376176 | Signaling by ROBO receptors | 9.294902e-01 | 0.032 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 9.299457e-01 | 0.032 |
R-HSA-9717207 | Sensory perception of sweet, bitter, and umami (glutamate) taste | 9.304541e-01 | 0.031 |
R-HSA-72172 | mRNA Splicing | 9.317032e-01 | 0.031 |
R-HSA-6809371 | Formation of the cornified envelope | 9.318000e-01 | 0.031 |
R-HSA-196854 | Metabolism of vitamins and cofactors | 9.406179e-01 | 0.027 |
R-HSA-9717189 | Sensory perception of taste | 9.428025e-01 | 0.026 |
R-HSA-195721 | Signaling by WNT | 9.464988e-01 | 0.024 |
R-HSA-3858494 | Beta-catenin independent WNT signaling | 9.491355e-01 | 0.023 |
R-HSA-5173105 | O-linked glycosylation | 9.501208e-01 | 0.022 |
R-HSA-5368287 | Mitochondrial translation | 9.510871e-01 | 0.022 |
R-HSA-9948299 | Ribosome-associated quality control | 9.510871e-01 | 0.022 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 9.536186e-01 | 0.021 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 9.556458e-01 | 0.020 |
R-HSA-72312 | rRNA processing | 9.565469e-01 | 0.019 |
R-HSA-2187338 | Visual phototransduction | 9.597808e-01 | 0.018 |
R-HSA-202733 | Cell surface interactions at the vascular wall | 9.599595e-01 | 0.018 |
R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | 9.635315e-01 | 0.016 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 9.656123e-01 | 0.015 |
R-HSA-5619115 | Disorders of transmembrane transporters | 9.660314e-01 | 0.015 |
R-HSA-9610379 | HCMV Late Events | 9.669334e-01 | 0.015 |
R-HSA-2408522 | Selenoamino acid metabolism | 9.711711e-01 | 0.013 |
R-HSA-211897 | Cytochrome P450 - arranged by substrate type | 9.728173e-01 | 0.012 |
R-HSA-5619102 | SLC transporter disorders | 9.728173e-01 | 0.012 |
R-HSA-418555 | G alpha (s) signalling events | 9.753553e-01 | 0.011 |
R-HSA-72766 | Translation | 9.755722e-01 | 0.011 |
R-HSA-556833 | Metabolism of lipids | 9.758004e-01 | 0.011 |
R-HSA-5689880 | Ub-specific processing proteases | 9.763030e-01 | 0.010 |
R-HSA-3781865 | Diseases of glycosylation | 9.809022e-01 | 0.008 |
R-HSA-8868773 | rRNA processing in the nucleus and cytosol | 9.823441e-01 | 0.008 |
R-HSA-9640148 | Infection with Enterobacteria | 9.868487e-01 | 0.006 |
R-HSA-1483206 | Glycerophospholipid biosynthesis | 9.868487e-01 | 0.006 |
R-HSA-388396 | GPCR downstream signalling | 9.874492e-01 | 0.005 |
R-HSA-6805567 | Keratinization | 9.878427e-01 | 0.005 |
R-HSA-425407 | SLC-mediated transmembrane transport | 9.880481e-01 | 0.005 |
R-HSA-198933 | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 9.922660e-01 | 0.003 |
R-HSA-1428517 | Aerobic respiration and respiratory electron transport | 9.930946e-01 | 0.003 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 9.952280e-01 | 0.002 |
R-HSA-372790 | Signaling by GPCR | 9.954801e-01 | 0.002 |
R-HSA-211945 | Phase I - Functionalization of compounds | 9.970558e-01 | 0.001 |
R-HSA-418594 | G alpha (i) signalling events | 9.978698e-01 | 0.001 |
R-HSA-8978868 | Fatty acid metabolism | 9.978698e-01 | 0.001 |
R-HSA-5668914 | Diseases of metabolism | 9.985082e-01 | 0.001 |
R-HSA-9824439 | Bacterial Infection Pathways | 9.996862e-01 | 0.000 |
R-HSA-373076 | Class A/1 (Rhodopsin-like receptors) | 9.997102e-01 | 0.000 |
R-HSA-71291 | Metabolism of amino acids and derivatives | 9.999547e-01 | 0.000 |
R-HSA-211859 | Biological oxidations | 9.999780e-01 | 0.000 |
R-HSA-500792 | GPCR ligand binding | 9.999941e-01 | 0.000 |
R-HSA-9709957 | Sensory Perception | 1.000000e+00 | 0.000 |
R-HSA-1430728 | Metabolism | 1.000000e+00 | 0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
CLK3 |
0.898 | 0.338 | 1 | 0.852 |
COT |
0.896 | 0.161 | 2 | 0.890 |
PIM3 |
0.891 | 0.232 | -3 | 0.884 |
RSK2 |
0.889 | 0.287 | -3 | 0.848 |
CDC7 |
0.888 | 0.123 | 1 | 0.856 |
NDR2 |
0.888 | 0.194 | -3 | 0.879 |
CAMK1B |
0.887 | 0.212 | -3 | 0.902 |
MOS |
0.886 | 0.134 | 1 | 0.868 |
NLK |
0.884 | 0.148 | 1 | 0.850 |
P90RSK |
0.883 | 0.242 | -3 | 0.846 |
PRKD1 |
0.883 | 0.215 | -3 | 0.868 |
PKN3 |
0.883 | 0.178 | -3 | 0.871 |
RAF1 |
0.883 | 0.058 | 1 | 0.856 |
MTOR |
0.883 | 0.043 | 1 | 0.824 |
PRPK |
0.883 | -0.084 | -1 | 0.876 |
PIM1 |
0.882 | 0.257 | -3 | 0.846 |
CDKL1 |
0.882 | 0.183 | -3 | 0.863 |
MARK4 |
0.880 | 0.227 | 4 | 0.894 |
SKMLCK |
0.880 | 0.217 | -2 | 0.894 |
NUAK2 |
0.880 | 0.186 | -3 | 0.890 |
PRKD2 |
0.880 | 0.241 | -3 | 0.841 |
RSK3 |
0.880 | 0.233 | -3 | 0.843 |
TBK1 |
0.880 | 0.029 | 1 | 0.784 |
DSTYK |
0.879 | 0.022 | 2 | 0.903 |
NDR1 |
0.879 | 0.166 | -3 | 0.879 |
MAPKAPK2 |
0.879 | 0.245 | -3 | 0.804 |
AMPKA1 |
0.879 | 0.224 | -3 | 0.890 |
IKKB |
0.879 | -0.029 | -2 | 0.755 |
CAMLCK |
0.878 | 0.192 | -2 | 0.897 |
P70S6KB |
0.878 | 0.206 | -3 | 0.858 |
NIK |
0.877 | 0.127 | -3 | 0.900 |
DAPK2 |
0.877 | 0.191 | -3 | 0.900 |
SRPK1 |
0.877 | 0.219 | -3 | 0.824 |
ICK |
0.876 | 0.189 | -3 | 0.885 |
RSK4 |
0.876 | 0.281 | -3 | 0.820 |
PKACG |
0.876 | 0.216 | -2 | 0.823 |
BMPR2 |
0.876 | -0.126 | -2 | 0.892 |
ATR |
0.876 | -0.002 | 1 | 0.797 |
GRK1 |
0.876 | 0.135 | -2 | 0.808 |
LATS1 |
0.876 | 0.244 | -3 | 0.890 |
CAMK2G |
0.875 | -0.042 | 2 | 0.827 |
PKCD |
0.875 | 0.185 | 2 | 0.799 |
MST4 |
0.875 | 0.115 | 2 | 0.859 |
MAPKAPK3 |
0.875 | 0.167 | -3 | 0.834 |
IKKE |
0.875 | -0.008 | 1 | 0.786 |
TSSK1 |
0.875 | 0.224 | -3 | 0.908 |
LATS2 |
0.875 | 0.114 | -5 | 0.752 |
CAMK2B |
0.875 | 0.192 | 2 | 0.801 |
AURC |
0.874 | 0.237 | -2 | 0.758 |
ERK5 |
0.874 | 0.036 | 1 | 0.788 |
PDHK4 |
0.874 | -0.220 | 1 | 0.860 |
CAMK2D |
0.874 | 0.112 | -3 | 0.874 |
AMPKA2 |
0.874 | 0.214 | -3 | 0.870 |
HIPK4 |
0.873 | 0.169 | 1 | 0.762 |
GCN2 |
0.873 | -0.152 | 2 | 0.824 |
CLK2 |
0.873 | 0.332 | -3 | 0.827 |
QSK |
0.873 | 0.264 | 4 | 0.879 |
PKN2 |
0.873 | 0.131 | -3 | 0.871 |
CDKL5 |
0.873 | 0.136 | -3 | 0.856 |
PKACB |
0.872 | 0.283 | -2 | 0.770 |
WNK1 |
0.872 | 0.066 | -2 | 0.889 |
TGFBR2 |
0.872 | -0.000 | -2 | 0.813 |
TSSK2 |
0.872 | 0.153 | -5 | 0.849 |
GRK6 |
0.871 | 0.058 | 1 | 0.870 |
SRPK2 |
0.871 | 0.220 | -3 | 0.761 |
ULK2 |
0.871 | -0.155 | 2 | 0.813 |
IKKA |
0.871 | 0.035 | -2 | 0.734 |
MSK1 |
0.870 | 0.242 | -3 | 0.815 |
MSK2 |
0.870 | 0.189 | -3 | 0.810 |
CLK4 |
0.870 | 0.263 | -3 | 0.837 |
PDHK1 |
0.870 | -0.160 | 1 | 0.854 |
HUNK |
0.870 | -0.032 | 2 | 0.841 |
SIK |
0.870 | 0.245 | -3 | 0.823 |
CLK1 |
0.868 | 0.263 | -3 | 0.821 |
NEK6 |
0.868 | -0.047 | -2 | 0.868 |
CAMK2A |
0.868 | 0.163 | 2 | 0.807 |
PRKX |
0.868 | 0.302 | -3 | 0.762 |
KIS |
0.868 | 0.138 | 1 | 0.728 |
GRK7 |
0.868 | 0.171 | 1 | 0.824 |
NIM1 |
0.867 | 0.094 | 3 | 0.795 |
BMPR1B |
0.867 | 0.141 | 1 | 0.812 |
GRK5 |
0.867 | -0.129 | -3 | 0.838 |
DYRK2 |
0.867 | 0.185 | 1 | 0.715 |
SGK3 |
0.867 | 0.246 | -3 | 0.825 |
CAMK4 |
0.867 | 0.096 | -3 | 0.861 |
NEK7 |
0.866 | -0.138 | -3 | 0.829 |
AURB |
0.866 | 0.208 | -2 | 0.754 |
TGFBR1 |
0.866 | 0.073 | -2 | 0.796 |
SRPK3 |
0.866 | 0.174 | -3 | 0.796 |
PRKD3 |
0.866 | 0.181 | -3 | 0.818 |
AKT2 |
0.866 | 0.247 | -3 | 0.776 |
NUAK1 |
0.866 | 0.146 | -3 | 0.852 |
MARK3 |
0.865 | 0.232 | 4 | 0.854 |
RIPK3 |
0.865 | -0.080 | 3 | 0.739 |
AURA |
0.865 | 0.201 | -2 | 0.730 |
ALK4 |
0.865 | 0.022 | -2 | 0.824 |
BCKDK |
0.864 | -0.074 | -1 | 0.824 |
MARK2 |
0.864 | 0.220 | 4 | 0.815 |
MASTL |
0.864 | -0.203 | -2 | 0.825 |
JNK2 |
0.863 | 0.168 | 1 | 0.678 |
PAK1 |
0.863 | 0.126 | -2 | 0.831 |
MELK |
0.863 | 0.123 | -3 | 0.857 |
PKG2 |
0.863 | 0.214 | -2 | 0.770 |
QIK |
0.862 | 0.108 | -3 | 0.865 |
WNK3 |
0.862 | -0.139 | 1 | 0.800 |
DLK |
0.862 | -0.132 | 1 | 0.833 |
CDK8 |
0.862 | 0.077 | 1 | 0.720 |
MYLK4 |
0.862 | 0.181 | -2 | 0.840 |
MNK2 |
0.862 | 0.139 | -2 | 0.854 |
MLK1 |
0.862 | -0.156 | 2 | 0.831 |
CHAK2 |
0.862 | -0.094 | -1 | 0.847 |
BRSK1 |
0.861 | 0.156 | -3 | 0.849 |
JNK3 |
0.861 | 0.140 | 1 | 0.713 |
PIM2 |
0.861 | 0.208 | -3 | 0.821 |
ATM |
0.861 | -0.014 | 1 | 0.745 |
CHK1 |
0.861 | 0.107 | -3 | 0.873 |
FAM20C |
0.860 | 0.144 | 2 | 0.670 |
HIPK1 |
0.860 | 0.220 | 1 | 0.727 |
MNK1 |
0.860 | 0.149 | -2 | 0.863 |
ULK1 |
0.860 | -0.199 | -3 | 0.797 |
PLK1 |
0.860 | -0.014 | -2 | 0.833 |
PAK3 |
0.859 | 0.081 | -2 | 0.830 |
ANKRD3 |
0.859 | -0.136 | 1 | 0.836 |
MARK1 |
0.859 | 0.190 | 4 | 0.864 |
CDK5 |
0.859 | 0.130 | 1 | 0.733 |
CDK1 |
0.859 | 0.126 | 1 | 0.689 |
PKACA |
0.859 | 0.260 | -2 | 0.728 |
ALK2 |
0.859 | 0.066 | -2 | 0.814 |
CDK7 |
0.859 | 0.081 | 1 | 0.720 |
NEK9 |
0.859 | -0.169 | 2 | 0.857 |
PAK6 |
0.858 | 0.175 | -2 | 0.777 |
PKCA |
0.858 | 0.103 | 2 | 0.743 |
HIPK2 |
0.858 | 0.210 | 1 | 0.632 |
ACVR2A |
0.858 | 0.041 | -2 | 0.795 |
PKCB |
0.857 | 0.081 | 2 | 0.749 |
PKCG |
0.857 | 0.075 | 2 | 0.748 |
AKT1 |
0.857 | 0.250 | -3 | 0.788 |
CDK18 |
0.857 | 0.136 | 1 | 0.656 |
ACVR2B |
0.857 | 0.049 | -2 | 0.801 |
GRK4 |
0.857 | -0.125 | -2 | 0.833 |
CDK19 |
0.857 | 0.083 | 1 | 0.684 |
DCAMKL1 |
0.857 | 0.153 | -3 | 0.849 |
MEK1 |
0.856 | -0.130 | 2 | 0.855 |
PKR |
0.856 | -0.037 | 1 | 0.789 |
BRSK2 |
0.856 | 0.091 | -3 | 0.858 |
DNAPK |
0.856 | 0.043 | 1 | 0.720 |
DYRK1A |
0.855 | 0.182 | 1 | 0.760 |
PAK2 |
0.855 | 0.084 | -2 | 0.819 |
YSK4 |
0.855 | -0.082 | 1 | 0.790 |
MLK2 |
0.855 | -0.182 | 2 | 0.835 |
P38A |
0.855 | 0.101 | 1 | 0.729 |
P38B |
0.854 | 0.121 | 1 | 0.682 |
PHKG1 |
0.854 | 0.039 | -3 | 0.869 |
CDK13 |
0.854 | 0.072 | 1 | 0.697 |
PLK3 |
0.854 | 0.001 | 2 | 0.796 |
PKCH |
0.854 | 0.060 | 2 | 0.742 |
CAMK1G |
0.853 | 0.119 | -3 | 0.827 |
RIPK1 |
0.853 | -0.203 | 1 | 0.760 |
CDK14 |
0.853 | 0.163 | 1 | 0.702 |
P38G |
0.853 | 0.126 | 1 | 0.612 |
VRK2 |
0.853 | -0.206 | 1 | 0.847 |
CDK17 |
0.853 | 0.116 | 1 | 0.621 |
DYRK4 |
0.853 | 0.188 | 1 | 0.662 |
SMMLCK |
0.852 | 0.154 | -3 | 0.867 |
CDK2 |
0.852 | 0.063 | 1 | 0.778 |
P70S6K |
0.852 | 0.156 | -3 | 0.784 |
NEK2 |
0.851 | -0.074 | 2 | 0.833 |
BRAF |
0.851 | -0.023 | -4 | 0.829 |
CAMK1D |
0.851 | 0.194 | -3 | 0.767 |
DYRK1B |
0.851 | 0.176 | 1 | 0.692 |
TTBK2 |
0.851 | -0.206 | 2 | 0.724 |
BMPR1A |
0.851 | 0.104 | 1 | 0.806 |
PASK |
0.851 | 0.116 | -3 | 0.889 |
PKCZ |
0.850 | 0.007 | 2 | 0.799 |
IRE2 |
0.850 | -0.070 | 2 | 0.777 |
DYRK3 |
0.850 | 0.216 | 1 | 0.720 |
HIPK3 |
0.850 | 0.161 | 1 | 0.727 |
MLK3 |
0.849 | -0.104 | 2 | 0.753 |
ERK1 |
0.849 | 0.088 | 1 | 0.668 |
DAPK3 |
0.849 | 0.215 | -3 | 0.858 |
CDK12 |
0.849 | 0.082 | 1 | 0.675 |
IRE1 |
0.849 | -0.153 | 1 | 0.716 |
PRP4 |
0.848 | 0.069 | -3 | 0.763 |
CDK3 |
0.848 | 0.133 | 1 | 0.636 |
SGK1 |
0.848 | 0.255 | -3 | 0.704 |
SSTK |
0.848 | 0.134 | 4 | 0.851 |
DRAK1 |
0.848 | -0.045 | 1 | 0.772 |
PLK4 |
0.847 | -0.049 | 2 | 0.665 |
ERK2 |
0.847 | 0.060 | 1 | 0.702 |
CDK9 |
0.847 | 0.056 | 1 | 0.703 |
DCAMKL2 |
0.847 | 0.068 | -3 | 0.868 |
MAPKAPK5 |
0.847 | 0.013 | -3 | 0.785 |
CDK10 |
0.846 | 0.162 | 1 | 0.682 |
CDK16 |
0.846 | 0.138 | 1 | 0.636 |
TAO3 |
0.846 | 0.025 | 1 | 0.800 |
MST3 |
0.846 | 0.036 | 2 | 0.849 |
AKT3 |
0.845 | 0.245 | -3 | 0.720 |
MEKK1 |
0.845 | -0.124 | 1 | 0.801 |
SNRK |
0.845 | -0.092 | 2 | 0.718 |
SMG1 |
0.844 | -0.110 | 1 | 0.739 |
MLK4 |
0.844 | -0.127 | 2 | 0.739 |
MRCKA |
0.844 | 0.235 | -3 | 0.819 |
TLK2 |
0.844 | -0.125 | 1 | 0.774 |
GRK2 |
0.844 | -0.079 | -2 | 0.715 |
CHAK1 |
0.844 | -0.176 | 2 | 0.797 |
PKCT |
0.844 | 0.084 | 2 | 0.749 |
P38D |
0.844 | 0.131 | 1 | 0.614 |
ZAK |
0.843 | -0.132 | 1 | 0.788 |
WNK4 |
0.843 | -0.064 | -2 | 0.868 |
DAPK1 |
0.843 | 0.190 | -3 | 0.843 |
MEK5 |
0.842 | -0.246 | 2 | 0.844 |
PHKG2 |
0.842 | 0.068 | -3 | 0.851 |
GAK |
0.842 | 0.065 | 1 | 0.821 |
MEKK3 |
0.842 | -0.170 | 1 | 0.795 |
MEKK2 |
0.841 | -0.108 | 2 | 0.823 |
NEK5 |
0.841 | -0.117 | 1 | 0.787 |
PERK |
0.841 | -0.187 | -2 | 0.848 |
MRCKB |
0.841 | 0.223 | -3 | 0.807 |
CAMK1A |
0.840 | 0.197 | -3 | 0.741 |
MAK |
0.840 | 0.215 | -2 | 0.728 |
ROCK2 |
0.839 | 0.231 | -3 | 0.842 |
SBK |
0.839 | 0.210 | -3 | 0.675 |
PAK5 |
0.839 | 0.127 | -2 | 0.713 |
GCK |
0.839 | 0.075 | 1 | 0.818 |
PINK1 |
0.839 | -0.176 | 1 | 0.788 |
HRI |
0.838 | -0.232 | -2 | 0.854 |
PDK1 |
0.838 | 0.012 | 1 | 0.798 |
CHK2 |
0.838 | 0.161 | -3 | 0.727 |
MPSK1 |
0.838 | 0.014 | 1 | 0.727 |
JNK1 |
0.838 | 0.096 | 1 | 0.682 |
TAO2 |
0.837 | -0.051 | 2 | 0.863 |
PKCI |
0.837 | 0.047 | 2 | 0.762 |
PKCE |
0.836 | 0.115 | 2 | 0.737 |
GSK3A |
0.836 | 0.040 | 4 | 0.449 |
NEK8 |
0.836 | -0.124 | 2 | 0.840 |
IRAK4 |
0.836 | -0.136 | 1 | 0.728 |
PKN1 |
0.835 | 0.123 | -3 | 0.799 |
PAK4 |
0.835 | 0.130 | -2 | 0.727 |
GSK3B |
0.835 | -0.013 | 4 | 0.438 |
DMPK1 |
0.835 | 0.260 | -3 | 0.829 |
LKB1 |
0.835 | -0.067 | -3 | 0.826 |
CAMKK1 |
0.835 | -0.166 | -2 | 0.795 |
NEK11 |
0.835 | -0.150 | 1 | 0.807 |
MST2 |
0.835 | -0.030 | 1 | 0.823 |
CK2A2 |
0.834 | 0.090 | 1 | 0.728 |
TNIK |
0.834 | 0.050 | 3 | 0.856 |
CAMKK2 |
0.834 | -0.117 | -2 | 0.792 |
TLK1 |
0.833 | -0.185 | -2 | 0.826 |
MINK |
0.832 | 0.010 | 1 | 0.794 |
MAP3K15 |
0.832 | -0.051 | 1 | 0.774 |
PLK2 |
0.832 | 0.052 | -3 | 0.823 |
HPK1 |
0.831 | 0.054 | 1 | 0.804 |
CK1E |
0.831 | -0.084 | -3 | 0.517 |
HGK |
0.831 | -0.016 | 3 | 0.850 |
CDK4 |
0.831 | 0.093 | 1 | 0.665 |
CDK6 |
0.830 | 0.085 | 1 | 0.677 |
EEF2K |
0.830 | -0.049 | 3 | 0.825 |
KHS1 |
0.830 | 0.100 | 1 | 0.796 |
MOK |
0.830 | 0.172 | 1 | 0.699 |
MEKK6 |
0.830 | -0.076 | 1 | 0.778 |
GRK3 |
0.830 | -0.074 | -2 | 0.669 |
TAK1 |
0.830 | -0.076 | 1 | 0.823 |
NEK4 |
0.829 | -0.101 | 1 | 0.766 |
KHS2 |
0.829 | 0.115 | 1 | 0.808 |
ERK7 |
0.829 | 0.029 | 2 | 0.561 |
LOK |
0.828 | -0.010 | -2 | 0.810 |
CRIK |
0.828 | 0.211 | -3 | 0.786 |
ROCK1 |
0.827 | 0.211 | -3 | 0.816 |
MST1 |
0.827 | -0.051 | 1 | 0.801 |
LRRK2 |
0.827 | -0.136 | 2 | 0.870 |
NEK1 |
0.826 | -0.081 | 1 | 0.762 |
PBK |
0.826 | 0.039 | 1 | 0.744 |
IRAK1 |
0.826 | -0.272 | -1 | 0.740 |
CK1D |
0.825 | -0.074 | -3 | 0.457 |
TTBK1 |
0.824 | -0.221 | 2 | 0.642 |
PKG1 |
0.824 | 0.165 | -2 | 0.691 |
BUB1 |
0.823 | 0.070 | -5 | 0.790 |
SLK |
0.822 | -0.056 | -2 | 0.742 |
CK2A1 |
0.822 | 0.054 | 1 | 0.706 |
CK1A2 |
0.822 | -0.082 | -3 | 0.463 |
VRK1 |
0.822 | -0.195 | 2 | 0.860 |
YSK1 |
0.821 | -0.058 | 2 | 0.825 |
MEK2 |
0.819 | -0.238 | 2 | 0.829 |
CK1G1 |
0.818 | -0.114 | -3 | 0.505 |
RIPK2 |
0.815 | -0.261 | 1 | 0.746 |
PDHK3_TYR |
0.815 | 0.174 | 4 | 0.889 |
TTK |
0.815 | -0.010 | -2 | 0.842 |
BIKE |
0.812 | 0.031 | 1 | 0.704 |
OSR1 |
0.811 | -0.101 | 2 | 0.813 |
STK33 |
0.810 | -0.234 | 2 | 0.636 |
NEK3 |
0.809 | -0.172 | 1 | 0.739 |
ALPHAK3 |
0.809 | -0.034 | -1 | 0.786 |
ASK1 |
0.808 | -0.133 | 1 | 0.769 |
PDHK4_TYR |
0.807 | 0.078 | 2 | 0.897 |
MYO3B |
0.807 | -0.062 | 2 | 0.838 |
MAP2K4_TYR |
0.806 | -0.018 | -1 | 0.898 |
TESK1_TYR |
0.806 | -0.029 | 3 | 0.888 |
TAO1 |
0.805 | -0.084 | 1 | 0.731 |
MAP2K6_TYR |
0.805 | -0.010 | -1 | 0.899 |
MYO3A |
0.804 | -0.078 | 1 | 0.759 |
BMPR2_TYR |
0.804 | 0.017 | -1 | 0.881 |
MAP2K7_TYR |
0.803 | -0.121 | 2 | 0.882 |
PKMYT1_TYR |
0.802 | -0.056 | 3 | 0.846 |
HASPIN |
0.802 | -0.076 | -1 | 0.692 |
YANK3 |
0.800 | -0.093 | 2 | 0.412 |
LIMK2_TYR |
0.800 | 0.006 | -3 | 0.894 |
PINK1_TYR |
0.800 | -0.137 | 1 | 0.822 |
PDHK1_TYR |
0.799 | -0.105 | -1 | 0.894 |
AAK1 |
0.798 | 0.083 | 1 | 0.600 |
EPHA6 |
0.797 | 0.019 | -1 | 0.848 |
RET |
0.797 | -0.062 | 1 | 0.802 |
EPHB4 |
0.795 | -0.013 | -1 | 0.834 |
STLK3 |
0.794 | -0.213 | 1 | 0.753 |
TYK2 |
0.793 | -0.145 | 1 | 0.806 |
MST1R |
0.792 | -0.123 | 3 | 0.799 |
TXK |
0.792 | 0.063 | 1 | 0.833 |
ROS1 |
0.791 | -0.100 | 3 | 0.758 |
LIMK1_TYR |
0.790 | -0.208 | 2 | 0.875 |
TYRO3 |
0.790 | -0.149 | 3 | 0.788 |
CSF1R |
0.790 | -0.091 | 3 | 0.779 |
YES1 |
0.789 | -0.044 | -1 | 0.828 |
JAK2 |
0.789 | -0.157 | 1 | 0.805 |
DDR1 |
0.788 | -0.151 | 4 | 0.801 |
ABL2 |
0.788 | -0.050 | -1 | 0.804 |
INSRR |
0.787 | -0.081 | 3 | 0.737 |
JAK3 |
0.787 | -0.120 | 1 | 0.786 |
EPHA4 |
0.786 | -0.044 | 2 | 0.795 |
FER |
0.786 | -0.140 | 1 | 0.875 |
FGR |
0.784 | -0.136 | 1 | 0.828 |
FGFR2 |
0.784 | -0.118 | 3 | 0.788 |
EPHB1 |
0.783 | -0.096 | 1 | 0.856 |
EPHB2 |
0.783 | -0.042 | -1 | 0.805 |
SRMS |
0.783 | -0.085 | 1 | 0.862 |
TNK2 |
0.783 | -0.093 | 3 | 0.753 |
JAK1 |
0.783 | -0.036 | 1 | 0.767 |
NEK10_TYR |
0.782 | -0.080 | 1 | 0.683 |
BLK |
0.782 | 0.019 | -1 | 0.813 |
HCK |
0.782 | -0.113 | -1 | 0.808 |
ITK |
0.782 | -0.085 | -1 | 0.786 |
LCK |
0.782 | -0.029 | -1 | 0.806 |
ABL1 |
0.782 | -0.100 | -1 | 0.792 |
EPHB3 |
0.781 | -0.100 | -1 | 0.815 |
KDR |
0.781 | -0.097 | 3 | 0.745 |
PDGFRB |
0.780 | -0.174 | 3 | 0.795 |
TEK |
0.780 | -0.129 | 3 | 0.720 |
TNNI3K_TYR |
0.780 | -0.044 | 1 | 0.771 |
FGFR1 |
0.779 | -0.146 | 3 | 0.759 |
KIT |
0.779 | -0.155 | 3 | 0.782 |
TNK1 |
0.779 | -0.102 | 3 | 0.766 |
FLT3 |
0.778 | -0.167 | 3 | 0.778 |
CK1A |
0.778 | -0.129 | -3 | 0.365 |
MERTK |
0.778 | -0.106 | 3 | 0.768 |
AXL |
0.778 | -0.138 | 3 | 0.772 |
FYN |
0.776 | 0.002 | -1 | 0.787 |
BMX |
0.776 | -0.077 | -1 | 0.720 |
TEC |
0.776 | -0.096 | -1 | 0.727 |
MET |
0.775 | -0.129 | 3 | 0.776 |
EPHA7 |
0.774 | -0.082 | 2 | 0.802 |
NTRK1 |
0.773 | -0.204 | -1 | 0.828 |
ALK |
0.773 | -0.163 | 3 | 0.700 |
PDGFRA |
0.773 | -0.244 | 3 | 0.790 |
BTK |
0.773 | -0.212 | -1 | 0.754 |
ERBB2 |
0.772 | -0.151 | 1 | 0.821 |
FGFR3 |
0.772 | -0.143 | 3 | 0.759 |
DDR2 |
0.772 | -0.022 | 3 | 0.724 |
LTK |
0.771 | -0.163 | 3 | 0.722 |
EPHA3 |
0.771 | -0.161 | 2 | 0.771 |
FLT1 |
0.771 | -0.150 | -1 | 0.827 |
FRK |
0.770 | -0.100 | -1 | 0.820 |
EPHA1 |
0.770 | -0.131 | 3 | 0.749 |
EPHA5 |
0.770 | -0.063 | 2 | 0.786 |
WEE1_TYR |
0.769 | -0.176 | -1 | 0.757 |
NTRK2 |
0.768 | -0.235 | 3 | 0.744 |
EGFR |
0.768 | -0.046 | 1 | 0.749 |
FLT4 |
0.767 | -0.206 | 3 | 0.734 |
INSR |
0.767 | -0.202 | 3 | 0.711 |
PTK2B |
0.767 | -0.106 | -1 | 0.750 |
LYN |
0.766 | -0.137 | 3 | 0.695 |
PTK6 |
0.765 | -0.276 | -1 | 0.716 |
EPHA8 |
0.765 | -0.092 | -1 | 0.794 |
NTRK3 |
0.764 | -0.188 | -1 | 0.784 |
CK1G3 |
0.763 | -0.122 | -3 | 0.315 |
YANK2 |
0.763 | -0.148 | 2 | 0.427 |
SRC |
0.763 | -0.103 | -1 | 0.781 |
SYK |
0.762 | -0.001 | -1 | 0.771 |
PTK2 |
0.761 | -0.025 | -1 | 0.775 |
MATK |
0.761 | -0.170 | -1 | 0.734 |
FGFR4 |
0.758 | -0.136 | -1 | 0.763 |
EPHA2 |
0.756 | -0.099 | -1 | 0.763 |
MUSK |
0.756 | -0.130 | 1 | 0.729 |
CSK |
0.755 | -0.215 | 2 | 0.800 |
ERBB4 |
0.753 | -0.048 | 1 | 0.773 |
IGF1R |
0.752 | -0.193 | 3 | 0.649 |
CK1G2 |
0.743 | -0.132 | -3 | 0.416 |
ZAP70 |
0.740 | -0.040 | -1 | 0.706 |
FES |
0.738 | -0.201 | -1 | 0.690 |